data_2nd5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nd5 _Structure_validation_residue.Date_analyzed 2017-05-12 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 CA-C-O 119.235 -0.758 . . . . 72.04 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.77 -36.09 2.29 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.056 2.504 . . . . 72.12 113.044 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.6 t 62.87 126.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.935 0.894 . . . . 75.41 111.897 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.6 mtt 63.13 125.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.922 0.889 . . . . 73.21 111.981 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -104.9 27.23 19.68 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.84 -0.618 . . . . 60.01 113.165 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.1 p -135.82 113.93 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.816 0.341 . . . . 72.33 110.5 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.96 117.44 32.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.764 -0.653 . . . . 74.24 110.904 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.4 p -107.9 132.55 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.912 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.22 123.88 45.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 74.44 110.261 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -77.81 125.92 30.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.122 -0.49 . . . . 75.4 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.22 -38.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.092 -0.958 . . . . 73.15 110.421 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -133.01 118.83 15.44 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.0 -0.545 . . . . 74.32 110.555 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.87 130.03 16.23 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.584 2.189 . . . . 71.0 113.185 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.28 -121.93 4.48 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.832 -0.622 . . . . 44.33 112.259 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.1 -46.69 12.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.66 0.23 . . . . 70.4 110.999 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.59 87.77 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.552 0.533 . . . . 63.51 113.827 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -134.59 -0.71 2.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.487 0.315 . . . . 75.24 111.754 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 m -119.9 93.41 4.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.033 0.444 . . . . 74.01 110.526 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -103.81 149.22 36.92 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 72.11 110.856 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.11 128.16 17.14 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.582 2.188 . . . . 73.5 113.05 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 115.374 -0.83 . . . . 74.32 111.215 -179.684 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -77.37 124.27 27.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.714 -0.675 . . . . 75.42 111.163 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.428 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 117.76 -28.81 6.88 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.712 -0.676 . . . . 64.12 113.197 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.67 160.15 14.54 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.43 0.292 . . . . 75.25 110.998 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.78 145.39 28.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.093 -0.503 . . . . 73.13 111.327 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 34.8 t -120.52 117.15 26.89 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.625 -0.716 . . . . 75.23 110.807 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.6 110.67 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.513 -0.767 . . . . 73.25 109.329 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.91 153.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.104 -0.498 . . . . 72.21 111.475 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.4 m-70 -103.12 125.28 49.76 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.454 -0.793 . . . . 75.31 109.314 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 39' ' ' SER . 39.4 p90 -116.23 168.14 10.39 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.403 0.519 . . . . 74.34 112.403 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.2 m -148.85 105.89 3.6 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.135 -0.939 . . . . 72.31 109.484 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.51 117.95 5.21 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.105 -0.569 . . . . 75.41 112.754 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.8 mtm -133.04 135.13 45.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.019 0.528 . . . . 73.1 110.946 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.53 172.01 0.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.438 -0.801 . . . . 75.02 112.27 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.92 -27.15 50.86 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.157 0.583 . . . . 72.0 111.951 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.95 -17.43 29.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.701 -0.681 . . . . 73.54 111.634 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.41 13.7 21.99 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.736 -0.745 . . . . 52.23 113.316 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.466 0 N-CA-C 110.13 -0.322 . . . . 74.31 110.13 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.417 HH23 ' OG ' ' A' ' 38' ' ' SER . . . . . . . . 0 C--N 1.343 0.288 0 N-CA-C 112.956 0.725 . . . . 75.44 112.956 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 21.9 p90 -134.81 -14.1 2.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.5 -1.227 . . . . 75.25 111.173 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.58 110.5 0.04 OUTLIER 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.13 0.49 . . . . 73.03 112.134 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' OG ' HH23 ' A' ' 35' ' ' MLY . 28.8 t -123.13 138.15 54.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.304 -0.862 . . . . 72.31 110.127 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.522 ' HG ' ' HD1' ' A' ' 25' ' ' HIS . 64.9 p -78.74 -35.74 44.28 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.792 -0.64 . . . . 71.12 112.587 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -72.37 -23.18 61.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.757 0.651 . . . . 63.42 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -28.27 69.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.871 0.367 . . . . 64.34 110.979 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -96.37 0.82 51.16 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.356 -0.838 . . . . 71.3 109.953 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.08 37.99 8.74 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.269 1.027 . . . . 75.12 111.559 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.717 -179.768 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -73.35 158.02 48.89 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.896 2.397 . . . . 72.54 113.02 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -102.45 118.83 37.72 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.781 -0.645 . . . . 73.33 112.097 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.493 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 115.175 -0.92 . . . . 75.21 110.034 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.7 p90 -149.23 161.77 41.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.314 0.384 . . . . 75.11 111.452 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.465 ' SD ' HH12 ' A' ' 52' ' ' MLY . 6.5 mtt -106.15 132.83 51.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 71.14 110.567 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.61 139.78 39.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.975 -0.557 . . . . 74.22 111.625 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.82 -10.88 50.04 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.39 -0.823 . . . . 71.31 113.373 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . 0.465 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 122.502 0.321 . . . . 75.32 110.721 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 70.05 27.27 4.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.08 0.952 . . . . 72.42 112.084 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -76.63 -13.48 60.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.043 -0.526 . . . . 75.25 110.854 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.26 -178.2 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.292 -0.867 . . . . 75.44 110.426 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -78.75 158.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 111.973 0.36 . . . . 64.33 111.973 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -59.35 -43.67 92.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.934 -0.576 . . . . 74.42 111.864 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.21 62.04 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.062 -0.517 . . . . 75.12 113.302 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -84.17 -44.19 14.22 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 122.292 0.237 . . . . 64.24 111.072 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.72 -37.35 84.51 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.352 0.408 . . . . 71.32 111.704 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.49 -25.38 28.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.015 -0.539 . . . . 73.22 111.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.7 -46.24 4.63 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.4 0.438 . . . . 71.54 113.839 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 64' ' ' ALA . 2.2 p -63.78 -25.81 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.728 0.411 . . . . 74.11 111.669 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 63' ' ' VAL . . . -75.55 -7.13 53.4 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.391 -0.822 . . . . 71.01 111.737 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -94.17 -4.94 48.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.812 -0.631 . . . . 73.32 111.324 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.13 158.22 19.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.447 -0.342 . . . . 71.25 110.645 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 p -116.53 150.84 37.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.086 -0.506 . . . . 63.14 110.788 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -40.08 119.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.584 0.754 . . . . 73.41 112.302 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 3.57 61.64 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.301 -0.863 . . . . 71.34 113.124 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -95.8 145.3 25.45 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.902 0.382 . . . . 75.44 111.366 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.86 108.5 12.53 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.039 -0.982 . . . . 74.25 109.342 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.85 157.02 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.939 -0.573 . . . . 72.53 111.878 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-N 116.078 -0.51 . . . . 73.55 110.382 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -104.85 128.93 53.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.118 -0.492 . . . . 74.52 110.833 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.7 m -96.33 113.72 25.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.672 -0.694 . . . . 71.34 109.466 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.2 mm -105.27 141.46 20.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.859 -0.609 . . . . 75.11 110.356 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.34 162.17 20.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 114.941 -1.027 . . . . 74.23 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.48 -14.47 39.49 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.58 2.187 . . . . 74.23 113.201 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.83 -29.49 22.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 74.51 110.777 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -98.72 -18.52 17.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.755 -0.657 . . . . 74.1 111.569 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.5 -63.47 1.33 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.778 0.659 . . . . 54.11 112.778 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -134.21 -51.21 0.82 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.608 0.225 . . . . 74.54 111.608 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.22 -143.29 10.69 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 71.34 111.948 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.6 -9.75 34.12 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 111.617 0.229 . . . . 63.32 111.617 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 m -100.44 -60.35 1.54 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.194 -0.457 . . . . 63.55 110.469 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.88 -166.93 53.05 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.315 0.384 . . . . 73.04 113.171 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -97.97 124.82 46.3 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 109.87 -0.419 . . . . 71.03 109.87 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.03 123.56 10.13 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.22 1.947 . . . . 65.12 113.624 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.19 -46.48 1.16 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.579 -0.737 . . . . 63.23 113.38 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mt -100.6 -51.88 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 111.563 0.209 . . . . 73.33 111.563 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 mm -109.92 98.62 35.04 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 123.212 0.32 . . . . 74.32 110.982 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.61 165.56 32.13 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.432 2.088 . . . . 74.2 112.755 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.84 142.57 28.55 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.507 2.138 . . . . 74.42 113.119 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 56.82 45.11 22.19 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.636 0.774 . . . . 70.34 111.689 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.43 133.01 52.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.678 -0.692 . . . . 71.42 111.824 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -83.22 140.64 32.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.714 -1.13 . . . . 74.25 110.791 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mt -118.18 155.71 30.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.686 -0.688 . . . . 75.55 111.072 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.48 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.83 -0.623 . . . . 72.32 109.699 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.5 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.3 m-85 -130.86 134.09 46.49 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.032 -0.531 . . . . 71.3 110.611 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.8 t70 -116.44 104.88 11.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.255 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 25.7 m -105.98 153.55 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.063 -0.517 . . . . 63.14 111.125 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.64 124.06 29.11 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.472 -0.786 . . . . 72.23 110.173 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.54 103.73 4.26 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.14 0.495 . . . . 70.2 110.89 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.75 -57.37 2.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.352 -0.84 . . . . 73.51 111.344 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 C-N-CA 122.834 0.454 . . . . 74.51 110.742 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.2 mt -123.28 145.91 48.3 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.099 -0.5 . . . . 71.15 110.735 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 116.114 -0.493 . . . . 72.13 110.807 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 CA-C-O 119.322 -0.71 . . . . 72.04 112.656 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.86 -38.39 1.7 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.035 2.49 . . . . 72.12 113.003 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.3 t -131.43 -47.84 0.98 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.38 0.425 . . . . 75.41 110.957 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 25.1 mmt -135.95 -45.81 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.345 0.403 . . . . 73.21 111.047 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 119.23 -42.71 1.72 Allowed Glycine 0 C--N 1.34 0.783 0 O-C-N 123.446 0.467 . . . . 60.01 112.388 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.1 p -128.04 119.64 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 120.7 0.286 . . . . 72.33 110.702 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.51 117.62 29.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.767 -0.652 . . . . 74.24 110.839 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.5 p -108.55 134.09 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.917 -0.583 . . . . 62.43 110.909 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.43 124.1 43.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.487 -0.778 . . . . 74.44 110.227 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -77.65 126.56 31.07 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.195 -0.457 . . . . 75.4 110.881 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.98 -38.47 3.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.074 -0.966 . . . . 73.15 110.412 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -133.09 118.64 15.27 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.004 -0.544 . . . . 74.32 110.574 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.96 129.73 15.7 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.567 2.178 . . . . 71.0 113.152 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.98 -121.68 4.37 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.82 -0.627 . . . . 44.33 112.233 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.56 -46.34 13.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.605 0.203 . . . . 70.4 111.0 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.51 -1.69 88.61 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.568 0.542 . . . . 63.51 113.808 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -135.27 -0.91 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.494 0.318 . . . . 75.24 111.734 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -120.14 93.14 3.96 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 74.01 110.451 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.24 149.14 36.65 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.604 -0.725 . . . . 72.11 110.948 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.63 130.36 20.62 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.57 2.18 . . . . 73.5 113.189 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 115.422 -0.808 . . . . 74.32 111.059 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.408 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 56.6 ttt180 -77.39 122.12 24.72 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.667 -0.697 . . . . 75.42 111.194 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.14 -27.65 6.94 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 115.831 -0.622 . . . . 64.12 113.466 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 160.33 14.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.373 0.269 . . . . 75.25 111.086 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -84.58 145.31 28.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.064 -0.516 . . . . 73.13 111.094 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 60.2 m -124.24 119.75 30.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.669 -0.696 . . . . 75.23 110.9 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.61 111.3 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.276 -0.875 . . . . 73.25 109.563 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.1 m -146.14 152.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.967 -0.56 . . . . 72.21 111.602 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.2 m-70 -103.73 125.48 50.22 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.367 -0.833 . . . . 75.31 109.229 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' A' ' 39' ' ' SER . 41.1 p90 -116.9 167.42 11.14 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.531 0.567 . . . . 74.34 112.531 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -147.83 110.78 4.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.217 -0.901 . . . . 72.31 109.595 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.6 119.55 6.0 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.081 -0.509 . . . . 75.41 112.619 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 mtm -135.15 132.93 38.61 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.976 0.51 . . . . 73.1 110.87 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.16 172.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.527 -0.761 . . . . 75.02 112.461 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -55.73 -27.49 50.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.142 0.577 . . . . 72.0 111.981 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.37 -17.48 30.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.628 -0.714 . . . . 73.54 111.556 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.67 13.89 22.89 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 120.73 -0.748 . . . . 52.23 113.313 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.397 0 N-CA-C 110.224 -0.288 . . . . 74.31 110.224 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 N-CA-C 112.862 0.69 . . . . 75.44 112.862 -179.686 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CZ ' HD23 ' A' ' 97' ' ' LEU . 28.8 p90 -133.62 -15.19 2.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.612 -1.176 . . . . 75.25 111.316 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.54 111.47 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.081 0.467 . . . . 73.03 111.884 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.459 ' HG ' ' HG3' ' A' ' 40' ' ' ARG . 29.9 t -122.19 143.66 49.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.315 -0.857 . . . . 72.31 110.174 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 8.1 t -78.28 -37.24 45.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.12 112.574 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HG3' ' HG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.29 -22.78 61.91 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.477 0.547 . . . . 63.42 112.477 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -29.65 68.74 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.87 0.367 . . . . 64.34 111.178 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HD2' ' A' ' 44' ' ' MLY . 55.6 mtm180 -94.04 0.7 56.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.349 -0.841 . . . . 71.3 110.219 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.89 37.46 9.55 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.193 0.997 . . . . 75.12 111.676 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . 0.467 ' HD2' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-N 116.046 -0.525 . . . . 74.11 111.486 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.99 157.92 53.59 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.811 2.341 . . . . 72.54 113.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CD1' ' HE1' ' A' ' 26' ' ' TYR . 19.9 t80 -104.0 118.12 35.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.685 -0.689 . . . . 73.33 111.933 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.376 0 CA-C-N 115.286 -0.87 . . . . 75.21 110.293 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 21' ' ' THR . 42.4 p90 -149.09 161.85 41.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.382 0.426 . . . . 75.11 111.332 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.417 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 7.0 mtt -106.8 134.85 49.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.126 -0.488 . . . . 71.14 110.661 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -79.56 140.72 37.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.849 -0.614 . . . . 74.22 111.57 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.54 -11.03 47.64 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.509 -0.769 . . . . 71.31 113.457 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 122.505 0.322 . . . . 75.32 110.698 179.359 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 69.21 29.62 4.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.077 0.951 . . . . 72.42 112.197 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 45.2 mt-10 -78.93 -11.54 60.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.89 -0.596 . . . . 75.25 110.889 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -131.24 -178.26 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.429 -0.805 . . . . 75.44 110.721 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 pt -76.91 160.25 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.045 0.387 . . . . 64.33 112.045 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -62.05 -43.17 99.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.004 -0.544 . . . . 74.42 111.842 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.82 -20.88 62.57 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 123.504 0.502 . . . . 75.12 113.25 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -84.2 -44.76 13.62 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 122.311 0.244 . . . . 64.24 111.18 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.66 -37.03 85.39 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.249 0.343 . . . . 71.32 111.605 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.47 -26.95 27.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.75 -0.659 . . . . 73.22 111.812 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.73 -46.15 4.95 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 123.507 0.504 . . . . 71.54 113.955 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 64' ' ' ALA . 2.1 p -63.54 -26.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.745 0.418 . . . . 74.11 111.712 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' N ' HG13 ' A' ' 63' ' ' VAL . . . -75.4 -6.36 49.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.481 -0.781 . . . . 71.01 111.725 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -94.73 -2.99 50.05 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.686 -0.688 . . . . 73.32 111.25 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.78 158.29 20.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.402 -0.363 . . . . 71.25 110.785 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -116.42 150.84 37.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.084 -0.507 . . . . 63.14 110.665 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -40.07 119.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.649 0.78 . . . . 73.41 112.214 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.44 4.21 60.96 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.329 -0.851 . . . . 71.34 113.133 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -96.18 145.77 25.24 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.983 0.421 . . . . 75.44 111.381 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.25 109.04 12.89 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.069 -0.969 . . . . 74.25 109.407 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.76 157.26 44.31 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.029 -0.532 . . . . 72.53 111.895 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.308 0 CA-C-N 116.127 -0.488 . . . . 73.55 110.495 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -104.08 134.37 47.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.076 -0.511 . . . . 74.52 110.824 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.8 m -100.41 112.95 25.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.614 -0.721 . . . . 71.34 109.371 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 mm -104.37 131.52 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.885 -0.598 . . . . 75.11 110.247 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.09 162.48 23.69 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.333 -0.849 . . . . 74.23 110.707 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -63.21 -14.4 41.63 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.343 2.029 . . . . 74.23 113.015 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.22 -28.25 21.27 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.195 -0.457 . . . . 74.51 110.684 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 -18.85 18.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.727 -0.67 . . . . 74.1 111.441 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.97 -64.51 1.14 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.779 0.659 . . . . 54.11 112.779 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -132.61 -53.46 0.94 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.645 0.239 . . . . 74.54 111.645 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.5 -141.33 8.5 Favored Glycine 0 C--N 1.338 0.658 0 O-C-N 123.515 0.509 . . . . 71.34 111.9 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.64 -10.56 29.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 111.586 0.217 . . . . 63.32 111.586 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.1 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.287 -0.415 . . . . 63.55 110.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.04 -168.54 53.58 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.376 0.422 . . . . 73.04 113.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -96.81 124.78 48.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.892 -0.41 . . . . 71.03 109.892 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.96 125.34 11.93 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.189 1.926 . . . . 65.12 113.601 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.52 -43.43 1.67 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.585 -0.734 . . . . 63.23 113.395 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.84 -52.12 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.651 0.225 . . . . 73.33 111.55 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -111.72 99.25 44.33 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 123.186 0.304 . . . . 74.32 111.159 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.34 165.67 31.71 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.381 2.054 . . . . 74.2 112.668 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.4 143.39 27.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.543 2.162 . . . . 74.42 113.302 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 56.54 41.29 28.82 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.621 0.768 . . . . 70.34 111.845 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.2 131.04 53.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.711 -0.677 . . . . 71.42 111.763 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -81.89 140.33 34.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.731 -1.122 . . . . 74.25 110.857 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.468 HD23 ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mt -117.56 155.41 29.85 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.572 -0.74 . . . . 75.55 110.979 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 129.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.822 -0.626 . . . . 72.32 109.575 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 27' ' ' THR . 88.1 m-85 -132.34 134.65 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.473 . . . . 71.3 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.0 t70 -116.46 105.54 12.61 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.076 -0.511 . . . . 73.13 110.253 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 25.8 m -105.26 153.5 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.071 -0.513 . . . . 63.14 111.031 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.24 123.62 28.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.461 -0.791 . . . . 72.23 110.063 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.53 102.56 3.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.122 0.487 . . . . 70.2 110.617 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.85 -56.51 3.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.448 -0.796 . . . . 73.51 111.414 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 122.843 0.457 . . . . 74.51 110.752 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.8 mt -122.97 146.99 47.13 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.052 -0.522 . . . . 71.15 110.737 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 N--CA 1.465 0.28 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.826 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 CA-C-O 119.116 -0.825 . . . . 72.04 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.28 156.01 41.73 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.891 2.394 . . . . 72.12 112.762 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 51.8 m -127.55 146.01 50.66 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.9 -0.591 . . . . 75.41 110.931 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 21.8 mmt -100.54 149.01 24.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.918 -0.583 . . . . 73.21 111.056 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -98.2 -20.43 20.59 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.724 -0.671 . . . . 60.01 113.019 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' THR . 8.5 p -118.04 119.72 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.708 0.29 . . . . 72.33 110.73 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.73 116.94 27.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.82 -0.627 . . . . 74.24 110.567 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.4 p -108.54 139.12 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.055 -0.521 . . . . 62.43 111.111 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.78 125.22 42.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.454 -0.794 . . . . 74.44 110.373 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -78.33 127.86 32.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 75.4 110.791 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.75 -39.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.122 -0.945 . . . . 73.15 110.4 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -132.35 118.86 16.17 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.047 -0.524 . . . . 74.32 110.443 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.61 129.57 15.84 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.606 2.204 . . . . 71.0 113.307 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.16 -121.17 4.31 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.749 -0.659 . . . . 44.33 112.117 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.77 -46.26 12.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.644 0.222 . . . . 70.4 110.945 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 -1.86 88.42 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.077 -0.511 . . . . 63.51 113.697 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -136.35 1.5 2.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.462 0.305 . . . . 75.24 111.747 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -122.39 92.21 3.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.104 0.478 . . . . 74.01 110.213 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -103.03 149.71 37.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.511 -0.768 . . . . 72.11 110.893 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.37 126.8 16.2 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.497 2.131 . . . . 73.5 112.918 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.48 -0.782 . . . . 74.32 111.483 -179.39 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 44.2 ttt180 -77.53 120.54 22.65 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.418 -0.81 . . . . 75.42 111.372 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.98 -25.65 7.82 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.967 -0.561 . . . . 64.12 113.498 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.59 160.45 14.34 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.323 0.249 . . . . 75.25 110.974 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -81.92 145.09 30.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.215 -0.448 . . . . 73.13 111.131 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 32.1 m -123.86 117.83 25.73 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.574 -0.739 . . . . 75.23 110.618 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.73 111.25 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.449 -0.796 . . . . 73.25 109.805 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.5 m -145.55 151.39 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.847 -0.615 . . . . 72.21 111.398 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.5 m-70 -102.68 125.27 49.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.537 -0.756 . . . . 75.31 109.499 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.527 ' H ' ' HG ' ' A' ' 39' ' ' SER . 39.2 p90 -115.72 166.22 12.18 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.436 0.532 . . . . 74.34 112.436 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -148.15 105.97 3.7 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.119 -0.946 . . . . 72.31 109.274 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 122.84 6.78 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.137 -0.554 . . . . 75.41 113.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.4 mtm -136.86 131.38 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.19 0.596 . . . . 73.1 110.624 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.25 170.42 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.622 -0.717 . . . . 75.02 112.337 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.14 -28.08 50.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.144 0.578 . . . . 72.0 112.135 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.91 -17.28 29.9 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.713 -0.676 . . . . 73.54 111.734 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 13.48 22.88 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 120.781 -0.723 . . . . 52.23 113.012 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.419 0 N-CA-C 109.628 -0.508 . . . . 74.31 109.628 179.257 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.51 HH13 ' CB ' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 112.916 0.709 . . . . 75.44 112.916 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -135.91 -12.78 1.95 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.34 -1.3 . . . . 75.25 111.743 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.5 111.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.074 0.768 . . . . 73.03 113.074 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.51 ' CB ' HH13 ' A' ' 35' ' ' MLY . 13.8 t -122.92 133.25 54.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.502 -0.772 . . . . 72.31 111.233 176.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.527 ' HG ' ' H ' ' A' ' 26' ' ' TYR . 52.7 p -79.63 -33.75 41.16 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.338 -0.846 . . . . 71.12 112.475 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -71.45 -39.36 71.02 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.085 0.772 . . . . 63.42 113.085 -178.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD2' HH22 ' A' ' 35' ' ' MLY . 1.1 t0 -66.73 -21.92 66.06 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.824 0.345 . . . . 64.34 110.897 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.6 -4.28 57.9 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.318 -0.855 . . . . 71.3 110.04 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 65.92 35.29 6.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.426 1.09 . . . . 75.12 112.021 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 39' ' ' SER . . . . . . . . 0 N--CA 1.472 0.651 0 CA-C-N 116.496 -0.32 . . . . 74.11 111.785 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.47 157.94 40.57 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.97 2.447 . . . . 72.54 112.847 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -102.53 117.94 35.79 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.86 -0.609 . . . . 73.33 112.06 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.443 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 115.041 -0.981 . . . . 75.21 109.929 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.9 p90 -151.97 164.18 37.7 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.242 0.339 . . . . 75.11 111.557 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.54 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.4 mpp? -107.25 135.5 48.66 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.186 -0.461 . . . . 71.14 110.603 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.33 141.5 35.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.838 -0.619 . . . . 74.22 111.612 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 83.0 -9.42 60.38 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.519 -0.764 . . . . 71.31 113.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 120.86 0.362 . . . . 75.32 110.705 179.38 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 68.43 28.38 6.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.108 0.963 . . . . 72.42 112.046 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.28 -33.44 61.23 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.948 -0.569 . . . . 75.25 110.545 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 m -104.12 -176.03 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.257 -0.883 . . . . 75.44 110.036 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -79.44 159.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 111.777 0.288 . . . . 64.33 111.777 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.23 -42.49 91.18 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.017 -0.538 . . . . 74.42 111.855 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.8 -23.14 65.12 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.858 -0.61 . . . . 75.12 113.188 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -82.45 -43.02 17.77 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 122.379 0.272 . . . . 64.24 111.231 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.14 -37.74 81.4 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.289 0.368 . . . . 71.32 111.7 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.57 -23.34 29.71 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.513 0.508 . . . . 73.22 111.797 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.19 -46.17 4.21 Favored Glycine 0 C--N 1.343 0.961 0 O-C-N 123.512 0.507 . . . . 71.54 113.68 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.96 -25.3 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.633 0.373 . . . . 74.11 111.617 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 -8.47 57.05 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.338 -0.847 . . . . 71.01 111.782 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -93.1 -7.45 45.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.798 -0.637 . . . . 73.32 111.265 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 156.94 19.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.867 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.1 p -111.28 166.75 10.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.891 -0.595 . . . . 63.14 110.587 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -55.69 122.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.036 0.535 . . . . 73.41 111.205 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.17 3.09 70.22 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.493 -0.776 . . . . 71.34 113.254 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.42 142.12 27.8 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 120.932 0.396 . . . . 75.44 111.313 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.76 109.3 15.0 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.099 -0.955 . . . . 74.25 109.476 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.79 156.44 45.98 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.051 -0.522 . . . . 72.53 111.818 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.342 0.281 0 CA-C-N 116.128 -0.487 . . . . 73.55 110.46 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -107.72 124.56 50.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.11 -0.496 . . . . 74.52 110.882 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m -95.44 112.73 24.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.737 -0.665 . . . . 71.34 109.407 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.46 141.48 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.284 0.564 . . . . 75.11 111.267 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.68 162.73 19.29 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 114.463 -1.244 . . . . 74.23 109.768 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.26 -17.52 57.52 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.18 1.92 . . . . 74.23 113.045 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.59 -5.79 59.27 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.29 -0.414 . . . . 74.51 111.109 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -125.01 -26.15 3.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.3 -0.863 . . . . 74.1 109.383 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.2 96.05 6.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.946 -1.024 . . . . 54.11 110.805 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 75.25 -50.7 0.65 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.914 -1.039 . . . . 74.54 112.252 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.65 -148.83 18.88 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.238 -0.506 . . . . 71.34 112.835 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.83 -8.88 56.91 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.473 0.546 . . . . 63.32 112.473 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 m -97.88 -60.19 1.61 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.52 -0.309 . . . . 63.55 110.496 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.53 -168.52 42.6 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.283 0.365 . . . . 73.04 113.292 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.482 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 4.0 t60 -94.26 129.0 38.49 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 110.155 -0.313 . . . . 71.03 110.155 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.23 123.27 9.79 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.354 2.036 . . . . 65.12 113.565 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.5 -43.19 1.72 Allowed Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.661 -0.7 . . . . 63.23 113.42 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.42 -52.08 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.599 0.199 . . . . 73.33 111.412 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 16.1 mm -110.82 99.6 42.84 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 123.245 0.34 . . . . 74.32 111.023 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.36 165.82 31.56 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.458 2.106 . . . . 74.2 112.657 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.39 142.59 30.12 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.465 2.11 . . . . 74.42 113.052 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 56.9 47.58 17.54 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.681 0.792 . . . . 70.34 111.53 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.88 136.2 52.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.55 -0.75 . . . . 71.42 111.525 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -83.49 144.61 29.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.791 -1.095 . . . . 74.25 110.88 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.23 155.08 44.02 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.691 -0.686 . . . . 75.55 111.25 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 52.8 t -121.79 133.26 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.8 -0.636 . . . . 72.32 109.44 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' O ' HD11 ' A' ' 74' ' ' LEU . 93.2 m-85 -134.75 133.28 39.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.258 -0.428 . . . . 71.3 110.856 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.2 t70 -116.46 102.56 9.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.177 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 25.7 m -104.51 153.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.105 -0.498 . . . . 63.14 111.118 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.17 126.43 35.6 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.453 -0.794 . . . . 72.23 110.288 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -73.13 102.45 3.58 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 70.2 110.324 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.03 -58.15 2.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.232 -0.44 . . . . 73.51 111.578 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 122.872 0.469 . . . . 74.51 110.811 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -119.57 147.69 44.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.055 -0.52 . . . . 71.15 110.79 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.274 -0.421 . . . . 72.13 110.812 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.72 0 CA-C-O 119.279 -0.734 . . . . 72.04 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.47 153.09 39.32 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.065 2.51 . . . . 72.12 112.757 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.7 p -103.2 -43.08 5.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.893 -0.594 . . . . 75.41 111.361 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 25.6 ptt? 46.52 125.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.123 1.369 . . . . 73.21 114.041 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -95.62 40.31 2.67 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.566 -0.743 . . . . 60.01 113.084 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.2 p -139.3 114.05 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.801 0.334 . . . . 72.33 110.419 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 120.5 40.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.693 -0.685 . . . . 74.24 110.588 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 17.1 t -109.31 124.01 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.109 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -113.45 124.85 53.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.652 -0.704 . . . . 74.44 110.11 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.1 m -78.98 127.63 32.24 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.49 0.494 . . . . 75.4 110.943 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.09 -41.98 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.106 -0.952 . . . . 73.15 110.244 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -129.46 118.78 19.14 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.927 -0.579 . . . . 74.32 110.4 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.21 129.07 15.51 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.584 2.189 . . . . 71.0 113.412 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.78 -120.9 4.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.731 -0.668 . . . . 44.33 112.119 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.65 -45.78 13.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.636 0.218 . . . . 70.4 110.906 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.95 -1.51 88.83 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.009 -0.541 . . . . 63.51 113.728 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.48 1.02 2.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.473 0.309 . . . . 75.24 111.801 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.86 92.08 3.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.065 0.459 . . . . 74.01 110.251 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -102.82 149.41 36.77 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 115.511 -0.768 . . . . 72.11 110.93 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.32 124.41 12.48 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.433 2.089 . . . . 73.5 112.956 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 115.386 -0.825 . . . . 74.32 111.386 -179.407 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -77.35 126.39 30.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.636 -0.711 . . . . 75.42 111.342 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 113.35 -25.83 10.88 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.744 -0.662 . . . . 64.12 113.418 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 160.13 14.5 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.31 0.244 . . . . 75.25 111.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.79 145.24 28.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.148 -0.478 . . . . 73.13 111.154 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 35.9 m -122.89 119.26 29.97 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.652 -0.704 . . . . 75.23 110.846 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -91.6 110.9 23.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.281 -0.872 . . . . 73.25 109.655 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.6 m -147.18 151.31 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.095 -0.502 . . . . 72.21 111.445 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -101.69 125.43 48.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.375 -0.83 . . . . 75.31 109.059 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 39' ' ' SER . 41.2 p90 -116.44 165.52 13.13 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.786 0.661 . . . . 74.34 112.786 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 3.0 m -149.0 112.1 4.91 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.997 -1.002 . . . . 72.31 109.379 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.9 121.08 6.79 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.999 -0.546 . . . . 75.41 112.8 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.1 mtm -130.65 131.05 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.891 0.477 . . . . 73.1 111.091 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.31 170.85 0.46 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.66 -0.7 . . . . 75.02 112.037 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -56.24 -26.5 51.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.047 0.539 . . . . 72.0 112.126 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.41 -17.34 28.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.748 -0.66 . . . . 73.54 111.75 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.59 13.76 21.51 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 120.838 -0.696 . . . . 52.23 113.337 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.893 -0.41 . . . . 74.31 109.893 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.433 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 112.853 0.686 . . . . 75.44 112.853 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 29.8 p90 -133.68 -9.63 2.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.338 -1.301 . . . . 75.25 111.42 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -167.18 111.54 0.72 Allowed 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.222 0.534 . . . . 73.03 111.714 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 3.0 p -116.9 118.15 31.67 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.863 -1.062 . . . . 72.31 110.729 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.501 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 19.6 t -78.65 -33.53 47.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.999 -0.546 . . . . 71.12 111.889 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -78.36 -23.22 47.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.78 0.659 . . . . 63.42 112.78 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -25.35 68.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.722 0.296 . . . . 64.34 111.33 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -91.68 1.24 57.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.505 -0.77 . . . . 71.3 109.734 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 62.7 36.41 13.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.144 0.978 . . . . 75.12 111.4 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 74.11 112.318 -179.164 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.56 158.01 48.1 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.937 2.425 . . . . 72.54 112.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CD1' ' HE2' ' A' ' 26' ' ' TYR . 20.5 t80 -100.65 118.63 37.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.842 -0.617 . . . . 73.33 112.02 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.531 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 115.224 -0.898 . . . . 75.21 110.225 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.1 p90 -149.77 164.91 34.01 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.374 0.421 . . . . 75.11 111.398 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.529 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 8.0 mtt -108.85 134.44 51.53 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.795 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.33 139.84 37.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.893 -0.594 . . . . 74.22 111.632 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.6 -10.52 50.47 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.508 -0.769 . . . . 71.31 113.375 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 122.497 0.319 . . . . 75.32 110.612 179.268 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 69.69 30.38 3.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.082 0.953 . . . . 72.42 112.181 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 44.3 mt-10 -79.62 -11.41 59.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.921 -0.581 . . . . 75.25 110.848 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.32 -177.25 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 115.378 -0.828 . . . . 75.44 110.565 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -79.23 159.94 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.066 0.395 . . . . 64.33 112.066 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -60.07 -44.5 94.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.911 -0.586 . . . . 74.42 111.816 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -20.78 61.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.167 -0.47 . . . . 75.12 113.533 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -84.15 -43.48 14.95 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 116.624 0.212 . . . . 64.24 111.212 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.36 -37.42 85.26 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.381 0.426 . . . . 71.32 111.601 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.51 -25.63 28.68 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.945 -0.57 . . . . 73.22 111.714 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.62 -46.54 4.86 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.435 0.459 . . . . 71.54 113.888 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.32 -25.13 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.804 0.442 . . . . 74.11 111.749 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.98 -8.01 55.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.407 -0.815 . . . . 71.01 111.657 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.8 mt-30 -92.3 -11.16 35.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.76 -0.655 . . . . 73.32 111.24 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.87 156.37 18.76 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.359 0.412 . . . . 71.25 110.957 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 p -110.99 166.75 10.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.829 -0.623 . . . . 63.14 110.613 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.98 123.07 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.03 0.532 . . . . 73.41 111.271 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.36 4.61 70.75 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 115.476 -0.784 . . . . 71.34 113.179 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -96.07 142.0 28.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.952 0.406 . . . . 75.44 111.312 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.81 108.25 14.17 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.1 -0.955 . . . . 74.25 109.389 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.49 155.06 48.05 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.974 -0.557 . . . . 72.53 111.882 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.048 -0.524 . . . . 73.55 110.255 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -111.65 125.63 54.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.245 -0.434 . . . . 74.52 111.092 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.5 m -93.91 114.12 26.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.419 -0.81 . . . . 71.34 109.527 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 mm -106.43 144.58 15.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.893 -0.594 . . . . 75.11 110.555 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.74 162.05 20.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.801 -1.091 . . . . 74.23 110.834 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.03 -17.29 51.0 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.787 2.324 . . . . 74.23 113.22 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.56 -25.7 26.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.19 -0.459 . . . . 74.51 111.313 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.09 -18.57 15.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.477 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.73 -62.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.673 0.619 . . . . 54.11 112.673 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -134.55 -51.98 0.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.549 0.203 . . . . 74.54 111.549 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.52 -140.18 7.79 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.475 0.484 . . . . 71.34 112.057 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.61 -10.91 26.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.602 0.223 . . . . 63.32 111.602 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.21 -60.37 1.54 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 63.55 110.533 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.17 -167.49 54.18 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.345 0.403 . . . . 73.04 113.143 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -97.23 124.15 50.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.942 -0.392 . . . . 71.03 109.942 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.5 124.07 10.82 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.213 1.942 . . . . 65.12 113.586 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.18 -47.98 0.99 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.564 -0.743 . . . . 63.23 113.404 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.03 -51.5 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 111.556 0.206 . . . . 73.33 111.556 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 mm -110.15 98.07 33.42 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 123.178 0.299 . . . . 74.32 111.084 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.77 165.76 31.56 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.449 2.099 . . . . 74.2 112.706 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.05 143.37 28.81 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.54 2.16 . . . . 74.42 113.164 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 56.71 42.89 26.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.634 0.774 . . . . 70.34 111.778 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.44 132.9 54.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.726 -0.67 . . . . 71.42 111.73 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -82.25 140.86 33.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.72 -1.127 . . . . 74.25 110.857 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.449 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 5.7 mt -119.28 153.99 34.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.66 -0.7 . . . . 75.55 111.029 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.57 131.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.791 -0.641 . . . . 72.32 109.58 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.5 m-85 -132.42 132.88 43.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.104 -0.498 . . . . 71.3 110.64 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -116.5 103.31 10.3 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.057 -0.519 . . . . 73.13 110.103 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 23.9 m -105.47 153.71 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 63.14 111.163 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.53 125.88 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.538 -0.755 . . . . 72.23 110.444 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -73.15 101.67 3.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.769 -0.65 . . . . 70.2 110.273 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.7 -58.67 2.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.279 -0.419 . . . . 73.51 111.361 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.926 0.49 . . . . 74.51 110.736 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.7 mt -120.89 149.17 43.02 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.178 -0.464 . . . . 71.15 110.814 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.027 -0.533 . . . . 72.13 110.836 179.819 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 CA-C-O 119.23 -0.761 . . . . 72.04 112.54 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.86 158.62 38.77 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.05 2.5 . . . . 72.12 112.771 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.4 t -98.08 -43.49 7.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.883 -0.599 . . . . 75.41 111.106 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 18.5 mmt -108.87 149.22 29.44 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.401 0.438 . . . . 73.21 111.074 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.69 10.81 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.625 -0.716 . . . . 60.01 112.792 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.4 p -123.23 124.9 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.66 0.267 . . . . 72.33 110.774 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.29 141.78 47.88 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.78 -0.645 . . . . 74.24 110.245 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.88 123.66 61.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.519 -0.764 . . . . 62.43 110.29 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -117.61 120.38 37.87 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.716 -0.674 . . . . 74.44 110.228 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 m -77.37 124.5 27.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.118 -0.492 . . . . 75.4 111.023 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mt -107.25 -40.29 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 114.954 -1.021 . . . . 73.15 110.24 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -131.06 118.94 17.63 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.902 -0.59 . . . . 74.32 110.436 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.64 130.33 16.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.555 2.17 . . . . 71.0 113.213 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.67 -122.16 4.6 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.724 -0.671 . . . . 44.33 112.15 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.67 -45.95 13.85 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.584 0.192 . . . . 70.4 110.961 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.84 -2.15 88.39 Favored Glycine 0 C--N 1.342 0.882 0 O-C-N 123.585 0.553 . . . . 63.51 113.833 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.97 -0.46 2.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.462 0.305 . . . . 75.24 111.698 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -120.23 93.21 3.98 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.013 0.435 . . . . 74.01 110.585 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -103.4 149.32 36.88 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.573 -0.739 . . . . 72.11 110.813 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.72 127.71 16.73 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.537 2.158 . . . . 73.5 113.102 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.41 0 CA-C-N 115.332 -0.849 . . . . 74.32 111.119 -179.668 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -77.3 125.01 28.65 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.856 -0.611 . . . . 75.42 111.256 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.77 -26.25 8.54 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.672 -0.694 . . . . 64.12 113.152 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.94 160.15 14.46 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.441 0.297 . . . . 75.25 110.967 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.74 145.31 28.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.329 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 37.1 t -120.72 117.66 28.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.563 -0.744 . . . . 75.23 110.701 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.88 110.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.389 -0.823 . . . . 73.25 109.408 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.25 152.55 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.116 -0.493 . . . . 72.21 111.569 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.8 m-70 -103.05 125.4 49.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.39 -0.823 . . . . 75.31 109.062 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 42.2 p90 -115.89 165.94 12.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.718 0.636 . . . . 74.34 112.718 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.6 m -148.54 109.95 4.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.931 -1.031 . . . . 72.31 109.258 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.58 119.54 6.12 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.111 -0.566 . . . . 75.41 112.865 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.6 mtm -129.62 131.3 46.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.924 0.49 . . . . 73.1 111.12 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -57.25 171.1 0.42 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 75.02 112.083 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.58 -26.2 54.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.042 0.537 . . . . 72.0 112.06 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.43 -17.45 28.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.772 -0.649 . . . . 73.54 111.74 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 13.77 22.19 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 120.812 -0.708 . . . . 52.23 113.508 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.428 0 N-CA-C 109.699 -0.482 . . . . 74.31 109.699 179.567 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.417 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 112.916 0.71 . . . . 75.44 112.916 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.7 p90 -133.79 -9.79 2.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.34 -1.3 . . . . 75.25 111.435 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -166.81 111.62 0.76 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.307 0.575 . . . . 73.03 111.703 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 3.3 p -117.01 119.28 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.855 -1.066 . . . . 72.31 110.954 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.4 p -78.48 -35.43 46.57 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.009 -0.541 . . . . 71.12 112.177 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -76.9 -23.22 52.55 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.807 0.669 . . . . 63.42 112.807 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -25.16 68.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.749 0.309 . . . . 64.34 111.307 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.538 ' O ' ' HD2' ' A' ' 44' ' ' MLY . 88.5 mtt180 -92.44 0.5 57.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.471 -0.786 . . . . 71.3 109.653 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 m120 63.24 36.7 11.7 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.217 1.007 . . . . 75.12 111.416 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . 0.538 ' HD2' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.67 0 CA-C-N 116.06 -0.518 . . . . 74.11 112.353 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.16 158.14 45.6 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.978 2.452 . . . . 72.54 112.794 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -100.08 118.82 37.26 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.877 -0.601 . . . . 73.33 112.029 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 115.248 -0.887 . . . . 75.21 110.215 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.9 p90 -149.62 163.44 37.89 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.388 0.43 . . . . 75.11 111.441 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.518 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 8.1 mtt -107.42 134.13 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.239 -0.437 . . . . 71.14 110.804 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.11 139.84 37.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 74.22 111.572 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.46 -9.87 52.88 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.544 -0.753 . . . . 71.31 113.36 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . 0.469 HH13 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.519 0 C-N-CA 122.48 0.312 . . . . 75.32 110.623 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 69.45 29.39 4.41 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.08 0.952 . . . . 72.42 112.189 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.518 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 45.6 mt-10 -78.78 -11.17 59.98 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.902 -0.59 . . . . 75.25 110.865 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.74 -177.16 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.304 -0.862 . . . . 75.44 110.571 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -79.13 158.73 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.997 0.369 . . . . 64.33 111.997 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -59.47 -44.25 93.05 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.935 -0.575 . . . . 74.42 111.852 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.51 -20.61 61.54 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 116.072 -0.513 . . . . 75.12 113.495 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.1 -43.68 14.81 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 116.698 0.249 . . . . 64.24 111.135 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -66.42 -37.18 84.62 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.309 0.381 . . . . 71.32 111.536 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -84.39 -27.0 27.93 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.935 -0.575 . . . . 73.22 111.697 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.36 -46.73 5.16 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.462 0.476 . . . . 71.54 113.981 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.39 -25.33 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.822 0.449 . . . . 74.11 111.821 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.96 -7.54 54.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.498 -0.773 . . . . 71.01 111.697 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -92.99 -6.59 48.03 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.852 -0.613 . . . . 73.32 111.351 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.23 157.81 19.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.43 -0.35 . . . . 71.25 110.879 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.408 ' C ' HD12 ' A' ' 103' ' ' LEU . 7.9 p -116.48 150.56 37.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.995 -0.548 . . . . 63.14 110.665 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -40.06 119.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.634 0.774 . . . . 73.41 112.295 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.56 4.36 62.26 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.312 -0.858 . . . . 71.34 113.138 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -96.5 145.75 25.41 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.925 0.393 . . . . 75.44 111.38 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.09 106.66 10.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.063 -0.971 . . . . 74.25 109.393 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.91 154.48 47.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.88 -0.6 . . . . 72.53 111.669 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.429 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 73.55 110.227 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -108.63 125.93 52.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.036 0.446 . . . . 74.52 111.334 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 77.6 m -93.03 112.45 24.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.033 -0.985 . . . . 71.34 109.46 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 mm -105.68 142.1 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 75.11 110.379 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.03 162.02 21.16 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 114.867 -1.061 . . . . 74.23 110.94 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.38 -17.33 52.67 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.691 2.26 . . . . 74.23 113.174 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.66 -25.71 26.41 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.452 0.47 . . . . 74.51 111.346 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -101.47 -19.7 15.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.066 -0.515 . . . . 74.1 111.416 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.75 -61.6 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.674 0.62 . . . . 54.11 112.674 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.1 -52.09 0.78 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.582 0.216 . . . . 74.54 111.582 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.53 -140.54 8.02 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 123.557 0.536 . . . . 71.34 112.018 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.4 -10.95 26.45 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.56 0.207 . . . . 63.32 111.56 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.07 -60.32 1.55 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.316 -0.402 . . . . 63.55 110.52 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.6 -166.25 54.17 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 123.333 0.395 . . . . 73.04 113.15 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -97.93 124.6 47.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.943 -0.391 . . . . 71.03 109.943 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.59 123.9 10.61 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.224 1.949 . . . . 65.12 113.665 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.61 -0.723 . . . . 63.23 113.376 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.44 -51.88 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.573 0.187 . . . . 73.33 111.488 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 mm -109.86 97.95 31.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.198 0.312 . . . . 74.32 111.076 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.76 165.76 31.55 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.438 2.092 . . . . 74.2 112.672 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.91 143.11 28.97 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.514 2.143 . . . . 74.42 113.209 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.66 43.11 25.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.603 0.761 . . . . 70.34 111.799 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.4 132.64 54.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.714 -0.676 . . . . 71.42 111.698 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -82.38 140.04 33.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.727 -1.124 . . . . 74.25 110.9 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.449 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mt -118.23 152.69 35.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.637 -0.71 . . . . 75.55 110.961 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.79 130.76 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.832 -0.622 . . . . 72.32 109.514 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' HD12 ' A' ' 74' ' ' LEU . 87.3 m-85 -131.57 133.48 45.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.264 -0.425 . . . . 71.3 111.042 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.6 t70 -116.4 105.63 12.73 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.949 -0.569 . . . . 73.13 110.097 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 25.3 m -108.53 153.96 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.048 -0.523 . . . . 63.14 111.119 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.57 123.83 28.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.559 -0.746 . . . . 72.23 110.268 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -73.66 103.05 4.11 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.167 0.508 . . . . 70.2 110.713 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.78 -57.93 2.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.403 -0.817 . . . . 73.51 111.353 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 122.82 0.448 . . . . 74.51 110.781 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.9 mt -124.22 147.54 47.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.166 -0.47 . . . . 71.15 110.762 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.98 -0.555 . . . . 72.13 110.833 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 CA-C-O 119.177 -0.791 . . . . 72.04 112.499 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.87 144.06 27.07 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.032 2.488 . . . . 72.12 112.771 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.8 m 63.69 137.48 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.037 0.935 . . . . 75.41 112.277 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -97.9 144.17 27.74 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.772 -0.649 . . . . 73.21 110.869 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -112.32 40.49 2.52 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.603 0.564 . . . . 60.01 112.996 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 75' ' ' THR . 9.5 p -138.28 112.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.86 0.362 . . . . 72.33 110.526 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.92 118.07 33.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.589 -0.732 . . . . 74.24 110.813 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.5 p -109.49 132.0 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.928 -0.578 . . . . 62.43 110.992 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -119.55 124.52 46.59 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.488 -0.778 . . . . 74.44 110.167 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -78.55 127.25 31.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.894 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -109.31 -41.14 4.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.123 -0.944 . . . . 73.15 110.306 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -130.67 118.9 18.01 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.92 -0.582 . . . . 74.32 110.481 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.56 129.19 15.35 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.544 2.162 . . . . 71.0 113.251 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.03 -121.16 4.08 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 115.747 -0.66 . . . . 44.33 112.189 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.18 -46.19 12.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.613 0.206 . . . . 70.4 110.941 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.96 -1.69 87.82 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.552 0.532 . . . . 63.51 113.757 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -136.62 1.2 2.55 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.399 0.28 . . . . 75.24 111.745 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -122.23 92.65 3.77 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.064 0.459 . . . . 74.01 110.247 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -103.6 149.98 37.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 72.11 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.87 126.85 17.38 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.469 2.113 . . . . 73.5 112.578 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 115.426 -0.806 . . . . 74.32 111.459 -179.083 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -77.46 125.07 28.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.594 -0.73 . . . . 75.42 111.088 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 114.54 -29.22 7.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.782 -0.645 . . . . 64.12 113.249 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 160.27 14.42 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.415 0.286 . . . . 75.25 110.989 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.19 145.28 30.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.033 -0.53 . . . . 73.13 111.499 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.2 t -119.78 116.53 26.1 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.576 -0.738 . . . . 75.23 110.514 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.81 110.71 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.436 -0.802 . . . . 73.25 109.682 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.69 152.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.029 -0.532 . . . . 72.21 111.502 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.0 m-70 -102.45 125.4 49.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.387 -0.824 . . . . 75.31 109.196 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 41.6 p90 -114.79 166.88 11.29 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.904 0.705 . . . . 74.34 112.904 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.8 m -149.19 110.72 4.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.856 -1.065 . . . . 72.31 109.272 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 35' ' ' MLY . . . -95.02 118.99 6.0 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.096 -0.573 . . . . 75.41 112.962 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 mtm -128.48 131.93 48.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.913 0.485 . . . . 73.1 111.114 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.5 170.96 0.66 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.745 -0.661 . . . . 75.02 111.953 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.4 -26.16 52.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.053 0.541 . . . . 72.0 112.013 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.05 -17.34 29.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.734 -0.666 . . . . 73.54 111.686 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.6 13.8 21.36 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 120.84 -0.695 . . . . 52.23 113.375 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.878 -0.416 . . . . 74.31 109.878 179.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.418 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 112.89 0.7 . . . . 75.44 112.89 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.6 p90 -134.55 -8.6 2.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.245 -1.343 . . . . 75.25 111.229 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -165.46 111.55 0.92 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.341 0.591 . . . . 73.03 111.505 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.418 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 4.8 p -118.18 118.33 31.56 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.812 -1.086 . . . . 72.31 111.033 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 p -78.72 -36.31 43.57 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.996 -0.547 . . . . 71.12 112.252 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -23.24 52.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.914 0.709 . . . . 63.42 112.914 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -24.15 67.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.778 0.323 . . . . 64.34 111.172 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -93.76 -0.19 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.432 -0.804 . . . . 71.3 109.687 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.83 36.02 10.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.241 1.017 . . . . 75.12 111.679 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 CA-C-N 116.239 -0.437 . . . . 74.11 112.161 -179.419 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.79 158.02 47.17 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.015 2.476 . . . . 72.54 112.69 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -100.85 118.55 37.14 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.611 0.569 . . . . 73.33 112.084 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 115.132 -0.94 . . . . 75.21 109.887 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.4 p90 -148.79 159.49 44.1 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.323 0.39 . . . . 75.11 111.48 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.426 ' SD ' HH11 ' A' ' 52' ' ' MLY . 6.4 mtt -104.3 132.3 50.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 71.14 110.734 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.38 139.94 39.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 74.22 111.654 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -10.84 52.65 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.536 -0.757 . . . . 71.31 113.308 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . 0.426 HH11 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 122.577 0.351 . . . . 75.32 110.718 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 69.86 27.55 4.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.114 0.966 . . . . 72.42 112.147 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.93 -13.25 60.0 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.93 -0.577 . . . . 75.25 110.932 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.29 -179.36 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.316 -0.856 . . . . 75.44 110.519 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.92 158.6 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.036 0.384 . . . . 64.33 112.036 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.32 -42.72 96.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.964 -0.562 . . . . 74.42 111.843 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 2' ' ' VAL . . . -63.29 -20.42 63.09 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.024 -0.534 . . . . 75.12 113.183 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -84.25 -45.0 13.33 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.336 0.254 . . . . 64.24 111.189 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.39 -37.51 87.2 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.291 0.37 . . . . 71.32 111.682 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.55 -26.14 28.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.935 -0.575 . . . . 73.22 111.792 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.41 -45.85 4.84 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.421 0.45 . . . . 71.54 113.958 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 64' ' ' ALA . 2.1 p -63.75 -25.77 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.665 0.386 . . . . 74.11 111.757 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 63' ' ' VAL . . . -75.62 -5.34 44.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.367 -0.833 . . . . 71.01 111.707 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -95.34 -11.14 28.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.637 -0.711 . . . . 73.32 111.215 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.74 156.6 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.268 0.355 . . . . 71.25 110.772 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.4 p -111.18 166.58 10.96 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.934 -0.575 . . . . 63.14 110.612 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.84 123.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 122.964 0.506 . . . . 73.41 111.23 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.38 2.76 70.14 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.565 -0.743 . . . . 71.34 113.179 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -94.04 142.67 27.12 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 120.953 0.406 . . . . 75.44 111.382 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.34 109.22 14.64 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.055 -0.975 . . . . 74.25 109.347 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.08 156.43 46.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.141 -0.481 . . . . 72.53 111.944 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.324 0 CA-C-N 116.063 -0.517 . . . . 73.55 110.263 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -105.1 134.29 48.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.037 -0.529 . . . . 74.52 110.699 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.621 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.1 m -99.74 114.07 26.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.649 -0.705 . . . . 71.34 109.557 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mm -106.18 134.24 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.937 -0.574 . . . . 75.11 110.136 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.63 162.12 22.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.402 -0.817 . . . . 74.23 110.755 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.17 -17.07 50.28 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.508 2.138 . . . . 74.23 113.111 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.93 -25.26 24.46 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.44 0.463 . . . . 74.51 111.24 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -101.41 -18.38 16.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 74.1 111.415 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.12 -62.34 1.54 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.649 0.611 . . . . 54.11 112.649 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -133.85 -54.0 0.87 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.63 0.233 . . . . 74.54 111.63 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.45 -139.84 7.29 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.536 0.522 . . . . 71.34 112.019 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.47 -10.78 26.69 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 111.59 0.218 . . . . 63.32 111.59 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.63 -60.33 1.54 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.314 -0.403 . . . . 63.55 110.534 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.52 -166.99 54.53 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 123.318 0.386 . . . . 73.04 113.155 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -97.58 124.08 49.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.942 -0.392 . . . . 71.03 109.942 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.5 124.0 10.75 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.208 1.939 . . . . 65.12 113.625 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.18 -48.17 0.97 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.553 -0.749 . . . . 63.23 113.372 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.97 -51.49 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.57 0.211 . . . . 73.33 111.57 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 mm -110.06 97.71 31.23 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 123.159 0.287 . . . . 74.32 111.111 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.37 165.61 31.9 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.391 2.061 . . . . 74.2 112.744 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.05 143.74 29.24 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.651 2.234 . . . . 74.42 113.249 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 56.54 41.3 28.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.652 0.781 . . . . 70.34 111.8 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.23 54.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.713 -0.676 . . . . 71.42 111.731 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -82.82 138.72 33.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.747 -1.115 . . . . 74.25 110.926 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.475 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 mt -116.67 155.07 29.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.526 -0.761 . . . . 75.55 110.901 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.48 129.59 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.824 -0.625 . . . . 72.32 109.481 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.545 ' O ' HD12 ' A' ' 74' ' ' LEU . 85.3 m-85 -130.94 133.26 45.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.072 -0.513 . . . . 71.3 110.741 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -116.6 102.63 9.63 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.586 0.554 . . . . 73.13 110.359 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 24.0 m -103.56 153.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.08 -0.509 . . . . 63.14 110.943 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.29 125.97 39.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 72.23 110.201 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.421 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -72.93 101.92 3.32 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.86 -0.609 . . . . 70.2 110.455 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.28 -58.38 2.52 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.146 -0.479 . . . . 73.51 111.394 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 122.821 0.448 . . . . 74.51 110.774 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.9 mt -122.77 146.31 47.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.087 -0.506 . . . . 71.15 110.799 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.003 -0.544 . . . . 72.13 110.809 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 CA-C-O 119.019 -0.878 . . . . 72.04 112.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.16 139.72 24.2 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.887 2.391 . . . . 72.12 112.784 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.1 t 61.91 118.37 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.96 0.904 . . . . 75.41 111.929 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.61 150.74 51.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.747 -0.66 . . . . 73.21 110.857 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -96.4 28.9 11.3 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 115.938 -0.573 . . . . 60.01 112.996 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.0 p -140.75 121.84 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.443 0.297 . . . . 72.33 110.433 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.78 120.29 36.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.851 -0.613 . . . . 74.24 110.76 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -106.36 122.76 60.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.98 -0.554 . . . . 62.43 109.912 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 73' ' ' MLY . 8.2 pt-20 -113.19 121.24 43.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.452 -0.795 . . . . 74.44 111.249 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -76.79 130.7 38.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.012 -0.54 . . . . 75.4 111.257 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.91 -41.23 3.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.095 -0.957 . . . . 73.15 110.12 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 t -129.72 118.16 18.68 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.882 -0.599 . . . . 74.32 110.433 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.72 127.58 13.24 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.59 2.193 . . . . 71.0 113.448 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.71 -121.64 4.31 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.772 -0.649 . . . . 44.33 111.856 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.49 -45.61 19.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.558 0.179 . . . . 70.4 110.79 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.99 -1.68 86.0 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.067 -0.515 . . . . 63.51 113.663 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -138.23 4.17 2.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.614 0.366 . . . . 75.24 111.66 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 68' ' ' VAL . 6.7 m -128.33 92.95 3.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.648 -0.501 . . . . 74.01 109.648 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.59 151.82 38.2 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.678 -0.692 . . . . 72.11 109.815 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.4 132.21 39.86 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.291 1.994 . . . . 73.5 111.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.51 0 O-C-N 123.452 0.47 . . . . 74.32 112.26 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -77.9 133.9 38.01 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.221 -0.9 . . . . 75.42 111.256 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.2 -21.3 46.31 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.183 -0.532 . . . . 64.12 113.222 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -100.84 159.26 15.34 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.632 0.254 . . . . 75.25 110.796 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.616 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -78.26 134.93 37.48 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.917 -0.583 . . . . 73.13 111.201 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.04 109.81 20.07 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.955 -0.566 . . . . 75.23 110.263 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.73 109.38 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.447 -0.797 . . . . 73.25 109.812 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.0 150.06 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.862 -0.608 . . . . 72.21 111.299 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 10.5 m-70 -101.09 125.34 47.7 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.416 -0.811 . . . . 75.31 109.058 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' H ' ' HG ' ' A' ' 39' ' ' SER . 40.4 p90 -116.3 166.33 12.17 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.86 0.689 . . . . 74.34 112.86 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.6 m -148.94 111.47 4.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.871 -1.059 . . . . 72.31 109.394 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.25 120.1 6.5 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.029 -0.532 . . . . 75.41 112.844 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.0 mtm -129.09 132.1 47.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.967 0.507 . . . . 73.1 111.015 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.5 170.77 0.5 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.776 -0.647 . . . . 75.02 112.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.62 -26.63 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.122 0.569 . . . . 72.0 112.159 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.41 -17.23 29.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.766 -0.652 . . . . 73.54 111.687 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.8 13.79 21.02 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 120.82 -0.705 . . . . 52.23 113.226 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.912 -0.403 . . . . 74.31 109.912 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.438 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.433 0 N-CA-C 112.824 0.676 . . . . 75.44 112.824 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.8 p90 -133.26 -14.54 2.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 75.25 111.288 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -161.68 111.51 1.59 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-O 121.018 0.437 . . . . 73.03 111.862 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 3.2 p -117.01 119.91 36.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.403 -0.817 . . . . 72.31 110.968 177.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.613 ' HG ' ' H ' ' A' ' 26' ' ' TYR . 56.6 p -78.49 -37.02 44.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.209 -0.451 . . . . 71.12 112.092 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.32 -24.32 57.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 63.42 112.98 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -25.48 68.35 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.733 0.302 . . . . 64.34 111.319 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -93.54 3.53 55.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.503 -0.771 . . . . 71.3 109.705 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 62.61 34.05 15.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.219 1.008 . . . . 75.12 111.713 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.416 0 N-CA-C 113.179 0.807 . . . . 74.11 113.179 -178.847 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.18 157.93 37.7 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.215 2.61 . . . . 72.54 112.652 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -99.01 118.26 35.38 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.961 -0.563 . . . . 73.33 112.013 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.31 0 CA-C-N 115.091 -0.959 . . . . 75.21 110.086 178.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.7 p90 -152.15 162.38 41.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.302 0.376 . . . . 75.11 111.537 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.616 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -105.09 132.96 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.396 -0.365 . . . . 71.14 110.929 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.8 143.49 37.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.73 -0.668 . . . . 74.22 111.658 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.49 -6.46 60.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.547 -0.751 . . . . 71.31 113.438 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.6 0.36 . . . . 75.32 110.695 179.437 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 69.51 28.71 4.56 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.163 0.985 . . . . 72.42 112.125 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.46 -33.63 60.86 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.942 -0.572 . . . . 75.25 110.563 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 m -102.16 -174.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.161 -0.927 . . . . 75.44 110.042 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 pt -80.6 157.89 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.761 0.282 . . . . 64.33 111.761 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -58.75 -44.02 90.44 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.035 -0.53 . . . . 74.42 111.839 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.45 -20.21 60.94 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.128 -0.487 . . . . 75.12 113.307 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.447 ' O ' HG11 ' A' ' 63' ' ' VAL . 6.7 m0 -84.24 -44.69 13.64 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 122.319 0.248 . . . . 64.24 111.325 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -66.07 -38.19 87.68 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.252 0.345 . . . . 71.32 111.596 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.43 -24.87 29.37 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.22 111.722 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.34 -46.22 4.74 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.45 0.468 . . . . 71.54 113.793 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 59' ' ' TRP . 2.7 p -63.37 -25.56 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.772 0.429 . . . . 74.11 111.691 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.41 -9.54 58.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.284 -0.871 . . . . 71.01 111.723 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.51 -11.08 41.26 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.783 -0.644 . . . . 73.32 111.174 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.446 ' SD ' ' HB1' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -106.66 156.4 18.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.11 -0.495 . . . . 71.25 110.437 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -107.69 165.01 11.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.086 -0.506 . . . . 63.14 110.604 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 14' ' ' THR . 72.2 t -57.78 122.06 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.988 0.515 . . . . 73.41 110.857 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 92.02 5.86 65.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.301 -0.863 . . . . 71.34 112.98 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -97.69 145.44 26.32 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.336 . . . . 75.44 111.387 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.55 110.62 16.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.441 -0.8 . . . . 74.25 109.362 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 66' ' ' MET . . . -134.06 152.7 51.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 72.53 112.031 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 C--N 1.344 0.354 0 CA-C-N 116.108 -0.496 . . . . 73.55 110.586 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -108.6 129.59 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.859 -0.609 . . . . 74.52 111.228 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.1 m -95.71 113.77 25.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.353 -0.84 . . . . 71.34 109.467 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.7 mm -106.45 142.36 19.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.967 -0.56 . . . . 75.11 110.56 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.31 162.49 19.7 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 114.877 -1.056 . . . . 74.23 110.683 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 -14.42 41.79 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.501 2.134 . . . . 74.23 113.234 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.57 -28.63 24.74 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.378 0.424 . . . . 74.51 110.793 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.9 -19.75 16.48 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.738 -0.665 . . . . 74.1 111.562 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.14 -62.44 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.763 0.653 . . . . 54.11 112.763 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.81 -52.71 0.8 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.547 0.203 . . . . 74.54 111.547 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.08 -140.27 7.76 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 116.139 -0.482 . . . . 71.34 112.007 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.89 -10.81 25.7 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 111.549 0.203 . . . . 63.32 111.549 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.03 -60.23 1.57 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.222 -0.444 . . . . 63.55 110.432 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 -168.53 53.98 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.357 0.411 . . . . 73.04 113.231 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -96.62 124.31 51.06 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.868 -0.419 . . . . 71.03 109.868 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.58 124.67 11.39 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.234 1.956 . . . . 65.12 113.637 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.43 -45.51 1.29 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.581 -0.736 . . . . 63.23 113.432 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.46 -51.57 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.632 0.216 . . . . 73.33 111.581 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 mm -111.03 98.94 41.05 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 123.202 0.314 . . . . 74.32 111.141 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.55 165.66 31.79 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.463 2.109 . . . . 74.2 112.683 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.32 143.91 28.64 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.522 2.148 . . . . 74.42 113.225 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.3 41.9 28.53 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.649 0.78 . . . . 70.34 111.799 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.91 131.81 53.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 71.42 111.807 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -81.01 141.9 33.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.732 -1.122 . . . . 74.25 110.856 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.8 mt -120.59 152.18 38.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.743 -0.662 . . . . 75.55 111.085 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -119.14 132.12 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 72.32 109.41 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' THR . 86.9 m-85 -133.16 132.93 42.18 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.381 0.426 . . . . 71.3 111.057 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 6.5 t70 -115.95 103.13 10.3 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.955 -0.566 . . . . 73.13 110.038 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 24.0 m -106.17 153.37 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.919 -0.582 . . . . 63.14 111.127 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.68 125.65 36.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.536 -0.756 . . . . 72.23 110.184 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.49 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -72.98 101.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.621 -0.718 . . . . 70.2 110.523 -179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.68 -58.1 2.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.524 -0.307 . . . . 73.51 111.649 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 122.702 0.401 . . . . 74.51 111.285 -179.812 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HB3' ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -106.33 151.21 25.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.161 -0.472 . . . . 71.15 110.343 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 72.13 110.79 179.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.731 0 CA-C-O 119.222 -0.765 . . . . 72.04 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.81 150.64 35.05 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.028 2.485 . . . . 72.12 112.737 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.8 m -128.17 144.39 51.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.846 -0.615 . . . . 75.41 110.936 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.7 mtt -101.27 144.43 30.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.87 -0.605 . . . . 73.21 110.825 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -107.01 35.43 5.04 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.952 -0.567 . . . . 60.01 112.966 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.4 p -137.36 118.81 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.707 0.289 . . . . 72.33 110.539 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.65 119.26 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.777 -0.647 . . . . 74.24 110.655 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 19.0 t -107.74 124.74 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.946 -0.57 . . . . 62.43 109.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.34 122.79 47.76 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.697 -0.683 . . . . 74.44 110.251 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -76.96 126.35 30.83 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.115 -0.493 . . . . 75.4 111.007 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mt -109.71 -39.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.011 -0.995 . . . . 73.15 110.271 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -131.25 118.62 17.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 74.32 110.384 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.29 130.52 17.6 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.543 2.162 . . . . 71.0 113.231 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.67 -121.59 4.49 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.79 -0.641 . . . . 44.33 112.386 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.4 -45.93 14.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.552 0.176 . . . . 70.4 110.696 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.4 -1.18 88.54 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.026 -0.534 . . . . 63.51 114.033 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -137.33 -1.03 2.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.369 0.267 . . . . 75.24 111.694 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -118.82 93.42 4.09 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 74.01 110.533 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.2 149.01 36.52 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.57 -0.741 . . . . 72.11 110.817 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.91 129.1 18.93 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.55 2.167 . . . . 73.5 113.201 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 CA-C-N 115.358 -0.837 . . . . 74.32 111.125 -179.738 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.35 124.64 28.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 75.42 111.36 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HE3' ' A' ' 49' ' ' MET . . . 116.88 -25.15 9.08 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.685 -0.688 . . . . 64.12 113.295 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 160.18 14.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.322 0.249 . . . . 75.25 111.023 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -84.94 145.34 27.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.162 -0.472 . . . . 73.13 111.007 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 59.7 m -124.32 120.64 32.76 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.758 -0.655 . . . . 75.23 111.01 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 t -90.27 111.32 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.263 -0.881 . . . . 73.25 109.633 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.03 151.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.063 -0.517 . . . . 72.21 111.481 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.0 m-70 -103.03 125.33 49.73 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.596 -0.729 . . . . 75.31 109.394 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 39.8 p90 -116.09 167.61 10.83 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.365 0.505 . . . . 74.34 112.365 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.74 105.56 3.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.093 -0.958 . . . . 72.31 109.417 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.78 118.27 5.32 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 121.017 -0.611 . . . . 75.41 112.806 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 mtm -133.16 134.78 44.6 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.067 0.547 . . . . 73.1 110.901 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.19 172.12 0.33 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.439 -0.8 . . . . 75.02 112.359 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.88 -27.3 51.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.099 0.56 . . . . 72.0 111.993 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.79 -17.4 29.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.639 -0.71 . . . . 73.54 111.695 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.99 13.77 22.6 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 120.738 -0.744 . . . . 52.23 113.314 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 N-CA-C 110.065 -0.346 . . . . 74.31 110.065 179.639 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.419 HH22 ' OG ' ' A' ' 38' ' ' SER . . . . . . . . 0 C--N 1.343 0.314 0 N-CA-C 113.017 0.747 . . . . 75.44 113.017 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -134.09 -14.31 2.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.546 -1.207 . . . . 75.25 111.231 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.98 110.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.104 0.478 . . . . 73.03 112.141 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.419 ' OG ' HH22 ' A' ' 35' ' ' MLY . 31.4 t -123.18 138.6 54.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.302 -0.863 . . . . 72.31 110.039 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.486 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 65.1 p -78.75 -33.14 46.79 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.696 0.628 . . . . 71.12 112.696 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -74.42 -23.13 58.9 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.636 0.606 . . . . 63.42 112.636 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -29.18 70.61 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.857 0.36 . . . . 64.34 110.91 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -95.7 -0.21 51.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.274 -0.876 . . . . 71.3 110.023 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 64.45 37.44 8.19 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.227 1.011 . . . . 75.12 111.771 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.573 0 CA-C-N 116.207 -0.451 . . . . 74.11 111.765 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.92 158.1 50.39 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.893 2.395 . . . . 72.54 112.919 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.05 118.39 36.69 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.74 -0.664 . . . . 73.33 112.039 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.49 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 115.237 -0.892 . . . . 75.21 110.208 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 21' ' ' THR . 42.3 p90 -150.44 163.44 38.39 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.371 0.42 . . . . 75.11 111.382 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.408 ' HE3' ' O ' ' A' ' 19' ' ' GLY . 7.5 mtt -106.96 133.98 50.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.1 -0.5 . . . . 71.14 110.767 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 139.88 38.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.98 -0.554 . . . . 74.22 111.497 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.92 -10.0 54.31 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.512 -0.767 . . . . 71.31 113.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 122.562 0.345 . . . . 75.32 110.696 179.228 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 69.82 27.51 4.54 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.13 0.972 . . . . 72.42 112.142 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -77.32 -12.76 59.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.0 -0.545 . . . . 75.25 110.863 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.33 -177.68 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.322 -0.854 . . . . 75.44 110.49 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.09 158.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 111.993 0.368 . . . . 64.33 111.993 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -59.55 -44.32 93.29 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.968 -0.56 . . . . 74.42 111.834 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.64 -20.28 61.45 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 123.533 0.521 . . . . 75.12 113.421 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -84.12 -43.9 14.57 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 122.307 0.243 . . . . 64.24 111.156 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.29 -37.76 86.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.329 0.393 . . . . 71.32 111.673 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.43 -25.04 29.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.987 -0.551 . . . . 73.22 111.857 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -88.35 -45.88 4.85 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.46 0.475 . . . . 71.54 113.839 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.76 -25.16 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.786 0.434 . . . . 74.11 111.646 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.97 -8.07 56.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.395 -0.82 . . . . 71.01 111.742 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.51 -4.43 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.819 -0.628 . . . . 73.32 111.201 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.42 158.37 19.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.332 -0.395 . . . . 71.25 110.874 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 p -117.14 150.52 38.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.021 -0.536 . . . . 63.14 110.655 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.4 t -40.24 117.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 73.41 112.356 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.24 59.2 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.187 -0.915 . . . . 71.34 113.08 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -96.73 144.84 26.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.937 0.398 . . . . 75.44 111.369 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.69 109.26 14.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.09 -0.959 . . . . 74.25 109.247 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.06 157.58 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.907 -0.588 . . . . 72.53 111.918 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.295 0 CA-C-N 115.947 -0.569 . . . . 73.55 110.283 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -110.16 125.25 52.83 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.232 -0.44 . . . . 74.52 111.235 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.9 m -93.56 113.82 26.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.389 -0.823 . . . . 71.34 109.531 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.82 143.1 17.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.852 -0.613 . . . . 75.11 110.577 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.66 161.79 21.74 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.877 -1.056 . . . . 74.23 110.916 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.14 -17.25 51.2 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.768 2.312 . . . . 74.23 113.192 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.99 -25.65 25.89 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.435 0.46 . . . . 74.51 111.341 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.73 -18.76 15.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.066 -0.516 . . . . 74.1 111.405 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.66 -63.07 1.4 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.722 0.638 . . . . 54.11 112.722 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.46 -50.99 0.86 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.593 0.22 . . . . 74.54 111.593 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.08 -141.48 8.99 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.533 0.52 . . . . 71.34 112.03 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.79 -11.16 27.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.607 0.225 . . . . 63.32 111.607 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -99.51 -60.33 1.55 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.267 -0.424 . . . . 63.55 110.49 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 -168.04 53.38 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.342 0.401 . . . . 73.04 113.21 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -96.93 124.67 49.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.932 -0.395 . . . . 71.03 109.932 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.86 124.16 10.77 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.195 1.93 . . . . 65.12 113.629 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.2 -46.3 1.19 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.604 -0.725 . . . . 63.23 113.394 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.7 -51.84 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 111.619 0.229 . . . . 73.33 111.619 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 mm -110.09 98.56 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.184 0.302 . . . . 74.32 111.045 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.71 165.65 31.87 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.404 2.07 . . . . 74.2 112.713 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.93 142.9 28.65 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.551 2.167 . . . . 74.42 113.188 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 56.67 44.34 23.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.598 0.759 . . . . 70.34 111.688 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.64 133.5 53.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.713 -0.676 . . . . 71.42 111.78 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.35 140.84 32.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.693 -1.14 . . . . 74.25 110.737 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -118.74 155.01 31.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.743 -0.662 . . . . 75.55 111.164 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -121.24 129.95 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.865 -0.607 . . . . 72.32 109.712 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 74' ' ' LEU . 90.2 m-85 -132.27 133.27 43.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.075 -0.511 . . . . 71.3 110.614 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.7 t70 -116.43 104.2 11.21 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.554 0.534 . . . . 73.13 110.159 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 24.9 m -106.0 153.46 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.078 -0.51 . . . . 63.14 111.179 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.86 124.84 30.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.488 -0.778 . . . . 72.23 110.239 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 104.15 5.02 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.133 0.492 . . . . 70.2 110.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.37 -57.74 2.73 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.429 -0.805 . . . . 73.51 111.372 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 122.887 0.475 . . . . 74.51 110.748 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.4 147.07 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.099 -0.5 . . . . 71.15 110.66 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.059 -0.519 . . . . 72.13 110.766 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 CA-C-O 119.044 -0.864 . . . . 72.04 112.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.12 -35.55 2.99 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.851 2.367 . . . . 72.12 113.108 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.4 m -107.51 -42.74 4.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.373 0.421 . . . . 75.41 111.325 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 84.4 mmm -100.83 133.73 44.87 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.405 0.44 . . . . 73.21 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -117.73 15.07 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 115.862 -0.608 . . . . 60.01 113.165 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.2 p -123.03 126.36 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 122.331 0.252 . . . . 72.33 110.621 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.628 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.77 141.47 48.37 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.839 -0.619 . . . . 74.24 110.447 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.88 124.07 62.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.443 -0.799 . . . . 62.43 110.107 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.08 120.54 38.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.718 -0.674 . . . . 74.44 110.317 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -77.35 124.55 28.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.112 -0.494 . . . . 75.4 110.853 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -107.32 -40.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.986 -1.006 . . . . 73.15 110.307 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -131.43 119.13 17.31 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.031 -0.531 . . . . 74.32 110.391 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.45 129.82 16.39 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.551 2.167 . . . . 71.0 113.378 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.53 -121.36 4.42 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.742 -0.663 . . . . 44.33 112.121 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -83.82 -46.37 12.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.647 0.223 . . . . 70.4 110.954 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.49 -0.96 88.49 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.051 -0.522 . . . . 63.51 113.662 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -136.82 0.91 2.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.795 0.295 . . . . 75.24 111.795 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.74 92.8 3.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.026 0.441 . . . . 74.01 110.327 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.52 149.39 37.0 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.57 -0.741 . . . . 72.11 110.949 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.21 125.75 14.57 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.533 2.155 . . . . 73.5 112.939 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.435 -0.802 . . . . 74.32 111.558 -179.325 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' NE ' ' HA3' ' A' ' 51' ' ' GLY . 41.7 ttt180 -77.43 124.25 27.63 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.525 -0.761 . . . . 75.42 111.468 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -24.3 11.81 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.889 -0.596 . . . . 64.12 113.51 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.7 160.17 14.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.573 0.225 . . . . 75.25 110.976 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.662 HG21 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -80.51 145.14 32.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.046 -0.525 . . . . 73.13 111.315 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 53.6 m -123.08 116.3 23.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.581 -0.736 . . . . 75.23 110.485 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.1 110.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.762 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 m -147.12 149.97 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.013 -0.54 . . . . 72.21 111.38 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.8 m-70 -101.13 125.33 47.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.411 -0.813 . . . . 75.31 109.059 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.562 ' CE1' ' HB3' ' A' ' 39' ' ' SER . 40.8 p90 -116.38 166.55 11.94 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 74.34 112.783 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.3 m -148.81 111.64 4.83 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.966 -1.015 . . . . 72.31 109.405 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.8 119.83 6.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.938 -0.574 . . . . 75.41 112.706 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.1 mtm -129.79 131.5 46.22 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.875 0.47 . . . . 73.1 111.115 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.8 mt -57.04 170.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.651 -0.704 . . . . 75.02 112.027 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.15 -25.9 48.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.058 0.543 . . . . 72.0 112.052 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.44 -17.39 28.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.762 -0.654 . . . . 73.54 111.639 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.87 13.77 22.83 Favored Glycine 0 C--N 1.346 1.125 0 C-N-CA 120.86 -0.686 . . . . 52.23 113.324 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.767 -0.457 . . . . 74.31 109.767 179.547 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.412 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 112.942 0.719 . . . . 75.44 112.942 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.6 p90 -133.47 -15.16 2.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.176 -1.375 . . . . 75.25 111.301 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' A' ' 36' ' ' PHE . 2.9 m-20 -160.89 111.47 1.76 Allowed 'General case' 0 C--N 1.357 0.921 0 CA-C-O 121.014 0.435 . . . . 73.03 112.052 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.412 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 2.9 p -116.95 119.88 36.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.404 -0.816 . . . . 72.31 110.917 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 53.9 p -78.35 -35.5 47.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.178 -0.464 . . . . 71.12 112.179 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -76.6 -23.25 53.45 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.797 0.665 . . . . 63.42 112.797 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -24.76 67.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.8 0.333 . . . . 64.34 111.392 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.516 ' O ' ' HE3' ' A' ' 44' ' ' MLY . 63.3 mtm180 -92.87 1.43 57.3 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.437 -0.802 . . . . 71.3 109.704 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.16 35.55 12.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.212 1.005 . . . . 75.12 111.529 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . 0.516 ' HE3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 112.478 0.548 . . . . 74.11 112.478 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.96 158.1 46.44 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 123.023 2.482 . . . . 72.54 112.768 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -98.74 118.27 35.1 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.973 -0.558 . . . . 73.33 112.029 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.568 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 115.241 -0.89 . . . . 75.21 110.163 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.5 p90 -151.21 164.11 37.33 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.289 0.368 . . . . 75.11 111.671 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.662 ' SD ' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -107.51 135.82 48.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.338 -0.392 . . . . 71.14 110.528 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.45 140.77 37.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.813 -0.63 . . . . 74.22 111.59 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.457 ' HA3' ' NE ' ' A' ' 18' ' ' ARG . . . 81.49 -7.61 60.96 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.551 -0.749 . . . . 71.31 113.294 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 122.597 0.359 . . . . 75.32 110.661 179.387 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 70.1 26.83 4.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.146 0.978 . . . . 72.42 112.202 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.02 -15.29 60.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.981 -0.554 . . . . 75.25 110.744 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.92 -177.69 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.244 -0.889 . . . . 75.44 110.431 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.77 159.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.04 0.385 . . . . 64.33 112.04 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -59.69 -44.21 93.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.975 -0.557 . . . . 74.42 111.774 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.69 -20.44 61.76 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 123.505 0.503 . . . . 75.12 113.462 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -84.1 -43.44 15.05 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 116.688 0.244 . . . . 64.24 111.065 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -66.52 -36.86 83.75 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.368 0.417 . . . . 71.32 111.514 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.49 -26.8 27.89 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.894 -0.594 . . . . 73.22 111.651 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.402 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -86.96 -46.93 4.93 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.438 0.461 . . . . 71.54 114.01 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.01 -25.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.826 0.45 . . . . 74.11 111.788 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.43 56.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.423 -0.808 . . . . 71.01 111.66 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.402 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 55.3 mt-30 -91.97 -9.15 44.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.817 -0.629 . . . . 73.32 111.256 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.27 156.29 20.12 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 71.25 111.008 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 p -111.27 167.09 10.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 63.14 110.509 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.14 123.08 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.965 0.506 . . . . 73.41 111.229 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.99 4.24 69.34 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.445 -0.798 . . . . 71.34 113.177 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -95.68 142.58 27.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.894 0.378 . . . . 75.44 111.376 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.54 107.34 12.74 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.066 -0.97 . . . . 74.25 109.383 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.07 154.4 47.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 72.53 111.633 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.443 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-N 116.034 -0.53 . . . . 73.55 110.201 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -111.03 126.55 54.92 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.046 0.451 . . . . 74.52 111.364 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 76.7 m -93.58 112.35 24.22 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.041 -0.981 . . . . 71.34 109.496 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.7 mm -105.63 141.21 21.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.02 -0.536 . . . . 75.11 110.477 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 162.07 21.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 114.837 -1.074 . . . . 74.23 110.91 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.47 -17.34 53.15 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.655 2.236 . . . . 74.23 113.221 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.41 -25.77 26.8 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.457 0.473 . . . . 74.51 111.368 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.7 -19.98 15.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.082 -0.508 . . . . 74.1 111.392 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.14 -61.79 1.76 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.651 0.611 . . . . 54.11 112.651 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.59 -52.51 0.81 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.558 0.207 . . . . 74.54 111.558 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.91 -140.56 7.98 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 116.109 -0.496 . . . . 71.34 112.051 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.92 26.62 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.609 0.225 . . . . 63.32 111.609 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.1 -60.33 1.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.254 -0.43 . . . . 63.55 110.441 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.05 -168.55 54.21 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.367 0.417 . . . . 73.04 113.16 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -96.95 123.8 52.16 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.949 -0.389 . . . . 71.03 109.949 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.22 124.73 11.61 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.216 1.944 . . . . 65.12 113.633 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.48 -47.47 1.04 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.545 -0.752 . . . . 63.23 113.332 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.87 -51.68 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 111.62 0.23 . . . . 73.33 111.62 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.13 98.17 33.75 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 123.207 0.317 . . . . 74.32 111.136 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.73 165.62 31.98 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.39 2.06 . . . . 74.2 112.684 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.12 143.8 29.1 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.552 2.168 . . . . 74.42 113.227 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 56.64 41.79 27.92 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.641 0.776 . . . . 70.34 111.77 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.33 132.19 54.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.749 -0.66 . . . . 71.42 111.751 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 m -82.6 139.27 33.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.787 -1.097 . . . . 74.25 110.901 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mt -117.96 151.45 37.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.589 -0.732 . . . . 75.55 110.939 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 37.4 t -119.14 129.61 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.88 -0.6 . . . . 72.32 109.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 27' ' ' THR . 88.0 m-85 -130.42 134.04 46.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.256 -0.429 . . . . 71.3 111.093 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.7 t70 -116.48 105.26 12.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.914 -0.585 . . . . 73.13 110.092 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 27.6 m -107.59 153.94 8.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.02 -0.536 . . . . 63.14 111.014 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.11 125.33 32.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.495 -0.775 . . . . 72.23 110.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.11 100.49 3.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.784 -0.644 . . . . 70.2 110.125 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -88.6 -58.33 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.407 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 122.747 0.419 . . . . 74.51 110.781 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.0 mt -125.45 145.55 50.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 71.15 110.72 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.004 -0.544 . . . . 72.13 110.865 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 CA-C-O 119.03 -0.872 . . . . 72.04 112.635 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.15 142.62 27.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.774 2.316 . . . . 72.12 112.796 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.4 m -127.82 146.59 50.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.897 -0.592 . . . . 75.41 110.957 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.5 mtt -118.76 -41.87 2.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.595 . . . . 73.21 111.219 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.8 1.68 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.489 0.493 . . . . 60.01 112.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.5 p -120.38 121.22 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.735 0.303 . . . . 72.33 110.633 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.3 119.23 32.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.806 -0.634 . . . . 74.24 110.844 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 13.9 p -110.65 135.69 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.977 -0.556 . . . . 62.43 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.25 125.64 45.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.474 -0.785 . . . . 74.44 110.279 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.27 128.68 34.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.15 -0.477 . . . . 75.4 110.912 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -111.46 -39.55 3.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.116 -0.947 . . . . 73.15 110.365 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -132.25 118.79 16.26 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.011 -0.54 . . . . 74.32 110.475 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.58 130.48 17.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.63 2.22 . . . . 71.0 113.29 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.64 -121.37 4.44 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.745 -0.661 . . . . 44.33 112.168 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.21 -46.42 11.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.682 0.241 . . . . 70.4 111.034 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.16 -1.01 87.66 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.548 0.53 . . . . 63.51 113.708 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -136.57 0.39 2.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.476 0.31 . . . . 75.24 111.819 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.52 92.91 3.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.022 0.439 . . . . 74.01 110.35 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -103.8 149.62 37.33 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.524 -0.762 . . . . 72.11 111.039 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.82 122.49 9.86 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.466 2.111 . . . . 73.5 112.707 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 115.419 -0.81 . . . . 74.32 111.649 -179.298 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -77.42 126.63 31.22 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.612 -0.722 . . . . 75.42 111.134 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 113.41 -27.98 8.99 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.767 -0.651 . . . . 64.12 113.162 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.26 160.18 14.46 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.337 0.255 . . . . 75.25 110.896 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.47 145.28 29.03 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.086 -0.506 . . . . 73.13 111.379 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 36.9 t -120.4 116.95 26.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.633 -0.712 . . . . 75.23 110.629 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.78 110.7 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.526 -0.761 . . . . 73.25 109.529 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.4 m -146.95 153.17 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.988 -0.551 . . . . 72.21 111.525 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.7 m-70 -103.36 125.33 49.92 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.485 -0.78 . . . . 75.31 109.412 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 40.8 p90 -115.15 167.46 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.534 0.568 . . . . 74.34 112.534 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.2 m -147.96 107.01 3.85 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.044 -0.98 . . . . 72.31 109.38 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.22 119.93 5.82 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.02 -0.536 . . . . 75.41 112.692 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.4 mtm -135.48 131.82 36.59 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.978 0.511 . . . . 73.1 110.915 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.6 mt -55.52 171.83 0.18 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.495 -0.775 . . . . 75.02 112.512 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.6 -27.81 51.57 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.188 0.595 . . . . 72.0 111.996 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.5 -17.38 30.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.672 -0.695 . . . . 73.54 111.657 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.59 13.9 23.01 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.849 -0.691 . . . . 52.23 113.228 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.441 0 N-CA-C 110.097 -0.334 . . . . 74.31 110.097 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.284 0 N-CA-C 112.937 0.718 . . . . 75.44 112.937 -179.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 25.2 p90 -132.81 -15.25 2.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.552 -1.204 . . . . 75.25 111.401 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.0 111.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.096 0.474 . . . . 73.03 112.223 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 28.4 t -122.29 142.66 50.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.274 -0.875 . . . . 72.31 110.093 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.513 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.5 p -78.65 -38.19 40.12 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.788 -0.642 . . . . 71.12 112.55 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -70.03 -22.93 63.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.529 0.566 . . . . 63.42 112.529 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -29.23 70.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.899 0.381 . . . . 64.34 110.834 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -96.9 -0.32 47.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.243 -0.889 . . . . 71.3 110.079 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t30 64.47 37.63 8.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.277 1.031 . . . . 75.12 111.717 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.189 -0.46 . . . . 74.11 111.588 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.46 157.93 55.24 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.859 2.372 . . . . 72.54 112.935 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.18 118.16 36.16 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.83 -0.623 . . . . 73.33 112.081 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.47 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 115.126 -0.943 . . . . 75.21 109.788 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.9 p90 -149.37 163.25 38.26 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.308 0.38 . . . . 75.11 111.451 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.427 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 7.2 mtt -107.0 133.74 51.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.052 -0.522 . . . . 71.14 110.779 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.97 141.16 36.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.836 -0.62 . . . . 74.22 111.588 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 -11.0 51.47 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.541 -0.754 . . . . 71.31 113.478 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.741 0.305 . . . . 75.32 110.63 179.312 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 68.34 30.4 5.5 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.08 0.952 . . . . 72.42 112.186 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.959 -0.564 . . . . 75.25 110.544 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -103.8 -173.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.23 -0.896 . . . . 75.44 110.194 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -81.62 158.28 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 111.695 0.257 . . . . 64.33 111.695 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -59.63 -43.42 93.85 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.054 -0.521 . . . . 74.42 111.974 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.82 63.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 123.515 0.509 . . . . 75.12 113.227 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -84.14 -44.6 13.84 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 122.294 0.237 . . . . 64.24 111.083 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.82 -37.44 86.25 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.19 0.306 . . . . 71.32 111.477 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.49 -25.8 28.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.852 -0.613 . . . . 73.22 111.736 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.62 -46.8 4.48 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.503 0.502 . . . . 71.54 113.867 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 64' ' ' ALA . 1.6 p -63.79 -26.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.754 0.422 . . . . 74.11 111.705 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.408 ' N ' HG11 ' A' ' 63' ' ' VAL . . . -74.95 -7.15 52.76 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.308 -0.86 . . . . 71.01 111.732 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -93.96 -8.56 39.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.748 -0.66 . . . . 73.32 111.32 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.35 156.58 19.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.38 . . . . 71.25 110.85 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 p -111.14 166.83 10.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.612 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.74 122.78 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.0 0.52 . . . . 73.41 111.215 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.55 3.63 68.79 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.487 -0.779 . . . . 71.34 113.257 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.76 142.95 26.86 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 120.928 0.394 . . . . 75.44 111.361 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.69 109.38 14.66 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.065 -0.971 . . . . 74.25 109.5 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.84 154.69 50.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.053 -0.522 . . . . 72.53 111.826 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.242 0 CA-C-N 116.028 -0.533 . . . . 73.55 110.463 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -107.26 135.77 48.2 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.167 -0.469 . . . . 74.52 110.782 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.4 m -101.46 111.56 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.655 -0.702 . . . . 71.34 109.324 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.94 130.7 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.873 -0.603 . . . . 75.11 110.262 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.32 161.44 27.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.304 -0.862 . . . . 74.23 110.869 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.41 -17.49 53.74 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.507 2.138 . . . . 74.23 113.007 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.61 -25.16 23.71 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.432 0.458 . . . . 74.51 111.228 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -99.72 -19.45 16.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.042 -0.526 . . . . 74.1 111.301 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.85 -63.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.793 0.664 . . . . 54.11 112.793 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.17 -53.66 0.97 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.534 0.198 . . . . 74.54 111.534 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.35 -139.83 7.43 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.522 0.513 . . . . 71.34 111.997 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.7 -10.57 26.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.608 0.225 . . . . 63.32 111.608 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 m -100.13 -60.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.253 -0.43 . . . . 63.55 110.431 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.7 -170.22 52.91 Favored Glycine 0 C--N 1.346 1.087 0 O-C-N 123.369 0.418 . . . . 73.04 113.204 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -95.9 124.02 53.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.928 -0.397 . . . . 71.03 109.928 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.72 125.53 12.27 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.25 1.967 . . . . 65.12 113.674 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.27 -43.34 1.69 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.617 -0.72 . . . . 63.23 113.413 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.26 -51.89 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.653 0.227 . . . . 73.33 111.569 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.66 99.32 44.36 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 123.255 0.347 . . . . 74.32 111.177 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.63 165.65 31.87 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.379 2.053 . . . . 74.2 112.663 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.44 143.72 28.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.611 2.207 . . . . 74.42 113.264 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 56.48 41.21 29.06 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.62 0.768 . . . . 70.34 111.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.81 131.68 54.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.74 -0.664 . . . . 71.42 111.652 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.96 138.71 33.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.787 -1.097 . . . . 74.25 110.897 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 3.5 mt -115.12 156.46 25.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.543 -0.753 . . . . 75.55 110.908 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.94 119.84 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.952 -0.567 . . . . 72.32 109.721 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.9 m-85 -122.17 135.28 54.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.142 -0.481 . . . . 71.3 111.009 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.529 ' OD1' HH22 ' A' ' 73' ' ' MLY . 9.3 t70 -116.6 103.92 10.87 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.595 0.559 . . . . 73.13 110.212 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 26.6 m -104.72 153.17 6.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.187 -0.461 . . . . 63.14 111.065 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.13 125.75 35.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.472 -0.786 . . . . 72.23 110.209 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -72.95 101.93 3.33 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.867 -0.606 . . . . 70.2 110.455 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.39 -58.24 2.56 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.049 -0.523 . . . . 73.51 111.471 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 122.843 0.457 . . . . 74.51 110.775 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -124.11 144.44 49.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.06 -0.518 . . . . 71.15 110.689 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.465 0.317 0 O-C-N 123.499 0.499 . . . . 72.13 110.796 179.877 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 CA-C-O 119.042 -0.866 . . . . 72.04 112.657 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.25 -35.89 2.71 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.849 2.366 . . . . 72.12 113.098 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.7 p -103.72 138.07 40.87 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.415 0.447 . . . . 75.41 110.964 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.6 mtt -125.86 146.44 49.81 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.645 0.59 . . . . 73.21 111.086 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -114.04 -14.08 9.53 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.68 -0.691 . . . . 60.01 113.0 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 75' ' ' THR . 14.8 p -120.0 122.8 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 122.352 0.261 . . . . 72.33 110.799 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.36 118.97 29.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.84 -0.618 . . . . 74.24 110.491 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.7 t -107.11 132.41 54.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.092 -0.504 . . . . 62.43 110.254 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -120.47 123.65 43.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.571 -0.74 . . . . 74.44 110.138 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -78.35 126.37 30.68 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.945 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.64 -41.24 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.063 -0.971 . . . . 73.15 110.282 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t -130.2 119.08 18.53 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.979 -0.555 . . . . 74.32 110.405 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.2 130.43 17.57 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.6 2.2 . . . . 71.0 113.451 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -121.09 4.5 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.674 -0.694 . . . . 44.33 112.137 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.48 -46.24 12.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.67 0.235 . . . . 70.4 111.01 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.51 -1.41 88.34 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.091 -0.504 . . . . 63.51 113.75 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -135.98 0.56 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.428 0.291 . . . . 75.24 111.713 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.93 92.28 3.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.038 0.447 . . . . 74.01 110.189 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -102.61 149.73 37.01 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 115.611 -0.722 . . . . 72.11 111.032 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.52 128.67 19.63 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.505 2.137 . . . . 73.5 112.696 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.331 0 CA-C-N 115.472 -0.786 . . . . 74.32 111.343 -179.046 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HE ' ' CA ' ' A' ' 51' ' ' GLY . 65.7 ttt180 -77.42 121.81 24.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.62 -0.718 . . . . 75.42 110.998 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.2 -28.96 6.37 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.998 -0.546 . . . . 64.12 113.322 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.45 160.56 14.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.403 0.281 . . . . 75.25 110.949 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.01 145.2 30.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.217 -0.447 . . . . 73.13 111.14 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 61.7 m -125.23 120.79 32.26 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.741 -0.663 . . . . 75.23 110.996 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.74 111.71 24.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.19 -0.914 . . . . 73.25 109.743 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.51 152.79 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.898 -0.592 . . . . 72.21 111.403 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.4 m-70 -103.48 125.19 49.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.488 -0.778 . . . . 75.31 109.311 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 39' ' ' SER . 40.1 p90 -115.95 167.66 10.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.493 0.553 . . . . 74.34 112.493 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.99 105.53 3.54 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.063 -0.971 . . . . 72.31 109.374 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.49 118.05 5.23 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.072 -0.585 . . . . 75.41 112.811 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.9 mtm -133.08 134.93 44.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.088 0.555 . . . . 73.1 110.92 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.18 172.03 0.33 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.435 -0.802 . . . . 75.02 112.318 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.97 -27.21 51.64 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.116 0.566 . . . . 72.0 111.947 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.79 -17.44 29.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.665 -0.698 . . . . 73.54 111.669 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.04 13.74 22.56 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.716 -0.755 . . . . 52.23 113.307 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.447 0 N-CA-C 110.067 -0.346 . . . . 74.31 110.067 179.601 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.41 HH21 ' OG ' ' A' ' 38' ' ' SER . . . . . . . . 0 C--O 1.235 0.31 0 N-CA-C 113.055 0.761 . . . . 75.44 113.055 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.69 -14.27 2.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.538 -1.21 . . . . 75.25 111.135 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.7 110.5 0.04 OUTLIER 'General case' 0 C--N 1.359 1.019 0 CA-C-O 121.088 0.47 . . . . 73.03 112.186 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.41 ' OG ' HH21 ' A' ' 35' ' ' MLY . 30.3 t -122.98 138.77 54.59 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.371 -0.832 . . . . 72.31 110.121 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.519 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 63.6 p -78.69 -36.56 43.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.879 -0.601 . . . . 71.12 112.557 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -22.97 62.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.68 0.622 . . . . 63.42 112.68 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -28.89 69.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.822 0.344 . . . . 64.34 110.904 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -95.5 -0.36 52.28 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.32 -0.854 . . . . 71.3 110.055 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 64.49 37.43 8.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.233 1.013 . . . . 75.12 111.822 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 116.201 -0.454 . . . . 74.11 111.585 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.33 157.92 55.68 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.839 2.359 . . . . 72.54 112.811 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -102.48 117.25 34.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.869 -0.605 . . . . 73.33 112.108 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 C--O 1.235 0.313 0 CA-C-N 115.147 -0.933 . . . . 75.21 109.858 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 21' ' ' THR . 31.3 p90 -147.18 165.58 29.58 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.347 0.405 . . . . 75.11 111.334 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 ttm -110.37 124.39 51.62 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.319 -0.623 . . . . 71.14 109.319 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -80.17 138.49 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.73 -0.668 . . . . 74.22 112.06 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' CA ' ' HE ' ' A' ' 18' ' ' ARG . . . 88.62 -5.57 84.52 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.13 -0.941 . . . . 71.31 112.899 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 122.443 0.297 . . . . 75.32 110.723 179.427 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 70.17 30.95 3.33 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.174 0.99 . . . . 72.42 112.159 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.03 -32.37 44.96 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.966 -0.561 . . . . 75.25 110.751 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 m -108.49 -175.87 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.254 -0.885 . . . . 75.44 110.37 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 pt -82.32 159.66 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.138 0.421 . . . . 64.33 112.138 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -59.17 -43.96 92.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.905 -0.589 . . . . 74.42 111.755 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.06 -18.36 62.35 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 123.532 0.52 . . . . 75.12 113.444 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.508 ' O ' HG11 ' A' ' 63' ' ' VAL . 3.4 m0 -84.21 -46.05 12.27 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 122.504 0.322 . . . . 64.24 111.328 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.32 -36.07 80.73 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.422 0.451 . . . . 71.32 111.448 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.68 -23.94 29.2 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.597 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.05 -44.6 5.33 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.387 0.429 . . . . 71.54 113.623 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 59' ' ' TRP . 5.0 p -65.55 -22.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.816 0.447 . . . . 74.11 111.616 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.92 -9.35 58.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.581 -0.736 . . . . 71.01 111.522 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -91.16 -11.92 36.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.64 -0.709 . . . . 73.32 111.336 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.42 156.64 19.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.365 -0.379 . . . . 71.25 111.02 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -111.66 167.36 10.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.783 -0.644 . . . . 63.14 110.579 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.26 123.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.937 0.495 . . . . 73.41 111.238 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.4 4.2 71.15 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.501 -0.772 . . . . 71.34 113.15 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -96.12 141.74 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.899 0.38 . . . . 75.44 111.335 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.18 108.85 15.17 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.167 -0.924 . . . . 74.25 109.297 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.22 156.59 45.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.992 -0.549 . . . . 72.53 111.864 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.292 0 CA-C-N 116.04 -0.527 . . . . 73.55 110.214 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -109.95 124.99 52.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.297 -0.41 . . . . 74.52 111.169 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m -93.55 112.78 24.75 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.283 -0.872 . . . . 71.34 109.464 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.8 mm -104.25 141.33 20.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 115.803 -0.635 . . . . 75.11 110.415 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.32 161.32 23.42 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.874 -1.057 . . . . 74.23 110.817 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.09 -16.97 49.32 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.78 2.32 . . . . 74.23 113.278 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.38 -25.49 25.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.392 0.433 . . . . 74.51 111.338 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -101.67 -19.28 15.48 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.013 -0.54 . . . . 74.1 111.369 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.19 -63.2 1.39 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.728 0.64 . . . . 54.11 112.728 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -133.68 -51.02 0.85 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.615 0.228 . . . . 74.54 111.615 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.15 -141.92 9.38 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.556 0.535 . . . . 71.34 112.029 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.42 -11.22 28.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 111.585 0.217 . . . . 63.32 111.585 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.54 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 63.55 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.16 -166.78 53.46 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.341 0.401 . . . . 73.04 113.223 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -97.93 124.92 46.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.885 -0.413 . . . . 71.03 109.885 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.96 123.74 10.33 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.223 1.949 . . . . 65.12 113.588 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.57 -46.08 1.22 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.618 -0.719 . . . . 63.23 113.394 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.77 -51.79 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.596 0.198 . . . . 73.33 111.527 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.4 mm -110.14 98.52 35.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 123.2 0.312 . . . . 74.32 111.013 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.69 165.71 31.7 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.427 2.085 . . . . 74.2 112.71 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.96 142.43 27.99 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.604 2.203 . . . . 74.42 113.197 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 56.84 44.44 23.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.599 0.76 . . . . 70.34 111.701 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.83 133.25 53.18 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.724 -0.671 . . . . 71.42 111.8 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -83.56 140.37 32.3 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.791 -1.095 . . . . 74.25 110.781 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 mt -117.26 155.7 29.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.651 -0.704 . . . . 75.55 111.064 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.93 127.97 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.828 -0.623 . . . . 72.32 109.772 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' O ' HD13 ' A' ' 74' ' ' LEU . 89.0 m-85 -130.13 132.64 46.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.126 -0.488 . . . . 71.3 110.565 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 t70 -115.37 104.3 11.65 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.13 -0.486 . . . . 73.13 110.142 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 26.2 m -106.78 153.13 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.08 -0.509 . . . . 63.14 111.126 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.94 125.98 36.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.507 -0.77 . . . . 72.23 110.24 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.06 101.96 3.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.708 -0.678 . . . . 70.2 110.485 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.91 -58.05 2.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.331 -0.395 . . . . 73.51 111.37 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 122.788 0.435 . . . . 74.51 110.862 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.32 147.61 49.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.07 -0.514 . . . . 71.15 110.622 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.465 0.287 0 CA-C-N 116.271 -0.422 . . . . 72.13 110.745 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 CA-C-O 119.059 -0.856 . . . . 72.04 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.51 135.91 18.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.881 2.387 . . . . 72.12 112.777 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.9 m -128.69 146.86 50.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.889 -0.596 . . . . 75.41 110.922 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.9 mmt 71.09 -49.08 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.43 1.092 . . . . 73.21 112.533 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 131.4 -22.33 4.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.465 -0.398 . . . . 60.01 112.986 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.9 p -116.38 122.91 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.409 0.284 . . . . 72.33 110.449 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.9 119.63 32.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.896 -0.593 . . . . 74.24 111.054 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.8 p -108.67 138.92 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.951 -0.568 . . . . 62.43 111.027 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -125.08 123.93 40.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.524 -0.762 . . . . 74.44 110.27 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.15 126.18 30.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.255 -0.429 . . . . 75.4 110.928 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -39.83 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.087 -0.96 . . . . 73.15 110.337 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -132.13 119.16 16.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 123.54 0.525 . . . . 74.32 110.467 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 130.33 17.01 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.619 2.213 . . . . 71.0 113.32 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.66 -121.45 4.46 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.746 -0.661 . . . . 44.33 112.18 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.09 -46.47 11.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.652 0.226 . . . . 70.4 111.015 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.13 -1.32 87.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 116.005 -0.543 . . . . 63.51 113.646 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -136.5 0.73 2.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.872 0.323 . . . . 75.24 111.872 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.91 92.79 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.056 0.455 . . . . 74.01 110.352 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.8 149.96 37.69 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.52 -0.764 . . . . 72.11 110.929 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -64.95 128.66 21.26 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.468 2.112 . . . . 73.5 112.639 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.409 0 CA-C-N 115.423 -0.808 . . . . 74.32 111.524 -178.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -77.36 125.87 30.02 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.583 -0.735 . . . . 75.42 111.191 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.81 -26.31 10.84 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 116.006 -0.543 . . . . 64.12 113.231 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 160.26 14.5 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.364 0.266 . . . . 75.25 110.891 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.555 HG22 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -81.91 145.15 30.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.023 -0.535 . . . . 73.13 111.523 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.5 t -120.1 115.66 24.12 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.48 -0.782 . . . . 75.23 110.343 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -89.65 110.49 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.612 -0.722 . . . . 73.25 109.745 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.8 m -147.44 151.75 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.035 -0.529 . . . . 72.21 111.464 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -102.28 125.41 48.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.386 -0.825 . . . . 75.31 109.031 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 41.3 p90 -116.15 167.79 10.68 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.877 0.695 . . . . 74.34 112.877 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.3 m -148.91 112.14 4.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.015 . . . . 72.31 109.535 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.27 119.18 6.09 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.042 -0.526 . . . . 75.41 112.698 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.8 mtm -130.06 131.3 45.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.876 0.47 . . . . 73.1 111.126 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.04 170.12 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.67 -0.696 . . . . 75.02 112.069 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -56.19 -25.24 46.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.108 0.563 . . . . 72.0 112.147 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.12 -17.36 27.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.83 -0.623 . . . . 73.54 111.351 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.34 13.79 21.9 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.765 -0.731 . . . . 52.23 113.377 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.851 -0.425 . . . . 74.31 109.851 179.63 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.402 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 112.916 0.71 . . . . 75.44 112.916 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.458 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.3 p90 -133.62 -14.54 2.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.266 -1.334 . . . . 75.25 111.275 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -161.62 111.54 1.6 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.069 0.461 . . . . 73.03 111.99 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 2.5 p -116.55 120.54 39.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.36 -0.836 . . . . 72.31 110.865 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.7 p -78.36 -35.5 47.31 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.231 -0.441 . . . . 71.12 112.159 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -76.73 -23.31 53.04 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.853 0.686 . . . . 63.42 112.853 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -25.37 68.19 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.752 0.311 . . . . 64.34 111.32 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -92.05 1.07 57.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.417 -0.81 . . . . 71.3 109.747 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 63.0 36.43 12.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.195 0.998 . . . . 75.12 111.441 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 112.393 0.516 . . . . 74.11 112.393 -179.287 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.92 158.07 46.61 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.901 2.401 . . . . 72.54 112.748 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -99.41 118.3 35.72 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.049 -0.523 . . . . 73.33 112.046 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.467 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.223 -0.898 . . . . 75.21 110.004 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.6 p90 -150.43 160.76 43.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.245 0.341 . . . . 75.11 111.621 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 21' ' ' THR . 3.3 mpp? -104.69 134.59 47.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.321 -0.399 . . . . 71.14 110.589 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -78.57 140.34 38.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.811 -0.632 . . . . 74.22 111.739 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.84 -8.14 60.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 115.437 -0.801 . . . . 71.31 113.354 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 122.562 0.345 . . . . 75.32 110.722 179.32 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 69.61 27.84 4.68 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.098 0.959 . . . . 72.42 112.203 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.75 -13.26 60.04 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.005 -0.543 . . . . 75.25 110.764 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.53 -178.56 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.157 -0.928 . . . . 75.44 110.544 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 pt -77.56 158.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.999 0.37 . . . . 64.33 111.999 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -59.81 -42.88 94.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.862 -0.608 . . . . 74.42 111.893 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.34 -20.59 63.38 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.031 -0.531 . . . . 75.12 113.253 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -84.12 -44.41 14.05 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 116.699 0.25 . . . . 64.24 111.052 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.89 -36.96 84.85 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.212 0.32 . . . . 71.32 111.53 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.57 -26.75 27.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.894 -0.594 . . . . 73.22 111.784 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.53 -46.35 4.95 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 123.435 0.459 . . . . 71.54 113.974 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 64' ' ' ALA . 2.1 p -63.51 -25.95 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.754 0.422 . . . . 74.11 111.697 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 63' ' ' VAL . . . -75.53 -7.25 53.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.42 -0.809 . . . . 71.01 111.618 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -93.77 -9.89 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.78 -0.645 . . . . 73.32 111.316 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.55 156.26 19.2 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.35 -0.386 . . . . 71.25 110.785 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 p -110.76 167.09 10.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.851 -0.613 . . . . 63.14 110.63 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.21 123.23 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.92 0.488 . . . . 73.41 111.165 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.28 3.34 69.7 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.421 -0.809 . . . . 71.34 113.17 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.87 142.07 27.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 75.44 111.353 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.75 108.73 14.33 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.106 -0.952 . . . . 74.25 109.401 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.38 157.08 44.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.02 -0.536 . . . . 72.53 111.848 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.299 0 CA-C-N 116.083 -0.508 . . . . 73.55 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -104.02 134.57 47.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 74.52 110.828 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.2 m -100.48 113.14 25.68 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 71.34 109.402 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.5 mm -105.16 134.83 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.255 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.92 161.64 23.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.175 -0.92 . . . . 74.23 110.712 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.94 -16.99 48.6 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.634 2.223 . . . . 74.23 113.237 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.76 -25.32 24.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.284 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -101.37 -19.18 15.71 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.0 -0.545 . . . . 74.1 111.362 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.78 -63.24 1.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.724 0.639 . . . . 54.11 112.724 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -133.51 -52.43 0.88 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.634 0.235 . . . . 74.54 111.634 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.79 -140.32 7.84 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.458 0.474 . . . . 71.34 112.053 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 -10.87 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 111.629 0.233 . . . . 63.32 111.629 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.29 -60.36 1.54 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.26 -0.427 . . . . 63.55 110.507 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.04 -166.93 54.41 Favored Glycine 0 C--N 1.346 1.108 0 O-C-N 123.331 0.394 . . . . 73.04 113.232 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -97.63 124.11 49.59 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.909 -0.404 . . . . 71.03 109.909 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.56 123.66 10.38 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.242 1.961 . . . . 65.12 113.589 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.66 -48.45 0.94 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.573 -0.739 . . . . 63.23 113.361 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.96 -51.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 111.594 0.22 . . . . 73.33 111.594 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 mm -109.55 97.54 27.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 123.273 0.358 . . . . 74.32 111.079 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.49 165.56 32.09 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.381 2.054 . . . . 74.2 112.747 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.06 143.55 29.01 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.558 2.172 . . . . 74.42 113.256 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.67 41.85 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.641 0.776 . . . . 70.34 111.793 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.94 132.32 54.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.683 -0.69 . . . . 71.42 111.697 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -83.27 136.85 34.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.719 -1.128 . . . . 74.25 110.991 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -115.18 153.32 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.518 -0.764 . . . . 75.55 110.875 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.88 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 72.32 109.559 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 27' ' ' THR . 86.3 m-85 -130.15 135.13 47.85 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.128 -0.487 . . . . 71.3 110.775 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.3 t70 -116.33 104.82 11.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.973 -0.558 . . . . 73.13 110.186 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 26.7 m -105.9 153.0 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 115.979 -0.555 . . . . 63.14 110.972 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.8 125.37 35.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.752 . . . . 72.23 110.182 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.98 100.94 3.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.77 -0.65 . . . . 70.2 110.388 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.3 -57.91 2.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.049 -0.523 . . . . 73.51 111.391 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 122.827 0.451 . . . . 74.51 110.774 -179.897 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -123.78 145.42 49.05 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.077 -0.511 . . . . 71.15 110.734 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.465 0.305 0 O-C-N 123.523 0.514 . . . . 72.13 110.821 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 118.993 -0.893 . . . . 72.04 112.687 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.38 157.63 41.1 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.824 2.349 . . . . 72.12 112.794 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.3 m -127.36 -40.9 1.77 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.842 -0.617 . . . . 75.41 111.258 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 72.4 mtm -97.36 -40.87 8.51 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.388 0.43 . . . . 73.21 111.29 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 123.98 -42.06 1.64 Allowed Glycine 0 C--N 1.339 0.713 0 O-C-N 123.508 0.505 . . . . 60.01 112.484 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.2 p -121.71 118.81 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.741 0.305 . . . . 72.33 110.736 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.23 118.34 30.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.714 -0.675 . . . . 74.24 110.751 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.5 p -108.76 138.13 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.887 -0.597 . . . . 62.43 111.039 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.41 124.31 42.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.452 -0.795 . . . . 74.44 110.181 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.01 127.05 31.73 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.447 0.467 . . . . 75.4 110.973 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -110.17 -39.58 3.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.132 -0.94 . . . . 73.15 110.323 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -132.42 119.24 16.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.526 . . . . 74.32 110.473 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.52 131.0 18.03 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.644 2.229 . . . . 71.0 113.336 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.34 -121.4 4.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.727 -0.67 . . . . 44.33 112.236 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -84.21 -46.58 11.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.688 0.244 . . . . 70.4 111.045 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.32 87.16 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.111 -0.495 . . . . 63.51 113.679 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -136.43 0.92 2.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.405 0.282 . . . . 75.24 111.76 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -122.35 92.88 3.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.101 0.477 . . . . 74.01 110.291 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -103.39 149.77 37.33 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 115.552 -0.749 . . . . 72.11 111.12 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.97 125.01 12.5 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.465 2.11 . . . . 73.5 112.74 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.397 0 CA-C-N 115.441 -0.8 . . . . 74.32 111.35 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.36 128.75 34.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 75.42 111.112 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.49 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 112.15 -26.74 10.93 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.847 -0.615 . . . . 64.12 113.066 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -99.56 160.43 14.3 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.54 0.336 . . . . 75.25 110.843 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.32 144.91 30.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.331 -0.395 . . . . 73.13 111.336 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 38.8 t -122.61 117.89 26.9 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.606 -0.724 . . . . 75.23 110.714 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.75 110.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.497 -0.774 . . . . 73.25 109.613 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.7 m -147.85 153.33 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.019 -0.537 . . . . 72.21 111.457 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.2 m-70 -103.66 125.31 50.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.45 -0.795 . . . . 75.31 109.355 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 40.9 p90 -116.5 165.95 12.65 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 74.34 112.361 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.5 m -148.05 108.45 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.189 -0.914 . . . . 72.31 109.402 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.534 ' O ' ' HG2' ' A' ' 35' ' ' MLY . . . -89.17 119.96 5.6 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.032 -0.531 . . . . 75.41 112.954 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 mtm -133.59 129.98 37.74 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.032 0.533 . . . . 73.1 111.0 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -54.79 170.53 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.622 -0.717 . . . . 75.02 112.457 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.5 -27.32 47.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.214 0.606 . . . . 72.0 112.184 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -88.98 -17.17 30.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.831 -0.622 . . . . 73.54 111.279 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.5 13.78 21.61 Favored Glycine 0 C--N 1.346 1.102 0 C-N-CA 120.823 -0.703 . . . . 52.23 113.004 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.722 -0.473 . . . . 74.31 109.722 179.488 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.534 ' HG2' ' O ' ' A' ' 28' ' ' GLY . . . . . . . . 0 CA--C 1.508 -0.653 0 CA-C-N 115.973 -0.558 . . . . 75.44 112.252 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.4 p90 -131.99 -11.52 3.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.586 -1.188 . . . . 75.25 111.945 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.84 115.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 112.708 0.633 . . . . 73.03 112.708 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.8 t -122.82 147.02 47.02 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.395 -0.82 . . . . 72.31 110.681 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.542 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 53.4 p -78.59 -30.56 46.76 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.574 -0.739 . . . . 71.12 112.115 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -75.17 -24.81 57.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.839 0.681 . . . . 63.42 112.839 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.86 -29.63 69.64 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.746 0.308 . . . . 64.34 111.061 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -92.54 1.33 57.32 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.455 -0.793 . . . . 71.3 109.999 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 61.79 40.13 13.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.127 0.971 . . . . 75.12 111.498 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.904 -0.589 . . . . 74.11 111.887 -179.297 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -71.49 157.88 55.26 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.741 2.294 . . . . 72.54 112.801 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -101.96 117.46 34.88 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.895 -0.593 . . . . 73.33 112.123 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.461 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 115.134 -0.939 . . . . 75.21 109.833 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' THR . 29.3 p90 -148.12 165.22 31.52 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.405 0.441 . . . . 75.11 111.401 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.49 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 2.9 mtt -109.46 126.94 54.02 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.03 -0.532 . . . . 71.14 109.75 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -82.6 138.05 34.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.688 -0.687 . . . . 74.22 112.11 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.46 -6.28 82.33 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.067 -0.969 . . . . 71.31 112.872 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 122.49 0.316 . . . . 75.32 110.673 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 69.16 31.61 3.96 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.186 0.994 . . . . 72.42 112.071 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -79.55 -32.03 42.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.872 -0.604 . . . . 75.25 110.84 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.46 -174.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.447 -0.797 . . . . 75.44 110.246 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.5 pt -81.98 157.95 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 111.903 0.334 . . . . 64.33 111.903 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -59.68 -43.83 93.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.001 -0.545 . . . . 74.42 112.166 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.44 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -64.45 -18.27 63.12 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.452 0.47 . . . . 75.12 113.326 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.412 ' O ' HG13 ' A' ' 63' ' ' VAL . 5.2 m0 -84.26 -46.81 11.44 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 122.438 0.295 . . . . 64.24 111.372 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.31 -36.35 83.79 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.265 0.353 . . . . 71.32 111.369 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.46 -24.21 29.59 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 73.22 111.69 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.05 -45.18 4.87 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.436 0.46 . . . . 71.54 113.639 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 59' ' ' TRP . 3.9 p -65.33 -24.21 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.796 0.438 . . . . 74.11 111.489 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.14 -7.17 54.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.445 -0.798 . . . . 71.01 111.53 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -94.3 -11.46 30.06 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.672 -0.695 . . . . 73.32 111.306 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.61 156.4 18.63 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.305 0.378 . . . . 71.25 110.794 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -110.91 167.33 10.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.941 -0.572 . . . . 63.14 110.639 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.21 123.36 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.928 0.491 . . . . 73.41 111.161 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.08 3.49 69.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.504 -0.771 . . . . 71.34 113.179 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.89 142.68 27.19 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 120.97 0.414 . . . . 75.44 111.352 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.04 109.2 14.77 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.097 -0.956 . . . . 74.25 109.413 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.33 156.34 46.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.034 -0.53 . . . . 72.53 111.917 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.537 HH21 ' OD2' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-N 116.111 -0.495 . . . . 73.55 110.455 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -104.26 135.29 46.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.912 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.0 m -100.77 111.46 23.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.705 -0.68 . . . . 71.34 109.344 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.6 mm -103.01 130.99 52.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.906 -0.588 . . . . 75.11 110.19 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.49 161.48 27.66 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.294 -0.866 . . . . 74.23 111.027 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.37 -17.11 51.41 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.626 2.217 . . . . 74.23 113.223 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.43 -27.13 21.74 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.511 0.507 . . . . 74.51 111.221 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.38 -18.96 18.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 74.1 111.362 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.87 -60.13 2.1 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.597 0.592 . . . . 54.11 112.597 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 91' ' ' ILE . 89.7 m-85 -129.59 -49.97 1.16 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 111.704 0.261 . . . . 74.54 111.704 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 85' ' ' THR . . . 128.97 55.71 0.11 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.216 -0.516 . . . . 71.34 113.572 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 64.38 -12.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.939 1.089 . . . . 63.32 113.939 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 83' ' ' GLY . 1.9 m -98.26 -60.22 1.6 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.257 -0.275 . . . . 63.55 110.257 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.22 -174.76 29.84 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.36 0.412 . . . . 73.04 113.66 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.502 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 5.1 t60 -93.92 128.55 40.97 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.915 -0.402 . . . . 71.03 109.915 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.04 122.96 10.09 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.271 1.981 . . . . 65.12 113.586 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.14 -46.69 1.13 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.573 -0.74 . . . . 63.23 113.293 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.57 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.511 0.189 . . . . 73.33 111.511 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 30.2 mm -109.85 98.72 35.27 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 123.249 0.343 . . . . 74.32 110.9 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.71 165.59 32.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.439 2.093 . . . . 74.2 112.629 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.5 146.89 31.45 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.466 2.11 . . . . 74.42 113.298 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 55.67 37.71 29.22 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.659 0.784 . . . . 70.34 111.993 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.37 128.97 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.734 -0.666 . . . . 71.42 111.73 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.41 135.44 34.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.828 -1.078 . . . . 74.25 110.688 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 3.1 mt -111.72 158.11 19.71 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.606 -0.725 . . . . 75.55 111.164 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.13 114.6 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.982 -0.554 . . . . 72.32 109.842 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.8 m-85 -116.79 136.16 53.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.131 -0.486 . . . . 71.3 111.043 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.537 ' OD2' HH21 ' A' ' 73' ' ' MLY . 10.0 t70 -116.58 104.69 11.65 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.909 -0.587 . . . . 73.13 110.197 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 25.0 m -105.57 152.71 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.076 -0.511 . . . . 63.14 110.967 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.3 125.46 36.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.543 -0.753 . . . . 72.23 110.085 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -72.98 101.22 3.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.724 -0.671 . . . . 70.2 110.548 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.87 -57.69 2.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.177 -0.465 . . . . 73.51 111.399 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 122.843 0.457 . . . . 74.51 110.843 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.65 145.6 49.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.02 -0.536 . . . . 71.15 110.664 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.281 -0.418 . . . . 72.13 110.757 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.715 0 CA-C-O 119.253 -0.748 . . . . 72.04 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.54 -34.68 3.22 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.059 2.506 . . . . 72.12 113.124 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.8 m 63.25 128.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.01 0.924 . . . . 75.41 112.148 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -97.84 -41.0 8.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.78 -0.646 . . . . 73.21 111.374 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 126.11 -39.58 1.99 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 123.449 0.468 . . . . 60.01 112.597 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 75' ' ' THR . 15.0 p -119.83 123.19 70.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.694 0.283 . . . . 72.33 110.701 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.72 120.22 32.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.839 -0.619 . . . . 74.24 110.485 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 11.6 t -107.89 128.83 62.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.119 -0.491 . . . . 62.43 110.232 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.41 123.87 47.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.596 -0.729 . . . . 74.44 110.007 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.4 m -78.81 128.61 33.59 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.482 0.489 . . . . 75.4 110.959 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.35 -41.73 4.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.175 -0.92 . . . . 73.15 110.259 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -129.67 118.84 18.95 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.938 -0.574 . . . . 74.32 110.399 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.33 129.36 15.83 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.568 2.179 . . . . 71.0 113.375 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.67 -120.96 4.17 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.661 -0.7 . . . . 44.33 112.157 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.74 -46.19 12.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.634 0.217 . . . . 70.4 111.003 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.4 -1.23 88.52 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.04 -0.527 . . . . 63.51 113.72 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -136.85 1.4 2.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.501 0.32 . . . . 75.24 111.76 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -122.21 92.73 3.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.048 0.451 . . . . 74.01 110.202 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -103.12 149.57 37.03 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.57 -0.741 . . . . 72.11 110.956 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.5 124.66 12.73 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.55 2.167 . . . . 73.5 112.962 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 CA-C-N 115.498 -0.774 . . . . 74.32 111.464 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.41 123.19 26.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.6 -0.727 . . . . 75.42 111.565 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.19 -23.5 10.55 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.881 -0.6 . . . . 64.12 113.668 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.438 HE22 HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -102.44 160.27 14.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.796 0.298 . . . . 75.25 110.985 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.656 HG21 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -79.37 143.5 35.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.133 -0.485 . . . . 73.13 111.276 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 57.3 m -122.36 116.22 23.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.662 -0.699 . . . . 75.23 110.44 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 t -90.4 110.78 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.492 -0.776 . . . . 73.25 109.863 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.94 151.73 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.915 -0.584 . . . . 72.21 111.327 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.7 m-70 -102.51 125.28 49.18 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.502 -0.772 . . . . 75.31 109.162 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 39' ' ' SER . 41.0 p90 -115.89 167.68 10.74 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.651 0.611 . . . . 74.34 112.651 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.8 m -148.92 108.54 4.0 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.042 -0.981 . . . . 72.31 109.58 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 115.76 5.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 121.163 -0.541 . . . . 75.41 112.555 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.3 mtm -130.44 136.48 49.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.039 0.535 . . . . 73.1 110.702 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.49 172.29 0.51 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.616 -0.72 . . . . 75.02 112.205 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -56.07 -26.29 48.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.157 0.583 . . . . 72.0 112.008 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.93 -17.39 28.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.671 -0.695 . . . . 73.54 111.307 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.55 13.79 21.5 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.715 -0.755 . . . . 52.23 113.385 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.43 0 N-CA-C 110.191 -0.3 . . . . 74.31 110.191 179.712 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 112.876 0.695 . . . . 75.44 112.876 -179.55 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 24.4 p90 -134.63 -12.35 2.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.512 -1.222 . . . . 75.25 110.98 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 179.18 110.96 0.03 OUTLIER 'General case' 0 C--N 1.36 1.049 0 CA-C-O 121.054 0.454 . . . . 73.03 112.089 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 t -122.26 137.39 54.86 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.339 -0.846 . . . . 72.31 110.131 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.583 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.2 t -78.52 -34.07 47.54 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.627 -0.715 . . . . 71.12 112.288 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -75.27 -23.17 57.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.422 0.527 . . . . 63.42 112.422 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -24.29 67.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.8 0.333 . . . . 64.34 111.051 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -96.13 -0.42 50.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.37 -0.832 . . . . 71.3 109.754 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 64.04 36.34 9.93 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.188 0.995 . . . . 75.12 111.525 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.115 -0.493 . . . . 74.11 111.873 -179.365 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -72.69 158.06 51.17 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.961 2.441 . . . . 72.54 113.056 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.01 118.85 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.848 -0.615 . . . . 73.33 112.068 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.297 -0.865 . . . . 75.21 110.286 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.3 p90 -151.05 164.36 36.62 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.295 0.372 . . . . 75.11 111.546 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.656 ' SD ' HG21 ' A' ' 21' ' ' THR . 0.7 OUTLIER -107.57 134.79 50.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.302 -0.408 . . . . 71.14 110.525 178.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.88 141.71 37.43 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.817 -0.629 . . . . 74.22 111.569 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.84 62.04 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.605 -0.725 . . . . 71.31 113.277 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 122.63 0.372 . . . . 75.32 110.707 179.362 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 70.02 27.5 4.34 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.147 0.979 . . . . 72.42 112.2 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.25 -19.9 57.9 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.016 -0.538 . . . . 75.25 110.715 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.86 -178.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.217 -0.901 . . . . 75.44 110.443 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -77.82 160.39 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 64.33 112.101 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -60.59 -44.43 96.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.024 -0.535 . . . . 74.42 111.811 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.05 61.54 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 116.099 -0.5 . . . . 75.12 113.418 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -84.1 -43.67 14.81 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.677 0.239 . . . . 64.24 111.07 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -66.83 -37.72 85.04 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.367 0.417 . . . . 71.32 111.594 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.45 -25.25 29.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.74 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.08 -46.35 4.78 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.445 0.465 . . . . 71.54 113.89 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.55 -25.41 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.827 0.451 . . . . 74.11 111.714 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.67 -8.72 57.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.342 -0.845 . . . . 71.01 111.728 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -91.69 -8.86 45.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.877 -0.601 . . . . 73.32 111.202 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.01 156.49 19.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.265 -0.425 . . . . 71.25 110.969 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 p -111.47 166.79 10.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.823 -0.626 . . . . 63.14 110.565 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.92 123.21 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.93 0.492 . . . . 73.41 111.279 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 3.73 70.2 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.475 -0.784 . . . . 71.34 113.122 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -95.51 141.38 29.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.96 0.41 . . . . 75.44 111.306 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.69 109.2 15.36 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.113 -0.949 . . . . 74.25 109.339 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.96 155.43 47.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.909 -0.587 . . . . 72.53 111.833 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-N 116.105 -0.498 . . . . 73.55 110.085 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -111.32 124.86 53.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.297 -0.41 . . . . 74.52 111.161 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.8 m -93.08 112.8 24.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.322 -0.853 . . . . 71.34 109.364 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.8 mm -104.4 142.1 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.758 -0.656 . . . . 75.11 110.463 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.485 ' H ' ' HG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -103.93 161.57 22.54 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 114.807 -1.088 . . . . 74.23 110.784 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.91 -17.19 49.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.806 2.338 . . . . 74.23 113.274 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.21 -25.29 25.7 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.465 0.478 . . . . 74.51 111.287 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -101.38 -19.52 15.56 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.037 -0.529 . . . . 74.1 111.456 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.25 1.37 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.785 0.661 . . . . 54.11 112.785 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -133.31 -51.16 0.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.637 0.236 . . . . 74.54 111.637 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.29 -141.44 8.92 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.489 0.493 . . . . 71.34 112.056 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.76 -11.31 27.18 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.569 0.211 . . . . 63.32 111.569 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.51 -60.39 1.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.303 -0.408 . . . . 63.55 110.46 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.84 53.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.368 0.418 . . . . 73.04 113.126 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -97.29 124.48 48.98 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.86 -0.422 . . . . 71.03 109.86 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.72 124.03 10.7 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.211 1.941 . . . . 65.12 113.653 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.99 -46.88 1.11 Allowed Glycine 0 C--N 1.337 0.605 0 CA-C-N 115.615 -0.721 . . . . 63.23 113.373 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.9 -51.67 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 111.602 0.223 . . . . 73.33 111.602 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.4 mm -109.95 98.36 33.89 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 123.176 0.298 . . . . 74.32 111.09 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.69 165.71 31.7 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.454 2.103 . . . . 74.2 112.676 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.03 143.09 28.54 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.544 2.163 . . . . 74.42 113.192 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 56.66 43.24 25.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.628 0.771 . . . . 70.34 111.795 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.82 132.84 53.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.731 -0.668 . . . . 71.42 111.773 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -82.55 141.22 32.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.784 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -119.01 154.46 33.04 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.693 -0.685 . . . . 75.55 111.068 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 128.01 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.835 -0.62 . . . . 72.32 109.838 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' THR . 89.8 m-85 -130.19 132.95 46.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.063 -0.517 . . . . 71.3 110.617 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 5.6 t70 -116.22 104.95 12.03 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.091 -0.504 . . . . 73.13 110.243 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 24.8 m -107.03 153.2 8.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.008 -0.542 . . . . 63.14 111.09 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.89 125.96 34.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.497 -0.774 . . . . 72.23 110.482 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 101.54 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.771 -0.649 . . . . 70.2 110.219 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -89.84 -58.53 2.48 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.222 -0.445 . . . . 73.51 111.391 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 122.839 0.456 . . . . 74.51 110.765 -179.896 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.438 HD23 HE22 ' A' ' 20' ' ' GLN . 9.7 mt -124.36 146.14 49.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.15 -0.477 . . . . 71.15 110.671 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.464 0.264 0 O-C-N 123.503 0.502 . . . . 72.13 110.818 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 CA-C-O 119.236 -0.758 . . . . 72.04 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.95 136.23 18.3 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 123.037 2.491 . . . . 72.12 112.814 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 45.8 p -128.09 -43.05 1.51 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.904 -0.589 . . . . 75.41 111.327 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 5.6 tpt -129.0 -43.25 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.425 0.453 . . . . 73.21 110.98 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 123.85 -46.84 1.06 Allowed Glycine 0 C--N 1.339 0.749 0 O-C-N 123.486 0.491 . . . . 60.01 112.455 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 75' ' ' THR . 14.4 p -122.75 122.56 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.638 0.256 . . . . 72.33 110.615 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.69 119.52 32.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 74.24 110.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.6 t -107.73 129.27 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.083 -0.508 . . . . 62.43 110.113 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.46 123.4 45.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.617 -0.72 . . . . 74.44 110.163 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -78.19 125.45 29.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.221 -0.445 . . . . 75.4 111.001 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -107.69 -41.35 5.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.055 -0.975 . . . . 73.15 110.272 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -129.98 119.19 18.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.936 -0.575 . . . . 74.32 110.382 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.29 130.43 17.46 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.623 2.215 . . . . 71.0 113.416 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.03 -121.11 4.47 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.712 -0.676 . . . . 44.33 112.096 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -83.96 -46.14 12.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.648 0.224 . . . . 70.4 110.939 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.66 -1.44 88.17 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.542 0.526 . . . . 63.51 113.757 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -136.33 0.6 2.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.427 0.291 . . . . 75.24 111.781 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 92.46 3.74 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.032 0.444 . . . . 74.01 110.333 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -103.49 149.56 37.16 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.544 -0.753 . . . . 72.11 110.958 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.88 123.06 10.79 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.51 2.14 . . . . 73.5 112.714 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 115.384 -0.825 . . . . 74.32 111.44 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -77.3 127.85 33.31 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.725 -0.67 . . . . 75.42 111.317 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' O ' ' HE3' ' A' ' 49' ' ' MET . . . 112.04 -26.34 11.56 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.716 -0.675 . . . . 64.12 113.105 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -99.77 160.23 14.46 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.443 0.297 . . . . 75.25 110.866 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.29 145.19 29.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 73.13 111.308 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.3 t -120.08 116.93 26.68 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.563 -0.744 . . . . 75.23 110.544 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -90.91 110.79 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.415 -0.812 . . . . 73.25 109.584 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.1 m -147.89 152.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.052 -0.522 . . . . 72.21 111.521 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.1 m-70 -102.62 125.27 49.3 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.401 -0.818 . . . . 75.31 109.066 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 41.5 p90 -115.33 166.3 12.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.802 0.667 . . . . 74.34 112.802 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.8 m -149.15 110.56 4.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.884 -1.053 . . . . 72.31 109.237 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 35' ' ' MLY . . . -95.43 117.26 5.59 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.157 -0.544 . . . . 75.41 112.994 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.0 mtm -126.38 129.97 49.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.918 0.487 . . . . 73.1 111.15 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.96 171.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.709 -0.678 . . . . 75.02 112.181 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -57.09 -26.27 60.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.085 0.554 . . . . 72.0 111.94 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.25 -17.95 28.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.812 -0.631 . . . . 73.54 111.716 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.03 14.1 23.56 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 120.75 -0.738 . . . . 52.23 113.367 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.379 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.41 ' HG2' ' O ' ' A' ' 28' ' ' GLY . . . . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 113.372 0.879 . . . . 75.44 113.372 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.486 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 34.5 p90 -134.12 -10.28 2.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.127 -1.397 . . . . 75.25 111.339 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -163.44 111.57 1.22 Allowed 'General case' 0 C--N 1.355 0.827 0 CA-C-O 121.312 0.577 . . . . 73.03 111.698 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 p -119.18 117.7 29.35 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.838 -1.074 . . . . 72.31 111.115 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.511 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 65.0 p -78.79 -36.49 42.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.929 -0.578 . . . . 71.12 112.25 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -23.1 53.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.979 0.733 . . . . 63.42 112.979 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -24.0 67.63 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.842 0.353 . . . . 64.34 111.233 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -93.7 -0.25 56.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.394 -0.821 . . . . 71.3 109.68 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 63.51 36.25 11.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.29 1.036 . . . . 75.12 111.568 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 CA-C-N 116.21 -0.45 . . . . 74.11 112.147 -179.402 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.68 158.07 51.2 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.937 2.424 . . . . 72.54 112.756 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.404 ' CD1' ' HE2' ' A' ' 26' ' ' TYR . 18.6 t80 -101.16 118.45 37.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.994 -0.548 . . . . 73.33 112.046 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.502 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 115.172 -0.922 . . . . 75.21 110.061 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.2 p90 -149.09 161.63 41.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.308 0.38 . . . . 75.11 111.383 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.413 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 7.2 mtt -105.78 132.26 52.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.69 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.45 139.51 39.67 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.946 -0.57 . . . . 74.22 111.657 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.73 53.99 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.524 -0.762 . . . . 71.31 113.249 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 122.516 0.327 . . . . 75.32 110.693 179.186 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 70.0 27.06 4.47 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.121 0.968 . . . . 72.42 112.152 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.413 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 46.3 mt-10 -76.31 -14.37 60.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.974 -0.557 . . . . 75.25 110.867 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.9 m -127.25 -177.63 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.342 -0.845 . . . . 75.44 110.537 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.89 159.76 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.086 0.402 . . . . 64.33 112.086 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -60.17 -44.18 95.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.999 -0.546 . . . . 74.42 111.784 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.44 -20.78 61.57 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.081 -0.509 . . . . 75.12 113.467 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -84.15 -43.7 14.73 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.636 0.218 . . . . 64.24 111.208 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.3 -37.9 86.5 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.364 0.415 . . . . 71.32 111.536 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.44 -25.63 28.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.872 -0.604 . . . . 73.22 111.759 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.68 -46.37 4.89 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.399 0.437 . . . . 71.54 113.894 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.67 -25.02 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.766 0.426 . . . . 74.11 111.776 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 -8.43 56.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.362 -0.836 . . . . 71.01 111.678 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -91.9 -11.38 36.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.857 -0.611 . . . . 73.32 111.274 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.69 156.07 19.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.349 -0.387 . . . . 71.25 110.991 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.6 p -110.96 166.92 10.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.818 -0.628 . . . . 63.14 110.588 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.13 123.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 122.942 0.497 . . . . 73.41 111.274 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.78 4.58 69.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.448 -0.796 . . . . 71.34 113.148 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.16 141.71 29.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.971 0.415 . . . . 75.44 111.298 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.54 108.47 14.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.093 -0.958 . . . . 74.25 109.305 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.67 156.42 44.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.975 -0.557 . . . . 72.53 111.825 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.291 0 CA-C-N 116.078 -0.51 . . . . 73.55 110.312 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -110.27 124.76 52.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.165 -0.47 . . . . 74.52 111.117 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.8 m -93.4 113.33 25.47 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.412 -0.813 . . . . 71.34 109.567 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.52 142.63 18.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.892 -0.594 . . . . 75.11 110.509 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.56 162.14 20.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.829 -1.078 . . . . 74.23 110.708 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.33 -17.21 45.72 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.767 2.311 . . . . 74.23 113.242 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 74.51 111.235 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -101.89 -19.14 15.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.993 -0.549 . . . . 74.1 111.364 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.78 -62.7 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.677 0.621 . . . . 54.11 112.677 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -133.52 -53.85 0.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.598 0.221 . . . . 74.54 111.598 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.59 -137.71 6.02 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 123.497 0.498 . . . . 71.34 111.991 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.56 -9.14 25.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.558 0.21 . . . . 63.32 111.564 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 m -102.63 -60.38 1.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.303 -0.408 . . . . 63.55 110.577 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.41 -169.34 54.16 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.395 0.435 . . . . 73.04 113.156 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -96.65 123.34 54.41 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.901 -0.407 . . . . 71.03 109.901 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.76 125.21 12.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.166 1.911 . . . . 65.12 113.638 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.23 -47.95 1.0 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.566 -0.743 . . . . 63.23 113.292 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.31 -51.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 111.576 0.213 . . . . 73.33 111.576 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 mm -111.63 98.48 41.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.187 0.305 . . . . 74.32 111.213 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.09 165.75 31.68 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 122.448 2.099 . . . . 74.2 112.709 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.23 143.9 28.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.571 2.181 . . . . 74.42 113.164 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 56.88 41.66 27.59 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.569 0.748 . . . . 70.34 111.818 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.59 132.46 54.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.78 -0.646 . . . . 71.42 111.776 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -82.45 139.87 33.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.69 -1.141 . . . . 74.25 110.904 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 5.4 mt -118.86 152.2 36.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.617 -0.719 . . . . 75.55 110.9 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.2 132.03 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.82 -0.627 . . . . 72.32 109.503 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' THR . 88.5 m-85 -132.87 132.94 42.65 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 71.3 110.787 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 73' ' ' MLY . 8.5 t70 -116.28 103.39 10.45 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.943 -0.571 . . . . 73.13 109.899 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 24.7 m -105.97 153.66 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.991 -0.549 . . . . 63.14 111.17 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.2 125.82 35.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.466 -0.788 . . . . 72.23 110.38 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.11 102.11 3.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.803 -0.635 . . . . 70.2 110.385 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.2 -58.84 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.139 -0.482 . . . . 73.51 111.334 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 122.74 0.416 . . . . 74.51 110.767 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.9 mt -126.84 144.46 50.96 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.045 -0.525 . . . . 71.15 110.679 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.464 0.268 0 O-C-N 123.534 0.521 . . . . 72.13 110.802 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 CA-C-O 119.185 -0.786 . . . . 72.04 112.47 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.86 134.69 16.7 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 123.069 2.513 . . . . 72.12 112.741 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.9 m -129.79 -42.26 1.28 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.881 -0.599 . . . . 75.41 111.267 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 21.5 mmt -117.83 154.22 32.17 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.398 0.436 . . . . 73.21 111.05 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -90.79 -26.07 23.35 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.844 -0.616 . . . . 60.01 113.002 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.2 p -131.27 118.8 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.72 0.295 . . . . 72.33 110.471 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.73 121.18 40.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.816 -0.629 . . . . 74.24 110.656 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 15.7 t -109.72 125.5 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.022 -0.536 . . . . 62.43 110.179 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.21 125.14 53.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.578 -0.737 . . . . 74.44 110.066 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -79.33 127.68 32.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.157 -0.474 . . . . 75.4 110.946 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -108.93 -42.14 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.166 -0.924 . . . . 73.15 110.294 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -129.3 118.89 19.33 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.919 -0.582 . . . . 74.32 110.38 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.2 129.45 16.11 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.637 2.225 . . . . 71.0 113.406 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.98 -120.9 4.22 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.702 -0.681 . . . . 44.33 112.141 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.86 -46.22 12.39 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.678 0.239 . . . . 70.4 110.91 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.64 -1.43 88.2 Favored Glycine 0 C--N 1.342 0.87 0 O-C-N 123.561 0.538 . . . . 63.51 113.699 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -136.64 1.02 2.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.482 0.313 . . . . 75.24 111.799 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.99 92.45 3.73 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.055 0.455 . . . . 74.01 110.27 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -103.51 149.39 36.99 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.558 -0.746 . . . . 72.11 110.938 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.39 123.49 11.22 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.474 2.116 . . . . 73.5 112.851 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.39 -0.823 . . . . 74.32 111.467 -179.268 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -77.31 124.86 28.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.502 -0.772 . . . . 75.42 111.328 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.6 -26.86 9.22 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.756 -0.657 . . . . 64.12 113.158 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.9 160.16 14.45 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.425 0.29 . . . . 75.25 110.904 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.564 HG22 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -83.58 145.09 29.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.318 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 37.6 t -120.65 116.19 24.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.437 -0.802 . . . . 75.23 110.39 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.64 110.42 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.577 -0.738 . . . . 73.25 109.557 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 152.06 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.086 -0.506 . . . . 72.21 111.585 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 11.3 m-70 -102.51 125.34 49.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.27 -0.877 . . . . 75.31 109.004 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 39' ' ' SER . 42.8 p90 -115.65 166.1 12.3 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.814 0.672 . . . . 74.34 112.814 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 3.2 m -148.83 112.18 4.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.838 -1.074 . . . . 72.31 109.328 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 120.18 6.53 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.131 -0.557 . . . . 75.41 112.813 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 mtm -129.8 131.3 46.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.963 0.505 . . . . 73.1 111.123 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.62 170.9 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.696 -0.684 . . . . 75.02 112.002 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.51 -26.12 53.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.082 0.553 . . . . 72.0 112.049 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.38 -17.4 28.89 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.762 -0.654 . . . . 73.54 111.76 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.52 13.79 21.56 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 120.828 -0.701 . . . . 52.23 113.394 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.411 0 N-CA-C 109.775 -0.454 . . . . 74.31 109.775 179.575 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.421 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 75.44 112.938 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 26.8 p90 -134.09 -9.36 2.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.369 -1.287 . . . . 75.25 111.393 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -166.55 111.59 0.79 Allowed 'General case' 0 C--N 1.355 0.846 0 CA-C-O 121.203 0.525 . . . . 73.03 111.621 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.421 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 4.2 p -116.94 118.22 31.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.893 -1.048 . . . . 72.31 111.012 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.524 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 21.1 t -78.82 -34.68 45.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.953 -0.567 . . . . 71.12 112.06 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.45 -23.25 46.63 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.973 0.731 . . . . 63.42 112.973 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.89 -24.91 67.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.771 0.319 . . . . 64.34 111.236 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -92.86 0.07 57.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.395 -0.82 . . . . 71.3 109.7 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 63.29 36.11 11.98 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 75.12 111.568 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.237 0.458 . . . . 74.11 112.237 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.85 158.01 43.02 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.956 2.437 . . . . 72.54 112.708 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -100.07 118.53 36.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.974 -0.557 . . . . 73.33 112.074 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.496 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 115.225 -0.898 . . . . 75.21 110.029 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.3 p90 -151.58 161.82 42.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.358 0.411 . . . . 75.11 111.571 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.564 ' SD ' HG22 ' A' ' 21' ' ' THR . 3.7 mpp? -105.67 135.18 47.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.415 -0.357 . . . . 71.14 110.48 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.31 140.18 38.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.838 -0.619 . . . . 74.22 111.648 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -8.57 61.95 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.442 -0.799 . . . . 71.31 113.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.849 0.357 . . . . 75.32 110.733 179.276 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 70.04 27.4 4.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 72.42 112.145 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.18 -14.58 60.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.021 -0.536 . . . . 75.25 110.82 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -126.72 -178.34 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.246 -0.888 . . . . 75.44 110.453 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.15 158.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.06 0.392 . . . . 64.33 112.06 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -59.37 -44.05 92.78 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.987 -0.551 . . . . 74.42 111.775 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.67 -20.58 61.88 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.161 -0.472 . . . . 75.12 113.461 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.13 -43.55 14.9 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 116.684 0.242 . . . . 64.24 111.107 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.16 -37.6 86.06 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.344 0.403 . . . . 71.32 111.566 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.51 -25.57 28.72 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.966 -0.561 . . . . 73.22 111.734 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.57 -46.34 4.94 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.477 0.486 . . . . 71.54 113.903 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.6 -25.09 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 122.768 0.427 . . . . 74.11 111.738 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 -8.64 57.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.355 -0.839 . . . . 71.01 111.651 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.75 -11.39 36.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.713 -0.676 . . . . 73.32 111.255 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.19 155.97 19.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.283 -0.417 . . . . 71.25 110.949 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 p -110.88 167.02 10.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.807 -0.633 . . . . 63.14 110.598 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.18 123.2 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.927 0.491 . . . . 73.41 111.231 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.55 4.68 70.12 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.421 -0.809 . . . . 71.34 113.137 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.2 142.01 28.88 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 120.943 0.401 . . . . 75.44 111.305 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.84 107.95 13.78 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.039 -0.982 . . . . 74.25 109.36 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.45 154.34 48.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.968 -0.56 . . . . 72.53 111.837 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.309 0 CA-C-N 116.04 -0.527 . . . . 73.55 110.248 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -111.31 126.05 54.49 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.444 0.465 . . . . 74.52 111.079 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.6 m -93.68 113.63 25.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.439 -0.801 . . . . 71.34 109.585 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 mm -106.16 143.47 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.874 -0.603 . . . . 75.11 110.433 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.17 161.88 21.46 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 114.871 -1.059 . . . . 74.23 110.814 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.94 -17.19 49.78 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.789 2.326 . . . . 74.23 113.243 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.94 -25.56 26.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.394 0.433 . . . . 74.51 111.288 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -101.86 -18.97 15.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.047 -0.524 . . . . 74.1 111.469 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 -61.82 1.7 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.696 0.628 . . . . 54.11 112.696 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -134.96 -52.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.586 0.217 . . . . 74.54 111.586 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.1 -140.34 7.81 Favored Glycine 0 C--N 1.337 0.617 0 O-C-N 123.516 0.51 . . . . 71.34 112.037 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.37 -11.13 26.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.603 0.223 . . . . 63.32 111.603 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.12 -60.43 1.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.236 -0.438 . . . . 63.55 110.516 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.14 -166.36 54.58 Favored Glycine 0 C--N 1.345 1.069 0 O-C-N 123.343 0.402 . . . . 73.04 113.16 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -97.82 124.43 48.04 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.918 -0.401 . . . . 71.03 109.918 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.52 124.17 10.91 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.278 1.986 . . . . 65.12 113.614 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.52 -47.92 1.0 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.575 -0.738 . . . . 63.23 113.364 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.65 -51.77 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.574 0.212 . . . . 73.33 111.574 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.1 mm -109.88 97.96 31.64 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 123.248 0.342 . . . . 74.32 111.055 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.65 165.67 31.81 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.451 2.101 . . . . 74.2 112.733 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.97 143.2 28.86 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.52 2.147 . . . . 74.42 113.259 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.8 42.56 26.46 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.613 0.765 . . . . 70.34 111.821 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.07 132.43 54.1 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.692 -0.686 . . . . 71.42 111.722 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -81.83 140.77 33.97 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.741 -1.118 . . . . 74.25 110.847 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 5.5 mt -119.09 153.77 34.26 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.657 -0.701 . . . . 75.55 111.076 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.89 130.35 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.842 -0.617 . . . . 72.32 109.595 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' THR . 90.2 m-85 -131.33 133.41 45.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.557 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -116.47 102.51 9.56 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 123.542 0.526 . . . . 73.13 110.119 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 26.4 m -104.34 153.75 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.884 -0.598 . . . . 63.14 111.101 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.16 125.44 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 72.23 110.413 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 101.93 3.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.855 -0.611 . . . . 70.2 110.203 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.88 -58.97 2.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.162 -0.472 . . . . 73.51 111.376 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 122.769 0.428 . . . . 74.51 110.792 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.2 mt -125.48 146.64 49.55 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.128 -0.487 . . . . 71.15 110.707 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.025 -0.534 . . . . 72.13 110.759 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 CA-C-O 119.186 -0.785 . . . . 72.04 112.453 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.85 151.37 35.73 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.041 2.494 . . . . 72.12 112.739 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.7 t -99.87 -43.33 6.45 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 115.882 -0.599 . . . . 75.41 111.038 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.4 mtt -100.4 144.45 29.38 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.452 0.47 . . . . 73.21 110.826 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -118.09 27.76 7.25 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.943 -0.571 . . . . 60.01 113.136 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.5 p -131.3 113.88 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.827 0.346 . . . . 72.33 110.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.19 116.97 29.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.638 -0.71 . . . . 74.24 110.701 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 13.8 p -107.22 134.77 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.984 -0.553 . . . . 62.43 110.936 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.45 124.44 44.47 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.462 -0.79 . . . . 74.44 110.266 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -78.12 126.28 30.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.463 0.477 . . . . 75.4 110.815 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.29 -39.18 3.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.132 -0.94 . . . . 73.15 110.404 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -132.73 119.0 15.82 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 74.32 110.49 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 129.84 16.23 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.573 2.182 . . . . 71.0 113.327 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.25 -121.25 4.34 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.776 -0.647 . . . . 44.33 112.221 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.19 -46.29 12.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.702 0.251 . . . . 70.4 110.977 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.77 -1.5 88.04 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.545 0.528 . . . . 63.51 113.695 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -136.61 1.08 2.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.745 0.276 . . . . 75.24 111.745 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.9 92.54 3.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.034 0.445 . . . . 74.01 110.353 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -103.53 149.71 37.33 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.564 -0.744 . . . . 72.11 110.986 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.73 123.29 10.85 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.488 2.125 . . . . 73.5 112.677 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.461 0 CA-C-N 115.435 -0.802 . . . . 74.32 111.573 -179.344 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 44.9 ttt180 -77.42 122.92 25.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.555 -0.748 . . . . 75.42 111.162 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' O ' ' HE1' ' A' ' 49' ' ' MET . . . 117.58 -29.21 6.75 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.814 -0.63 . . . . 64.12 113.225 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.29 160.31 14.41 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.45 0.3 . . . . 75.25 110.985 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.61 145.3 29.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.095 -0.502 . . . . 73.13 111.42 -179.518 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 35.2 t -120.81 117.19 26.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.625 -0.716 . . . . 75.23 110.693 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.62 110.75 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.562 -0.745 . . . . 73.25 109.472 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.7 m -146.89 152.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.949 -0.569 . . . . 72.21 111.456 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.6 ' HD1' ' HG ' ' A' ' 39' ' ' SER . 5.6 m-70 -103.12 125.17 49.71 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.532 -0.758 . . . . 75.31 109.437 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 39.5 p90 -115.45 166.82 11.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.284 0.476 . . . . 74.34 112.284 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -147.72 106.12 3.78 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.173 -0.921 . . . . 72.31 109.454 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.73 116.46 4.88 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.05 -0.523 . . . . 75.41 112.707 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.7 mtm -131.89 134.41 45.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.043 0.537 . . . . 73.1 110.833 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mt -56.38 172.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 75.02 112.462 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.89 -27.02 50.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.125 0.57 . . . . 72.0 111.893 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.36 -17.47 30.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.685 -0.688 . . . . 73.54 111.487 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.11 13.84 22.19 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.726 -0.75 . . . . 52.23 113.373 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.447 0 CA-C-O 120.696 0.284 . . . . 74.31 110.405 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 N-CA-C 112.934 0.716 . . . . 75.44 112.934 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 21.2 p90 -131.59 -16.05 3.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.619 -1.173 . . . . 75.25 111.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.8 110.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.025 0.441 . . . . 73.03 111.977 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.554 ' HB3' ' OD1' ' A' ' 41' ' ' ASP . 43.5 t -123.24 143.38 50.08 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.42 -0.809 . . . . 72.31 109.901 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.6 ' HG ' ' HD1' ' A' ' 25' ' ' HIS . 64.3 p -78.82 -24.63 44.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.815 0.672 . . . . 71.12 112.815 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -82.93 -26.26 31.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.363 0.505 . . . . 63.42 112.363 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.554 ' OD1' ' HB3' ' A' ' 38' ' ' SER . 14.8 p30 -70.04 -18.09 63.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.102 0.477 . . . . 64.34 110.709 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HG2' ' OD2' ' A' ' 41' ' ' ASP . 19.8 mmt180 -97.23 -6.48 34.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.863 -1.062 . . . . 71.3 109.532 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 66.73 40.9 3.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.488 1.115 . . . . 75.12 111.81 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.836 -179.754 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.36 157.87 55.68 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.693 2.262 . . . . 72.54 112.807 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -103.29 118.2 36.24 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.86 -0.609 . . . . 73.33 112.115 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.455 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 115.097 -0.956 . . . . 75.21 109.788 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.6 p90 -149.6 162.7 39.67 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.284 0.365 . . . . 75.11 111.422 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.416 ' HE1' ' O ' ' A' ' 19' ' ' GLY . 6.7 mtt -106.65 133.27 51.59 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.118 -0.492 . . . . 71.14 110.795 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.38 141.31 37.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.925 -0.58 . . . . 74.22 111.649 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.31 -11.72 48.81 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.52 -0.764 . . . . 71.31 113.481 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.775 0.321 . . . . 75.32 110.609 179.309 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 68.18 30.11 5.87 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.11 0.964 . . . . 72.42 112.102 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.02 -31.15 56.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.918 -0.583 . . . . 75.25 110.62 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -106.2 -174.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.325 -0.852 . . . . 75.44 110.247 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -81.51 158.47 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 111.774 0.287 . . . . 64.33 111.774 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -59.46 -43.82 93.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.058 -0.519 . . . . 74.42 111.913 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.62 -20.48 61.65 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 123.54 0.525 . . . . 75.12 113.321 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -84.21 -44.29 14.08 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 122.255 0.222 . . . . 64.24 111.147 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.58 -36.64 83.13 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.256 0.348 . . . . 71.32 111.571 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.53 -26.29 28.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.934 -0.575 . . . . 73.22 111.855 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.31 -46.52 4.66 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.454 0.472 . . . . 71.54 113.872 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 64' ' ' ALA . 1.9 p -63.66 -25.66 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.754 0.421 . . . . 74.11 111.734 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' N ' HG13 ' A' ' 63' ' ' VAL . . . -75.74 -7.18 53.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.395 -0.82 . . . . 71.01 111.669 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -93.86 -8.77 39.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.792 -0.64 . . . . 73.32 111.297 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.16 156.49 19.26 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.374 -0.376 . . . . 71.25 110.873 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 p -110.99 166.52 10.98 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.946 -0.57 . . . . 63.14 110.626 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.63 122.64 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.042 0.537 . . . . 73.41 111.216 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.71 2.78 69.33 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.47 -0.786 . . . . 71.34 113.236 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -94.16 142.12 27.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.947 0.403 . . . . 75.44 111.315 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.94 109.11 14.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.094 -0.957 . . . . 74.25 109.416 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.86 156.76 45.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.013 -0.539 . . . . 72.53 111.882 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.303 0 CA-C-N 116.063 -0.517 . . . . 73.55 110.426 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -105.98 127.7 53.33 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.858 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m -95.32 112.64 24.32 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.675 -0.693 . . . . 71.34 109.393 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 mm -104.46 140.83 21.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.903 -0.59 . . . . 75.11 110.519 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.16 162.09 21.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.84 -1.073 . . . . 74.23 110.671 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.77 -14.43 40.45 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.577 2.185 . . . . 74.23 113.231 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -28.96 22.9 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.4 . . . . 74.51 110.797 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -98.99 -19.37 17.32 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.753 -0.658 . . . . 74.1 111.594 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.78 -63.17 1.4 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.848 0.684 . . . . 54.11 112.848 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -134.43 -50.85 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.691 0.256 . . . . 74.54 111.691 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.88 -143.66 11.21 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 123.494 0.496 . . . . 71.34 111.957 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.43 -10.03 33.73 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 111.612 0.227 . . . . 63.32 111.612 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.02 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.201 -0.454 . . . . 63.55 110.388 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.27 -167.24 53.31 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.326 0.391 . . . . 73.04 113.187 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -97.6 124.49 48.29 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 109.876 -0.416 . . . . 71.03 109.876 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.8 123.64 10.29 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.195 1.93 . . . . 65.12 113.628 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.94 -46.86 1.11 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.601 -0.727 . . . . 63.23 113.436 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.4 -51.74 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 111.577 0.214 . . . . 73.33 111.577 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 mm -109.88 98.38 33.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 123.224 0.327 . . . . 74.32 111.068 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.3 165.66 31.75 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.439 2.093 . . . . 74.2 112.76 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.92 143.14 28.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.521 2.148 . . . . 74.42 113.157 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.57 43.87 24.95 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.644 0.778 . . . . 70.34 111.738 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.09 132.69 53.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.663 -0.699 . . . . 71.42 111.795 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 m -83.29 140.3 32.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.771 -1.104 . . . . 74.25 110.839 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.2 mt -117.94 154.31 32.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.635 -0.712 . . . . 75.55 111.026 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.3 t -121.68 127.84 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.829 -0.623 . . . . 72.32 109.684 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 27' ' ' THR . 91.0 m-85 -129.94 132.87 46.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.06 -0.518 . . . . 71.3 110.709 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.9 t70 -115.02 103.71 11.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.067 -0.515 . . . . 73.13 110.273 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 25.7 m -104.64 152.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 63.14 111.02 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.83 125.99 35.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 72.23 110.384 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.411 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -73.03 101.98 3.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.825 -0.625 . . . . 70.2 110.453 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.35 -58.1 2.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.046 -0.524 . . . . 73.51 111.469 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 122.819 0.448 . . . . 74.51 110.728 -179.842 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.5 mt -122.21 145.83 47.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.098 -0.501 . . . . 71.15 110.792 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.466 0.327 0 O-C-N 123.506 0.504 . . . . 72.13 110.825 179.878 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 119.012 -0.882 . . . . 72.04 112.66 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.18 141.99 26.78 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.869 2.38 . . . . 72.12 112.725 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.7 m -108.53 -39.9 5.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.867 -0.606 . . . . 75.41 111.346 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -96.85 151.22 19.88 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.407 0.442 . . . . 73.21 111.115 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -94.64 -15.86 44.78 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.809 -0.632 . . . . 60.01 113.334 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 75' ' ' THR . 13.5 p -117.65 123.38 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.381 0.272 . . . . 72.33 110.593 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.78 121.11 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.902 -0.59 . . . . 74.24 110.611 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.0 t -108.9 130.14 62.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.101 -0.5 . . . . 62.43 110.079 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -119.23 123.48 44.4 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.617 -0.72 . . . . 74.44 110.161 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -77.93 126.29 30.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.245 -0.434 . . . . 75.4 110.934 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.64 -41.1 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.055 -0.975 . . . . 73.15 110.229 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -130.17 118.86 18.48 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.948 -0.569 . . . . 74.32 110.341 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 129.17 15.52 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.602 2.201 . . . . 71.0 113.433 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.79 -120.89 4.18 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.744 -0.662 . . . . 44.33 112.033 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.69 -45.89 12.91 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.676 0.238 . . . . 70.4 110.865 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.94 -1.4 88.89 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.028 -0.533 . . . . 63.51 113.705 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -136.71 1.06 2.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.493 0.317 . . . . 75.24 111.853 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.96 92.84 3.82 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.097 0.475 . . . . 74.01 110.281 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -103.13 149.69 37.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.521 -0.763 . . . . 72.11 110.898 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.1 126.44 15.8 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.517 2.145 . . . . 73.5 112.95 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 115.433 -0.803 . . . . 74.32 111.551 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 41.9 ttt180 -77.54 121.14 23.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.376 -0.829 . . . . 75.42 111.428 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.46 -24.2 9.27 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.014 -0.539 . . . . 64.12 113.48 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.2 160.33 14.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.356 0.262 . . . . 75.25 110.977 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.64 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -80.43 145.1 32.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.154 -0.476 . . . . 73.13 111.219 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.9 m -124.19 116.59 22.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.645 -0.707 . . . . 75.23 110.475 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -89.97 111.08 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.497 -0.774 . . . . 73.25 109.76 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.81 151.42 14.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.898 -0.592 . . . . 72.21 111.36 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.4 m-70 -102.68 125.32 49.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.653 -0.703 . . . . 75.31 109.389 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.518 ' CE2' ' HB3' ' A' ' 39' ' ' SER . 40.3 p90 -115.71 166.35 12.03 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.51 0.559 . . . . 74.34 112.51 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.22 107.06 3.82 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.091 -0.958 . . . . 72.31 109.375 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.12 119.43 5.79 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 116.038 -0.528 . . . . 75.41 112.739 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.5 mtm -134.38 132.21 39.17 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.989 0.516 . . . . 73.1 110.827 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mt -54.74 171.41 0.13 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.594 -0.73 . . . . 75.02 112.464 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -55.27 -27.65 48.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.18 0.592 . . . . 72.0 112.114 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.32 -17.26 29.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.663 -0.698 . . . . 73.54 111.709 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.65 13.76 21.38 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 120.828 -0.701 . . . . 52.23 113.167 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.457 0 N-CA-C 110.219 -0.289 . . . . 74.31 110.219 179.721 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.912 0.708 . . . . 75.44 112.912 -179.738 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 26.6 p90 -133.13 -15.24 2.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.532 -1.213 . . . . 75.25 111.364 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.16 111.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.121 0.486 . . . . 73.03 112.184 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.403 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 29.3 t -122.58 142.6 50.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.275 -0.875 . . . . 72.31 109.971 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.518 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 54.6 p -78.55 -36.68 44.29 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.593 0.59 . . . . 71.12 112.593 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.17 -23.08 61.98 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.543 0.571 . . . . 63.42 112.543 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -30.47 71.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.882 0.372 . . . . 64.34 110.817 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' O ' ' HD2' ' A' ' 44' ' ' MLY . 49.0 mtm180 -95.43 -1.84 50.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.262 -0.881 . . . . 71.3 110.183 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 66.18 37.62 4.98 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.297 1.039 . . . . 75.12 111.897 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . 0.428 ' HD2' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.52 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.78 157.97 51.05 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.974 2.45 . . . . 72.54 112.847 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -102.22 118.26 36.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.883 -0.598 . . . . 73.33 112.13 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.464 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 115.139 -0.937 . . . . 75.21 110.092 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.0 p90 -151.97 165.17 35.45 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.349 0.405 . . . . 75.11 111.627 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.64 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -107.81 135.95 48.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.182 -0.463 . . . . 71.14 110.61 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -80.62 140.93 35.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.882 -0.599 . . . . 74.22 111.506 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 83.32 -9.42 61.32 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.562 -0.745 . . . . 71.31 113.295 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.831 0.348 . . . . 75.32 110.72 179.408 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 68.55 28.25 5.93 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.076 0.95 . . . . 72.42 112.102 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -75.25 -33.32 61.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.006 -0.543 . . . . 75.25 110.543 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 m -103.4 -174.63 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 115.21 -0.905 . . . . 75.44 110.11 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 pt -81.1 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 111.706 0.262 . . . . 64.33 111.706 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.85 -43.79 90.87 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 74.42 111.852 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.26 62.45 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.53 0.519 . . . . 75.12 113.406 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -84.11 -43.76 14.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 116.65 0.225 . . . . 64.24 111.1 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.27 -37.47 85.54 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.304 0.378 . . . . 71.32 111.6 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.5 -25.44 28.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.872 -0.604 . . . . 73.22 111.765 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.17 -46.39 4.74 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.413 0.446 . . . . 71.54 113.871 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.33 -25.44 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.829 0.452 . . . . 74.11 111.728 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.74 -8.97 58.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.33 -0.85 . . . . 71.01 111.699 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -91.61 -7.8 49.08 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.811 -0.631 . . . . 73.32 111.189 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.0 156.6 20.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.321 -0.4 . . . . 71.25 111.066 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.1 p -111.06 167.19 10.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.816 -0.629 . . . . 63.14 110.529 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -56.05 123.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.035 0.534 . . . . 73.41 111.261 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.05 4.32 72.02 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.532 -0.758 . . . . 71.34 113.244 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -95.54 141.42 29.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.909 0.385 . . . . 75.44 111.296 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.48 109.07 15.31 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.138 -0.937 . . . . 74.25 109.399 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 156.97 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.959 -0.564 . . . . 72.53 111.883 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.472 ' HG3' ' OD2' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.235 0.325 0 CA-C-N 116.026 -0.534 . . . . 73.55 110.317 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -110.91 124.82 52.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.272 -0.422 . . . . 74.52 111.231 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m -93.6 112.84 24.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.325 -0.852 . . . . 71.34 109.417 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mm -104.29 142.18 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.864 -0.607 . . . . 75.11 110.557 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.7 161.83 21.81 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.774 -1.103 . . . . 74.23 110.772 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.61 -14.5 40.24 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.699 2.266 . . . . 74.23 113.303 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.59 -28.07 23.51 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.347 0.404 . . . . 74.51 110.846 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -99.89 -19.7 16.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.641 -0.708 . . . . 74.1 111.543 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.48 -62.93 1.45 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.794 0.664 . . . . 54.11 112.794 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -134.5 -50.84 0.8 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 111.589 0.218 . . . . 74.54 111.589 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.82 -142.8 10.23 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.181 -0.463 . . . . 71.34 112.013 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.98 -10.81 29.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 111.59 0.218 . . . . 63.32 111.59 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.53 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.231 -0.44 . . . . 63.55 110.373 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.55 -165.96 53.26 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.337 0.398 . . . . 73.04 113.255 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.405 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -97.5 125.72 44.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.853 -0.425 . . . . 71.03 109.853 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.16 123.95 10.45 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.29 1.993 . . . . 65.12 113.617 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.76 -45.42 1.31 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.601 -0.727 . . . . 63.23 113.466 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -99.75 -52.25 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.625 0.212 . . . . 73.33 111.516 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.1 mm -109.98 98.69 35.62 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 123.22 0.325 . . . . 74.32 111.037 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.42 165.78 31.39 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.469 2.113 . . . . 74.2 112.711 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.65 141.96 28.44 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.483 2.122 . . . . 74.42 113.17 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 56.8 46.44 19.89 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.639 0.775 . . . . 70.34 111.628 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.88 134.06 51.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.64 -0.709 . . . . 71.42 111.836 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -84.31 140.8 31.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.702 -1.135 . . . . 74.25 110.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -118.62 154.22 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.66 -0.7 . . . . 75.55 111.042 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.6 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.901 -0.591 . . . . 72.32 109.652 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.0 m-85 -133.14 132.36 41.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.135 -0.484 . . . . 71.3 110.77 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 t70 -115.98 104.19 11.35 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.075 -0.512 . . . . 73.13 110.161 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 28.2 m -105.9 153.63 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.034 -0.53 . . . . 63.14 111.143 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.15 126.1 34.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.486 -0.779 . . . . 72.23 110.397 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 101.84 3.43 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.718 -0.674 . . . . 70.2 110.465 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.8 mt -89.53 -58.33 2.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.35 -0.386 . . . . 73.51 111.567 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 122.73 0.412 . . . . 74.51 110.986 179.891 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.7 mt -118.51 143.18 46.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.164 -0.471 . . . . 71.15 110.345 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.465 0.301 0 O-C-N 123.421 0.45 . . . . 72.13 110.822 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 CA-C-O 119.374 -0.681 . . . . 72.04 112.661 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 135.49 18.32 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.051 2.501 . . . . 72.12 112.799 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.8 t 61.74 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.947 0.899 . . . . 75.41 111.966 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 64.9 mtt -132.1 144.2 50.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.791 -0.641 . . . . 73.21 110.905 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -121.04 27.96 6.25 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.627 0.579 . . . . 60.01 112.98 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.6 p -138.21 119.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.697 0.284 . . . . 72.33 110.553 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.64 119.82 35.61 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.81 -0.632 . . . . 74.24 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 16.6 t -108.03 126.66 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.006 -0.543 . . . . 62.43 110.076 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -115.6 123.65 48.96 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.649 -0.705 . . . . 74.44 110.227 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -78.0 125.85 29.96 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.947 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.26 -40.69 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.047 -0.979 . . . . 73.15 110.253 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -130.56 118.98 18.14 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.568 0.543 . . . . 74.32 110.35 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 129.6 16.1 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.571 2.181 . . . . 71.0 113.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.47 -120.92 4.33 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.658 -0.701 . . . . 44.33 112.099 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.84 -46.19 12.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.639 0.219 . . . . 70.4 110.947 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.35 88.66 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.07 -0.514 . . . . 63.51 113.695 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -136.58 1.06 2.55 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.409 0.283 . . . . 75.24 111.721 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.99 92.25 3.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.06 0.457 . . . . 74.01 110.345 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -103.34 149.57 37.12 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.601 -0.727 . . . . 72.11 111.013 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.49 124.08 11.98 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.502 2.135 . . . . 73.5 112.74 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 115.391 -0.822 . . . . 74.32 111.45 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -77.26 125.79 29.89 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.645 -0.707 . . . . 75.42 111.16 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.81 -26.75 9.19 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.609 -0.723 . . . . 64.12 112.956 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -99.48 160.12 14.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.46 0.304 . . . . 75.25 110.715 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.62 145.23 28.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.14 -0.482 . . . . 73.13 111.366 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.9 t -119.87 116.94 26.85 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.615 -0.72 . . . . 75.23 110.597 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -91.7 110.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.398 -0.819 . . . . 73.25 109.588 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -147.39 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.064 -0.516 . . . . 72.21 111.487 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 11.9 m-70 -102.37 125.34 49.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.365 -0.834 . . . . 75.31 109.031 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' CE2' ' HB2' ' A' ' 39' ' ' SER . 41.3 p90 -116.23 167.04 11.36 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.944 0.72 . . . . 74.34 112.944 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.7 m -148.79 112.46 5.07 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 114.81 -1.086 . . . . 72.31 109.464 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.67 119.79 6.45 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 116.025 -0.534 . . . . 75.41 112.757 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.0 mtm -129.59 131.49 46.53 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.912 0.485 . . . . 73.1 111.129 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.23 170.41 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 75.02 111.963 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.32 -25.95 50.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.008 0.523 . . . . 72.0 112.076 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.35 -17.39 28.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.777 -0.647 . . . . 73.54 111.726 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.14 13.77 22.31 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 120.852 -0.689 . . . . 52.23 113.362 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.411 0 N-CA-C 109.745 -0.465 . . . . 74.31 109.745 179.569 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.409 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 112.92 0.711 . . . . 75.44 112.92 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.1 p90 -133.34 -14.38 2.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.186 -1.37 . . . . 75.25 111.345 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -161.55 111.63 1.63 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.047 0.451 . . . . 73.03 111.987 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 4.0 p -116.98 119.26 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.377 -0.829 . . . . 72.31 111.176 178.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.529 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 19.2 t -78.8 -35.37 44.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.154 -0.475 . . . . 71.12 112.185 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -23.13 44.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.082 0.771 . . . . 63.42 113.082 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.805 0.336 . . . . 64.34 111.124 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -92.7 -0.15 57.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.417 -0.81 . . . . 71.3 109.622 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 63.7 36.43 10.72 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.294 1.038 . . . . 75.12 111.696 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 112.156 0.428 . . . . 74.11 112.156 -179.51 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 157.97 47.36 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.924 2.416 . . . . 72.54 112.688 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -100.64 118.03 35.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.943 -0.571 . . . . 73.33 112.06 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.484 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.156 -0.929 . . . . 75.21 110.078 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.7 p90 -148.64 161.93 40.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.334 0.396 . . . . 75.11 111.406 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' HE3' ' A' ' 52' ' ' MLY . 29.6 ttm -106.77 130.64 54.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.136 -0.484 . . . . 71.14 110.159 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -76.38 141.46 41.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.936 -0.575 . . . . 74.22 111.926 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.66 -9.43 55.76 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.492 -0.776 . . . . 71.31 113.536 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . 0.485 ' HE3' ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.388 0.275 . . . . 75.32 110.662 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 69.01 28.29 5.15 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.034 0.934 . . . . 72.42 112.296 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.4 -22.7 57.25 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.588 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.81 -175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.108 -0.951 . . . . 75.44 110.38 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -80.42 158.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.915 0.339 . . . . 64.33 111.915 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -59.24 -43.91 92.37 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.006 -0.543 . . . . 74.42 111.819 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.62 -20.75 61.98 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.547 0.53 . . . . 75.12 113.442 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.15 -43.77 14.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 122.287 0.235 . . . . 64.24 111.306 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.35 -37.37 85.17 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.345 0.403 . . . . 71.32 111.632 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.43 -25.99 28.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.976 -0.556 . . . . 73.22 111.743 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.7 -46.45 4.86 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.459 0.475 . . . . 71.54 113.94 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.59 -24.74 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.791 0.436 . . . . 74.11 111.769 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 -8.09 56.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.437 -0.801 . . . . 71.01 111.625 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.442 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.09 -10.83 37.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.799 -0.637 . . . . 73.32 111.306 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.85 156.24 18.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.315 -0.402 . . . . 71.25 111.034 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -110.88 166.87 10.68 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.801 -0.636 . . . . 63.14 110.556 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.08 123.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.901 0.48 . . . . 73.41 111.323 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.12 4.98 70.98 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.47 -0.787 . . . . 71.34 113.232 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -96.37 141.57 29.53 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.909 0.385 . . . . 75.44 111.249 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.4 108.85 15.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.08 -0.964 . . . . 74.25 109.385 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.09 156.91 44.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.012 -0.54 . . . . 72.53 111.842 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.289 0 CA-C-N 116.026 -0.534 . . . . 73.55 110.286 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -109.89 127.06 54.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.225 -0.443 . . . . 74.52 111.109 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.3 m -94.62 113.82 25.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.391 -0.822 . . . . 71.34 109.598 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.4 143.36 17.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.856 -0.611 . . . . 75.11 110.398 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.06 162.13 20.68 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 114.893 -1.049 . . . . 74.23 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 -17.03 48.62 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.725 2.283 . . . . 74.23 113.254 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -25.7 25.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.27 -0.423 . . . . 74.51 111.3 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.89 -18.76 15.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.076 -0.511 . . . . 74.1 111.391 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.67 -62.0 1.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.626 0.602 . . . . 54.11 112.626 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -134.94 -51.99 0.78 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.622 0.23 . . . . 74.54 111.622 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.51 -140.34 7.89 Favored Glycine 0 C--N 1.336 0.559 0 O-C-N 123.478 0.486 . . . . 71.34 112.089 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.55 -11.06 25.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.58 0.215 . . . . 63.32 111.58 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -100.06 -60.36 1.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.353 0.408 . . . . 63.55 110.511 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.75 54.2 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.322 0.389 . . . . 73.04 113.166 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -98.42 124.39 46.91 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.902 -0.407 . . . . 71.03 109.902 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.57 123.85 10.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.235 1.957 . . . . 65.12 113.627 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.81 -47.95 1.0 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.579 -0.737 . . . . 63.23 113.408 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.42 -51.98 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.584 0.192 . . . . 73.33 111.507 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.5 mm -109.71 97.87 30.43 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 123.209 0.318 . . . . 74.32 111.056 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.59 165.6 32.01 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.413 2.075 . . . . 74.2 112.765 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 143.09 29.42 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.553 2.168 . . . . 74.42 113.183 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.63 43.76 25.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.614 0.765 . . . . 70.34 111.716 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.81 133.01 53.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.695 -0.684 . . . . 71.42 111.716 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 m -82.91 139.09 33.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.755 -1.111 . . . . 74.25 110.929 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.447 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mt -117.73 152.14 35.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.592 -0.731 . . . . 75.55 110.938 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.95 130.98 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.835 -0.62 . . . . 72.32 109.599 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' THR . 89.2 m-85 -131.63 133.74 45.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.482 . . . . 71.3 110.75 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.4 t70 -116.15 104.04 11.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.954 -0.566 . . . . 73.13 110.117 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 26.4 m -105.96 153.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.964 -0.562 . . . . 63.14 110.952 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.33 125.74 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 72.23 110.321 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -73.02 101.96 3.38 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.808 -0.633 . . . . 70.2 110.408 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.67 -58.53 2.49 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.098 -0.501 . . . . 73.51 111.419 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 122.803 0.441 . . . . 74.51 110.703 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -124.4 144.56 49.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.158 -0.474 . . . . 71.15 110.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.465 0.302 0 O-C-N 123.571 0.544 . . . . 72.13 110.765 179.936 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-O 119.275 -0.736 . . . . 72.04 112.527 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.64 157.64 40.02 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 123.063 2.508 . . . . 72.12 112.795 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.7 m -121.64 -42.69 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.928 -0.578 . . . . 75.41 111.299 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.2 mtt -116.34 141.36 48.26 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.357 0.41 . . . . 73.21 110.872 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -107.31 36.21 4.53 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.885 -0.598 . . . . 60.01 112.807 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 75' ' ' THR . 13.1 p -136.22 120.64 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.711 0.291 . . . . 72.33 110.584 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.21 120.05 35.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.783 -0.644 . . . . 74.24 110.665 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 16.6 t -108.54 126.71 65.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.036 -0.529 . . . . 62.43 110.077 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.08 123.73 48.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.635 -0.711 . . . . 74.44 110.159 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.1 m -77.93 126.03 30.23 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.144 -0.48 . . . . 75.4 110.967 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.57 -40.61 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.103 -0.953 . . . . 73.15 110.296 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 t -130.77 118.92 17.92 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 116.014 -0.539 . . . . 74.32 110.4 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.37 129.77 16.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.592 2.194 . . . . 71.0 113.404 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.51 -121.07 4.36 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.688 -0.687 . . . . 44.33 112.118 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -83.77 -46.09 12.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.633 0.216 . . . . 70.4 110.963 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.59 88.48 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.028 -0.533 . . . . 63.51 113.689 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -136.03 0.51 2.63 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.281 . . . . 75.24 111.76 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.44 92.36 3.73 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.075 0.464 . . . . 74.01 110.301 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -103.19 149.62 37.1 Favored Pre-proline 0 C--O 1.235 0.302 0 CA-C-N 115.591 -0.731 . . . . 72.11 110.961 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -65.92 122.51 10.11 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.47 2.114 . . . . 73.5 112.698 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 115.433 -0.803 . . . . 74.32 111.554 -179.228 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -77.49 123.83 27.09 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.593 -0.73 . . . . 75.42 111.183 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.21 -28.66 7.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.732 -0.667 . . . . 64.12 113.282 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.45 HE22 HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -99.4 160.29 14.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.626 0.213 . . . . 75.25 111.017 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -81.75 145.28 30.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.087 -0.506 . . . . 73.13 111.525 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 38.6 t -120.0 117.07 27.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.565 -0.743 . . . . 75.23 110.599 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.7 111.05 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.405 -0.816 . . . . 73.25 109.685 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 m -147.5 151.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.073 -0.512 . . . . 72.21 111.482 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -101.69 125.38 48.34 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.308 -0.86 . . . . 75.31 108.98 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 39' ' ' SER . 41.9 p90 -115.85 166.87 11.48 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.877 0.695 . . . . 74.34 112.877 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.5 m -148.84 113.27 5.29 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.85 -1.068 . . . . 72.31 109.482 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.59 119.79 6.53 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.109 -0.567 . . . . 75.41 112.957 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.8 mtm -128.35 131.4 48.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.977 0.511 . . . . 73.1 111.018 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 mt -58.5 171.4 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.726 -0.67 . . . . 75.02 112.166 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -57.53 -25.05 59.31 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 123.067 0.547 . . . . 72.0 111.769 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -88.29 -17.8 29.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.751 -0.659 . . . . 73.54 111.275 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.06 25.39 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.616 -0.802 . . . . 52.23 113.694 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.777 -0.823 . . . . 74.31 108.777 179.633 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MLY . . . . . 0.423 ' HD3' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 113.487 0.921 . . . . 75.44 113.487 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 34.9 p90 -132.53 -15.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.02 -1.446 . . . . 75.25 111.18 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.453 ' OD2' ' HD1' ' A' ' 36' ' ' PHE . 3.0 m-20 -160.98 113.42 1.92 Allowed 'General case' 0 C--N 1.357 0.913 0 CA-C-O 120.984 0.421 . . . . 73.03 111.859 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 35' ' ' MLY . 5.2 p -118.12 119.29 34.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.41 -0.814 . . . . 72.31 111.164 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.537 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 20.1 t -78.87 -36.87 41.57 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.055 -0.521 . . . . 71.12 112.252 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -23.13 48.92 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.176 0.806 . . . . 63.42 113.176 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -23.72 67.45 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.795 0.331 . . . . 64.34 111.206 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -94.12 2.2 56.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.466 -0.788 . . . . 71.3 109.758 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 63.75 33.35 12.96 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.297 1.039 . . . . 75.12 111.839 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.404 0 N-CA-C 112.979 0.733 . . . . 74.11 112.979 -179.126 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 157.82 41.05 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 123.08 2.52 . . . . 72.54 112.647 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.46 117.83 35.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.885 -0.598 . . . . 73.33 112.087 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MLY . . . . . 0.486 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.314 0 CA-C-N 115.052 -0.976 . . . . 75.21 109.884 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.3 p90 -149.19 160.11 43.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.299 0.375 . . . . 75.11 111.499 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 mtm -104.28 132.18 50.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.103 -0.499 . . . . 71.14 110.637 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.46 139.81 39.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.916 -0.583 . . . . 74.22 111.632 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.07 -10.44 53.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.468 -0.787 . . . . 71.31 113.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 C-N-CA 122.537 0.335 . . . . 75.32 110.682 179.195 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 69.79 26.79 4.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.09 0.956 . . . . 72.42 112.263 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -21.7 59.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.089 -0.505 . . . . 75.25 110.779 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.67 -175.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.22 -0.9 . . . . 75.44 110.525 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.6 pt -81.48 158.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 111.883 0.327 . . . . 64.33 111.883 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -59.33 -44.09 92.64 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.986 -0.552 . . . . 74.42 111.891 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.6 -20.61 61.77 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 116.085 -0.507 . . . . 75.12 113.486 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -84.16 -43.77 14.64 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 122.242 0.217 . . . . 64.24 111.261 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.09 -37.52 85.97 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.359 0.412 . . . . 71.32 111.572 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.38 -25.94 28.74 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.924 -0.58 . . . . 73.22 111.794 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.92 -46.28 4.85 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.461 0.476 . . . . 71.54 113.89 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.85 -24.8 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.824 0.45 . . . . 74.11 111.686 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.94 -8.07 56.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.419 -0.809 . . . . 71.01 111.601 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.452 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.18 -10.3 39.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.83 -0.623 . . . . 73.32 111.211 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.79 156.58 18.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.351 -0.386 . . . . 71.25 111.118 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.2 p -111.38 166.7 10.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.812 -0.631 . . . . 63.14 110.538 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.85 123.12 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.898 0.479 . . . . 73.41 111.348 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.72 4.42 69.95 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.498 -0.774 . . . . 71.34 113.207 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -95.77 142.1 28.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.861 0.362 . . . . 75.44 111.347 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.01 108.84 14.79 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.135 -0.939 . . . . 74.25 109.35 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.94 156.81 44.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.049 -0.523 . . . . 72.53 111.894 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-N 116.06 -0.518 . . . . 73.55 110.384 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -110.31 127.45 55.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.284 -0.416 . . . . 74.52 111.144 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.2 m -94.9 114.09 25.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.455 -0.793 . . . . 71.34 109.593 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mm -106.71 142.16 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.897 -0.592 . . . . 75.11 110.528 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.33 162.2 20.47 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 114.904 -1.044 . . . . 74.23 110.776 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 -17.26 50.66 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.702 2.268 . . . . 74.23 113.243 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 -25.74 26.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.164 -0.471 . . . . 74.51 111.327 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.99 -18.98 15.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.085 -0.507 . . . . 74.1 111.462 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.52 -62.8 1.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.73 0.641 . . . . 54.11 112.73 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -133.4 -52.08 0.88 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.611 0.226 . . . . 74.54 111.611 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.42 -139.77 7.52 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.496 0.497 . . . . 71.34 112.049 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 -10.51 25.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 111.568 0.21 . . . . 63.32 111.568 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.61 -60.37 1.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.28 -0.418 . . . . 63.55 110.515 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.81 53.62 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.295 0.372 . . . . 73.04 113.207 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -96.52 123.74 53.27 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.933 -0.395 . . . . 71.03 109.933 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.07 124.72 11.66 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.212 1.941 . . . . 65.12 113.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.76 -47.47 1.04 Allowed Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.605 -0.725 . . . . 63.23 113.348 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -101.01 -50.84 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 111.67 0.248 . . . . 73.33 111.67 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.46 98.68 41.35 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 123.177 0.298 . . . . 74.32 111.244 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.12 165.71 31.8 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.493 2.129 . . . . 74.2 112.733 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.34 143.44 28.02 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.552 2.168 . . . . 74.42 113.22 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.76 43.2 25.57 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.609 0.764 . . . . 70.34 111.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.05 133.58 53.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.707 -0.679 . . . . 71.42 111.747 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 m -83.46 139.98 32.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.76 -1.109 . . . . 74.25 110.89 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.464 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mt -119.3 151.79 37.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.568 -0.742 . . . . 75.55 110.897 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.75 131.46 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.889 -0.596 . . . . 72.32 109.453 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' THR . 88.8 m-85 -131.92 133.55 44.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.165 -0.47 . . . . 71.3 110.886 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 73' ' ' MLY . 8.3 t70 -115.95 102.86 10.04 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.906 -0.588 . . . . 73.13 110.0 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 26.1 m -104.81 153.34 6.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 116.012 -0.54 . . . . 63.14 111.084 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.37 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.508 -0.769 . . . . 72.23 110.356 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -72.97 102.35 3.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.61 . . . . 70.2 110.455 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.41 -58.76 2.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.137 -0.483 . . . . 73.51 111.306 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 122.824 0.45 . . . . 74.51 110.709 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD23 HE22 ' A' ' 20' ' ' GLN . 10.7 mt -126.17 144.76 50.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.132 -0.486 . . . . 71.15 110.686 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.465 0.281 0 CA-C-N 116.056 -0.52 . . . . 72.13 110.772 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 CA-C-O 119.235 -0.758 . . . . 43.119999999999997 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.77 -36.09 2.29 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.056 2.504 . . . . 72.120000000000005 113.044 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.6 t 62.87 126.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.935 0.894 . . . . 74.209999999999994 111.897 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.6 mtt 63.13 125.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.922 0.889 . . . . 73.209999999999994 111.981 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -104.9 27.23 19.68 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.84 -0.618 . . . . 60.009999999999998 113.165 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.1 p -135.82 113.93 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.816 0.341 . . . . 71.540000000000006 110.5 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.96 117.44 32.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.764 -0.653 . . . . 73.140000000000001 110.904 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.4 p -107.9 132.55 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.912 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.22 123.88 45.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 74.439999999999998 110.261 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -77.81 125.92 30.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.122 -0.49 . . . . 74.150000000000006 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.22 -38.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.092 -0.958 . . . . 72.430000000000007 110.421 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -133.01 118.83 15.44 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.0 -0.545 . . . . 74.319999999999993 110.555 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.87 130.03 16.23 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.584 2.189 . . . . 61.420000000000002 113.185 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.28 -121.93 4.48 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.832 -0.622 . . . . 44.329999999999998 112.259 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.1 -46.69 12.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.66 0.23 . . . . 61.450000000000003 110.999 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.83 -2.59 87.77 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.552 0.533 . . . . 63.509999999999998 113.827 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -134.59 -0.71 2.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.487 0.315 . . . . 75.239999999999995 111.754 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 m -119.9 93.41 4.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.033 0.444 . . . . 71.400000000000006 110.526 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -103.81 149.22 36.92 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 72.109999999999999 110.856 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.11 128.16 17.14 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.582 2.188 . . . . 64.230000000000004 113.05 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 115.374 -0.83 . . . . 72.299999999999997 111.215 -179.684 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 47.8 ttt180 -77.37 124.27 27.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.714 -0.675 . . . . 75.420000000000002 111.163 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.76 -28.81 6.88 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.712 -0.676 . . . . 64.120000000000005 113.197 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.67 160.15 14.54 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.43 0.292 . . . . 72.140000000000001 110.998 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.78 145.39 28.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.093 -0.503 . . . . 73.129999999999995 111.327 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 34.8 t -120.52 117.15 26.89 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.625 -0.716 . . . . 70.120000000000005 110.807 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.6 110.67 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.513 -0.767 . . . . 63.039999999999999 109.329 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 103' ' ' LEU . 28.3 m -146.91 153.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.104 -0.498 . . . . 42.420000000000002 111.475 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.4 m-70 -103.12 125.28 49.76 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.454 -0.793 . . . . 75.310000000000002 109.314 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.4 p90 -116.23 168.14 10.39 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.403 0.519 . . . . 74.340000000000003 112.403 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.2 m -148.85 105.89 3.6 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.135 -0.939 . . . . 54.439999999999998 109.484 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.51 117.95 5.21 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.105 -0.569 . . . . 74.5 112.754 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.8 mtm -133.04 135.13 45.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.019 0.528 . . . . 72.230000000000004 110.946 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.53 172.01 0.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.438 -0.801 . . . . 42.340000000000003 112.27 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.92 -27.15 50.86 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.157 0.583 . . . . 72.0 111.951 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.95 -17.43 29.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.701 -0.681 . . . . 53.299999999999997 111.634 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.41 13.7 21.99 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.736 -0.745 . . . . 51.420000000000002 113.316 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.466 0 N-CA-C 110.13 -0.322 . . . . 63.25 110.13 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.288 0 N-CA-C 112.956 0.725 . . . . 75.25 112.956 -179.569 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.9 p90 -134.81 -14.1 2.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.5 -1.227 . . . . 74.109999999999999 111.173 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.58 110.5 0.04 OUTLIER 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.13 0.49 . . . . 71.540000000000006 112.134 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -123.13 138.15 54.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.304 -0.862 . . . . 72.049999999999997 110.127 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 64.9 p -78.74 -35.74 44.28 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.792 -0.64 . . . . 71.120000000000005 112.587 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -72.37 -23.18 61.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.757 0.651 . . . . 54.32 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -28.27 69.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.871 0.367 . . . . 64.340000000000003 110.979 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -96.37 0.82 51.16 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.356 -0.838 . . . . 71.299999999999997 109.953 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.08 37.99 8.74 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.269 1.027 . . . . 72.439999999999998 111.559 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 111.717 -179.768 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -73.35 158.02 48.89 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.896 2.397 . . . . 72.540000000000006 113.02 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -102.45 118.83 37.72 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.781 -0.645 . . . . 73.329999999999998 112.097 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.504 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 115.175 -0.92 . . . . 74.450000000000003 110.034 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 40.7 p90 -149.23 161.77 41.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.314 0.384 . . . . 73.329999999999998 111.452 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.491 ' SD ' HH12 ' A' ' 52' ' ' MLY . 6.5 mtt -106.15 132.83 51.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 71.140000000000001 110.567 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.61 139.78 39.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.975 -0.557 . . . . 74.219999999999999 111.625 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.82 -10.88 50.04 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.39 -0.823 . . . . 71.310000000000002 113.373 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MLY . . . . . 0.491 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 122.502 0.321 . . . . 72.219999999999999 110.721 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 70.05 27.27 4.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.08 0.952 . . . . 64.219999999999999 112.084 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -76.63 -13.48 60.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.043 -0.526 . . . . 75.25 110.854 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.26 -178.2 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.292 -0.867 . . . . 74.450000000000003 110.426 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -78.75 158.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 111.973 0.36 . . . . 53.420000000000002 111.973 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -59.35 -43.67 92.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.934 -0.576 . . . . 73.409999999999997 111.864 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.619 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.93 -20.21 62.04 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.062 -0.517 . . . . 75.120000000000005 113.302 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -84.17 -44.19 14.22 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 122.292 0.237 . . . . 64.239999999999995 111.072 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.72 -37.35 84.51 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.352 0.408 . . . . 71.319999999999993 111.704 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.49 -25.38 28.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.015 -0.539 . . . . 73.219999999999999 111.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.7 -46.24 4.63 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.4 0.438 . . . . 71.540000000000006 113.839 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.47 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.2 p -63.78 -25.81 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.728 0.411 . . . . 73.299999999999997 111.669 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.13 53.4 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.391 -0.822 . . . . 33.409999999999997 111.737 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -94.17 -4.94 48.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.812 -0.631 . . . . 54.100000000000001 111.324 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.512 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.13 158.22 19.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.447 -0.342 . . . . 71.25 110.645 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.653 ' C ' HD13 ' A' ' 103' ' ' LEU . 8.8 p -116.53 150.84 37.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.086 -0.506 . . . . 51.25 110.788 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.723 ' HA ' HD22 ' A' ' 103' ' ' LEU . 53.2 t -40.08 119.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.584 0.754 . . . . 53.100000000000001 112.302 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 3.57 61.64 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.301 -0.863 . . . . 71.340000000000003 113.124 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -95.8 145.3 25.45 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.902 0.382 . . . . 75.439999999999998 111.366 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.86 108.5 12.53 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.039 -0.982 . . . . 73.140000000000001 109.342 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.85 157.02 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.939 -0.573 . . . . 61.039999999999999 111.878 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-N 116.078 -0.51 . . . . 72.400000000000006 110.382 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.838 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.85 128.93 53.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.118 -0.492 . . . . 74.519999999999996 110.833 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.7 m -96.33 113.72 25.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.672 -0.694 . . . . 53.119999999999997 109.466 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.619 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.2 mm -105.27 141.46 20.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.859 -0.609 . . . . 75.109999999999999 110.356 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.34 162.17 20.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 114.941 -1.027 . . . . 74.230000000000004 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.48 -14.47 39.49 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.58 2.187 . . . . 62.43 113.201 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.83 -29.49 22.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 110.777 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -98.72 -18.52 17.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.755 -0.657 . . . . 73.030000000000001 111.569 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.5 -63.47 1.33 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.778 0.659 . . . . 54.109999999999999 112.778 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -134.21 -51.21 0.82 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.608 0.225 . . . . 74.540000000000006 111.608 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.22 -143.29 10.69 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 71.340000000000003 111.948 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.6 -9.75 34.12 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 111.617 0.229 . . . . 51.549999999999997 111.617 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 m -100.44 -60.35 1.54 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.194 -0.457 . . . . 63.549999999999997 110.469 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.88 -166.93 53.05 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.315 0.384 . . . . 73.040000000000006 113.171 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.453 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.97 124.82 46.3 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 109.87 -0.419 . . . . 71.030000000000001 109.87 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.03 123.56 10.13 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.22 1.947 . . . . 52.530000000000001 113.624 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.19 -46.48 1.16 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.579 -0.737 . . . . 63.229999999999997 113.38 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mt -100.6 -51.88 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 111.563 0.209 . . . . 73.329999999999998 111.563 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.453 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.2 mm -109.92 98.62 35.04 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 123.212 0.32 . . . . 74.319999999999993 110.982 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.61 165.56 32.13 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.432 2.088 . . . . 65.319999999999993 112.755 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.84 142.57 28.55 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.507 2.138 . . . . 73.209999999999994 113.119 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 56.82 45.11 22.19 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.636 0.774 . . . . 70.340000000000003 111.689 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.43 133.01 52.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.678 -0.692 . . . . 71.420000000000002 111.824 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -83.22 140.64 32.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.714 -1.13 . . . . 74.25 110.791 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mt -118.18 155.71 30.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.686 -0.688 . . . . 71.519999999999996 111.072 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.48 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.83 -0.623 . . . . 72.319999999999993 109.699 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.3 m-85 -130.86 134.09 46.49 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.032 -0.531 . . . . 71.299999999999997 110.611 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.8 t70 -116.44 104.88 11.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.148 -0.478 . . . . 62.020000000000003 110.255 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.838 HG22 HD11 ' A' ' 74' ' ' LEU . 25.7 m -105.98 153.55 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.063 -0.517 . . . . 60.420000000000002 111.125 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.64 124.06 29.11 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.472 -0.786 . . . . 72.230000000000004 110.173 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.752 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -73.54 103.73 4.26 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.14 0.495 . . . . 64.0 110.89 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.75 -57.37 2.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.352 -0.84 . . . . 73.510000000000005 111.344 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 C-N-CA 122.834 0.454 . . . . 74.319999999999993 110.742 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.2 mt -123.28 145.91 48.3 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.099 -0.5 . . . . 64.409999999999997 110.735 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 116.114 -0.493 . . . . 65.530000000000001 110.807 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 CA-C-O 119.322 -0.71 . . . . 43.119999999999997 112.656 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.86 -38.39 1.7 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.035 2.49 . . . . 72.120000000000005 113.003 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.3 t -131.43 -47.84 0.98 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.38 0.425 . . . . 74.209999999999994 110.957 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 25.1 mmt -135.95 -45.81 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.345 0.403 . . . . 73.209999999999994 111.047 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 119.23 -42.71 1.72 Allowed Glycine 0 C--N 1.34 0.783 0 O-C-N 123.446 0.467 . . . . 60.009999999999998 112.388 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.1 p -128.04 119.64 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 120.7 0.286 . . . . 71.540000000000006 110.702 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -118.51 117.62 29.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.767 -0.652 . . . . 73.140000000000001 110.839 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.5 p -108.55 134.09 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.917 -0.583 . . . . 62.43 110.909 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.43 124.1 43.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.487 -0.778 . . . . 74.439999999999998 110.227 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -77.65 126.56 31.07 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.881 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.98 -38.47 3.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.074 -0.966 . . . . 72.430000000000007 110.412 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -133.09 118.64 15.27 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.004 -0.544 . . . . 74.319999999999993 110.574 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.96 129.73 15.7 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.567 2.178 . . . . 61.420000000000002 113.152 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.98 -121.68 4.37 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.82 -0.627 . . . . 44.329999999999998 112.233 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.56 -46.34 13.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.605 0.203 . . . . 61.450000000000003 111.0 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.51 -1.69 88.61 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.568 0.542 . . . . 63.509999999999998 113.808 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -135.27 -0.91 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.494 0.318 . . . . 75.239999999999995 111.734 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -120.14 93.14 3.96 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 71.400000000000006 110.451 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.24 149.14 36.65 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.604 -0.725 . . . . 72.109999999999999 110.948 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.63 130.36 20.62 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.57 2.18 . . . . 64.230000000000004 113.189 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 115.422 -0.808 . . . . 72.299999999999997 111.059 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 56.6 ttt180 -77.39 122.12 24.72 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.667 -0.697 . . . . 75.420000000000002 111.194 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.14 -27.65 6.94 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 115.831 -0.622 . . . . 64.120000000000005 113.466 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 160.33 14.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.373 0.269 . . . . 72.140000000000001 111.086 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -84.58 145.31 28.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 111.094 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 60.2 m -124.24 119.75 30.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.669 -0.696 . . . . 70.120000000000005 110.9 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.61 111.3 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.276 -0.875 . . . . 63.039999999999999 109.563 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 103' ' ' LEU . 30.1 m -146.14 152.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.967 -0.56 . . . . 42.420000000000002 111.602 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.2 m-70 -103.73 125.48 50.22 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.367 -0.833 . . . . 75.310000000000002 109.229 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.625 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.1 p90 -116.9 167.42 11.14 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.531 0.567 . . . . 74.340000000000003 112.531 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -147.83 110.78 4.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.217 -0.901 . . . . 54.439999999999998 109.595 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.6 119.55 6.0 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.081 -0.509 . . . . 74.5 112.619 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 mtm -135.15 132.93 38.61 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.976 0.51 . . . . 72.230000000000004 110.87 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.16 172.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.527 -0.761 . . . . 42.340000000000003 112.461 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -55.73 -27.49 50.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.142 0.577 . . . . 72.0 111.981 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.37 -17.48 30.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.628 -0.714 . . . . 53.299999999999997 111.556 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.67 13.89 22.89 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 120.73 -0.748 . . . . 51.420000000000002 113.313 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.397 0 N-CA-C 110.224 -0.288 . . . . 63.25 110.224 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 N-CA-C 112.862 0.69 . . . . 75.25 112.862 -179.686 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.8 p90 -133.62 -15.19 2.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.612 -1.176 . . . . 74.109999999999999 111.316 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.54 111.47 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.081 0.467 . . . . 71.540000000000006 111.884 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -122.19 143.66 49.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.315 -0.857 . . . . 72.049999999999997 110.174 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.584 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 8.1 t -78.28 -37.24 45.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.120000000000005 112.574 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -22.78 61.91 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.477 0.547 . . . . 54.32 112.477 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -29.65 68.74 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.87 0.367 . . . . 64.340000000000003 111.178 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' O ' ' HD3' ' A' ' 44' ' ' MLY . 55.6 mtm180 -94.04 0.7 56.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.349 -0.841 . . . . 71.299999999999997 110.219 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.89 37.46 9.55 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.193 0.997 . . . . 72.439999999999998 111.676 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MLY . . . . . 0.48 ' HD3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-N 116.046 -0.525 . . . . 74.109999999999999 111.486 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.99 157.92 53.59 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.811 2.341 . . . . 72.540000000000006 113.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CD1' ' HE1' ' A' ' 26' ' ' TYR . 19.9 t80 -104.0 118.12 35.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.685 -0.689 . . . . 73.329999999999998 111.933 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.432 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.376 0 CA-C-N 115.286 -0.87 . . . . 74.450000000000003 110.293 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' THR . 42.4 p90 -149.09 161.85 41.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.382 0.426 . . . . 73.329999999999998 111.332 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.434 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 7.0 mtt -106.8 134.85 49.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.126 -0.488 . . . . 71.140000000000001 110.661 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm? -79.56 140.72 37.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.849 -0.614 . . . . 74.219999999999999 111.57 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.54 -11.03 47.64 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.509 -0.769 . . . . 71.310000000000002 113.457 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 122.505 0.322 . . . . 72.219999999999999 110.698 179.359 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 69.21 29.62 4.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.077 0.951 . . . . 64.219999999999999 112.197 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 45.2 mt-10 -78.93 -11.54 60.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.89 -0.596 . . . . 75.25 110.889 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -131.24 -178.26 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.429 -0.805 . . . . 74.450000000000003 110.721 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 HD12 HG21 ' A' ' 76' ' ' ILE . 7.0 pt -76.91 160.25 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.045 0.387 . . . . 53.420000000000002 112.045 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -62.05 -43.17 99.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.004 -0.544 . . . . 73.409999999999997 111.842 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.82 -20.88 62.57 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 123.504 0.502 . . . . 75.120000000000005 113.25 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.403 ' CD1' HD11 ' A' ' 56' ' ' ILE . 8.1 m0 -84.2 -44.76 13.62 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 122.311 0.244 . . . . 64.239999999999995 111.18 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.5 mt-10 -65.66 -37.03 85.39 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.249 0.343 . . . . 71.319999999999993 111.605 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.47 -26.95 27.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.75 -0.659 . . . . 73.219999999999999 111.812 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.73 -46.15 4.95 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 123.507 0.504 . . . . 71.540000000000006 113.955 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.1 p -63.54 -26.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.745 0.418 . . . . 73.299999999999997 111.712 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.36 49.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.481 -0.781 . . . . 33.409999999999997 111.725 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -94.73 -2.99 50.05 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.686 -0.688 . . . . 54.100000000000001 111.25 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.519 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.78 158.29 20.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.402 -0.363 . . . . 71.25 110.785 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.658 ' C ' HD13 ' A' ' 103' ' ' LEU . 7.6 p -116.42 150.84 37.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.084 -0.507 . . . . 51.25 110.665 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.725 ' HA ' HD22 ' A' ' 103' ' ' LEU . 53.9 t -40.07 119.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.649 0.78 . . . . 53.100000000000001 112.214 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.44 4.21 60.96 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.329 -0.851 . . . . 71.340000000000003 113.133 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -96.18 145.77 25.24 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.983 0.421 . . . . 75.439999999999998 111.381 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.25 109.04 12.89 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.069 -0.969 . . . . 73.140000000000001 109.407 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.76 157.26 44.31 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.029 -0.532 . . . . 61.039999999999999 111.895 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.308 0 CA-C-N 116.127 -0.488 . . . . 72.400000000000006 110.495 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.841 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.08 134.37 47.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.076 -0.511 . . . . 74.519999999999996 110.824 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.8 m -100.41 112.95 25.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.614 -0.721 . . . . 53.119999999999997 109.371 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.555 HG21 HD12 ' A' ' 56' ' ' ILE . 7.2 mm -104.37 131.52 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.885 -0.598 . . . . 75.109999999999999 110.247 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.09 162.48 23.69 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.333 -0.849 . . . . 74.230000000000004 110.707 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -63.21 -14.4 41.63 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.343 2.029 . . . . 62.43 113.015 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.22 -28.25 21.27 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.684 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 -18.85 18.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.727 -0.67 . . . . 73.030000000000001 111.441 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.97 -64.51 1.14 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.779 0.659 . . . . 54.109999999999999 112.779 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -132.61 -53.46 0.94 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.645 0.239 . . . . 74.540000000000006 111.645 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.5 -141.33 8.5 Favored Glycine 0 C--N 1.338 0.658 0 O-C-N 123.515 0.509 . . . . 71.340000000000003 111.9 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.64 -10.56 29.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 111.586 0.217 . . . . 51.549999999999997 111.586 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.1 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.287 -0.415 . . . . 63.549999999999997 110.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.04 -168.54 53.58 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.376 0.422 . . . . 73.040000000000006 113.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 37.3 t-80 -96.81 124.78 48.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.892 -0.41 . . . . 71.030000000000001 109.892 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.96 125.34 11.93 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.189 1.926 . . . . 52.530000000000001 113.601 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.52 -43.43 1.67 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.585 -0.734 . . . . 63.229999999999997 113.395 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.84 -52.12 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.651 0.225 . . . . 73.329999999999998 111.55 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 22.2 mm -111.72 99.25 44.33 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 123.186 0.304 . . . . 74.319999999999993 111.159 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.34 165.67 31.71 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.381 2.054 . . . . 65.319999999999993 112.668 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.4 143.39 27.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.543 2.162 . . . . 73.209999999999994 113.302 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 56.54 41.29 28.82 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.621 0.768 . . . . 70.340000000000003 111.845 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.2 131.04 53.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.711 -0.677 . . . . 71.420000000000002 111.763 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -81.89 140.33 34.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.731 -1.122 . . . . 74.25 110.857 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.52 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mt -117.56 155.41 29.85 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.572 -0.74 . . . . 71.519999999999996 110.979 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 129.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.822 -0.626 . . . . 72.319999999999993 109.575 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 27' ' ' THR . 88.1 m-85 -132.34 134.65 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.473 . . . . 71.299999999999997 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.0 t70 -116.46 105.54 12.61 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.076 -0.511 . . . . 62.020000000000003 110.253 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.841 HG22 HD11 ' A' ' 74' ' ' LEU . 25.8 m -105.26 153.5 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.071 -0.513 . . . . 60.420000000000002 111.031 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.24 123.62 28.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.461 -0.791 . . . . 72.230000000000004 110.063 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.729 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -73.53 102.56 3.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.122 0.487 . . . . 64.0 110.617 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.85 -56.51 3.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.448 -0.796 . . . . 73.510000000000005 111.414 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 122.843 0.457 . . . . 74.319999999999993 110.752 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.8 mt -122.97 146.99 47.13 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.052 -0.522 . . . . 64.409999999999997 110.737 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 N--CA 1.465 0.28 0 CA-C-N 116.137 -0.483 . . . . 65.530000000000001 110.826 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 CA-C-O 119.116 -0.825 . . . . 43.119999999999997 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.28 156.01 41.73 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.891 2.394 . . . . 72.120000000000005 112.762 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 51.8 m -127.55 146.01 50.66 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.9 -0.591 . . . . 74.209999999999994 110.931 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 21.8 mmt -100.54 149.01 24.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.918 -0.583 . . . . 73.209999999999994 111.056 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -98.2 -20.43 20.59 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.724 -0.671 . . . . 60.009999999999998 113.019 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 76' ' ' ILE . 8.5 p -118.04 119.72 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.708 0.29 . . . . 71.540000000000006 110.73 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -118.73 116.94 27.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.82 -0.627 . . . . 73.140000000000001 110.567 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.4 p -108.54 139.12 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.055 -0.521 . . . . 62.43 111.111 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.78 125.22 42.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.454 -0.794 . . . . 74.439999999999998 110.373 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -78.33 127.86 32.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.791 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.414 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.2 mt -110.75 -39.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.122 -0.945 . . . . 72.430000000000007 110.4 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -132.35 118.86 16.17 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.047 -0.524 . . . . 74.319999999999993 110.443 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.61 129.57 15.84 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.606 2.204 . . . . 61.420000000000002 113.307 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.16 -121.17 4.31 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.749 -0.659 . . . . 44.329999999999998 112.117 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.77 -46.26 12.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.644 0.222 . . . . 61.450000000000003 110.945 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.25 -1.86 88.42 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.077 -0.511 . . . . 63.509999999999998 113.697 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -136.35 1.5 2.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.462 0.305 . . . . 75.239999999999995 111.747 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -122.39 92.21 3.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.104 0.478 . . . . 71.400000000000006 110.213 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -103.03 149.71 37.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.511 -0.768 . . . . 72.109999999999999 110.893 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.37 126.8 16.2 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.497 2.131 . . . . 64.230000000000004 112.918 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.48 -0.782 . . . . 72.299999999999997 111.483 -179.39 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 44.2 ttt180 -77.53 120.54 22.65 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.418 -0.81 . . . . 75.420000000000002 111.372 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.98 -25.65 7.82 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.967 -0.561 . . . . 64.120000000000005 113.498 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.59 160.45 14.34 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.323 0.249 . . . . 72.140000000000001 110.974 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.511 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -81.92 145.09 30.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 111.131 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 32.1 m -123.86 117.83 25.73 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.574 -0.739 . . . . 70.120000000000005 110.618 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.73 111.25 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.449 -0.796 . . . . 63.039999999999999 109.805 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.5 m -145.55 151.39 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.847 -0.615 . . . . 42.420000000000002 111.398 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.5 m-70 -102.68 125.27 49.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.537 -0.756 . . . . 75.310000000000002 109.499 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.2 p90 -115.72 166.22 12.18 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.436 0.532 . . . . 74.340000000000003 112.436 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -148.15 105.97 3.7 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.119 -0.946 . . . . 54.439999999999998 109.274 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 122.84 6.78 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.137 -0.554 . . . . 74.5 113.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.4 mtm -136.86 131.38 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.19 0.596 . . . . 72.230000000000004 110.624 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.25 170.42 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.622 -0.717 . . . . 42.340000000000003 112.337 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.14 -28.08 50.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.144 0.578 . . . . 72.0 112.135 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.91 -17.28 29.9 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.713 -0.676 . . . . 53.299999999999997 111.734 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 13.48 22.88 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 120.781 -0.723 . . . . 51.420000000000002 113.012 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.419 0 N-CA-C 109.628 -0.508 . . . . 63.25 109.628 179.257 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.504 ' HD2' ' HB2' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 112.916 0.709 . . . . 75.25 112.916 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -135.91 -12.78 1.95 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.34 -1.3 . . . . 74.109999999999999 111.743 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.5 111.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.074 0.768 . . . . 71.540000000000006 113.074 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 35' ' ' MLY . 13.8 t -122.92 133.25 54.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.502 -0.772 . . . . 72.049999999999997 111.233 176.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' MLY . 52.7 p -79.63 -33.75 41.16 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.338 -0.846 . . . . 71.120000000000005 112.475 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -71.45 -39.36 71.02 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.085 0.772 . . . . 54.32 113.085 -178.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD2' HH21 ' A' ' 35' ' ' MLY . 1.1 t0 -66.73 -21.92 66.06 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.824 0.345 . . . . 64.340000000000003 110.897 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.6 -4.28 57.9 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.318 -0.855 . . . . 71.299999999999997 110.04 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 65.92 35.29 6.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.426 1.09 . . . . 72.439999999999998 112.021 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 39' ' ' SER . . . . . . . . 0 N--CA 1.472 0.651 0 CA-C-N 116.496 -0.32 . . . . 74.109999999999999 111.785 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.47 157.94 40.57 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.97 2.447 . . . . 72.540000000000006 112.847 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -102.53 117.94 35.79 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.86 -0.609 . . . . 73.329999999999998 112.06 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 115.041 -0.981 . . . . 74.450000000000003 109.929 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.9 p90 -151.97 164.18 37.7 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.242 0.339 . . . . 73.329999999999998 111.557 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.511 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.4 mpp? -107.25 135.5 48.66 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.186 -0.461 . . . . 71.140000000000001 110.603 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 60' ' ' GLU . 2.2 mm? -80.33 141.5 35.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.838 -0.619 . . . . 74.219999999999999 111.612 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.47 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 83.0 -9.42 60.38 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.519 -0.764 . . . . 71.310000000000002 113.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 110.705 179.38 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 68.43 28.38 6.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.108 0.963 . . . . 64.219999999999999 112.046 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.28 -33.44 61.23 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.948 -0.569 . . . . 75.25 110.545 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 m -104.12 -176.03 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.257 -0.883 . . . . 74.450000000000003 110.036 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -79.44 159.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 111.777 0.288 . . . . 53.420000000000002 111.777 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.23 -42.49 91.18 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.017 -0.538 . . . . 73.409999999999997 111.855 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.8 -23.14 65.12 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.858 -0.61 . . . . 75.120000000000005 113.188 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -82.45 -43.02 17.77 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 122.379 0.272 . . . . 64.239999999999995 111.231 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HA ' HD11 ' A' ' 50' ' ' LEU . 29.6 mt-10 -68.14 -37.74 81.4 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.289 0.368 . . . . 71.319999999999993 111.7 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.57 -23.34 29.71 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.513 0.508 . . . . 73.219999999999999 111.797 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.19 -46.17 4.21 Favored Glycine 0 C--N 1.343 0.961 0 O-C-N 123.512 0.507 . . . . 71.540000000000006 113.68 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.4 p -63.96 -25.3 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.633 0.373 . . . . 73.299999999999997 111.617 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 -8.47 57.05 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.338 -0.847 . . . . 33.409999999999997 111.782 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -93.1 -7.45 45.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.798 -0.637 . . . . 54.100000000000001 111.265 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -110.13 156.94 19.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.867 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.1 p -111.28 166.75 10.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.891 -0.595 . . . . 51.25 110.587 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.644 ' HA ' HD12 ' A' ' 103' ' ' LEU . 58.3 t -55.69 122.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.036 0.535 . . . . 53.100000000000001 111.205 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.17 3.09 70.22 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.493 -0.776 . . . . 71.340000000000003 113.254 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.42 142.12 27.8 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 120.932 0.396 . . . . 75.439999999999998 111.313 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -120.76 109.3 15.0 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.099 -0.955 . . . . 73.140000000000001 109.476 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.79 156.44 45.98 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.051 -0.522 . . . . 61.039999999999999 111.818 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.342 0.281 0 CA-C-N 116.128 -0.487 . . . . 72.400000000000006 110.46 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.813 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.72 124.56 50.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.11 -0.496 . . . . 74.519999999999996 110.882 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m -95.44 112.73 24.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.737 -0.665 . . . . 53.119999999999997 109.407 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.715 HD12 ' HA3' ' A' ' 58' ' ' GLY . 5.2 mm -107.46 141.48 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.284 0.564 . . . . 75.109999999999999 111.267 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.68 162.73 19.29 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 114.463 -1.244 . . . . 74.230000000000004 109.768 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.26 -17.52 57.52 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.18 1.92 . . . . 62.43 113.045 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.59 -5.79 59.27 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.29 -0.414 . . . . 74.510000000000005 111.109 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -125.01 -26.15 3.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.3 -0.863 . . . . 73.030000000000001 109.383 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.2 96.05 6.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.946 -1.024 . . . . 54.109999999999999 110.805 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 75.25 -50.7 0.65 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.914 -1.039 . . . . 74.540000000000006 112.252 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.65 -148.83 18.88 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.238 -0.506 . . . . 71.340000000000003 112.835 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.83 -8.88 56.91 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.473 0.546 . . . . 51.549999999999997 112.473 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 m -97.88 -60.19 1.61 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.52 -0.309 . . . . 63.549999999999997 110.496 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.53 -168.52 42.6 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.283 0.365 . . . . 73.040000000000006 113.292 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.551 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 32.9 t-80 -94.26 129.0 38.49 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 110.155 -0.313 . . . . 71.030000000000001 110.155 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.23 123.27 9.79 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.354 2.036 . . . . 52.530000000000001 113.565 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.5 -43.19 1.72 Allowed Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.661 -0.7 . . . . 63.229999999999997 113.42 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.42 -52.08 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.599 0.199 . . . . 73.329999999999998 111.412 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 16.1 mm -110.82 99.6 42.84 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 123.245 0.34 . . . . 74.319999999999993 111.023 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.36 165.82 31.56 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.458 2.106 . . . . 65.319999999999993 112.657 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.39 142.59 30.12 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.465 2.11 . . . . 73.209999999999994 113.052 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 56.9 47.58 17.54 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.681 0.792 . . . . 70.340000000000003 111.53 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.88 136.2 52.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 111.525 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -83.49 144.61 29.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.791 -1.095 . . . . 74.25 110.88 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.23 155.08 44.02 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.691 -0.686 . . . . 71.519999999999996 111.25 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 52.8 t -121.79 133.26 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.8 -0.636 . . . . 72.319999999999993 109.44 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.564 ' O ' HD12 ' A' ' 74' ' ' LEU . 93.2 m-85 -134.75 133.28 39.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.258 -0.428 . . . . 71.299999999999997 110.856 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.2 t70 -116.46 102.56 9.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.094 -0.503 . . . . 62.020000000000003 110.177 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.813 HG22 HD11 ' A' ' 74' ' ' LEU . 25.7 m -104.51 153.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.105 -0.498 . . . . 60.420000000000002 111.118 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.17 126.43 35.6 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.453 -0.794 . . . . 72.230000000000004 110.288 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.13 102.45 3.58 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 64.0 110.324 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.03 -58.15 2.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.232 -0.44 . . . . 73.510000000000005 111.578 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 122.872 0.469 . . . . 74.319999999999993 110.811 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -119.57 147.69 44.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.055 -0.52 . . . . 64.409999999999997 110.79 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.274 -0.421 . . . . 65.530000000000001 110.812 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.72 0 CA-C-O 119.279 -0.734 . . . . 43.119999999999997 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.47 153.09 39.32 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.065 2.51 . . . . 72.120000000000005 112.757 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.7 p -103.2 -43.08 5.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.893 -0.594 . . . . 74.209999999999994 111.361 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 25.6 ptt? 46.52 125.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.123 1.369 . . . . 73.209999999999994 114.041 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -95.62 40.31 2.67 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.566 -0.743 . . . . 60.009999999999998 113.084 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.2 p -139.3 114.05 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.801 0.334 . . . . 71.540000000000006 110.419 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -114.06 120.5 40.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.693 -0.685 . . . . 73.140000000000001 110.588 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 17.1 t -109.31 124.01 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.109 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -113.45 124.85 53.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.652 -0.704 . . . . 74.439999999999998 110.11 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.1 m -78.98 127.63 32.24 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.49 0.494 . . . . 74.150000000000006 110.943 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.461 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -109.09 -41.98 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.106 -0.952 . . . . 72.430000000000007 110.244 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -129.46 118.78 19.14 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.927 -0.579 . . . . 74.319999999999993 110.4 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.21 129.07 15.51 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.584 2.189 . . . . 61.420000000000002 113.412 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.78 -120.9 4.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.731 -0.668 . . . . 44.329999999999998 112.119 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.65 -45.78 13.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.636 0.218 . . . . 61.450000000000003 110.906 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 84.95 -1.51 88.83 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.009 -0.541 . . . . 63.509999999999998 113.728 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.48 1.02 2.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.473 0.309 . . . . 75.239999999999995 111.801 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.86 92.08 3.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.065 0.459 . . . . 71.400000000000006 110.251 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -102.82 149.41 36.77 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 115.511 -0.768 . . . . 72.109999999999999 110.93 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.32 124.41 12.48 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.433 2.089 . . . . 64.230000000000004 112.956 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 115.386 -0.825 . . . . 72.299999999999997 111.386 -179.407 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 46.0 ttt180 -77.35 126.39 30.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.636 -0.711 . . . . 75.420000000000002 111.342 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.35 -25.83 10.88 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.744 -0.662 . . . . 64.120000000000005 113.418 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 160.13 14.5 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.31 0.244 . . . . 72.140000000000001 111.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.79 145.24 28.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.148 -0.478 . . . . 73.129999999999995 111.154 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 35.9 m -122.89 119.26 29.97 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.652 -0.704 . . . . 70.120000000000005 110.846 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -91.6 110.9 23.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.281 -0.872 . . . . 63.039999999999999 109.655 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 103' ' ' LEU . 30.6 m -147.18 151.31 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.095 -0.502 . . . . 42.420000000000002 111.445 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -101.69 125.43 48.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.375 -0.83 . . . . 75.310000000000002 109.059 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.2 p90 -116.44 165.52 13.13 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.786 0.661 . . . . 74.340000000000003 112.786 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 3.0 m -149.0 112.1 4.91 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.997 -1.002 . . . . 54.439999999999998 109.379 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.9 121.08 6.79 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.999 -0.546 . . . . 74.5 112.8 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.1 mtm -130.65 131.05 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.891 0.477 . . . . 72.230000000000004 111.091 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.31 170.85 0.46 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.66 -0.7 . . . . 42.340000000000003 112.037 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -56.24 -26.5 51.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.047 0.539 . . . . 72.0 112.126 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.41 -17.34 28.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.748 -0.66 . . . . 53.299999999999997 111.75 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.59 13.76 21.51 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 120.838 -0.696 . . . . 51.420000000000002 113.337 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.893 -0.41 . . . . 63.25 109.893 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.465 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 112.853 0.686 . . . . 75.25 112.853 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 29.8 p90 -133.68 -9.63 2.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.338 -1.301 . . . . 74.109999999999999 111.42 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -167.18 111.54 0.72 Allowed 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.222 0.534 . . . . 71.540000000000006 111.714 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 3.0 p -116.9 118.15 31.67 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.863 -1.062 . . . . 72.049999999999997 110.729 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 19.6 t -78.65 -33.53 47.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.999 -0.546 . . . . 71.120000000000005 111.889 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -78.36 -23.22 47.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.78 0.659 . . . . 54.32 112.78 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -25.35 68.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.722 0.296 . . . . 64.340000000000003 111.33 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -91.68 1.24 57.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.505 -0.77 . . . . 71.299999999999997 109.734 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 62.7 36.41 13.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.144 0.978 . . . . 72.439999999999998 111.4 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 74.109999999999999 112.318 -179.164 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.56 158.01 48.1 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.937 2.425 . . . . 72.540000000000006 112.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CD1' ' HE2' ' A' ' 26' ' ' TYR . 20.5 t80 -100.65 118.63 37.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.842 -0.617 . . . . 73.329999999999998 112.02 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 115.224 -0.898 . . . . 74.450000000000003 110.225 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.1 p90 -149.77 164.91 34.01 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.374 0.421 . . . . 73.329999999999998 111.398 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.545 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 8.0 mtt -108.85 134.44 51.53 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.795 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.7 mm? -79.33 139.84 37.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 111.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.6 -10.52 50.47 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.508 -0.769 . . . . 71.310000000000002 113.375 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 122.497 0.319 . . . . 72.219999999999999 110.612 179.268 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 69.69 30.38 3.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.082 0.953 . . . . 64.219999999999999 112.181 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.545 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 44.3 mt-10 -79.62 -11.41 59.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.921 -0.581 . . . . 75.25 110.848 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.32 -177.25 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 115.378 -0.828 . . . . 74.450000000000003 110.565 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -79.23 159.94 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.066 0.395 . . . . 53.420000000000002 112.066 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -60.07 -44.5 94.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.911 -0.586 . . . . 73.409999999999997 111.816 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.26 -20.78 61.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.167 -0.47 . . . . 75.120000000000005 113.533 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -84.15 -43.48 14.95 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 116.624 0.212 . . . . 64.239999999999995 111.212 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.9 mt-10 -66.36 -37.42 85.26 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.381 0.426 . . . . 71.319999999999993 111.601 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.51 -25.63 28.68 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.945 -0.57 . . . . 73.219999999999999 111.714 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.62 -46.54 4.86 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.435 0.459 . . . . 71.540000000000006 113.888 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.32 -25.13 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.804 0.442 . . . . 73.299999999999997 111.749 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.98 -8.01 55.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.407 -0.815 . . . . 33.409999999999997 111.657 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.436 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.8 mt-30 -92.3 -11.16 35.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.76 -0.655 . . . . 54.100000000000001 111.24 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.436 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.87 156.37 18.76 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.359 0.412 . . . . 71.25 110.957 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.413 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.3 p -110.99 166.75 10.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.829 -0.623 . . . . 51.25 110.613 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 103' ' ' LEU . 60.7 t -55.98 123.07 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.03 0.532 . . . . 53.100000000000001 111.271 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.36 4.61 70.75 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 115.476 -0.784 . . . . 71.340000000000003 113.179 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.07 142.0 28.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.952 0.406 . . . . 75.439999999999998 111.312 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -119.81 108.25 14.17 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.1 -0.955 . . . . 73.140000000000001 109.389 178.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.415 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.49 155.06 48.05 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.974 -0.557 . . . . 61.039999999999999 111.882 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.048 -0.524 . . . . 72.400000000000006 110.255 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.65 125.63 54.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.245 -0.434 . . . . 74.519999999999996 111.092 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.5 m -93.91 114.12 26.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.419 -0.81 . . . . 53.119999999999997 109.527 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.693 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.0 mm -106.43 144.58 15.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.893 -0.594 . . . . 75.109999999999999 110.555 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.74 162.05 20.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.801 -1.091 . . . . 74.230000000000004 110.834 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.03 -17.29 51.0 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.787 2.324 . . . . 62.43 113.22 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.56 -25.7 26.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 111.313 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.09 -18.57 15.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.074 -0.512 . . . . 73.030000000000001 111.477 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.73 -62.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.673 0.619 . . . . 54.109999999999999 112.673 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -134.55 -51.98 0.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.549 0.203 . . . . 74.540000000000006 111.549 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.52 -140.18 7.79 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.475 0.484 . . . . 71.340000000000003 112.057 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.61 -10.91 26.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.602 0.223 . . . . 51.549999999999997 111.602 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.21 -60.37 1.54 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 63.549999999999997 110.533 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.17 -167.49 54.18 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.345 0.403 . . . . 73.040000000000006 113.143 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -97.23 124.15 50.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.942 -0.392 . . . . 71.030000000000001 109.942 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.5 124.07 10.82 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.213 1.942 . . . . 52.530000000000001 113.586 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.18 -47.98 0.99 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.564 -0.743 . . . . 63.229999999999997 113.404 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.03 -51.5 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 111.556 0.206 . . . . 73.329999999999998 111.556 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.7 mm -110.15 98.07 33.42 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 123.178 0.299 . . . . 74.319999999999993 111.084 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.77 165.76 31.56 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.449 2.099 . . . . 65.319999999999993 112.706 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.05 143.37 28.81 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.54 2.16 . . . . 73.209999999999994 113.164 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 56.71 42.89 26.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.634 0.774 . . . . 70.340000000000003 111.778 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.44 132.9 54.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.726 -0.67 . . . . 71.420000000000002 111.73 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -82.25 140.86 33.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.72 -1.127 . . . . 74.25 110.857 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.513 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.7 mt -119.28 153.99 34.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.66 -0.7 . . . . 71.519999999999996 111.029 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.57 131.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.791 -0.641 . . . . 72.319999999999993 109.58 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.583 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.5 m-85 -132.42 132.88 43.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.104 -0.498 . . . . 71.299999999999997 110.64 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 4.9 t70 -116.5 103.31 10.3 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.057 -0.519 . . . . 62.020000000000003 110.103 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.814 HG22 HD11 ' A' ' 74' ' ' LEU . 23.9 m -105.47 153.71 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 60.420000000000002 111.163 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.53 125.88 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.538 -0.755 . . . . 72.230000000000004 110.444 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.15 101.67 3.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.769 -0.65 . . . . 64.0 110.273 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.7 -58.67 2.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.279 -0.419 . . . . 73.510000000000005 111.361 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.926 0.49 . . . . 74.319999999999993 110.736 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.7 mt -120.89 149.17 43.02 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.178 -0.464 . . . . 64.409999999999997 110.814 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.027 -0.533 . . . . 65.530000000000001 110.836 179.819 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 CA-C-O 119.23 -0.761 . . . . 43.119999999999997 112.54 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.86 158.62 38.77 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.05 2.5 . . . . 72.120000000000005 112.771 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.4 t -98.08 -43.49 7.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.883 -0.599 . . . . 74.209999999999994 111.106 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 18.5 mmt -108.87 149.22 29.44 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.401 0.438 . . . . 73.209999999999994 111.074 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.69 10.81 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.625 -0.716 . . . . 60.009999999999998 112.792 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.4 p -123.23 124.9 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.66 0.267 . . . . 71.540000000000006 110.774 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.29 141.78 47.88 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.78 -0.645 . . . . 73.140000000000001 110.245 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.88 123.66 61.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.519 -0.764 . . . . 62.43 110.29 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -117.61 120.38 37.87 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.716 -0.674 . . . . 74.439999999999998 110.228 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 m -77.37 124.5 27.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.118 -0.492 . . . . 74.150000000000006 111.023 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mt -107.25 -40.29 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 114.954 -1.021 . . . . 72.430000000000007 110.24 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -131.06 118.94 17.63 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.902 -0.59 . . . . 74.319999999999993 110.436 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.64 130.33 16.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.555 2.17 . . . . 61.420000000000002 113.213 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.67 -122.16 4.6 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.724 -0.671 . . . . 44.329999999999998 112.15 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.67 -45.95 13.85 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.584 0.192 . . . . 61.450000000000003 110.961 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.84 -2.15 88.39 Favored Glycine 0 C--N 1.342 0.882 0 O-C-N 123.585 0.553 . . . . 63.509999999999998 113.833 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.97 -0.46 2.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.462 0.305 . . . . 75.239999999999995 111.698 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -120.23 93.21 3.98 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.013 0.435 . . . . 71.400000000000006 110.585 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -103.4 149.32 36.88 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.573 -0.739 . . . . 72.109999999999999 110.813 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.72 127.71 16.73 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.537 2.158 . . . . 64.230000000000004 113.102 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.41 0 CA-C-N 115.332 -0.849 . . . . 72.299999999999997 111.119 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -77.3 125.01 28.65 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.856 -0.611 . . . . 75.420000000000002 111.256 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.77 -26.25 8.54 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.672 -0.694 . . . . 64.120000000000005 113.152 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -98.94 160.15 14.46 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.441 0.297 . . . . 72.140000000000001 110.967 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.74 145.31 28.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 111.329 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 37.1 t -120.72 117.66 28.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.563 -0.744 . . . . 70.120000000000005 110.701 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.88 110.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.389 -0.823 . . . . 63.039999999999999 109.408 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.3 m -147.25 152.55 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.116 -0.493 . . . . 42.420000000000002 111.569 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.8 m-70 -103.05 125.4 49.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.39 -0.823 . . . . 75.310000000000002 109.062 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' HB3' HG12 ' A' ' 101' ' ' VAL . 42.2 p90 -115.89 165.94 12.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.718 0.636 . . . . 74.340000000000003 112.718 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.6 m -148.54 109.95 4.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.931 -1.031 . . . . 54.439999999999998 109.258 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -94.58 119.54 6.12 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.111 -0.566 . . . . 74.5 112.865 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.6 mtm -129.62 131.3 46.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.924 0.49 . . . . 72.230000000000004 111.12 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -57.25 171.1 0.42 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 42.340000000000003 112.083 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.58 -26.2 54.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.042 0.537 . . . . 72.0 112.06 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.43 -17.45 28.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.772 -0.649 . . . . 53.299999999999997 111.74 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 13.77 22.19 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 120.812 -0.708 . . . . 51.420000000000002 113.508 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.428 0 N-CA-C 109.699 -0.482 . . . . 63.25 109.699 179.567 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.454 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 112.916 0.71 . . . . 75.25 112.916 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.7 p90 -133.79 -9.79 2.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.34 -1.3 . . . . 74.109999999999999 111.435 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -166.81 111.62 0.76 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.307 0.575 . . . . 71.540000000000006 111.703 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 3.3 p -117.01 119.28 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.855 -1.066 . . . . 72.049999999999997 110.954 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.535 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.4 p -78.48 -35.43 46.57 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.009 -0.541 . . . . 71.120000000000005 112.177 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -76.9 -23.22 52.55 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.807 0.669 . . . . 54.32 112.807 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -25.16 68.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.749 0.309 . . . . 64.340000000000003 111.307 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 44' ' ' MLY . 88.5 mtt180 -92.44 0.5 57.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.471 -0.786 . . . . 71.299999999999997 109.653 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 m120 63.24 36.7 11.7 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.217 1.007 . . . . 72.439999999999998 111.416 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MLY . . . . . 0.546 ' HD3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.67 0 CA-C-N 116.06 -0.518 . . . . 74.109999999999999 112.353 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.16 158.14 45.6 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.978 2.452 . . . . 72.540000000000006 112.794 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -100.08 118.82 37.26 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.877 -0.601 . . . . 73.329999999999998 112.029 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.556 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 115.248 -0.887 . . . . 74.450000000000003 110.215 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.9 p90 -149.62 163.44 37.89 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.388 0.43 . . . . 73.329999999999998 111.441 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.534 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 8.1 mtt -107.42 134.13 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.239 -0.437 . . . . 71.140000000000001 110.804 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.7 mm? -79.11 139.84 37.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 74.219999999999999 111.572 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.46 -9.87 52.88 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.544 -0.753 . . . . 71.310000000000002 113.36 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MLY . . . . . 0.48 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.519 0 C-N-CA 122.48 0.312 . . . . 72.219999999999999 110.623 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 69.45 29.39 4.41 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.08 0.952 . . . . 64.219999999999999 112.189 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 45.6 mt-10 -78.78 -11.17 59.98 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.902 -0.59 . . . . 75.25 110.865 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.74 -177.16 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.304 -0.862 . . . . 74.450000000000003 110.571 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -79.13 158.73 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.997 0.369 . . . . 53.420000000000002 111.997 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -59.47 -44.25 93.05 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.935 -0.575 . . . . 73.409999999999997 111.852 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.692 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.51 -20.61 61.54 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 116.072 -0.513 . . . . 75.120000000000005 113.495 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.1 -43.68 14.81 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 116.698 0.249 . . . . 64.239999999999995 111.135 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.6 mt-10 -66.42 -37.18 84.62 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.309 0.381 . . . . 71.319999999999993 111.536 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -84.39 -27.0 27.93 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.935 -0.575 . . . . 73.219999999999999 111.697 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.36 -46.73 5.16 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.462 0.476 . . . . 71.540000000000006 113.981 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.39 -25.33 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.822 0.449 . . . . 73.299999999999997 111.821 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.96 -7.54 54.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.498 -0.773 . . . . 33.409999999999997 111.697 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -92.99 -6.59 48.03 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.852 -0.613 . . . . 54.100000000000001 111.351 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.517 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.23 157.81 19.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.43 -0.35 . . . . 71.25 110.879 -179.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.659 ' C ' HD13 ' A' ' 103' ' ' LEU . 7.9 p -116.48 150.56 37.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.995 -0.548 . . . . 51.25 110.665 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.731 ' HA ' HD22 ' A' ' 103' ' ' LEU . 58.9 t -40.06 119.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.634 0.774 . . . . 53.100000000000001 112.295 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.56 4.36 62.26 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.312 -0.858 . . . . 71.340000000000003 113.138 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -96.5 145.75 25.41 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.925 0.393 . . . . 75.439999999999998 111.38 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.09 106.66 10.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.063 -0.971 . . . . 73.140000000000001 109.393 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -129.91 154.48 47.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.88 -0.6 . . . . 61.039999999999999 111.669 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.421 ' HG2' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 72.400000000000006 110.227 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.801 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.63 125.93 52.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.036 0.446 . . . . 74.519999999999996 111.334 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 77.6 m -93.03 112.45 24.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.033 -0.985 . . . . 53.119999999999997 109.46 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.692 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.1 mm -105.68 142.1 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 75.109999999999999 110.379 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.03 162.02 21.16 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 114.867 -1.061 . . . . 74.230000000000004 110.94 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.38 -17.33 52.67 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.691 2.26 . . . . 62.43 113.174 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.66 -25.71 26.41 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.452 0.47 . . . . 74.510000000000005 111.346 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -101.47 -19.7 15.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.066 -0.515 . . . . 73.030000000000001 111.416 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.75 -61.6 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.674 0.62 . . . . 54.109999999999999 112.674 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.1 -52.09 0.78 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.582 0.216 . . . . 74.540000000000006 111.582 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.53 -140.54 8.02 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 123.557 0.536 . . . . 71.340000000000003 112.018 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.4 -10.95 26.45 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.56 0.207 . . . . 51.549999999999997 111.56 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.07 -60.32 1.55 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.316 -0.402 . . . . 63.549999999999997 110.52 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.6 -166.25 54.17 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 123.333 0.395 . . . . 73.040000000000006 113.15 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.462 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.93 124.6 47.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.943 -0.391 . . . . 71.030000000000001 109.943 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.59 123.9 10.61 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.224 1.949 . . . . 52.530000000000001 113.665 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.61 -0.723 . . . . 63.229999999999997 113.376 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.44 -51.88 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.573 0.187 . . . . 73.329999999999998 111.488 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.6 mm -109.86 97.95 31.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.198 0.312 . . . . 74.319999999999993 111.076 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.76 165.76 31.55 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.438 2.092 . . . . 65.319999999999993 112.672 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.91 143.11 28.97 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.514 2.143 . . . . 73.209999999999994 113.209 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.66 43.11 25.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.603 0.761 . . . . 70.340000000000003 111.799 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.4 132.64 54.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.714 -0.676 . . . . 71.420000000000002 111.698 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -82.38 140.04 33.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.727 -1.124 . . . . 74.25 110.9 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mt -118.23 152.69 35.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.637 -0.71 . . . . 71.519999999999996 110.961 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.79 130.76 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.832 -0.622 . . . . 72.319999999999993 109.514 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.57 ' O ' HD12 ' A' ' 74' ' ' LEU . 87.3 m-85 -131.57 133.48 45.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.264 -0.425 . . . . 71.299999999999997 111.042 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.6 t70 -116.4 105.63 12.73 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.949 -0.569 . . . . 62.020000000000003 110.097 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.801 HG22 HD11 ' A' ' 74' ' ' LEU . 25.3 m -108.53 153.96 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.048 -0.523 . . . . 60.420000000000002 111.119 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.57 123.83 28.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.559 -0.746 . . . . 72.230000000000004 110.268 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.745 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -73.66 103.05 4.11 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.167 0.508 . . . . 64.0 110.713 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.78 -57.93 2.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.403 -0.817 . . . . 73.510000000000005 111.353 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 122.82 0.448 . . . . 74.319999999999993 110.781 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.9 mt -124.22 147.54 47.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.762 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.98 -0.555 . . . . 65.530000000000001 110.833 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 CA-C-O 119.177 -0.791 . . . . 43.119999999999997 112.499 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.87 144.06 27.07 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.032 2.488 . . . . 72.120000000000005 112.771 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.8 m 63.69 137.48 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.037 0.935 . . . . 74.209999999999994 112.277 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -97.9 144.17 27.74 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.772 -0.649 . . . . 73.209999999999994 110.869 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -112.32 40.49 2.52 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.603 0.564 . . . . 60.009999999999998 112.996 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 75' ' ' THR . 9.5 p -138.28 112.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.86 0.362 . . . . 71.540000000000006 110.526 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.92 118.07 33.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.589 -0.732 . . . . 73.140000000000001 110.813 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.5 p -109.49 132.0 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.928 -0.578 . . . . 62.43 110.992 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -119.55 124.52 46.59 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.488 -0.778 . . . . 74.439999999999998 110.167 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -78.55 127.25 31.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.113 -0.494 . . . . 74.150000000000006 110.894 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.2 mt -109.31 -41.14 4.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.123 -0.944 . . . . 72.430000000000007 110.306 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -130.67 118.9 18.01 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.92 -0.582 . . . . 74.319999999999993 110.481 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.56 129.19 15.35 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.544 2.162 . . . . 61.420000000000002 113.251 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.03 -121.16 4.08 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 115.747 -0.66 . . . . 44.329999999999998 112.189 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.18 -46.19 12.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.613 0.206 . . . . 61.450000000000003 110.941 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.96 -1.69 87.82 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.552 0.532 . . . . 63.509999999999998 113.757 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -136.62 1.2 2.55 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.399 0.28 . . . . 75.239999999999995 111.745 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -122.23 92.65 3.77 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.064 0.459 . . . . 71.400000000000006 110.247 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -103.6 149.98 37.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 72.109999999999999 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.87 126.85 17.38 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.469 2.113 . . . . 64.230000000000004 112.578 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 115.426 -0.806 . . . . 72.299999999999997 111.459 -179.083 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 62.3 ttt180 -77.46 125.07 28.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.594 -0.73 . . . . 75.420000000000002 111.088 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.54 -29.22 7.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.782 -0.645 . . . . 64.120000000000005 113.249 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 160.27 14.42 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.415 0.286 . . . . 72.140000000000001 110.989 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.19 145.28 30.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.033 -0.53 . . . . 73.129999999999995 111.499 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.2 t -119.78 116.53 26.1 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.576 -0.738 . . . . 70.120000000000005 110.514 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.81 110.71 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.436 -0.802 . . . . 63.039999999999999 109.682 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 103' ' ' LEU . 28.6 m -147.69 152.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.029 -0.532 . . . . 42.420000000000002 111.502 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 3.0 m80 -102.45 125.4 49.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.387 -0.824 . . . . 75.310000000000002 109.196 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.633 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.6 p90 -114.79 166.88 11.29 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.904 0.705 . . . . 74.340000000000003 112.904 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.8 m -149.19 110.72 4.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.856 -1.065 . . . . 54.439999999999998 109.272 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.02 118.99 6.0 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.096 -0.573 . . . . 74.5 112.962 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 mtm -128.48 131.93 48.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.913 0.485 . . . . 72.230000000000004 111.114 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.5 170.96 0.66 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.745 -0.661 . . . . 42.340000000000003 111.953 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.4 -26.16 52.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.053 0.541 . . . . 72.0 112.013 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.05 -17.34 29.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.734 -0.666 . . . . 53.299999999999997 111.686 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.6 13.8 21.36 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 120.84 -0.695 . . . . 51.420000000000002 113.375 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.878 -0.416 . . . . 63.25 109.878 179.672 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.459 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 112.89 0.7 . . . . 75.25 112.89 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.6 p90 -134.55 -8.6 2.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.245 -1.343 . . . . 74.109999999999999 111.229 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -165.46 111.55 0.92 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.341 0.591 . . . . 71.540000000000006 111.505 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 4.8 p -118.18 118.33 31.56 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.812 -1.086 . . . . 72.049999999999997 111.033 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.526 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 p -78.72 -36.31 43.57 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.996 -0.547 . . . . 71.120000000000005 112.252 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -23.24 52.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.914 0.709 . . . . 54.32 112.914 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -24.15 67.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.778 0.323 . . . . 64.340000000000003 111.172 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -93.76 -0.19 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.432 -0.804 . . . . 71.299999999999997 109.687 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.83 36.02 10.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.241 1.017 . . . . 72.439999999999998 111.679 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 CA-C-N 116.239 -0.437 . . . . 74.109999999999999 112.161 -179.419 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.79 158.02 47.17 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.015 2.476 . . . . 72.540000000000006 112.69 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -100.85 118.55 37.14 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.611 0.569 . . . . 73.329999999999998 112.084 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 115.132 -0.94 . . . . 74.450000000000003 109.887 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 40.4 p90 -148.79 159.49 44.1 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.323 0.39 . . . . 73.329999999999998 111.48 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' HH12 ' A' ' 52' ' ' MLY . 6.4 mtt -104.3 132.3 50.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.734 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.38 139.94 39.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 74.219999999999999 111.654 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.434 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.24 -10.84 52.65 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.536 -0.757 . . . . 71.310000000000002 113.308 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MLY . . . . . 0.445 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 122.577 0.351 . . . . 72.219999999999999 110.718 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 69.86 27.55 4.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.114 0.966 . . . . 64.219999999999999 112.147 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -76.93 -13.25 60.0 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.93 -0.577 . . . . 75.25 110.932 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.29 -179.36 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.316 -0.856 . . . . 74.450000000000003 110.519 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 76' ' ' ILE . 7.2 pt -76.92 158.6 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.036 0.384 . . . . 53.420000000000002 112.036 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.32 -42.72 96.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.964 -0.562 . . . . 73.409999999999997 111.843 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.29 -20.42 63.09 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 113.183 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -84.25 -45.0 13.33 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.336 0.254 . . . . 64.239999999999995 111.189 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.39 -37.51 87.2 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.291 0.37 . . . . 71.319999999999993 111.682 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.55 -26.14 28.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.935 -0.575 . . . . 73.219999999999999 111.792 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.41 -45.85 4.84 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.421 0.45 . . . . 71.540000000000006 113.958 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.1 p -63.75 -25.77 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.665 0.386 . . . . 73.299999999999997 111.757 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.62 -5.34 44.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.367 -0.833 . . . . 33.409999999999997 111.707 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -95.34 -11.14 28.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.637 -0.711 . . . . 54.100000000000001 111.215 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -105.74 156.6 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.268 0.355 . . . . 71.25 110.772 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.419 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 23.4 p -111.18 166.58 10.96 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.934 -0.575 . . . . 51.25 110.612 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.635 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.6 t -55.84 123.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 122.964 0.506 . . . . 53.100000000000001 111.23 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.38 2.76 70.14 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.565 -0.743 . . . . 71.340000000000003 113.179 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -94.04 142.67 27.12 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 120.953 0.406 . . . . 75.439999999999998 111.382 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -121.34 109.22 14.64 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.055 -0.975 . . . . 73.140000000000001 109.347 178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.08 156.43 46.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.141 -0.481 . . . . 61.039999999999999 111.944 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.324 0 CA-C-N 116.063 -0.517 . . . . 72.400000000000006 110.263 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.919 HD11 HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -105.1 134.29 48.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.037 -0.529 . . . . 74.519999999999996 110.699 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.1 m -99.74 114.07 26.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.649 -0.705 . . . . 53.119999999999997 109.557 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG21 HD12 ' A' ' 56' ' ' ILE . 7.4 mm -106.18 134.24 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 110.136 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.63 162.12 22.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.402 -0.817 . . . . 74.230000000000004 110.755 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.17 -17.07 50.28 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.508 2.138 . . . . 62.43 113.111 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.93 -25.26 24.46 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.44 0.463 . . . . 74.510000000000005 111.24 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -101.41 -18.38 16.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 73.030000000000001 111.415 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.12 -62.34 1.54 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.649 0.611 . . . . 54.109999999999999 112.649 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -133.85 -54.0 0.87 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.63 0.233 . . . . 74.540000000000006 111.63 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.45 -139.84 7.29 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.536 0.522 . . . . 71.340000000000003 112.019 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.47 -10.78 26.69 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 111.59 0.218 . . . . 51.549999999999997 111.59 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.63 -60.33 1.54 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.314 -0.403 . . . . 63.549999999999997 110.534 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.52 -166.99 54.53 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 123.318 0.386 . . . . 73.040000000000006 113.155 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.446 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.58 124.08 49.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.942 -0.392 . . . . 71.030000000000001 109.942 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.5 124.0 10.75 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.208 1.939 . . . . 52.530000000000001 113.625 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.18 -48.17 0.97 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.553 -0.749 . . . . 63.229999999999997 113.372 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.97 -51.49 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.57 0.211 . . . . 73.329999999999998 111.57 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.9 mm -110.06 97.71 31.23 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 123.159 0.287 . . . . 74.319999999999993 111.111 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.37 165.61 31.9 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.391 2.061 . . . . 65.319999999999993 112.744 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.05 143.74 29.24 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.651 2.234 . . . . 73.209999999999994 113.249 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 56.54 41.3 28.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.652 0.781 . . . . 70.340000000000003 111.8 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.23 54.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.713 -0.676 . . . . 71.420000000000002 111.731 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -82.82 138.72 33.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.747 -1.115 . . . . 74.25 110.926 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.532 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 mt -116.67 155.07 29.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.526 -0.761 . . . . 71.519999999999996 110.901 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.48 129.59 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.824 -0.625 . . . . 72.319999999999993 109.481 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' O ' HD12 ' A' ' 74' ' ' LEU . 85.3 m-85 -130.94 133.26 45.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.072 -0.513 . . . . 71.299999999999997 110.741 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -116.6 102.63 9.63 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.586 0.554 . . . . 62.020000000000003 110.359 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.919 HG22 HD11 ' A' ' 74' ' ' LEU . 24.0 m -103.56 153.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.08 -0.509 . . . . 60.420000000000002 110.943 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.29 125.97 39.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 72.230000000000004 110.201 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.93 101.92 3.32 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.86 -0.609 . . . . 64.0 110.455 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.28 -58.38 2.52 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.146 -0.479 . . . . 73.510000000000005 111.394 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 122.821 0.448 . . . . 74.319999999999993 110.774 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.9 mt -122.77 146.31 47.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.087 -0.506 . . . . 64.409999999999997 110.799 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.003 -0.544 . . . . 65.530000000000001 110.809 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 CA-C-O 119.019 -0.878 . . . . 43.119999999999997 112.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.16 139.72 24.2 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.887 2.391 . . . . 72.120000000000005 112.784 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.1 t 61.91 118.37 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.96 0.904 . . . . 74.209999999999994 111.929 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.61 150.74 51.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.747 -0.66 . . . . 73.209999999999994 110.857 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -96.4 28.9 11.3 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 115.938 -0.573 . . . . 60.009999999999998 112.996 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG23 HD13 ' A' ' 76' ' ' ILE . 12.0 p -140.75 121.84 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.443 0.297 . . . . 71.540000000000006 110.433 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -119.78 120.29 36.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.851 -0.613 . . . . 73.140000000000001 110.76 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -106.36 122.76 60.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.98 -0.554 . . . . 62.43 109.912 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 73' ' ' MLY . 8.2 pt-20 -113.19 121.24 43.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.452 -0.795 . . . . 74.439999999999998 111.249 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -76.79 130.7 38.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.012 -0.54 . . . . 74.150000000000006 111.257 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.52 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.0 mt -113.91 -41.23 3.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.095 -0.957 . . . . 72.430000000000007 110.12 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 t -129.72 118.16 18.68 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 110.433 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.72 127.58 13.24 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.59 2.193 . . . . 61.420000000000002 113.448 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.71 -121.64 4.31 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.772 -0.649 . . . . 44.329999999999998 111.856 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.49 -45.61 19.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.558 0.179 . . . . 61.450000000000003 110.79 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 81.99 -1.68 86.0 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.067 -0.515 . . . . 63.509999999999998 113.663 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -138.23 4.17 2.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.614 0.366 . . . . 75.239999999999995 111.66 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.7 m -128.33 92.95 3.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.648 -0.501 . . . . 71.400000000000006 109.648 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.59 151.82 38.2 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.678 -0.692 . . . . 72.109999999999999 109.815 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.4 132.21 39.86 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.291 1.994 . . . . 64.230000000000004 111.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.51 0 O-C-N 123.452 0.47 . . . . 72.299999999999997 112.26 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -77.9 133.9 38.01 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.221 -0.9 . . . . 75.420000000000002 111.256 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.2 -21.3 46.31 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.183 -0.532 . . . . 64.120000000000005 113.222 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -100.84 159.26 15.34 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.632 0.254 . . . . 72.140000000000001 110.796 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.645 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -78.26 134.93 37.48 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.917 -0.583 . . . . 73.129999999999995 111.201 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 50' ' ' LEU . 66.0 m -111.04 109.81 20.07 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.955 -0.566 . . . . 70.120000000000005 110.263 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.73 109.38 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.447 -0.797 . . . . 63.039999999999999 109.812 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG12 ' HA ' ' A' ' 103' ' ' LEU . 29.8 m -146.0 150.06 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.862 -0.608 . . . . 42.420000000000002 111.299 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 10.5 m-70 -101.09 125.34 47.7 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.416 -0.811 . . . . 75.310000000000002 109.058 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.6 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.4 p90 -116.3 166.33 12.17 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.86 0.689 . . . . 74.340000000000003 112.86 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.6 m -148.94 111.47 4.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.871 -1.059 . . . . 54.439999999999998 109.394 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -96.25 120.1 6.5 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.029 -0.532 . . . . 74.5 112.844 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.0 mtm -129.09 132.1 47.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.967 0.507 . . . . 72.230000000000004 111.015 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.5 170.77 0.5 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.776 -0.647 . . . . 42.340000000000003 112.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.62 -26.63 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.122 0.569 . . . . 72.0 112.159 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.41 -17.23 29.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.766 -0.652 . . . . 53.299999999999997 111.687 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.8 13.79 21.02 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 120.82 -0.705 . . . . 51.420000000000002 113.226 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.912 -0.403 . . . . 63.25 109.912 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.473 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.433 0 N-CA-C 112.824 0.676 . . . . 75.25 112.824 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.8 p90 -133.26 -14.54 2.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 74.109999999999999 111.288 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -161.68 111.51 1.59 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-O 121.018 0.437 . . . . 71.540000000000006 111.862 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 3.2 p -117.01 119.91 36.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.403 -0.817 . . . . 72.049999999999997 110.968 177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.6 p -78.49 -37.02 44.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.209 -0.451 . . . . 71.120000000000005 112.092 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.32 -24.32 57.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 54.32 112.98 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -25.48 68.35 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.733 0.302 . . . . 64.340000000000003 111.319 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -93.54 3.53 55.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.503 -0.771 . . . . 71.299999999999997 109.705 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 62.61 34.05 15.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.219 1.008 . . . . 72.439999999999998 111.713 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.416 0 N-CA-C 113.179 0.807 . . . . 74.109999999999999 113.179 -178.847 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.18 157.93 37.7 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.215 2.61 . . . . 72.540000000000006 112.652 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -99.01 118.26 35.38 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.961 -0.563 . . . . 73.329999999999998 112.013 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.31 0 CA-C-N 115.091 -0.959 . . . . 74.450000000000003 110.086 178.937 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.7 p90 -152.15 162.38 41.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.302 0.376 . . . . 73.329999999999998 111.537 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.645 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -105.09 132.96 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.396 -0.365 . . . . 71.140000000000001 110.929 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD11 ' HA ' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -77.8 143.49 37.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.73 -0.668 . . . . 74.219999999999999 111.658 179.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.49 -6.46 60.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.547 -0.751 . . . . 71.310000000000002 113.438 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.6 0.36 . . . . 72.219999999999999 110.695 179.437 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 69.51 28.71 4.56 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.163 0.985 . . . . 64.219999999999999 112.125 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.46 -33.63 60.86 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.942 -0.572 . . . . 75.25 110.563 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 m -102.16 -174.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.161 -0.927 . . . . 74.450000000000003 110.042 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 pt -80.6 157.89 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.761 0.282 . . . . 53.420000000000002 111.761 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -58.75 -44.02 90.44 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.035 -0.53 . . . . 73.409999999999997 111.839 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.664 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.45 -20.21 60.94 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.128 -0.487 . . . . 75.120000000000005 113.307 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -84.24 -44.69 13.64 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 122.319 0.248 . . . . 64.239999999999995 111.325 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 50' ' ' LEU . 30.3 mt-10 -66.07 -38.19 87.68 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.252 0.345 . . . . 71.319999999999993 111.596 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.43 -24.87 29.37 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.219999999999999 111.722 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.34 -46.22 4.74 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.45 0.468 . . . . 71.540000000000006 113.793 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.37 -25.56 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.772 0.429 . . . . 73.299999999999997 111.691 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.41 -9.54 58.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.284 -0.871 . . . . 33.409999999999997 111.723 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.51 -11.08 41.26 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.783 -0.644 . . . . 54.100000000000001 111.174 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -106.66 156.4 18.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.11 -0.495 . . . . 71.25 110.437 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 18.5 p -107.69 165.01 11.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.086 -0.506 . . . . 51.25 110.604 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HA ' HD12 ' A' ' 103' ' ' LEU . 72.2 t -57.78 122.06 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.988 0.515 . . . . 53.100000000000001 110.857 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 92.02 5.86 65.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.301 -0.863 . . . . 71.340000000000003 112.98 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -97.69 145.44 26.32 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.336 . . . . 75.439999999999998 111.387 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -120.55 110.62 16.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.441 -0.8 . . . . 73.140000000000001 109.362 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -134.06 152.7 51.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 61.039999999999999 112.031 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 C--N 1.344 0.354 0 CA-C-N 116.108 -0.496 . . . . 72.400000000000006 110.586 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.824 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.6 129.59 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.859 -0.609 . . . . 74.519999999999996 111.228 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.1 m -95.71 113.77 25.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.353 -0.84 . . . . 53.119999999999997 109.467 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.664 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.7 mm -106.45 142.36 19.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.967 -0.56 . . . . 75.109999999999999 110.56 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.31 162.49 19.7 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 114.877 -1.056 . . . . 74.230000000000004 110.683 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 -14.42 41.79 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.501 2.134 . . . . 62.43 113.234 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.57 -28.63 24.74 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.378 0.424 . . . . 74.510000000000005 110.793 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.9 -19.75 16.48 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.738 -0.665 . . . . 73.030000000000001 111.562 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.14 -62.44 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.763 0.653 . . . . 54.109999999999999 112.763 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.81 -52.71 0.8 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.547 0.203 . . . . 74.540000000000006 111.547 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.08 -140.27 7.76 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 116.139 -0.482 . . . . 71.340000000000003 112.007 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.89 -10.81 25.7 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 111.549 0.203 . . . . 51.549999999999997 111.549 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.03 -60.23 1.57 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.222 -0.444 . . . . 63.549999999999997 110.432 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 -168.53 53.98 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.357 0.411 . . . . 73.040000000000006 113.231 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.45 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.62 124.31 51.06 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.868 -0.419 . . . . 71.030000000000001 109.868 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.58 124.67 11.39 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.234 1.956 . . . . 52.530000000000001 113.637 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.43 -45.51 1.29 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.581 -0.736 . . . . 63.229999999999997 113.432 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.46 -51.57 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.632 0.216 . . . . 73.329999999999998 111.581 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.8 mm -111.03 98.94 41.05 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 123.202 0.314 . . . . 74.319999999999993 111.141 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.55 165.66 31.79 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.463 2.109 . . . . 65.319999999999993 112.683 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.32 143.91 28.64 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.522 2.148 . . . . 73.209999999999994 113.225 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.3 41.9 28.53 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.649 0.78 . . . . 70.340000000000003 111.799 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.91 131.81 53.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 71.420000000000002 111.807 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -81.01 141.9 33.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.732 -1.122 . . . . 74.25 110.856 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.508 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.8 mt -120.59 152.18 38.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.743 -0.662 . . . . 71.519999999999996 111.085 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -119.14 132.12 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 72.319999999999993 109.41 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.561 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.9 m-85 -133.16 132.93 42.18 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.381 0.426 . . . . 71.299999999999997 111.057 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 6.5 t70 -115.95 103.13 10.3 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.955 -0.566 . . . . 62.020000000000003 110.038 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 74' ' ' LEU . 24.0 m -106.17 153.37 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.919 -0.582 . . . . 60.420000000000002 111.127 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.68 125.65 36.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.536 -0.756 . . . . 72.230000000000004 110.184 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.98 101.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.621 -0.718 . . . . 64.0 110.523 -179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.68 -58.1 2.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.524 -0.307 . . . . 73.510000000000005 111.649 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 122.702 0.401 . . . . 74.319999999999993 111.285 -179.812 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.33 151.21 25.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.161 -0.472 . . . . 64.409999999999997 110.343 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 65.530000000000001 110.79 179.705 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.731 0 CA-C-O 119.222 -0.765 . . . . 43.119999999999997 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.81 150.64 35.05 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.028 2.485 . . . . 72.120000000000005 112.737 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.8 m -128.17 144.39 51.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.936 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.7 mtt -101.27 144.43 30.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.87 -0.605 . . . . 73.209999999999994 110.825 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -107.01 35.43 5.04 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.952 -0.567 . . . . 60.009999999999998 112.966 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.4 p -137.36 118.81 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.707 0.289 . . . . 71.540000000000006 110.539 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.65 119.26 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.777 -0.647 . . . . 73.140000000000001 110.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 19.0 t -107.74 124.74 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.946 -0.57 . . . . 62.43 109.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.34 122.79 47.76 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.697 -0.683 . . . . 74.439999999999998 110.251 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -76.96 126.35 30.83 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.115 -0.493 . . . . 74.150000000000006 111.007 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.403 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.6 mt -109.71 -39.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.011 -0.995 . . . . 72.430000000000007 110.271 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -131.25 118.62 17.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 74.319999999999993 110.384 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.29 130.52 17.6 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.543 2.162 . . . . 61.420000000000002 113.231 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.67 -121.59 4.49 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.79 -0.641 . . . . 44.329999999999998 112.386 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.4 -45.93 14.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.552 0.176 . . . . 61.450000000000003 110.696 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.4 -1.18 88.54 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.026 -0.534 . . . . 63.509999999999998 114.033 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -137.33 -1.03 2.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.369 0.267 . . . . 75.239999999999995 111.694 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -118.82 93.42 4.09 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 71.400000000000006 110.533 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.2 149.01 36.52 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.57 -0.741 . . . . 72.109999999999999 110.817 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.91 129.1 18.93 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.55 2.167 . . . . 64.230000000000004 113.201 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 CA-C-N 115.358 -0.837 . . . . 72.299999999999997 111.125 -179.738 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.35 124.64 28.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 75.420000000000002 111.36 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.88 -25.15 9.08 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.685 -0.688 . . . . 64.120000000000005 113.295 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 160.18 14.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.322 0.249 . . . . 72.140000000000001 111.023 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -84.94 145.34 27.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 111.007 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 59.7 m -124.32 120.64 32.76 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.758 -0.655 . . . . 70.120000000000005 111.01 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 t -90.27 111.32 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.263 -0.881 . . . . 63.039999999999999 109.633 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 103' ' ' LEU . 29.5 m -146.03 151.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.063 -0.517 . . . . 42.420000000000002 111.481 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.0 m-70 -103.03 125.33 49.73 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.596 -0.729 . . . . 75.310000000000002 109.394 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.8 p90 -116.09 167.61 10.83 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.365 0.505 . . . . 74.340000000000003 112.365 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.74 105.56 3.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.093 -0.958 . . . . 54.439999999999998 109.417 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.78 118.27 5.32 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 121.017 -0.611 . . . . 74.5 112.806 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 mtm -133.16 134.78 44.6 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.067 0.547 . . . . 72.230000000000004 110.901 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.19 172.12 0.33 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.439 -0.8 . . . . 42.340000000000003 112.359 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.88 -27.3 51.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.099 0.56 . . . . 72.0 111.993 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.79 -17.4 29.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.639 -0.71 . . . . 53.299999999999997 111.695 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.99 13.77 22.6 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 120.738 -0.744 . . . . 51.420000000000002 113.314 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 N-CA-C 110.065 -0.346 . . . . 63.25 110.065 179.639 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.314 0 N-CA-C 113.017 0.747 . . . . 75.25 113.017 -179.52 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 22.3 p90 -134.09 -14.31 2.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.546 -1.207 . . . . 74.109999999999999 111.231 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.98 110.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.104 0.478 . . . . 71.540000000000006 112.141 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 31.4 t -123.18 138.6 54.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.302 -0.863 . . . . 72.049999999999997 110.039 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.488 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 65.1 p -78.75 -33.14 46.79 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.696 0.628 . . . . 71.120000000000005 112.696 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -74.42 -23.13 58.9 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.636 0.606 . . . . 54.32 112.636 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' HA ' HH21 ' A' ' 40' ' ' ARG . 0.5 OUTLIER -62.96 -29.18 70.61 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.857 0.36 . . . . 64.340000000000003 110.91 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -95.7 -0.21 51.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.274 -0.876 . . . . 71.299999999999997 110.023 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 64.45 37.44 8.19 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.227 1.011 . . . . 72.439999999999998 111.771 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.573 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.765 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.92 158.1 50.39 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.893 2.395 . . . . 72.540000000000006 112.919 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.05 118.39 36.69 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.74 -0.664 . . . . 73.329999999999998 112.039 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.502 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 115.237 -0.892 . . . . 74.450000000000003 110.208 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' THR . 42.3 p90 -150.44 163.44 38.39 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.371 0.42 . . . . 73.329999999999998 111.382 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.418 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 7.5 mtt -106.96 133.98 50.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.767 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -78.83 139.88 38.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.98 -0.554 . . . . 74.219999999999999 111.497 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.92 -10.0 54.31 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.512 -0.767 . . . . 71.310000000000002 113.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 122.562 0.345 . . . . 72.219999999999999 110.696 179.228 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 69.82 27.51 4.54 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.13 0.972 . . . . 64.219999999999999 112.142 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -77.32 -12.76 59.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.0 -0.545 . . . . 75.25 110.863 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.33 -177.68 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.322 -0.854 . . . . 74.450000000000003 110.49 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.09 158.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 111.993 0.368 . . . . 53.420000000000002 111.993 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -59.55 -44.32 93.29 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.968 -0.56 . . . . 73.409999999999997 111.834 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.688 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.64 -20.28 61.45 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 123.533 0.521 . . . . 75.120000000000005 113.421 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -84.12 -43.9 14.57 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 122.307 0.243 . . . . 64.239999999999995 111.156 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.7 mt-10 -66.29 -37.76 86.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.329 0.393 . . . . 71.319999999999993 111.673 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.43 -25.04 29.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.987 -0.551 . . . . 73.219999999999999 111.857 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -88.35 -45.88 4.85 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.46 0.475 . . . . 71.540000000000006 113.839 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.76 -25.16 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.786 0.434 . . . . 73.299999999999997 111.646 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.97 -8.07 56.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.395 -0.82 . . . . 33.409999999999997 111.742 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.51 -4.43 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.819 -0.628 . . . . 54.100000000000001 111.201 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.536 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.42 158.37 19.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.332 -0.395 . . . . 71.25 110.874 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.652 ' C ' HD13 ' A' ' 103' ' ' LEU . 10.3 p -117.14 150.52 38.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.021 -0.536 . . . . 51.25 110.655 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.737 ' HA ' HD22 ' A' ' 103' ' ' LEU . 54.4 t -40.24 117.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 53.100000000000001 112.356 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.24 59.2 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.187 -0.915 . . . . 71.340000000000003 113.08 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -96.73 144.84 26.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.369 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -122.69 109.26 14.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.09 -0.959 . . . . 73.140000000000001 109.247 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.06 157.58 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.907 -0.588 . . . . 61.039999999999999 111.918 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.295 0 CA-C-N 115.947 -0.569 . . . . 72.400000000000006 110.283 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.795 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.16 125.25 52.83 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 111.235 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.9 m -93.56 113.82 26.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.389 -0.823 . . . . 53.119999999999997 109.531 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.5 mm -105.82 143.1 17.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.852 -0.613 . . . . 75.109999999999999 110.577 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.66 161.79 21.74 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.877 -1.056 . . . . 74.230000000000004 110.916 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.14 -17.25 51.2 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.768 2.312 . . . . 62.43 113.192 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.99 -25.65 25.89 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.435 0.46 . . . . 74.510000000000005 111.341 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.73 -18.76 15.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.066 -0.516 . . . . 73.030000000000001 111.405 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.66 -63.07 1.4 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.722 0.638 . . . . 54.109999999999999 112.722 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.46 -50.99 0.86 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.593 0.22 . . . . 74.540000000000006 111.593 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.08 -141.48 8.99 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.533 0.52 . . . . 71.340000000000003 112.03 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.79 -11.16 27.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.607 0.225 . . . . 51.549999999999997 111.607 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -99.51 -60.33 1.55 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.267 -0.424 . . . . 63.549999999999997 110.49 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 -168.04 53.38 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.342 0.401 . . . . 73.040000000000006 113.21 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.451 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.93 124.67 49.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.932 -0.395 . . . . 71.030000000000001 109.932 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.86 124.16 10.77 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.195 1.93 . . . . 52.530000000000001 113.629 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.2 -46.3 1.19 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.604 -0.725 . . . . 63.229999999999997 113.394 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.7 -51.84 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 111.619 0.229 . . . . 73.329999999999998 111.619 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.9 mm -110.09 98.56 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.184 0.302 . . . . 74.319999999999993 111.045 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.71 165.65 31.87 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.404 2.07 . . . . 65.319999999999993 112.713 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.93 142.9 28.65 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.551 2.167 . . . . 73.209999999999994 113.188 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 56.67 44.34 23.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.598 0.759 . . . . 70.340000000000003 111.688 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.64 133.5 53.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.713 -0.676 . . . . 71.420000000000002 111.78 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.35 140.84 32.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.693 -1.14 . . . . 74.25 110.737 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.463 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.8 mt -118.74 155.01 31.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.743 -0.662 . . . . 71.519999999999996 111.164 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -121.24 129.95 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.865 -0.607 . . . . 72.319999999999993 109.712 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.2 m-85 -132.27 133.27 43.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.075 -0.511 . . . . 71.299999999999997 110.614 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.7 t70 -116.43 104.2 11.21 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.554 0.534 . . . . 62.020000000000003 110.159 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.795 HG22 HD11 ' A' ' 74' ' ' LEU . 24.9 m -106.0 153.46 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.078 -0.51 . . . . 60.420000000000002 111.179 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.86 124.84 30.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.488 -0.778 . . . . 72.230000000000004 110.239 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.761 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -74.38 104.15 5.02 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.133 0.492 . . . . 64.0 110.721 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.37 -57.74 2.73 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.429 -0.805 . . . . 73.510000000000005 111.372 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 122.887 0.475 . . . . 74.319999999999993 110.748 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.4 147.07 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.099 -0.5 . . . . 64.409999999999997 110.66 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.059 -0.519 . . . . 65.530000000000001 110.766 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 CA-C-O 119.044 -0.864 . . . . 43.119999999999997 112.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.12 -35.55 2.99 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.851 2.367 . . . . 72.120000000000005 113.108 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.4 m -107.51 -42.74 4.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.373 0.421 . . . . 74.209999999999994 111.325 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 84.4 mmm -100.83 133.73 44.87 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.405 0.44 . . . . 73.209999999999994 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -117.73 15.07 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 115.862 -0.608 . . . . 60.009999999999998 113.165 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.597 HG23 HD13 ' A' ' 76' ' ' ILE . 11.2 p -123.03 126.36 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 122.331 0.252 . . . . 71.540000000000006 110.621 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.77 141.47 48.37 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.839 -0.619 . . . . 73.140000000000001 110.447 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.88 124.07 62.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.443 -0.799 . . . . 62.43 110.107 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.08 120.54 38.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.718 -0.674 . . . . 74.439999999999998 110.317 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -77.35 124.55 28.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.112 -0.494 . . . . 74.150000000000006 110.853 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -107.32 -40.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.986 -1.006 . . . . 72.430000000000007 110.307 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -131.43 119.13 17.31 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.031 -0.531 . . . . 74.319999999999993 110.391 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.45 129.82 16.39 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.551 2.167 . . . . 61.420000000000002 113.378 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.53 -121.36 4.42 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.742 -0.663 . . . . 44.329999999999998 112.121 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -83.82 -46.37 12.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.647 0.223 . . . . 61.450000000000003 110.954 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.49 -0.96 88.49 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.051 -0.522 . . . . 63.509999999999998 113.662 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -136.82 0.91 2.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.795 0.295 . . . . 75.239999999999995 111.795 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.74 92.8 3.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.026 0.441 . . . . 71.400000000000006 110.327 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.52 149.39 37.0 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.57 -0.741 . . . . 72.109999999999999 110.949 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.21 125.75 14.57 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.533 2.155 . . . . 64.230000000000004 112.939 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.435 -0.802 . . . . 72.299999999999997 111.558 -179.325 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' NE ' ' HA3' ' A' ' 51' ' ' GLY . 41.7 ttt180 -77.43 124.25 27.63 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.525 -0.761 . . . . 75.420000000000002 111.468 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -24.3 11.81 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.889 -0.596 . . . . 64.120000000000005 113.51 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.7 160.17 14.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.573 0.225 . . . . 72.140000000000001 110.976 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.664 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -80.51 145.14 32.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.046 -0.525 . . . . 73.129999999999995 111.315 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 53.6 m -123.08 116.3 23.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.581 -0.736 . . . . 70.120000000000005 110.485 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.1 110.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.554 -0.748 . . . . 63.039999999999999 109.762 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.2 m -147.12 149.97 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.013 -0.54 . . . . 42.420000000000002 111.38 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.8 m-70 -101.13 125.33 47.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.411 -0.813 . . . . 75.310000000000002 109.059 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.617 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.8 p90 -116.38 166.55 11.94 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 74.340000000000003 112.783 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.3 m -148.81 111.64 4.83 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.966 -1.015 . . . . 54.439999999999998 109.405 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.8 119.83 6.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.938 -0.574 . . . . 74.5 112.706 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.1 mtm -129.79 131.5 46.22 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.875 0.47 . . . . 72.230000000000004 111.115 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.8 mt -57.04 170.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.651 -0.704 . . . . 42.340000000000003 112.027 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.15 -25.9 48.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.058 0.543 . . . . 72.0 112.052 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.44 -17.39 28.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.762 -0.654 . . . . 53.299999999999997 111.639 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.87 13.77 22.83 Favored Glycine 0 C--N 1.346 1.125 0 C-N-CA 120.86 -0.686 . . . . 51.420000000000002 113.324 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.767 -0.457 . . . . 63.25 109.767 179.547 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.446 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 112.942 0.719 . . . . 75.25 112.942 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.6 p90 -133.47 -15.16 2.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.176 -1.375 . . . . 74.109999999999999 111.301 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 36' ' ' PHE . 2.9 m-20 -160.89 111.47 1.76 Allowed 'General case' 0 C--N 1.357 0.921 0 CA-C-O 121.014 0.435 . . . . 71.540000000000006 112.052 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 2.9 p -116.95 119.88 36.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.404 -0.816 . . . . 72.049999999999997 110.917 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 53.9 p -78.35 -35.5 47.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.178 -0.464 . . . . 71.120000000000005 112.179 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH21 HH22 ' A' ' 35' ' ' MLY . 18.1 ptt180 -76.6 -23.25 53.45 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.797 0.665 . . . . 54.32 112.797 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -24.76 67.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.8 0.333 . . . . 64.340000000000003 111.392 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' O ' ' HE2' ' A' ' 44' ' ' MLY . 63.3 mtm180 -92.87 1.43 57.3 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.437 -0.802 . . . . 71.299999999999997 109.704 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.16 35.55 12.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.212 1.005 . . . . 72.439999999999998 111.529 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MLY . . . . . 0.526 ' HE2' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 112.478 0.548 . . . . 74.109999999999999 112.478 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.96 158.1 46.44 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 123.023 2.482 . . . . 72.540000000000006 112.768 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -98.74 118.27 35.1 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.973 -0.558 . . . . 73.329999999999998 112.029 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.577 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 115.241 -0.89 . . . . 74.450000000000003 110.163 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.5 p90 -151.21 164.11 37.33 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.289 0.368 . . . . 73.329999999999998 111.671 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.8 OUTLIER -107.51 135.82 48.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.338 -0.392 . . . . 71.140000000000001 110.528 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -79.45 140.77 37.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.813 -0.63 . . . . 74.219999999999999 111.59 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' HA3' ' NE ' ' A' ' 18' ' ' ARG . . . 81.49 -7.61 60.96 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.551 -0.749 . . . . 71.310000000000002 113.294 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 122.597 0.359 . . . . 72.219999999999999 110.661 179.387 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 70.1 26.83 4.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.146 0.978 . . . . 64.219999999999999 112.202 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.02 -15.29 60.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.981 -0.554 . . . . 75.25 110.744 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.92 -177.69 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.244 -0.889 . . . . 74.450000000000003 110.431 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.77 159.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.04 0.385 . . . . 53.420000000000002 112.04 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -59.69 -44.21 93.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.975 -0.557 . . . . 73.409999999999997 111.774 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.69 -20.44 61.76 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 123.505 0.503 . . . . 75.120000000000005 113.462 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -84.1 -43.44 15.05 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 116.688 0.244 . . . . 64.239999999999995 111.065 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.6 mt-10 -66.52 -36.86 83.75 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.368 0.417 . . . . 71.319999999999993 111.514 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.49 -26.8 27.89 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.894 -0.594 . . . . 73.219999999999999 111.651 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -86.96 -46.93 4.93 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.438 0.461 . . . . 71.540000000000006 114.01 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.01 -25.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.826 0.45 . . . . 73.299999999999997 111.788 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.43 56.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.423 -0.808 . . . . 33.409999999999997 111.66 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 55.3 mt-30 -91.97 -9.15 44.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.817 -0.629 . . . . 54.100000000000001 111.256 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -109.27 156.29 20.12 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 71.25 111.008 -179.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 21.8 p -111.27 167.09 10.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 51.25 110.509 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.0 t -56.14 123.08 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.965 0.506 . . . . 53.100000000000001 111.229 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.99 4.24 69.34 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.445 -0.798 . . . . 71.340000000000003 113.177 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -95.68 142.58 27.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.894 0.378 . . . . 75.439999999999998 111.376 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -120.54 107.34 12.74 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.066 -0.97 . . . . 73.140000000000001 109.383 178.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.07 154.4 47.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 61.039999999999999 111.633 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.435 ' HG2' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-N 116.034 -0.53 . . . . 72.400000000000006 110.201 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.798 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.03 126.55 54.92 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.046 0.451 . . . . 74.519999999999996 111.364 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 76.7 m -93.58 112.35 24.22 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.041 -0.981 . . . . 53.119999999999997 109.496 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.693 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.7 mm -105.63 141.21 21.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.02 -0.536 . . . . 75.109999999999999 110.477 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 162.07 21.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 114.837 -1.074 . . . . 74.230000000000004 110.91 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.47 -17.34 53.15 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.655 2.236 . . . . 62.43 113.221 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.41 -25.77 26.8 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.457 0.473 . . . . 74.510000000000005 111.368 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.7 -19.98 15.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.082 -0.508 . . . . 73.030000000000001 111.392 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.14 -61.79 1.76 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.651 0.611 . . . . 54.109999999999999 112.651 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.59 -52.51 0.81 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.558 0.207 . . . . 74.540000000000006 111.558 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.91 -140.56 7.98 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 116.109 -0.496 . . . . 71.340000000000003 112.051 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.92 26.62 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.609 0.225 . . . . 51.549999999999997 111.609 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.1 -60.33 1.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.254 -0.43 . . . . 63.549999999999997 110.441 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.05 -168.55 54.21 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.367 0.417 . . . . 73.040000000000006 113.16 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.449 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.95 123.8 52.16 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.949 -0.389 . . . . 71.030000000000001 109.949 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.22 124.73 11.61 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.216 1.944 . . . . 52.530000000000001 113.633 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.48 -47.47 1.04 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.545 -0.752 . . . . 63.229999999999997 113.332 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.87 -51.68 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 111.62 0.23 . . . . 73.329999999999998 111.62 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.2 mm -110.13 98.17 33.75 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 123.207 0.317 . . . . 74.319999999999993 111.136 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.73 165.62 31.98 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.39 2.06 . . . . 65.319999999999993 112.684 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.12 143.8 29.1 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.552 2.168 . . . . 73.209999999999994 113.227 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 56.64 41.79 27.92 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.641 0.776 . . . . 70.340000000000003 111.77 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.33 132.19 54.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.749 -0.66 . . . . 71.420000000000002 111.751 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 m -82.6 139.27 33.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.787 -1.097 . . . . 74.25 110.901 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mt -117.96 151.45 37.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.589 -0.732 . . . . 71.519999999999996 110.939 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 37.4 t -119.14 129.61 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.88 -0.6 . . . . 72.319999999999993 109.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.0 m-85 -130.42 134.04 46.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.256 -0.429 . . . . 71.299999999999997 111.093 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.7 t70 -116.48 105.26 12.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.914 -0.585 . . . . 62.020000000000003 110.092 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.798 HG22 HD11 ' A' ' 74' ' ' LEU . 27.6 m -107.59 153.94 8.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.02 -0.536 . . . . 60.420000000000002 111.014 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.11 125.33 32.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.495 -0.775 . . . . 72.230000000000004 110.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.11 100.49 3.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.784 -0.644 . . . . 64.0 110.125 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -88.6 -58.33 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.407 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 122.747 0.419 . . . . 74.319999999999993 110.781 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.0 mt -125.45 145.55 50.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 64.409999999999997 110.72 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.004 -0.544 . . . . 65.530000000000001 110.865 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 CA-C-O 119.03 -0.872 . . . . 43.119999999999997 112.635 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.15 142.62 27.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.774 2.316 . . . . 72.120000000000005 112.796 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.4 m -127.82 146.59 50.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.897 -0.592 . . . . 74.209999999999994 110.957 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.5 mtt -118.76 -41.87 2.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.595 . . . . 73.209999999999994 111.219 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.8 1.68 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.489 0.493 . . . . 60.009999999999998 112.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.5 p -120.38 121.22 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.735 0.303 . . . . 71.540000000000006 110.633 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -120.3 119.23 32.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.806 -0.634 . . . . 73.140000000000001 110.844 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 13.9 p -110.65 135.69 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.977 -0.556 . . . . 62.43 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.25 125.64 45.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.474 -0.785 . . . . 74.439999999999998 110.279 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.27 128.68 34.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.15 -0.477 . . . . 74.150000000000006 110.912 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -111.46 -39.55 3.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.116 -0.947 . . . . 72.430000000000007 110.365 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -132.25 118.79 16.26 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.011 -0.54 . . . . 74.319999999999993 110.475 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.58 130.48 17.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.63 2.22 . . . . 61.420000000000002 113.29 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.64 -121.37 4.44 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.745 -0.661 . . . . 44.329999999999998 112.168 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.21 -46.42 11.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.682 0.241 . . . . 61.450000000000003 111.034 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 86.16 -1.01 87.66 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.548 0.53 . . . . 63.509999999999998 113.708 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -136.57 0.39 2.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.476 0.31 . . . . 75.239999999999995 111.819 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.52 92.91 3.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.022 0.439 . . . . 71.400000000000006 110.35 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -103.8 149.62 37.33 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.524 -0.762 . . . . 72.109999999999999 111.039 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.82 122.49 9.86 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.466 2.111 . . . . 64.230000000000004 112.707 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 115.419 -0.81 . . . . 72.299999999999997 111.649 -179.298 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 46.3 ttt180 -77.42 126.63 31.22 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.612 -0.722 . . . . 75.420000000000002 111.134 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.41 -27.98 8.99 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.767 -0.651 . . . . 64.120000000000005 113.162 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.26 160.18 14.46 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.337 0.255 . . . . 72.140000000000001 110.896 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.47 145.28 29.03 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.086 -0.506 . . . . 73.129999999999995 111.379 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 36.9 t -120.4 116.95 26.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.633 -0.712 . . . . 70.120000000000005 110.629 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.78 110.7 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.526 -0.761 . . . . 63.039999999999999 109.529 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 103' ' ' LEU . 26.4 m -146.95 153.17 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.988 -0.551 . . . . 42.420000000000002 111.525 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.7 m-70 -103.36 125.33 49.92 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.485 -0.78 . . . . 75.310000000000002 109.412 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.607 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.8 p90 -115.15 167.46 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.534 0.568 . . . . 74.340000000000003 112.534 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.2 m -147.96 107.01 3.85 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.044 -0.98 . . . . 54.439999999999998 109.38 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.22 119.93 5.82 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.02 -0.536 . . . . 74.5 112.692 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.4 mtm -135.48 131.82 36.59 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.978 0.511 . . . . 72.230000000000004 110.915 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.6 mt -55.52 171.83 0.18 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.495 -0.775 . . . . 42.340000000000003 112.512 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.6 -27.81 51.57 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.188 0.595 . . . . 72.0 111.996 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.5 -17.38 30.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.672 -0.695 . . . . 53.299999999999997 111.657 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.59 13.9 23.01 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.849 -0.691 . . . . 51.420000000000002 113.228 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.441 0 N-CA-C 110.097 -0.334 . . . . 63.25 110.097 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.284 0 N-CA-C 112.937 0.718 . . . . 75.25 112.937 -179.663 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 25.2 p90 -132.81 -15.25 2.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.552 -1.204 . . . . 74.109999999999999 111.401 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.0 111.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.096 0.474 . . . . 71.540000000000006 112.223 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 28.4 t -122.29 142.66 50.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.274 -0.875 . . . . 72.049999999999997 110.093 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.5 p -78.65 -38.19 40.12 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.788 -0.642 . . . . 71.120000000000005 112.55 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.425 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -70.03 -22.93 63.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.529 0.566 . . . . 54.32 112.529 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -29.23 70.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.899 0.381 . . . . 64.340000000000003 110.834 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -96.9 -0.32 47.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.243 -0.889 . . . . 71.299999999999997 110.079 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t30 64.47 37.63 8.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.277 1.031 . . . . 72.439999999999998 111.717 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 111.588 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.46 157.93 55.24 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.859 2.372 . . . . 72.540000000000006 112.935 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.18 118.16 36.16 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.83 -0.623 . . . . 73.329999999999998 112.081 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.482 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 115.126 -0.943 . . . . 74.450000000000003 109.788 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 39.9 p90 -149.37 163.25 38.26 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.308 0.38 . . . . 73.329999999999998 111.451 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.2 mtt -107.0 133.74 51.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.052 -0.522 . . . . 71.140000000000001 110.779 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.97 141.16 36.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.836 -0.62 . . . . 74.219999999999999 111.588 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.15 -11.0 51.47 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.541 -0.754 . . . . 71.310000000000002 113.478 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.741 0.305 . . . . 72.219999999999999 110.63 179.312 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 68.34 30.4 5.5 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.08 0.952 . . . . 64.219999999999999 112.186 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.959 -0.564 . . . . 75.25 110.544 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -103.8 -173.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.23 -0.896 . . . . 74.450000000000003 110.194 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 76' ' ' ILE . 7.4 pt -81.62 158.28 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 111.695 0.257 . . . . 53.420000000000002 111.695 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -59.63 -43.42 93.85 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.054 -0.521 . . . . 73.409999999999997 111.974 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.62 -19.82 63.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 123.515 0.509 . . . . 75.120000000000005 113.227 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -84.14 -44.6 13.84 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 122.294 0.237 . . . . 64.239999999999995 111.083 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.82 -37.44 86.25 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.19 0.306 . . . . 71.319999999999993 111.477 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.49 -25.8 28.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.852 -0.613 . . . . 73.219999999999999 111.736 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.62 -46.8 4.48 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.503 0.502 . . . . 71.540000000000006 113.867 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -63.79 -26.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.754 0.422 . . . . 73.299999999999997 111.705 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -7.15 52.76 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.308 -0.86 . . . . 33.409999999999997 111.732 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -93.96 -8.56 39.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.748 -0.66 . . . . 54.100000000000001 111.32 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.445 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.35 156.58 19.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.38 . . . . 71.25 110.85 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.412 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.7 p -111.14 166.83 10.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.863 -0.608 . . . . 51.25 110.612 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' HD12 ' A' ' 103' ' ' LEU . 55.1 t -55.74 122.78 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.0 0.52 . . . . 53.100000000000001 111.215 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.55 3.63 68.79 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.487 -0.779 . . . . 71.340000000000003 113.257 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.76 142.95 26.86 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 120.928 0.394 . . . . 75.439999999999998 111.361 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.69 109.38 14.66 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.065 -0.971 . . . . 73.140000000000001 109.5 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.84 154.69 50.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.053 -0.522 . . . . 61.039999999999999 111.826 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.242 0 CA-C-N 116.028 -0.533 . . . . 72.400000000000006 110.463 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.866 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.26 135.77 48.2 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.167 -0.469 . . . . 74.519999999999996 110.782 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.4 m -101.46 111.56 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.655 -0.702 . . . . 53.119999999999997 109.324 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.619 HG21 HD12 ' A' ' 56' ' ' ILE . 7.9 mm -102.94 130.7 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.873 -0.603 . . . . 75.109999999999999 110.262 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.32 161.44 27.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.304 -0.862 . . . . 74.230000000000004 110.869 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.41 -17.49 53.74 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.507 2.138 . . . . 62.43 113.007 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.61 -25.16 23.71 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.432 0.458 . . . . 74.510000000000005 111.228 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -99.72 -19.45 16.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.042 -0.526 . . . . 73.030000000000001 111.301 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.85 -63.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.793 0.664 . . . . 54.109999999999999 112.793 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' A' ' 91' ' ' ILE . 77.2 m-85 -132.17 -53.66 0.97 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.534 0.198 . . . . 74.540000000000006 111.534 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.35 -139.83 7.43 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.522 0.513 . . . . 71.340000000000003 111.997 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.7 -10.57 26.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.608 0.225 . . . . 51.549999999999997 111.608 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 m -100.13 -60.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.253 -0.43 . . . . 63.549999999999997 110.431 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.7 -170.22 52.91 Favored Glycine 0 C--N 1.346 1.087 0 O-C-N 123.369 0.418 . . . . 73.040000000000006 113.204 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.427 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -95.9 124.02 53.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.928 -0.397 . . . . 71.030000000000001 109.928 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.72 125.53 12.27 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.25 1.967 . . . . 52.530000000000001 113.674 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.27 -43.34 1.69 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.617 -0.72 . . . . 63.229999999999997 113.413 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.26 -51.89 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.653 0.227 . . . . 73.329999999999998 111.569 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 22.8 mm -111.66 99.32 44.36 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 123.255 0.347 . . . . 74.319999999999993 111.177 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.63 165.65 31.87 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.379 2.053 . . . . 65.319999999999993 112.663 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.44 143.72 28.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.611 2.207 . . . . 73.209999999999994 113.264 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 56.48 41.21 29.06 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.62 0.768 . . . . 70.340000000000003 111.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.81 131.68 54.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.74 -0.664 . . . . 71.420000000000002 111.652 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.96 138.71 33.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.787 -1.097 . . . . 74.25 110.897 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 3.5 mt -115.12 156.46 25.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.543 -0.753 . . . . 71.519999999999996 110.908 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.94 119.84 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 109.721 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.9 m-85 -122.17 135.28 54.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.142 -0.481 . . . . 71.299999999999997 111.009 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.544 ' OD1' HH23 ' A' ' 73' ' ' MLY . 9.3 t70 -116.6 103.92 10.87 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.595 0.559 . . . . 62.020000000000003 110.212 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.866 HG22 HD11 ' A' ' 74' ' ' LEU . 26.6 m -104.72 153.17 6.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.187 -0.461 . . . . 60.420000000000002 111.065 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.13 125.75 35.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.472 -0.786 . . . . 72.230000000000004 110.209 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.658 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -72.95 101.93 3.33 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.867 -0.606 . . . . 64.0 110.455 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.39 -58.24 2.56 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.049 -0.523 . . . . 73.510000000000005 111.471 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 122.843 0.457 . . . . 74.319999999999993 110.775 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -124.11 144.44 49.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.06 -0.518 . . . . 64.409999999999997 110.689 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.465 0.317 0 O-C-N 123.499 0.499 . . . . 65.530000000000001 110.796 179.877 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 CA-C-O 119.042 -0.866 . . . . 43.119999999999997 112.657 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.25 -35.89 2.71 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.849 2.366 . . . . 72.120000000000005 113.098 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.7 p -103.72 138.07 40.87 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.415 0.447 . . . . 74.209999999999994 110.964 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.6 mtt -125.86 146.44 49.81 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.645 0.59 . . . . 73.209999999999994 111.086 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -114.04 -14.08 9.53 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.68 -0.691 . . . . 60.009999999999998 113.0 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 75' ' ' THR . 14.8 p -120.0 122.8 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 122.352 0.261 . . . . 71.540000000000006 110.799 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.36 118.97 29.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.84 -0.618 . . . . 73.140000000000001 110.491 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.7 t -107.11 132.41 54.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.092 -0.504 . . . . 62.43 110.254 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -120.47 123.65 43.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.571 -0.74 . . . . 74.439999999999998 110.138 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -78.35 126.37 30.68 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 110.945 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.64 -41.24 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.063 -0.971 . . . . 72.430000000000007 110.282 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t -130.2 119.08 18.53 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.979 -0.555 . . . . 74.319999999999993 110.405 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.2 130.43 17.57 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.6 2.2 . . . . 61.420000000000002 113.451 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -121.09 4.5 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.674 -0.694 . . . . 44.329999999999998 112.137 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.48 -46.24 12.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.67 0.235 . . . . 61.450000000000003 111.01 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.51 -1.41 88.34 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.091 -0.504 . . . . 63.509999999999998 113.75 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -135.98 0.56 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.428 0.291 . . . . 75.239999999999995 111.713 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.93 92.28 3.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.038 0.447 . . . . 71.400000000000006 110.189 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -102.61 149.73 37.01 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 115.611 -0.722 . . . . 72.109999999999999 111.032 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.52 128.67 19.63 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.505 2.137 . . . . 64.230000000000004 112.696 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.331 0 CA-C-N 115.472 -0.786 . . . . 72.299999999999997 111.343 -179.046 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HE ' ' CA ' ' A' ' 51' ' ' GLY . 65.7 ttt180 -77.42 121.81 24.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.62 -0.718 . . . . 75.420000000000002 110.998 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.2 -28.96 6.37 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.998 -0.546 . . . . 64.120000000000005 113.322 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.45 160.56 14.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.403 0.281 . . . . 72.140000000000001 110.949 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.01 145.2 30.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.217 -0.447 . . . . 73.129999999999995 111.14 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 61.7 m -125.23 120.79 32.26 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.741 -0.663 . . . . 70.120000000000005 110.996 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.74 111.71 24.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.19 -0.914 . . . . 63.039999999999999 109.743 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 103' ' ' LEU . 25.6 m -147.51 152.79 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.898 -0.592 . . . . 42.420000000000002 111.403 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.4 m-70 -103.48 125.19 49.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.488 -0.778 . . . . 75.310000000000002 109.311 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.1 p90 -115.95 167.66 10.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.493 0.553 . . . . 74.340000000000003 112.493 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.99 105.53 3.54 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.063 -0.971 . . . . 54.439999999999998 109.374 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.49 118.05 5.23 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.072 -0.585 . . . . 74.5 112.811 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.9 mtm -133.08 134.93 44.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.088 0.555 . . . . 72.230000000000004 110.92 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.18 172.03 0.33 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.435 -0.802 . . . . 42.340000000000003 112.318 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.97 -27.21 51.64 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.116 0.566 . . . . 72.0 111.947 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.79 -17.44 29.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.665 -0.698 . . . . 53.299999999999997 111.669 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.04 13.74 22.56 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.716 -0.755 . . . . 51.420000000000002 113.307 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.447 0 N-CA-C 110.067 -0.346 . . . . 63.25 110.067 179.601 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.31 0 N-CA-C 113.055 0.761 . . . . 75.25 113.055 -179.513 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 22.1 p90 -134.69 -14.27 2.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.538 -1.21 . . . . 74.109999999999999 111.135 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.7 110.5 0.04 OUTLIER 'General case' 0 C--N 1.359 1.019 0 CA-C-O 121.088 0.47 . . . . 71.540000000000006 112.186 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -122.98 138.77 54.59 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.371 -0.832 . . . . 72.049999999999997 110.121 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 63.6 p -78.69 -36.56 43.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.879 -0.601 . . . . 71.120000000000005 112.557 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -22.97 62.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.68 0.622 . . . . 54.32 112.68 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -28.89 69.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.822 0.344 . . . . 64.340000000000003 110.904 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -95.5 -0.36 52.28 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.32 -0.854 . . . . 71.299999999999997 110.055 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 64.49 37.43 8.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.233 1.013 . . . . 72.439999999999998 111.822 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.585 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.33 157.92 55.68 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.839 2.359 . . . . 72.540000000000006 112.811 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -102.48 117.25 34.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 112.108 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.436 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 C--O 1.235 0.313 0 CA-C-N 115.147 -0.933 . . . . 74.450000000000003 109.858 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 21' ' ' THR . 31.3 p90 -147.18 165.58 29.58 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.347 0.405 . . . . 73.329999999999998 111.334 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 ttm -110.37 124.39 51.62 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.319 -0.623 . . . . 71.140000000000001 109.319 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -80.17 138.49 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.73 -0.668 . . . . 74.219999999999999 112.06 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.556 ' CA ' ' HE ' ' A' ' 18' ' ' ARG . . . 88.62 -5.57 84.52 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.13 -0.941 . . . . 71.310000000000002 112.899 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 122.443 0.297 . . . . 72.219999999999999 110.723 179.427 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 70.17 30.95 3.33 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.174 0.99 . . . . 64.219999999999999 112.159 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.03 -32.37 44.96 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.966 -0.561 . . . . 75.25 110.751 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 m -108.49 -175.87 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.254 -0.885 . . . . 74.450000000000003 110.37 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 pt -82.32 159.66 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.138 0.421 . . . . 53.420000000000002 112.138 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -59.17 -43.96 92.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.905 -0.589 . . . . 73.409999999999997 111.755 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.672 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -64.06 -18.36 62.35 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 123.532 0.52 . . . . 75.120000000000005 113.444 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.408 ' O ' HG12 ' A' ' 63' ' ' VAL . 3.4 m0 -84.21 -46.05 12.27 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 122.504 0.322 . . . . 64.239999999999995 111.328 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.32 -36.07 80.73 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.422 0.451 . . . . 71.319999999999993 111.448 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.68 -23.94 29.2 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 111.597 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.05 -44.6 5.33 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.387 0.429 . . . . 71.540000000000006 113.623 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 59' ' ' TRP . 5.0 p -65.55 -22.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.816 0.447 . . . . 73.299999999999997 111.616 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.92 -9.35 58.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.581 -0.736 . . . . 33.409999999999997 111.522 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -91.16 -11.92 36.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.64 -0.709 . . . . 54.100000000000001 111.336 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -108.42 156.64 19.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.365 -0.379 . . . . 71.25 111.02 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.416 ' C ' ' HG ' ' A' ' 103' ' ' LEU . 21.6 p -111.66 167.36 10.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.783 -0.644 . . . . 51.25 110.579 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.632 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.8 t -56.26 123.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.937 0.495 . . . . 53.100000000000001 111.238 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.4 4.2 71.15 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.501 -0.772 . . . . 71.340000000000003 113.15 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.12 141.74 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.899 0.38 . . . . 75.439999999999998 111.335 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.18 108.85 15.17 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.167 -0.924 . . . . 73.140000000000001 109.297 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.22 156.59 45.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.992 -0.549 . . . . 61.039999999999999 111.864 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.292 0 CA-C-N 116.04 -0.527 . . . . 72.400000000000006 110.214 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.8 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -109.95 124.99 52.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.297 -0.41 . . . . 74.519999999999996 111.169 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m -93.55 112.78 24.75 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.283 -0.872 . . . . 53.119999999999997 109.464 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.672 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.8 mm -104.25 141.33 20.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 115.803 -0.635 . . . . 75.109999999999999 110.415 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.32 161.32 23.42 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.874 -1.057 . . . . 74.230000000000004 110.817 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.09 -16.97 49.32 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.78 2.32 . . . . 62.43 113.278 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.38 -25.49 25.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.392 0.433 . . . . 74.510000000000005 111.338 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -101.67 -19.28 15.48 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.013 -0.54 . . . . 73.030000000000001 111.369 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.19 -63.2 1.39 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.728 0.64 . . . . 54.109999999999999 112.728 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -133.68 -51.02 0.85 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.615 0.228 . . . . 74.540000000000006 111.615 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.15 -141.92 9.38 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.556 0.535 . . . . 71.340000000000003 112.029 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.42 -11.22 28.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 111.585 0.217 . . . . 51.549999999999997 111.585 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.54 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 63.549999999999997 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.16 -166.78 53.46 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.341 0.401 . . . . 73.040000000000006 113.223 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.465 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -97.93 124.92 46.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.885 -0.413 . . . . 71.030000000000001 109.885 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.96 123.74 10.33 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.223 1.949 . . . . 52.530000000000001 113.588 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.57 -46.08 1.22 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.618 -0.719 . . . . 63.229999999999997 113.394 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.77 -51.79 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.596 0.198 . . . . 73.329999999999998 111.527 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.4 mm -110.14 98.52 35.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 123.2 0.312 . . . . 74.319999999999993 111.013 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.69 165.71 31.7 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.427 2.085 . . . . 65.319999999999993 112.71 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.96 142.43 27.99 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.604 2.203 . . . . 73.209999999999994 113.197 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 56.84 44.44 23.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.599 0.76 . . . . 70.340000000000003 111.701 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.83 133.25 53.18 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.724 -0.671 . . . . 71.420000000000002 111.8 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -83.56 140.37 32.3 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.791 -1.095 . . . . 74.25 110.781 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.6 mt -117.26 155.7 29.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.651 -0.704 . . . . 71.519999999999996 111.064 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.93 127.97 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.828 -0.623 . . . . 72.319999999999993 109.772 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' O ' HD12 ' A' ' 74' ' ' LEU . 89.0 m-85 -130.13 132.64 46.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.126 -0.488 . . . . 71.299999999999997 110.565 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 t70 -115.37 104.3 11.65 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.13 -0.486 . . . . 62.020000000000003 110.142 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.8 HG22 HD11 ' A' ' 74' ' ' LEU . 26.2 m -106.78 153.13 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.08 -0.509 . . . . 60.420000000000002 111.126 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.94 125.98 36.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.507 -0.77 . . . . 72.230000000000004 110.24 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.06 101.96 3.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.708 -0.678 . . . . 64.0 110.485 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.91 -58.05 2.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.331 -0.395 . . . . 73.510000000000005 111.37 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 122.788 0.435 . . . . 74.319999999999993 110.862 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.32 147.61 49.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.07 -0.514 . . . . 64.409999999999997 110.622 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.465 0.287 0 CA-C-N 116.271 -0.422 . . . . 65.530000000000001 110.745 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 CA-C-O 119.059 -0.856 . . . . 43.119999999999997 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' PRO . . . . . 0.435 ' HB3' ' NE2' ' A' ' 3' ' ' GLN . 6.1 Cg_exo -75.51 135.91 18.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.881 2.387 . . . . 72.120000000000005 112.777 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.9 m -128.69 146.86 50.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.889 -0.596 . . . . 74.209999999999994 110.922 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.9 mmt 71.09 -49.08 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.43 1.092 . . . . 73.209999999999994 112.533 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 131.4 -22.33 4.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.465 -0.398 . . . . 60.009999999999998 112.986 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.9 p -116.38 122.91 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.409 0.284 . . . . 71.540000000000006 110.449 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' NE2' ' HB3' ' A' ' -2' ' ' PRO . 1.2 mp0 -121.9 119.63 32.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.896 -0.593 . . . . 73.140000000000001 111.054 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.8 p -108.67 138.92 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.951 -0.568 . . . . 62.43 111.027 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -125.08 123.93 40.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.524 -0.762 . . . . 74.439999999999998 110.27 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.15 126.18 30.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.255 -0.429 . . . . 74.150000000000006 110.928 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -109.05 -39.83 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.087 -0.96 . . . . 72.430000000000007 110.337 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -132.13 119.16 16.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 123.54 0.525 . . . . 74.319999999999993 110.467 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 130.33 17.01 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.619 2.213 . . . . 61.420000000000002 113.32 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.66 -121.45 4.46 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.746 -0.661 . . . . 44.329999999999998 112.18 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.09 -46.47 11.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.652 0.226 . . . . 61.450000000000003 111.015 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 86.13 -1.32 87.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 116.005 -0.543 . . . . 63.509999999999998 113.646 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -136.5 0.73 2.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.872 0.323 . . . . 75.239999999999995 111.872 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.91 92.79 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.056 0.455 . . . . 71.400000000000006 110.352 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.8 149.96 37.69 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.52 -0.764 . . . . 72.109999999999999 110.929 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -64.95 128.66 21.26 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.468 2.112 . . . . 64.230000000000004 112.639 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.409 0 CA-C-N 115.423 -0.808 . . . . 72.299999999999997 111.524 -178.961 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 64.7 ttt180 -77.36 125.87 30.02 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.583 -0.735 . . . . 75.420000000000002 111.191 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.81 -26.31 10.84 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 116.006 -0.543 . . . . 64.120000000000005 113.231 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 160.26 14.5 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.364 0.266 . . . . 72.140000000000001 110.891 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.535 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -81.91 145.15 30.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.023 -0.535 . . . . 73.129999999999995 111.523 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.5 t -120.1 115.66 24.12 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.48 -0.782 . . . . 70.120000000000005 110.343 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -89.65 110.49 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.612 -0.722 . . . . 63.039999999999999 109.745 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 103' ' ' LEU . 29.8 m -147.44 151.75 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.035 -0.529 . . . . 42.420000000000002 111.464 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -102.28 125.41 48.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.386 -0.825 . . . . 75.310000000000002 109.031 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.616 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.3 p90 -116.15 167.79 10.68 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.877 0.695 . . . . 74.340000000000003 112.877 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.3 m -148.91 112.14 4.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.015 . . . . 54.439999999999998 109.535 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.27 119.18 6.09 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.042 -0.526 . . . . 74.5 112.698 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.8 mtm -130.06 131.3 45.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.876 0.47 . . . . 72.230000000000004 111.126 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.04 170.12 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.67 -0.696 . . . . 42.340000000000003 112.069 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -56.19 -25.24 46.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.108 0.563 . . . . 72.0 112.147 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.12 -17.36 27.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.83 -0.623 . . . . 53.299999999999997 111.351 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.34 13.79 21.9 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.765 -0.731 . . . . 51.420000000000002 113.377 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.851 -0.425 . . . . 63.25 109.851 179.63 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.435 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 112.916 0.71 . . . . 75.25 112.916 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.3 p90 -133.62 -14.54 2.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.266 -1.334 . . . . 74.109999999999999 111.275 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -161.62 111.54 1.6 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.069 0.461 . . . . 71.540000000000006 111.99 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.435 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 2.5 p -116.55 120.54 39.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.36 -0.836 . . . . 72.049999999999997 110.865 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.558 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.7 p -78.36 -35.5 47.31 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.231 -0.441 . . . . 71.120000000000005 112.159 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -76.73 -23.31 53.04 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.853 0.686 . . . . 54.32 112.853 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -25.37 68.19 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.752 0.311 . . . . 64.340000000000003 111.32 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -92.05 1.07 57.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.417 -0.81 . . . . 71.299999999999997 109.747 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 63.0 36.43 12.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.195 0.998 . . . . 72.439999999999998 111.441 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 112.393 0.516 . . . . 74.109999999999999 112.393 -179.287 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.92 158.07 46.61 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.901 2.401 . . . . 72.540000000000006 112.748 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -99.41 118.3 35.72 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.049 -0.523 . . . . 73.329999999999998 112.046 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.477 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.223 -0.898 . . . . 74.450000000000003 110.004 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.6 p90 -150.43 160.76 43.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.245 0.341 . . . . 73.329999999999998 111.621 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.535 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.3 mpp? -104.69 134.59 47.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.321 -0.399 . . . . 71.140000000000001 110.589 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.9 mm? -78.57 140.34 38.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.811 -0.632 . . . . 74.219999999999999 111.739 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.84 -8.14 60.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 115.437 -0.801 . . . . 71.310000000000002 113.354 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 122.562 0.345 . . . . 72.219999999999999 110.722 179.32 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 69.61 27.84 4.68 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.098 0.959 . . . . 64.219999999999999 112.203 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.75 -13.26 60.04 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.005 -0.543 . . . . 75.25 110.764 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.53 -178.56 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.157 -0.928 . . . . 74.450000000000003 110.544 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.495 HD12 HG21 ' A' ' 76' ' ' ILE . 7.2 pt -77.56 158.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.999 0.37 . . . . 53.420000000000002 111.999 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -59.81 -42.88 94.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.862 -0.608 . . . . 73.409999999999997 111.893 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.34 -20.59 63.38 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.031 -0.531 . . . . 75.120000000000005 113.253 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -84.12 -44.41 14.05 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 116.699 0.25 . . . . 64.239999999999995 111.052 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.9 mt-10 -65.89 -36.96 84.85 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.212 0.32 . . . . 71.319999999999993 111.53 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.57 -26.75 27.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.894 -0.594 . . . . 73.219999999999999 111.784 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.53 -46.35 4.95 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 123.435 0.459 . . . . 71.540000000000006 113.974 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.452 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.1 p -63.51 -25.95 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.754 0.422 . . . . 73.299999999999997 111.697 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.53 -7.25 53.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.42 -0.809 . . . . 33.409999999999997 111.618 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -93.77 -9.89 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.78 -0.645 . . . . 54.100000000000001 111.316 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.451 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.55 156.26 19.2 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.35 -0.386 . . . . 71.25 110.785 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.412 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.8 p -110.76 167.09 10.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.851 -0.613 . . . . 51.25 110.63 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' HA ' HD12 ' A' ' 103' ' ' LEU . 54.0 t -56.21 123.23 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.92 0.488 . . . . 53.100000000000001 111.165 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.28 3.34 69.7 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.421 -0.809 . . . . 71.340000000000003 113.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.87 142.07 27.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 75.439999999999998 111.353 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -120.75 108.73 14.33 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.401 178.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.38 157.08 44.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.02 -0.536 . . . . 61.039999999999999 111.848 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.299 0 CA-C-N 116.083 -0.508 . . . . 72.400000000000006 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.821 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.02 134.57 47.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 74.519999999999996 110.828 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.2 m -100.48 113.14 25.68 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 53.119999999999997 109.402 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.539 HD12 ' HA3' ' A' ' 58' ' ' GLY . 8.5 mm -105.16 134.83 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.255 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.92 161.64 23.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.175 -0.92 . . . . 74.230000000000004 110.712 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.94 -16.99 48.6 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.634 2.223 . . . . 62.43 113.237 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.76 -25.32 24.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.152 -0.476 . . . . 74.510000000000005 111.284 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -101.37 -19.18 15.71 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.0 -0.545 . . . . 73.030000000000001 111.362 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.78 -63.24 1.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.724 0.639 . . . . 54.109999999999999 112.724 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -133.51 -52.43 0.88 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.634 0.235 . . . . 74.540000000000006 111.634 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.79 -140.32 7.84 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.458 0.474 . . . . 71.340000000000003 112.053 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 -10.87 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 111.629 0.233 . . . . 51.549999999999997 111.629 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.29 -60.36 1.54 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.26 -0.427 . . . . 63.549999999999997 110.507 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.04 -166.93 54.41 Favored Glycine 0 C--N 1.346 1.108 0 O-C-N 123.331 0.394 . . . . 73.040000000000006 113.232 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.452 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.63 124.11 49.59 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.909 -0.404 . . . . 71.030000000000001 109.909 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.56 123.66 10.38 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.242 1.961 . . . . 52.530000000000001 113.589 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.66 -48.45 0.94 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.573 -0.739 . . . . 63.229999999999997 113.361 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.96 -51.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 111.594 0.22 . . . . 73.329999999999998 111.594 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.0 mm -109.55 97.54 27.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 123.273 0.358 . . . . 74.319999999999993 111.079 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.49 165.56 32.09 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.381 2.054 . . . . 65.319999999999993 112.747 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.06 143.55 29.01 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.558 2.172 . . . . 73.209999999999994 113.256 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.67 41.85 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.641 0.776 . . . . 70.340000000000003 111.793 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.94 132.32 54.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.683 -0.69 . . . . 71.420000000000002 111.697 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -83.27 136.85 34.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.719 -1.128 . . . . 74.25 110.991 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -115.18 153.32 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.518 -0.764 . . . . 71.519999999999996 110.875 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.88 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 72.319999999999993 109.559 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.3 m-85 -130.15 135.13 47.85 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.128 -0.487 . . . . 71.299999999999997 110.775 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.3 t70 -116.33 104.82 11.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.973 -0.558 . . . . 62.020000000000003 110.186 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.821 HG22 HD11 ' A' ' 74' ' ' LEU . 26.7 m -105.9 153.0 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 115.979 -0.555 . . . . 60.420000000000002 110.972 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.8 125.37 35.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.752 . . . . 72.230000000000004 110.182 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.643 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -72.98 100.94 3.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.77 -0.65 . . . . 64.0 110.388 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.3 -57.91 2.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.049 -0.523 . . . . 73.510000000000005 111.391 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 122.827 0.451 . . . . 74.319999999999993 110.774 -179.897 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -123.78 145.42 49.05 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.077 -0.511 . . . . 64.409999999999997 110.734 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.465 0.305 0 O-C-N 123.523 0.514 . . . . 65.530000000000001 110.821 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 118.993 -0.893 . . . . 43.119999999999997 112.687 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.38 157.63 41.1 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.824 2.349 . . . . 72.120000000000005 112.794 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.3 m -127.36 -40.9 1.77 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.842 -0.617 . . . . 74.209999999999994 111.258 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 72.4 mtm -97.36 -40.87 8.51 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.388 0.43 . . . . 73.209999999999994 111.29 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 123.98 -42.06 1.64 Allowed Glycine 0 C--N 1.339 0.713 0 O-C-N 123.508 0.505 . . . . 60.009999999999998 112.484 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.2 p -121.71 118.81 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.741 0.305 . . . . 71.540000000000006 110.736 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -120.23 118.34 30.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.714 -0.675 . . . . 73.140000000000001 110.751 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.5 p -108.76 138.13 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.887 -0.597 . . . . 62.43 111.039 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.41 124.31 42.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.452 -0.795 . . . . 74.439999999999998 110.181 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.01 127.05 31.73 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.447 0.467 . . . . 74.150000000000006 110.973 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -110.17 -39.58 3.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.132 -0.94 . . . . 72.430000000000007 110.323 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -132.42 119.24 16.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.526 . . . . 74.319999999999993 110.473 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.52 131.0 18.03 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.644 2.229 . . . . 61.420000000000002 113.336 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.34 -121.4 4.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.727 -0.67 . . . . 44.329999999999998 112.236 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -84.21 -46.58 11.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.688 0.244 . . . . 61.450000000000003 111.045 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 86.59 -1.32 87.16 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.111 -0.495 . . . . 63.509999999999998 113.679 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -136.43 0.92 2.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.405 0.282 . . . . 75.239999999999995 111.76 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -122.35 92.88 3.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.101 0.477 . . . . 71.400000000000006 110.291 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -103.39 149.77 37.33 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 115.552 -0.749 . . . . 72.109999999999999 111.12 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.97 125.01 12.5 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.465 2.11 . . . . 64.230000000000004 112.74 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.397 0 CA-C-N 115.441 -0.8 . . . . 72.299999999999997 111.35 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.36 128.75 34.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 75.420000000000002 111.112 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.74 10.93 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.847 -0.615 . . . . 64.120000000000005 113.066 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -99.56 160.43 14.3 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.54 0.336 . . . . 72.140000000000001 110.843 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.32 144.91 30.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.331 -0.395 . . . . 73.129999999999995 111.336 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 38.8 t -122.61 117.89 26.9 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.606 -0.724 . . . . 70.120000000000005 110.714 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.75 110.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.497 -0.774 . . . . 63.039999999999999 109.613 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 103' ' ' LEU . 24.7 m -147.85 153.33 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.019 -0.537 . . . . 42.420000000000002 111.457 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.2 m-70 -103.66 125.31 50.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.45 -0.795 . . . . 75.310000000000002 109.355 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.9 p90 -116.5 165.95 12.65 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 74.340000000000003 112.361 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.5 m -148.05 108.45 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.189 -0.914 . . . . 54.439999999999998 109.402 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -89.17 119.96 5.6 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.032 -0.531 . . . . 74.5 112.954 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 mtm -133.59 129.98 37.74 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.032 0.533 . . . . 72.230000000000004 111.0 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -54.79 170.53 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.622 -0.717 . . . . 42.340000000000003 112.457 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.5 -27.32 47.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.214 0.606 . . . . 72.0 112.184 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -88.98 -17.17 30.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.831 -0.622 . . . . 53.299999999999997 111.279 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.5 13.78 21.61 Favored Glycine 0 C--N 1.346 1.102 0 C-N-CA 120.823 -0.703 . . . . 51.420000000000002 113.004 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.722 -0.473 . . . . 63.25 109.722 179.488 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.552 ' HG3' ' O ' ' A' ' 28' ' ' GLY . . . . . . . . 0 CA--C 1.508 -0.653 0 CA-C-N 115.973 -0.558 . . . . 75.25 112.252 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.4 p90 -131.99 -11.52 3.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.586 -1.188 . . . . 74.109999999999999 111.945 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.84 115.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 112.708 0.633 . . . . 71.540000000000006 112.708 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.8 t -122.82 147.02 47.02 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.395 -0.82 . . . . 72.049999999999997 110.681 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.546 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 53.4 p -78.59 -30.56 46.76 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.574 -0.739 . . . . 71.120000000000005 112.115 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -75.17 -24.81 57.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.839 0.681 . . . . 54.32 112.839 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CG ' HH21 ' A' ' 35' ' ' MLY . 3.1 t70 -60.86 -29.63 69.64 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.746 0.308 . . . . 64.340000000000003 111.061 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -92.54 1.33 57.32 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.455 -0.793 . . . . 71.299999999999997 109.999 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 61.79 40.13 13.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.127 0.971 . . . . 72.439999999999998 111.498 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 111.887 -179.297 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -71.49 157.88 55.26 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.741 2.294 . . . . 72.540000000000006 112.801 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -101.96 117.46 34.88 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.895 -0.593 . . . . 73.329999999999998 112.123 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.472 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 115.134 -0.939 . . . . 74.450000000000003 109.833 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' THR . 29.3 p90 -148.12 165.22 31.52 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.405 0.441 . . . . 73.329999999999998 111.401 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mtt -109.46 126.94 54.02 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.03 -0.532 . . . . 71.140000000000001 109.75 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -82.6 138.05 34.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.688 -0.687 . . . . 74.219999999999999 112.11 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.46 -6.28 82.33 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.067 -0.969 . . . . 71.310000000000002 112.872 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 122.49 0.316 . . . . 72.219999999999999 110.673 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 69.16 31.61 3.96 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.186 0.994 . . . . 64.219999999999999 112.071 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -79.55 -32.03 42.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.872 -0.604 . . . . 75.25 110.84 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.46 -174.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.447 -0.797 . . . . 74.450000000000003 110.246 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.694 HD12 HG21 ' A' ' 76' ' ' ILE . 9.5 pt -81.98 157.95 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 111.903 0.334 . . . . 53.420000000000002 111.903 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -59.68 -43.83 93.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.001 -0.545 . . . . 73.409999999999997 112.166 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.45 -18.27 63.12 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.452 0.47 . . . . 75.120000000000005 113.326 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.415 ' CD1' HD11 ' A' ' 56' ' ' ILE . 5.2 m0 -84.26 -46.81 11.44 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 122.438 0.295 . . . . 64.239999999999995 111.372 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.31 -36.35 83.79 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.265 0.353 . . . . 71.319999999999993 111.369 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.46 -24.21 29.59 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 73.219999999999999 111.69 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.05 -45.18 4.87 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.436 0.46 . . . . 71.540000000000006 113.639 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.33 -24.21 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.796 0.438 . . . . 73.299999999999997 111.489 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.14 -7.17 54.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.445 -0.798 . . . . 33.409999999999997 111.53 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -94.3 -11.46 30.06 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.672 -0.695 . . . . 54.100000000000001 111.306 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.444 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.61 156.4 18.63 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.305 0.378 . . . . 71.25 110.794 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.412 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 24.5 p -110.91 167.33 10.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.941 -0.572 . . . . 51.25 110.639 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.633 ' HA ' HD12 ' A' ' 103' ' ' LEU . 55.4 t -56.21 123.36 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.928 0.491 . . . . 53.100000000000001 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.08 3.49 69.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.504 -0.771 . . . . 71.340000000000003 113.179 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.89 142.68 27.19 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 120.97 0.414 . . . . 75.439999999999998 111.352 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.04 109.2 14.77 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.097 -0.956 . . . . 73.140000000000001 109.413 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.33 156.34 46.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.034 -0.53 . . . . 61.039999999999999 111.917 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.549 HH23 ' OD2' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-N 116.111 -0.495 . . . . 72.400000000000006 110.455 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.827 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.26 135.29 46.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.912 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.0 m -100.77 111.46 23.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.705 -0.68 . . . . 53.119999999999997 109.344 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.694 HG21 HD12 ' A' ' 56' ' ' ILE . 7.6 mm -103.01 130.99 52.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 110.19 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.49 161.48 27.66 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.294 -0.866 . . . . 74.230000000000004 111.027 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.37 -17.11 51.41 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.626 2.217 . . . . 62.43 113.223 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.43 -27.13 21.74 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.511 0.507 . . . . 74.510000000000005 111.221 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.38 -18.96 18.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 73.030000000000001 111.362 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' HB2' HG22 ' A' ' 76' ' ' ILE . . . -85.87 -60.13 2.1 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.597 0.592 . . . . 54.109999999999999 112.597 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 91' ' ' ILE . 89.7 m-85 -129.59 -49.97 1.16 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 111.704 0.261 . . . . 74.540000000000006 111.704 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 128.97 55.71 0.11 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.216 -0.516 . . . . 71.340000000000003 113.572 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 64.38 -12.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.939 1.089 . . . . 51.549999999999997 113.939 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 m -98.26 -60.22 1.6 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.257 -0.275 . . . . 63.549999999999997 110.257 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.22 -174.76 29.84 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.36 0.412 . . . . 73.040000000000006 113.66 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.563 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 5.1 t60 -93.92 128.55 40.97 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.915 -0.402 . . . . 71.030000000000001 109.915 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.04 122.96 10.09 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.271 1.981 . . . . 52.530000000000001 113.586 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.14 -46.69 1.13 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.573 -0.74 . . . . 63.229999999999997 113.293 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.57 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.511 0.189 . . . . 73.329999999999998 111.511 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.563 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 30.2 mm -109.85 98.72 35.27 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 123.249 0.343 . . . . 74.319999999999993 110.9 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.71 165.59 32.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.439 2.093 . . . . 65.319999999999993 112.629 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.5 146.89 31.45 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.466 2.11 . . . . 73.209999999999994 113.298 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 55.67 37.71 29.22 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.659 0.784 . . . . 70.340000000000003 111.993 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.37 128.97 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.734 -0.666 . . . . 71.420000000000002 111.73 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.41 135.44 34.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.828 -1.078 . . . . 74.25 110.688 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 3.1 mt -111.72 158.11 19.71 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.606 -0.725 . . . . 71.519999999999996 111.164 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.13 114.6 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.982 -0.554 . . . . 72.319999999999993 109.842 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.8 m-85 -116.79 136.16 53.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.131 -0.486 . . . . 71.299999999999997 111.043 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.549 ' OD2' HH23 ' A' ' 73' ' ' MLY . 10.0 t70 -116.58 104.69 11.65 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.909 -0.587 . . . . 62.020000000000003 110.197 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.827 HG22 HD11 ' A' ' 74' ' ' LEU . 25.0 m -105.57 152.71 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.076 -0.511 . . . . 60.420000000000002 110.967 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.3 125.46 36.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.543 -0.753 . . . . 72.230000000000004 110.085 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.98 101.22 3.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.724 -0.671 . . . . 64.0 110.548 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.87 -57.69 2.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 111.399 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 122.843 0.457 . . . . 74.319999999999993 110.843 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.65 145.6 49.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.02 -0.536 . . . . 64.409999999999997 110.664 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.281 -0.418 . . . . 65.530000000000001 110.757 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.715 0 CA-C-O 119.253 -0.748 . . . . 43.119999999999997 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.54 -34.68 3.22 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.059 2.506 . . . . 72.120000000000005 113.124 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.8 m 63.25 128.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.01 0.924 . . . . 74.209999999999994 112.148 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -97.84 -41.0 8.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.78 -0.646 . . . . 73.209999999999994 111.374 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 126.11 -39.58 1.99 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 123.449 0.468 . . . . 60.009999999999998 112.597 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG23 HD13 ' A' ' 76' ' ' ILE . 15.0 p -119.83 123.19 70.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.694 0.283 . . . . 71.540000000000006 110.701 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -122.72 120.22 32.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.839 -0.619 . . . . 73.140000000000001 110.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 11.6 t -107.89 128.83 62.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.119 -0.491 . . . . 62.43 110.232 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.41 123.87 47.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.596 -0.729 . . . . 74.439999999999998 110.007 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.4 m -78.81 128.61 33.59 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.482 0.489 . . . . 74.150000000000006 110.959 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.483 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -110.35 -41.73 4.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.175 -0.92 . . . . 72.430000000000007 110.259 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -129.67 118.84 18.95 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.938 -0.574 . . . . 74.319999999999993 110.399 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.33 129.36 15.83 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.568 2.179 . . . . 61.420000000000002 113.375 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.67 -120.96 4.17 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.661 -0.7 . . . . 44.329999999999998 112.157 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.74 -46.19 12.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.634 0.217 . . . . 61.450000000000003 111.003 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.4 -1.23 88.52 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.04 -0.527 . . . . 63.509999999999998 113.72 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -136.85 1.4 2.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.501 0.32 . . . . 75.239999999999995 111.76 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -122.21 92.73 3.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.048 0.451 . . . . 71.400000000000006 110.202 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -103.12 149.57 37.03 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.57 -0.741 . . . . 72.109999999999999 110.956 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.5 124.66 12.73 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.55 2.167 . . . . 64.230000000000004 112.962 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 CA-C-N 115.498 -0.774 . . . . 72.299999999999997 111.464 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.41 123.19 26.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.6 -0.727 . . . . 75.420000000000002 111.565 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.19 -23.5 10.55 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.881 -0.6 . . . . 64.120000000000005 113.668 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -102.44 160.27 14.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.796 0.298 . . . . 72.140000000000001 110.985 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.662 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -79.37 143.5 35.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.133 -0.485 . . . . 73.129999999999995 111.276 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 57.3 m -122.36 116.22 23.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.662 -0.699 . . . . 70.120000000000005 110.44 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 t -90.4 110.78 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.492 -0.776 . . . . 63.039999999999999 109.863 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.2 m -146.94 151.73 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.915 -0.584 . . . . 42.420000000000002 111.327 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.7 m-70 -102.51 125.28 49.18 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.502 -0.772 . . . . 75.310000000000002 109.162 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.0 p90 -115.89 167.68 10.74 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.651 0.611 . . . . 74.340000000000003 112.651 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.8 m -148.92 108.54 4.0 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.042 -0.981 . . . . 54.439999999999998 109.58 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 115.76 5.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 121.163 -0.541 . . . . 74.5 112.555 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.3 mtm -130.44 136.48 49.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.039 0.535 . . . . 72.230000000000004 110.702 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.49 172.29 0.51 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.616 -0.72 . . . . 42.340000000000003 112.205 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -56.07 -26.29 48.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.157 0.583 . . . . 72.0 112.008 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.93 -17.39 28.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.671 -0.695 . . . . 53.299999999999997 111.307 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.55 13.79 21.5 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.715 -0.755 . . . . 51.420000000000002 113.385 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.43 0 N-CA-C 110.191 -0.3 . . . . 63.25 110.191 179.712 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.418 ' HE3' ' CG2' ' A' ' 27' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 112.876 0.695 . . . . 75.25 112.876 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 24.4 p90 -134.63 -12.35 2.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.512 -1.222 . . . . 74.109999999999999 110.98 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 179.18 110.96 0.03 OUTLIER 'General case' 0 C--N 1.36 1.049 0 CA-C-O 121.054 0.454 . . . . 71.540000000000006 112.089 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 t -122.26 137.39 54.86 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.339 -0.846 . . . . 72.049999999999997 110.131 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.59 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.2 t -78.52 -34.07 47.54 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.627 -0.715 . . . . 71.120000000000005 112.288 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -75.27 -23.17 57.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.422 0.527 . . . . 54.32 112.422 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -24.29 67.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.8 0.333 . . . . 64.340000000000003 111.051 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -96.13 -0.42 50.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.37 -0.832 . . . . 71.299999999999997 109.754 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 64.04 36.34 9.93 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.188 0.995 . . . . 72.439999999999998 111.525 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.115 -0.493 . . . . 74.109999999999999 111.873 -179.365 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -72.69 158.06 51.17 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.961 2.441 . . . . 72.540000000000006 113.056 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.01 118.85 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.848 -0.615 . . . . 73.329999999999998 112.068 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.548 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.297 -0.865 . . . . 74.450000000000003 110.286 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.3 p90 -151.05 164.36 36.62 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.295 0.372 . . . . 73.329999999999998 111.546 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.662 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -107.57 134.79 50.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.302 -0.408 . . . . 71.140000000000001 110.525 178.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -78.88 141.71 37.43 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.817 -0.629 . . . . 74.219999999999999 111.569 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.84 62.04 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.605 -0.725 . . . . 71.310000000000002 113.277 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 122.63 0.372 . . . . 72.219999999999999 110.707 179.362 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 70.02 27.5 4.34 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.147 0.979 . . . . 64.219999999999999 112.2 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.25 -19.9 57.9 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.016 -0.538 . . . . 75.25 110.715 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.86 -178.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.217 -0.901 . . . . 74.450000000000003 110.443 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -77.82 160.39 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 53.420000000000002 112.101 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -60.59 -44.43 96.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.024 -0.535 . . . . 73.409999999999997 111.811 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.7 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.8 -20.05 61.54 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 116.099 -0.5 . . . . 75.120000000000005 113.418 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -84.1 -43.67 14.81 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.677 0.239 . . . . 64.239999999999995 111.07 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' HD11 ' A' ' 50' ' ' LEU . 30.8 mt-10 -66.83 -37.72 85.04 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.367 0.417 . . . . 71.319999999999993 111.594 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.45 -25.25 29.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.961 -0.563 . . . . 73.219999999999999 111.74 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.08 -46.35 4.78 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.445 0.465 . . . . 71.540000000000006 113.89 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.55 -25.41 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.827 0.451 . . . . 73.299999999999997 111.714 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.67 -8.72 57.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.342 -0.845 . . . . 33.409999999999997 111.728 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -91.69 -8.86 45.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.877 -0.601 . . . . 54.100000000000001 111.202 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.437 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.01 156.49 19.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.265 -0.425 . . . . 71.25 110.969 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.404 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.3 p -111.47 166.79 10.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.823 -0.626 . . . . 51.25 110.565 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.65 ' HA ' HD12 ' A' ' 103' ' ' LEU . 54.7 t -55.92 123.21 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.93 0.492 . . . . 53.100000000000001 111.279 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 3.73 70.2 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.475 -0.784 . . . . 71.340000000000003 113.122 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -95.51 141.38 29.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.96 0.41 . . . . 75.439999999999998 111.306 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.483 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -119.69 109.2 15.36 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.113 -0.949 . . . . 73.140000000000001 109.339 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.96 155.43 47.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.909 -0.587 . . . . 61.039999999999999 111.833 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-N 116.105 -0.498 . . . . 72.400000000000006 110.085 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.813 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.32 124.86 53.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.297 -0.41 . . . . 74.519999999999996 111.161 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.8 m -93.08 112.8 24.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.322 -0.853 . . . . 53.119999999999997 109.364 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.7 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.8 mm -104.4 142.1 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.758 -0.656 . . . . 75.109999999999999 110.463 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.93 161.57 22.54 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 114.807 -1.088 . . . . 74.230000000000004 110.784 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.91 -17.19 49.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.806 2.338 . . . . 62.43 113.274 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.21 -25.29 25.7 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.465 0.478 . . . . 74.510000000000005 111.287 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -101.38 -19.52 15.56 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.037 -0.529 . . . . 73.030000000000001 111.456 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.25 1.37 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.785 0.661 . . . . 54.109999999999999 112.785 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -133.31 -51.16 0.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.637 0.236 . . . . 74.540000000000006 111.637 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.29 -141.44 8.92 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.489 0.493 . . . . 71.340000000000003 112.056 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.76 -11.31 27.18 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.569 0.211 . . . . 51.549999999999997 111.569 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.51 -60.39 1.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.303 -0.408 . . . . 63.549999999999997 110.46 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.84 53.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.368 0.418 . . . . 73.040000000000006 113.126 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.457 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.29 124.48 48.98 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.86 -0.422 . . . . 71.030000000000001 109.86 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.72 124.03 10.7 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.211 1.941 . . . . 52.530000000000001 113.653 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.99 -46.88 1.11 Allowed Glycine 0 C--N 1.337 0.605 0 CA-C-N 115.615 -0.721 . . . . 63.229999999999997 113.373 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.9 -51.67 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 111.602 0.223 . . . . 73.329999999999998 111.602 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.4 mm -109.95 98.36 33.89 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 123.176 0.298 . . . . 74.319999999999993 111.09 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.69 165.71 31.7 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.454 2.103 . . . . 65.319999999999993 112.676 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.03 143.09 28.54 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.544 2.163 . . . . 73.209999999999994 113.192 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 56.66 43.24 25.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.628 0.771 . . . . 70.340000000000003 111.795 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.82 132.84 53.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.731 -0.668 . . . . 71.420000000000002 111.773 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -82.55 141.22 32.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.784 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -119.01 154.46 33.04 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.693 -0.685 . . . . 71.519999999999996 111.068 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 128.01 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.835 -0.62 . . . . 72.319999999999993 109.838 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 74' ' ' LEU . 89.8 m-85 -130.19 132.95 46.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.063 -0.517 . . . . 71.299999999999997 110.617 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 5.6 t70 -116.22 104.95 12.03 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.091 -0.504 . . . . 62.020000000000003 110.243 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.813 HG22 HD11 ' A' ' 74' ' ' LEU . 24.8 m -107.03 153.2 8.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.008 -0.542 . . . . 60.420000000000002 111.09 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.89 125.96 34.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.497 -0.774 . . . . 72.230000000000004 110.482 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.17 101.54 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.771 -0.649 . . . . 64.0 110.219 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -89.84 -58.53 2.48 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.222 -0.445 . . . . 73.510000000000005 111.391 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 122.839 0.456 . . . . 74.319999999999993 110.765 -179.896 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB3' HE22 ' A' ' 20' ' ' GLN . 9.7 mt -124.36 146.14 49.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.15 -0.477 . . . . 64.409999999999997 110.671 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 45.4 mt-10 . . . . . 0 N--CA 1.464 0.264 0 O-C-N 123.503 0.502 . . . . 65.530000000000001 110.818 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 CA-C-O 119.236 -0.758 . . . . 43.119999999999997 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.95 136.23 18.3 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 123.037 2.491 . . . . 72.120000000000005 112.814 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 45.8 p -128.09 -43.05 1.51 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.904 -0.589 . . . . 74.209999999999994 111.327 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 5.6 tpt -129.0 -43.25 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.425 0.453 . . . . 73.209999999999994 110.98 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 123.85 -46.84 1.06 Allowed Glycine 0 C--N 1.339 0.749 0 O-C-N 123.486 0.491 . . . . 60.009999999999998 112.455 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 75' ' ' THR . 14.4 p -122.75 122.56 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.638 0.256 . . . . 71.540000000000006 110.615 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.69 119.52 32.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 73.140000000000001 110.604 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.6 t -107.73 129.27 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.083 -0.508 . . . . 62.43 110.113 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.46 123.4 45.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.617 -0.72 . . . . 74.439999999999998 110.163 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -78.19 125.45 29.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.221 -0.445 . . . . 74.150000000000006 111.001 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -107.69 -41.35 5.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 110.272 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -129.98 119.19 18.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 110.382 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.29 130.43 17.46 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.623 2.215 . . . . 61.420000000000002 113.416 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.03 -121.11 4.47 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.712 -0.676 . . . . 44.329999999999998 112.096 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -83.96 -46.14 12.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.648 0.224 . . . . 61.450000000000003 110.939 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.66 -1.44 88.17 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.542 0.526 . . . . 63.509999999999998 113.757 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -136.33 0.6 2.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.427 0.291 . . . . 75.239999999999995 111.781 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 92.46 3.74 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.032 0.444 . . . . 71.400000000000006 110.333 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -103.49 149.56 37.16 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.544 -0.753 . . . . 72.109999999999999 110.958 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.88 123.06 10.79 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.51 2.14 . . . . 64.230000000000004 112.714 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 115.384 -0.825 . . . . 72.299999999999997 111.44 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -77.3 127.85 33.31 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.725 -0.67 . . . . 75.420000000000002 111.317 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.04 -26.34 11.56 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.716 -0.675 . . . . 64.120000000000005 113.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -99.77 160.23 14.46 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.443 0.297 . . . . 72.140000000000001 110.866 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.29 145.19 29.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 111.308 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.3 t -120.08 116.93 26.68 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.563 -0.744 . . . . 70.120000000000005 110.544 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -90.91 110.79 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.415 -0.812 . . . . 63.039999999999999 109.584 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 103' ' ' LEU . 25.1 m -147.89 152.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.052 -0.522 . . . . 42.420000000000002 111.521 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 3.0 m80 -102.62 125.27 49.3 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.401 -0.818 . . . . 75.310000000000002 109.066 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.602 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.5 p90 -115.33 166.3 12.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.802 0.667 . . . . 74.340000000000003 112.802 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.8 m -149.15 110.56 4.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.884 -1.053 . . . . 54.439999999999998 109.237 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.43 117.26 5.59 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.157 -0.544 . . . . 74.5 112.994 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.0 mtm -126.38 129.97 49.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.918 0.487 . . . . 72.230000000000004 111.15 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.96 171.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.709 -0.678 . . . . 42.340000000000003 112.181 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -57.09 -26.27 60.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.085 0.554 . . . . 72.0 111.94 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.25 -17.95 28.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.812 -0.631 . . . . 53.299999999999997 111.716 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.03 14.1 23.56 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 120.75 -0.738 . . . . 51.420000000000002 113.367 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.379 0 N-CA-C 108.635 -0.876 . . . . 63.25 108.635 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.434 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 113.372 0.879 . . . . 75.25 113.372 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 34.5 p90 -134.12 -10.28 2.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.127 -1.397 . . . . 74.109999999999999 111.339 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -163.44 111.57 1.22 Allowed 'General case' 0 C--N 1.355 0.827 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 111.698 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.434 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 5.4 p -119.18 117.7 29.35 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.838 -1.074 . . . . 72.049999999999997 111.115 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 65.0 p -78.79 -36.49 42.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.929 -0.578 . . . . 71.120000000000005 112.25 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -23.1 53.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.979 0.733 . . . . 54.32 112.979 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -24.0 67.63 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.842 0.353 . . . . 64.340000000000003 111.233 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -93.7 -0.25 56.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.394 -0.821 . . . . 71.299999999999997 109.68 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 63.51 36.25 11.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.29 1.036 . . . . 72.439999999999998 111.568 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 112.147 -179.402 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.68 158.07 51.2 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.937 2.424 . . . . 72.540000000000006 112.756 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.405 ' CD1' ' HE2' ' A' ' 26' ' ' TYR . 18.6 t80 -101.16 118.45 37.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 112.046 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 115.172 -0.922 . . . . 74.450000000000003 110.061 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.2 p90 -149.09 161.63 41.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.308 0.38 . . . . 73.329999999999998 111.383 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.43 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 7.2 mtt -105.78 132.26 52.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.69 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.7 mm? -77.45 139.51 39.67 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.946 -0.57 . . . . 74.219999999999999 111.657 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.73 53.99 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.524 -0.762 . . . . 71.310000000000002 113.249 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 122.516 0.327 . . . . 72.219999999999999 110.693 179.186 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 70.0 27.06 4.47 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.121 0.968 . . . . 64.219999999999999 112.152 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 46.3 mt-10 -76.31 -14.37 60.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.974 -0.557 . . . . 75.25 110.867 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.9 m -127.25 -177.63 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.342 -0.845 . . . . 74.450000000000003 110.537 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.89 159.76 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.086 0.402 . . . . 53.420000000000002 112.086 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -60.17 -44.18 95.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.999 -0.546 . . . . 73.409999999999997 111.784 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.44 -20.78 61.57 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.081 -0.509 . . . . 75.120000000000005 113.467 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -84.15 -43.7 14.73 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.636 0.218 . . . . 64.239999999999995 111.208 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.9 mt-10 -66.3 -37.9 86.5 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.364 0.415 . . . . 71.319999999999993 111.536 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.44 -25.63 28.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.872 -0.604 . . . . 73.219999999999999 111.759 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.68 -46.37 4.89 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.399 0.437 . . . . 71.540000000000006 113.894 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.3 p -63.67 -25.02 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.766 0.426 . . . . 73.299999999999997 111.776 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 -8.43 56.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.362 -0.836 . . . . 33.409999999999997 111.678 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -91.9 -11.38 36.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.857 -0.611 . . . . 54.100000000000001 111.274 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.436 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.69 156.07 19.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.349 -0.387 . . . . 71.25 110.991 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.6 p -110.96 166.92 10.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.818 -0.628 . . . . 51.25 110.588 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.654 ' HA ' HD12 ' A' ' 103' ' ' LEU . 54.2 t -56.13 123.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 122.942 0.497 . . . . 53.100000000000001 111.274 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.78 4.58 69.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.448 -0.796 . . . . 71.340000000000003 113.148 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.16 141.71 29.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.971 0.415 . . . . 75.439999999999998 111.298 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.54 108.47 14.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.093 -0.958 . . . . 73.140000000000001 109.305 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.67 156.42 44.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.975 -0.557 . . . . 61.039999999999999 111.825 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.291 0 CA-C-N 116.078 -0.51 . . . . 72.400000000000006 110.312 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.82 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.27 124.76 52.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 111.117 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.8 m -93.4 113.33 25.47 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.412 -0.813 . . . . 53.119999999999997 109.567 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.715 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.2 mm -105.52 142.63 18.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.892 -0.594 . . . . 75.109999999999999 110.509 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.56 162.14 20.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.829 -1.078 . . . . 74.230000000000004 110.708 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.33 -17.21 45.72 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.767 2.311 . . . . 62.43 113.242 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 111.235 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -101.89 -19.14 15.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.993 -0.549 . . . . 73.030000000000001 111.364 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.78 -62.7 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.677 0.621 . . . . 54.109999999999999 112.677 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -133.52 -53.85 0.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.598 0.221 . . . . 74.540000000000006 111.598 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.59 -137.71 6.02 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 123.497 0.498 . . . . 71.340000000000003 111.991 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.56 -9.14 25.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.558 0.21 . . . . 51.549999999999997 111.564 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 m -102.63 -60.38 1.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.303 -0.408 . . . . 63.549999999999997 110.577 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.41 -169.34 54.16 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.395 0.435 . . . . 73.040000000000006 113.156 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.65 123.34 54.41 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.901 -0.407 . . . . 71.030000000000001 109.901 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.76 125.21 12.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.166 1.911 . . . . 52.530000000000001 113.638 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.23 -47.95 1.0 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.566 -0.743 . . . . 63.229999999999997 113.292 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.31 -51.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 111.576 0.213 . . . . 73.329999999999998 111.576 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.434 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.2 mm -111.63 98.48 41.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.187 0.305 . . . . 74.319999999999993 111.213 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.09 165.75 31.68 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 122.448 2.099 . . . . 65.319999999999993 112.709 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.23 143.9 28.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.571 2.181 . . . . 73.209999999999994 113.164 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 56.88 41.66 27.59 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.569 0.748 . . . . 70.340000000000003 111.818 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.59 132.46 54.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 111.776 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -82.45 139.87 33.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.69 -1.141 . . . . 74.25 110.904 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.534 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.4 mt -118.86 152.2 36.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.617 -0.719 . . . . 71.519999999999996 110.9 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.2 132.03 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.82 -0.627 . . . . 72.319999999999993 109.503 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.5 m-85 -132.87 132.94 42.65 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 71.299999999999997 110.787 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 73' ' ' MLY . 8.5 t70 -116.28 103.39 10.45 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.943 -0.571 . . . . 62.020000000000003 109.899 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.82 HG22 HD11 ' A' ' 74' ' ' LEU . 24.7 m -105.97 153.66 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.991 -0.549 . . . . 60.420000000000002 111.17 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.2 125.82 35.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.466 -0.788 . . . . 72.230000000000004 110.38 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.654 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -73.11 102.11 3.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.803 -0.635 . . . . 64.0 110.385 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.2 -58.84 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.139 -0.482 . . . . 73.510000000000005 111.334 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 122.74 0.416 . . . . 74.319999999999993 110.767 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.9 mt -126.84 144.46 50.96 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.045 -0.525 . . . . 64.409999999999997 110.679 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.464 0.268 0 O-C-N 123.534 0.521 . . . . 65.530000000000001 110.802 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 CA-C-O 119.185 -0.786 . . . . 43.119999999999997 112.47 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.86 134.69 16.7 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 123.069 2.513 . . . . 72.120000000000005 112.741 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.9 m -129.79 -42.26 1.28 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.881 -0.599 . . . . 74.209999999999994 111.267 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 21.5 mmt -117.83 154.22 32.17 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.398 0.436 . . . . 73.209999999999994 111.05 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -90.79 -26.07 23.35 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.844 -0.616 . . . . 60.009999999999998 113.002 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.2 p -131.27 118.8 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.72 0.295 . . . . 71.540000000000006 110.471 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.73 121.18 40.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.816 -0.629 . . . . 73.140000000000001 110.656 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 15.7 t -109.72 125.5 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.022 -0.536 . . . . 62.43 110.179 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.21 125.14 53.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.578 -0.737 . . . . 74.439999999999998 110.066 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -79.33 127.68 32.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.946 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.467 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -108.93 -42.14 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.166 -0.924 . . . . 72.430000000000007 110.294 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -129.3 118.89 19.33 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.919 -0.582 . . . . 74.319999999999993 110.38 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.2 129.45 16.11 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.637 2.225 . . . . 61.420000000000002 113.406 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.98 -120.9 4.22 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.702 -0.681 . . . . 44.329999999999998 112.141 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.86 -46.22 12.39 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.678 0.239 . . . . 61.450000000000003 110.91 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.64 -1.43 88.2 Favored Glycine 0 C--N 1.342 0.87 0 O-C-N 123.561 0.538 . . . . 63.509999999999998 113.699 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -136.64 1.02 2.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.482 0.313 . . . . 75.239999999999995 111.799 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.99 92.45 3.73 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.055 0.455 . . . . 71.400000000000006 110.27 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -103.51 149.39 36.99 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.558 -0.746 . . . . 72.109999999999999 110.938 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.39 123.49 11.22 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.474 2.116 . . . . 64.230000000000004 112.851 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.39 -0.823 . . . . 72.299999999999997 111.467 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -77.31 124.86 28.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.502 -0.772 . . . . 75.420000000000002 111.328 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.6 -26.86 9.22 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.756 -0.657 . . . . 64.120000000000005 113.158 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -98.9 160.16 14.45 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.425 0.29 . . . . 72.140000000000001 110.904 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.541 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -83.58 145.09 29.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 111.318 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 37.6 t -120.65 116.19 24.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.437 -0.802 . . . . 70.120000000000005 110.39 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.64 110.42 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.577 -0.738 . . . . 63.039999999999999 109.557 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.1 m -146.86 152.06 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.086 -0.506 . . . . 42.420000000000002 111.585 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.7 m80 -102.51 125.34 49.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.27 -0.877 . . . . 75.310000000000002 109.004 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' VAL . 42.8 p90 -115.65 166.1 12.3 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.814 0.672 . . . . 74.340000000000003 112.814 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 3.2 m -148.83 112.18 4.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.838 -1.074 . . . . 54.439999999999998 109.328 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -96.23 120.18 6.53 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.131 -0.557 . . . . 74.5 112.813 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 mtm -129.8 131.3 46.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.963 0.505 . . . . 72.230000000000004 111.123 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.62 170.9 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.696 -0.684 . . . . 42.340000000000003 112.002 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.51 -26.12 53.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.082 0.553 . . . . 72.0 112.049 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.38 -17.4 28.89 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.762 -0.654 . . . . 53.299999999999997 111.76 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.52 13.79 21.56 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 120.828 -0.701 . . . . 51.420000000000002 113.394 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.411 0 N-CA-C 109.775 -0.454 . . . . 63.25 109.775 179.575 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.452 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 75.25 112.938 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 26.8 p90 -134.09 -9.36 2.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.369 -1.287 . . . . 74.109999999999999 111.393 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -166.55 111.59 0.79 Allowed 'General case' 0 C--N 1.355 0.846 0 CA-C-O 121.203 0.525 . . . . 71.540000000000006 111.621 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 4.2 p -116.94 118.22 31.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.893 -1.048 . . . . 72.049999999999997 111.012 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.527 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 21.1 t -78.82 -34.68 45.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.953 -0.567 . . . . 71.120000000000005 112.06 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.45 -23.25 46.63 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.973 0.731 . . . . 54.32 112.973 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.89 -24.91 67.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.771 0.319 . . . . 64.340000000000003 111.236 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -92.86 0.07 57.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.395 -0.82 . . . . 71.299999999999997 109.7 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 63.29 36.11 11.98 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 72.439999999999998 111.568 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.237 0.458 . . . . 74.109999999999999 112.237 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.85 158.01 43.02 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.956 2.437 . . . . 72.540000000000006 112.708 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -100.07 118.53 36.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.974 -0.557 . . . . 73.329999999999998 112.074 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.506 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 115.225 -0.898 . . . . 74.450000000000003 110.029 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.3 p90 -151.58 161.82 42.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.358 0.411 . . . . 73.329999999999998 111.571 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.541 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.7 mpp? -105.67 135.18 47.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.415 -0.357 . . . . 71.140000000000001 110.48 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -78.31 140.18 38.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.838 -0.619 . . . . 74.219999999999999 111.648 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -8.57 61.95 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.442 -0.799 . . . . 71.310000000000002 113.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.849 0.357 . . . . 72.219999999999999 110.733 179.276 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 70.04 27.4 4.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 64.219999999999999 112.145 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.18 -14.58 60.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.021 -0.536 . . . . 75.25 110.82 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -126.72 -178.34 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.246 -0.888 . . . . 74.450000000000003 110.453 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.15 158.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.06 0.392 . . . . 53.420000000000002 112.06 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -59.37 -44.05 92.78 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.987 -0.551 . . . . 73.409999999999997 111.775 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.687 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.67 -20.58 61.88 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 113.461 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.13 -43.55 14.9 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 116.684 0.242 . . . . 64.239999999999995 111.107 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.7 mt-10 -66.16 -37.6 86.06 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.344 0.403 . . . . 71.319999999999993 111.566 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.51 -25.57 28.72 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.966 -0.561 . . . . 73.219999999999999 111.734 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.57 -46.34 4.94 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.477 0.486 . . . . 71.540000000000006 113.903 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.6 -25.09 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 122.768 0.427 . . . . 73.299999999999997 111.738 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 -8.64 57.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.355 -0.839 . . . . 33.409999999999997 111.651 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.75 -11.39 36.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.713 -0.676 . . . . 54.100000000000001 111.255 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.44 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.19 155.97 19.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.283 -0.417 . . . . 71.25 110.949 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 23.2 p -110.88 167.02 10.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.807 -0.633 . . . . 51.25 110.598 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.652 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.1 t -56.18 123.2 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.927 0.491 . . . . 53.100000000000001 111.231 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.55 4.68 70.12 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.421 -0.809 . . . . 71.340000000000003 113.137 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.2 142.01 28.88 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 120.943 0.401 . . . . 75.439999999999998 111.305 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -119.84 107.95 13.78 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.039 -0.982 . . . . 73.140000000000001 109.36 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.45 154.34 48.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.968 -0.56 . . . . 61.039999999999999 111.837 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.309 0 CA-C-N 116.04 -0.527 . . . . 72.400000000000006 110.248 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.824 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.31 126.05 54.49 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.444 0.465 . . . . 74.519999999999996 111.079 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.6 m -93.68 113.63 25.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.439 -0.801 . . . . 53.119999999999997 109.585 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.687 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.0 mm -106.16 143.47 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.874 -0.603 . . . . 75.109999999999999 110.433 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.17 161.88 21.46 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 114.871 -1.059 . . . . 74.230000000000004 110.814 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.94 -17.19 49.78 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.789 2.326 . . . . 62.43 113.243 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.94 -25.56 26.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.394 0.433 . . . . 74.510000000000005 111.288 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -101.86 -18.97 15.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.047 -0.524 . . . . 73.030000000000001 111.469 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 -61.82 1.7 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.696 0.628 . . . . 54.109999999999999 112.696 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -134.96 -52.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.586 0.217 . . . . 74.540000000000006 111.586 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.1 -140.34 7.81 Favored Glycine 0 C--N 1.337 0.617 0 O-C-N 123.516 0.51 . . . . 71.340000000000003 112.037 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.37 -11.13 26.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.603 0.223 . . . . 51.549999999999997 111.603 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.12 -60.43 1.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.236 -0.438 . . . . 63.549999999999997 110.516 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.14 -166.36 54.58 Favored Glycine 0 C--N 1.345 1.069 0 O-C-N 123.343 0.402 . . . . 73.040000000000006 113.16 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.82 124.43 48.04 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.918 -0.401 . . . . 71.030000000000001 109.918 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.52 124.17 10.91 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.278 1.986 . . . . 52.530000000000001 113.614 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.52 -47.92 1.0 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.575 -0.738 . . . . 63.229999999999997 113.364 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.65 -51.77 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.574 0.212 . . . . 73.329999999999998 111.574 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.1 mm -109.88 97.96 31.64 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 123.248 0.342 . . . . 74.319999999999993 111.055 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.65 165.67 31.81 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.451 2.101 . . . . 65.319999999999993 112.733 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.97 143.2 28.86 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.52 2.147 . . . . 73.209999999999994 113.259 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.8 42.56 26.46 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.613 0.765 . . . . 70.340000000000003 111.821 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.07 132.43 54.1 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.692 -0.686 . . . . 71.420000000000002 111.722 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -81.83 140.77 33.97 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.741 -1.118 . . . . 74.25 110.847 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.5 mt -119.09 153.77 34.26 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.657 -0.701 . . . . 71.519999999999996 111.076 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.89 130.35 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.842 -0.617 . . . . 72.319999999999993 109.595 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.2 m-85 -131.33 133.41 45.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 110.557 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -116.47 102.51 9.56 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 123.542 0.526 . . . . 62.020000000000003 110.119 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 74' ' ' LEU . 26.4 m -104.34 153.75 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.884 -0.598 . . . . 60.420000000000002 111.101 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.16 125.44 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 72.230000000000004 110.413 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.15 101.93 3.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.855 -0.611 . . . . 64.0 110.203 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.88 -58.97 2.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 111.376 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 122.769 0.428 . . . . 74.319999999999993 110.792 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.2 mt -125.48 146.64 49.55 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.128 -0.487 . . . . 64.409999999999997 110.707 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.025 -0.534 . . . . 65.530000000000001 110.759 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 CA-C-O 119.186 -0.785 . . . . 43.119999999999997 112.453 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.85 151.37 35.73 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.041 2.494 . . . . 72.120000000000005 112.739 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.7 t -99.87 -43.33 6.45 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 115.882 -0.599 . . . . 74.209999999999994 111.038 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.4 mtt -100.4 144.45 29.38 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.452 0.47 . . . . 73.209999999999994 110.826 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -118.09 27.76 7.25 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.943 -0.571 . . . . 60.009999999999998 113.136 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.5 p -131.3 113.88 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.827 0.346 . . . . 71.540000000000006 110.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -114.19 116.97 29.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.638 -0.71 . . . . 73.140000000000001 110.701 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 13.8 p -107.22 134.77 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.984 -0.553 . . . . 62.43 110.936 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.45 124.44 44.47 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.462 -0.79 . . . . 74.439999999999998 110.266 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -78.12 126.28 30.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.463 0.477 . . . . 74.150000000000006 110.815 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.3 mt -109.29 -39.18 3.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.132 -0.94 . . . . 72.430000000000007 110.404 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -132.73 119.0 15.82 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 74.319999999999993 110.49 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 129.84 16.23 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.573 2.182 . . . . 61.420000000000002 113.327 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.25 -121.25 4.34 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.776 -0.647 . . . . 44.329999999999998 112.221 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.19 -46.29 12.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.702 0.251 . . . . 61.450000000000003 110.977 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.77 -1.5 88.04 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.545 0.528 . . . . 63.509999999999998 113.695 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -136.61 1.08 2.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.745 0.276 . . . . 75.239999999999995 111.745 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.9 92.54 3.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.034 0.445 . . . . 71.400000000000006 110.353 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -103.53 149.71 37.33 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.564 -0.744 . . . . 72.109999999999999 110.986 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.73 123.29 10.85 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.488 2.125 . . . . 64.230000000000004 112.677 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.461 0 CA-C-N 115.435 -0.802 . . . . 72.299999999999997 111.573 -179.344 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 44.9 ttt180 -77.42 122.92 25.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.555 -0.748 . . . . 75.420000000000002 111.162 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.58 -29.21 6.75 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.814 -0.63 . . . . 64.120000000000005 113.225 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.29 160.31 14.41 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.45 0.3 . . . . 72.140000000000001 110.985 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.61 145.3 29.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.095 -0.502 . . . . 73.129999999999995 111.42 -179.518 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 35.2 t -120.81 117.19 26.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.625 -0.716 . . . . 70.120000000000005 110.693 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.62 110.75 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.562 -0.745 . . . . 63.039999999999999 109.472 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 103' ' ' LEU . 24.7 m -146.89 152.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.949 -0.569 . . . . 42.420000000000002 111.456 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.6 m-70 -103.12 125.17 49.71 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.532 -0.758 . . . . 75.310000000000002 109.437 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.619 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.5 p90 -115.45 166.82 11.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.284 0.476 . . . . 74.340000000000003 112.284 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.508 HG21 HH21 ' A' ' 40' ' ' ARG . 0.8 OUTLIER -147.72 106.12 3.78 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.173 -0.921 . . . . 54.439999999999998 109.454 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.73 116.46 4.88 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.05 -0.523 . . . . 74.5 112.707 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.7 mtm -131.89 134.41 45.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.043 0.537 . . . . 72.230000000000004 110.833 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mt -56.38 172.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 42.340000000000003 112.462 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.89 -27.02 50.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.125 0.57 . . . . 72.0 111.893 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.36 -17.47 30.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.685 -0.688 . . . . 53.299999999999997 111.487 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.11 13.84 22.19 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.726 -0.75 . . . . 51.420000000000002 113.373 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.447 0 CA-C-O 120.696 0.284 . . . . 63.25 110.405 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 N-CA-C 112.934 0.716 . . . . 75.25 112.934 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.2 p90 -131.59 -16.05 3.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.619 -1.173 . . . . 74.109999999999999 111.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.8 110.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.025 0.441 . . . . 71.540000000000006 111.977 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.566 ' HB3' ' OD1' ' A' ' 41' ' ' ASP . 43.5 t -123.24 143.38 50.08 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.42 -0.809 . . . . 72.049999999999997 109.901 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 64.3 p -78.82 -24.63 44.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.815 0.672 . . . . 71.120000000000005 112.815 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.508 HH21 HG21 ' A' ' 27' ' ' THR . 6.0 ptt180 -82.93 -26.26 31.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.363 0.505 . . . . 54.32 112.363 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 38' ' ' SER . 14.8 p30 -70.04 -18.09 63.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.102 0.477 . . . . 64.340000000000003 110.709 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.442 ' HG2' ' OD2' ' A' ' 41' ' ' ASP . 19.8 mmt180 -97.23 -6.48 34.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.863 -1.062 . . . . 71.299999999999997 109.532 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 66.73 40.9 3.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.488 1.115 . . . . 72.439999999999998 111.81 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 116.309 -0.405 . . . . 74.109999999999999 111.836 -179.754 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.36 157.87 55.68 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.693 2.262 . . . . 72.540000000000006 112.807 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -103.29 118.2 36.24 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.86 -0.609 . . . . 73.329999999999998 112.115 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.466 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 115.097 -0.956 . . . . 74.450000000000003 109.788 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 39.6 p90 -149.6 162.7 39.67 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.284 0.365 . . . . 73.329999999999998 111.422 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 mtt -106.65 133.27 51.59 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.118 -0.492 . . . . 71.140000000000001 110.795 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.38 141.31 37.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.925 -0.58 . . . . 74.219999999999999 111.649 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.447 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.31 -11.72 48.81 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.52 -0.764 . . . . 71.310000000000002 113.481 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.775 0.321 . . . . 72.219999999999999 110.609 179.309 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 68.18 30.11 5.87 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.11 0.964 . . . . 64.219999999999999 112.102 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.02 -31.15 56.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.918 -0.583 . . . . 75.25 110.62 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -106.2 -174.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.325 -0.852 . . . . 74.450000000000003 110.247 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -81.51 158.47 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 111.774 0.287 . . . . 53.420000000000002 111.774 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -59.46 -43.82 93.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.058 -0.519 . . . . 73.409999999999997 111.913 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.654 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.62 -20.48 61.65 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 123.54 0.525 . . . . 75.120000000000005 113.321 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -84.21 -44.29 14.08 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 122.255 0.222 . . . . 64.239999999999995 111.147 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.58 -36.64 83.13 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.256 0.348 . . . . 71.319999999999993 111.571 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.53 -26.29 28.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.934 -0.575 . . . . 73.219999999999999 111.855 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.31 -46.52 4.66 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.454 0.472 . . . . 71.540000000000006 113.872 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 1.9 p -63.66 -25.66 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.754 0.421 . . . . 73.299999999999997 111.734 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.74 -7.18 53.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.395 -0.82 . . . . 33.409999999999997 111.669 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -93.86 -8.77 39.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.792 -0.64 . . . . 54.100000000000001 111.297 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.445 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.16 156.49 19.26 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.374 -0.376 . . . . 71.25 110.873 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.5 p -110.99 166.52 10.98 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.946 -0.57 . . . . 51.25 110.626 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.645 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.6 t -55.63 122.64 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.042 0.537 . . . . 53.100000000000001 111.216 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.71 2.78 69.33 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.47 -0.786 . . . . 71.340000000000003 113.236 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -94.16 142.12 27.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.947 0.403 . . . . 75.439999999999998 111.315 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.401 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -120.94 109.11 14.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.094 -0.957 . . . . 73.140000000000001 109.416 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.86 156.76 45.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.013 -0.539 . . . . 61.039999999999999 111.882 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.303 0 CA-C-N 116.063 -0.517 . . . . 72.400000000000006 110.426 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.98 127.7 53.33 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 74.519999999999996 110.858 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m -95.32 112.64 24.32 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.675 -0.693 . . . . 53.119999999999997 109.393 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.5 mm -104.46 140.83 21.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.903 -0.59 . . . . 75.109999999999999 110.519 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.16 162.09 21.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.84 -1.073 . . . . 74.230000000000004 110.671 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.77 -14.43 40.45 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.577 2.185 . . . . 62.43 113.231 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -28.96 22.9 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.4 . . . . 74.510000000000005 110.797 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -98.99 -19.37 17.32 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.753 -0.658 . . . . 73.030000000000001 111.594 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.78 -63.17 1.4 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.848 0.684 . . . . 54.109999999999999 112.848 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -134.43 -50.85 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.691 0.256 . . . . 74.540000000000006 111.691 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.88 -143.66 11.21 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 123.494 0.496 . . . . 71.340000000000003 111.957 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.43 -10.03 33.73 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 111.612 0.227 . . . . 51.549999999999997 111.612 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.02 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.201 -0.454 . . . . 63.549999999999997 110.388 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.27 -167.24 53.31 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.326 0.391 . . . . 73.040000000000006 113.187 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.452 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -97.6 124.49 48.29 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 109.876 -0.416 . . . . 71.030000000000001 109.876 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.8 123.64 10.29 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.195 1.93 . . . . 52.530000000000001 113.628 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.94 -46.86 1.11 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.601 -0.727 . . . . 63.229999999999997 113.436 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.4 -51.74 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 111.577 0.214 . . . . 73.329999999999998 111.577 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.2 mm -109.88 98.38 33.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 123.224 0.327 . . . . 74.319999999999993 111.068 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.3 165.66 31.75 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.439 2.093 . . . . 65.319999999999993 112.76 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.92 143.14 28.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.521 2.148 . . . . 73.209999999999994 113.157 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.57 43.87 24.95 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.644 0.778 . . . . 70.340000000000003 111.738 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.09 132.69 53.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.663 -0.699 . . . . 71.420000000000002 111.795 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 m -83.29 140.3 32.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.771 -1.104 . . . . 74.25 110.839 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.2 mt -117.94 154.31 32.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.635 -0.712 . . . . 71.519999999999996 111.026 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.3 t -121.68 127.84 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.829 -0.623 . . . . 72.319999999999993 109.684 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' O ' HD12 ' A' ' 74' ' ' LEU . 91.0 m-85 -129.94 132.87 46.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.06 -0.518 . . . . 71.299999999999997 110.709 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.9 t70 -115.02 103.71 11.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.067 -0.515 . . . . 62.020000000000003 110.273 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.814 HG22 HD11 ' A' ' 74' ' ' LEU . 25.7 m -104.64 152.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 60.420000000000002 111.02 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.83 125.99 35.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 72.230000000000004 110.384 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.65 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -73.03 101.98 3.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.825 -0.625 . . . . 64.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.35 -58.1 2.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.046 -0.524 . . . . 73.510000000000005 111.469 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 122.819 0.448 . . . . 74.319999999999993 110.728 -179.842 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.5 mt -122.21 145.83 47.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.098 -0.501 . . . . 64.409999999999997 110.792 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.466 0.327 0 O-C-N 123.506 0.504 . . . . 65.530000000000001 110.825 179.878 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 119.012 -0.882 . . . . 43.119999999999997 112.66 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.18 141.99 26.78 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.869 2.38 . . . . 72.120000000000005 112.725 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.7 m -108.53 -39.9 5.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.867 -0.606 . . . . 74.209999999999994 111.346 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -96.85 151.22 19.88 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.407 0.442 . . . . 73.209999999999994 111.115 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -94.64 -15.86 44.78 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.809 -0.632 . . . . 60.009999999999998 113.334 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 76' ' ' ILE . 13.5 p -117.65 123.38 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.381 0.272 . . . . 71.540000000000006 110.593 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -121.78 121.11 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.902 -0.59 . . . . 73.140000000000001 110.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.0 t -108.9 130.14 62.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.101 -0.5 . . . . 62.43 110.079 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -119.23 123.48 44.4 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.617 -0.72 . . . . 74.439999999999998 110.161 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -77.93 126.29 30.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.245 -0.434 . . . . 74.150000000000006 110.934 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.405 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.7 mt -108.64 -41.1 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 110.229 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -130.17 118.86 18.48 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.948 -0.569 . . . . 74.319999999999993 110.341 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 129.17 15.52 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.602 2.201 . . . . 61.420000000000002 113.433 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.79 -120.89 4.18 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.744 -0.662 . . . . 44.329999999999998 112.033 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.69 -45.89 12.91 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.676 0.238 . . . . 61.450000000000003 110.865 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 84.94 -1.4 88.89 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.028 -0.533 . . . . 63.509999999999998 113.705 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -136.71 1.06 2.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.493 0.317 . . . . 75.239999999999995 111.853 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.96 92.84 3.82 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.097 0.475 . . . . 71.400000000000006 110.281 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -103.13 149.69 37.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.521 -0.763 . . . . 72.109999999999999 110.898 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.1 126.44 15.8 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.517 2.145 . . . . 64.230000000000004 112.95 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 115.433 -0.803 . . . . 72.299999999999997 111.551 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 41.9 ttt180 -77.54 121.14 23.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.376 -0.829 . . . . 75.420000000000002 111.428 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.46 -24.2 9.27 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.014 -0.539 . . . . 64.120000000000005 113.48 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.2 160.33 14.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.356 0.262 . . . . 72.140000000000001 110.977 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.63 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -80.43 145.1 32.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 111.219 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.9 m -124.19 116.59 22.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.645 -0.707 . . . . 70.120000000000005 110.475 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -89.97 111.08 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.497 -0.774 . . . . 63.039999999999999 109.76 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 103' ' ' LEU . 30.9 m -145.81 151.42 14.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.898 -0.592 . . . . 42.420000000000002 111.36 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.4 m-70 -102.68 125.32 49.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.653 -0.703 . . . . 75.310000000000002 109.389 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.3 p90 -115.71 166.35 12.03 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.51 0.559 . . . . 74.340000000000003 112.51 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.22 107.06 3.82 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.091 -0.958 . . . . 54.439999999999998 109.375 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.12 119.43 5.79 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 116.038 -0.528 . . . . 74.5 112.739 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.5 mtm -134.38 132.21 39.17 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.989 0.516 . . . . 72.230000000000004 110.827 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mt -54.74 171.41 0.13 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.594 -0.73 . . . . 42.340000000000003 112.464 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -55.27 -27.65 48.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.18 0.592 . . . . 72.0 112.114 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.32 -17.26 29.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.663 -0.698 . . . . 53.299999999999997 111.709 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.65 13.76 21.38 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 120.828 -0.701 . . . . 51.420000000000002 113.167 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.457 0 N-CA-C 110.219 -0.289 . . . . 63.25 110.219 179.721 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.912 0.708 . . . . 75.25 112.912 -179.738 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 26.6 p90 -133.13 -15.24 2.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.532 -1.213 . . . . 74.109999999999999 111.364 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.16 111.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.121 0.486 . . . . 71.540000000000006 112.184 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 29.3 t -122.58 142.6 50.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.275 -0.875 . . . . 72.049999999999997 109.971 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.519 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 54.6 p -78.55 -36.68 44.29 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.593 0.59 . . . . 71.120000000000005 112.593 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.17 -23.08 61.98 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.543 0.571 . . . . 54.32 112.543 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -30.47 71.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.882 0.372 . . . . 64.340000000000003 110.817 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 44' ' ' MLY . 49.0 mtm180 -95.43 -1.84 50.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.262 -0.881 . . . . 71.299999999999997 110.183 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 66.18 37.62 4.98 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.297 1.039 . . . . 72.439999999999998 111.897 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MLY . . . . . 0.444 ' HD3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 111.52 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.78 157.97 51.05 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.974 2.45 . . . . 72.540000000000006 112.847 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -102.22 118.26 36.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.883 -0.598 . . . . 73.329999999999998 112.13 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 115.139 -0.937 . . . . 74.450000000000003 110.092 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.0 p90 -151.97 165.17 35.45 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.349 0.405 . . . . 73.329999999999998 111.627 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.63 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -107.81 135.95 48.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.182 -0.463 . . . . 71.140000000000001 110.61 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.9 mm? -80.62 140.93 35.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.882 -0.599 . . . . 74.219999999999999 111.506 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.474 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 83.32 -9.42 61.32 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.562 -0.745 . . . . 71.310000000000002 113.295 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.72 179.408 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 68.55 28.25 5.93 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.076 0.95 . . . . 64.219999999999999 112.102 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -75.25 -33.32 61.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.006 -0.543 . . . . 75.25 110.543 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 m -103.4 -174.63 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 115.21 -0.905 . . . . 74.450000000000003 110.11 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 pt -81.1 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 111.706 0.262 . . . . 53.420000000000002 111.706 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.85 -43.79 90.87 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 73.409999999999997 111.852 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.689 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.09 -20.26 62.45 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.53 0.519 . . . . 75.120000000000005 113.406 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -84.11 -43.76 14.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 116.65 0.225 . . . . 64.239999999999995 111.1 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.3 mt-10 -66.27 -37.47 85.54 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.304 0.378 . . . . 71.319999999999993 111.6 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.5 -25.44 28.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.872 -0.604 . . . . 73.219999999999999 111.765 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.17 -46.39 4.74 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.413 0.446 . . . . 71.540000000000006 113.871 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.33 -25.44 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.829 0.452 . . . . 73.299999999999997 111.728 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.74 -8.97 58.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.33 -0.85 . . . . 33.409999999999997 111.699 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -91.61 -7.8 49.08 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.811 -0.631 . . . . 54.100000000000001 111.189 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -110.0 156.6 20.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.321 -0.4 . . . . 71.25 111.066 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.1 p -111.06 167.19 10.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.816 -0.629 . . . . 51.25 110.529 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.641 ' HA ' HD12 ' A' ' 103' ' ' LEU . 66.8 t -56.05 123.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.035 0.534 . . . . 53.100000000000001 111.261 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.05 4.32 72.02 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.532 -0.758 . . . . 71.340000000000003 113.244 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -95.54 141.42 29.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.909 0.385 . . . . 75.439999999999998 111.296 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -119.48 109.07 15.31 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.138 -0.937 . . . . 73.140000000000001 109.399 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.58 156.97 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.959 -0.564 . . . . 61.039999999999999 111.883 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.467 ' HG2' ' OD2' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.235 0.325 0 CA-C-N 116.026 -0.534 . . . . 72.400000000000006 110.317 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.806 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.91 124.82 52.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.272 -0.422 . . . . 74.519999999999996 111.231 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m -93.6 112.84 24.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.325 -0.852 . . . . 53.119999999999997 109.417 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.689 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.7 mm -104.29 142.18 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.864 -0.607 . . . . 75.109999999999999 110.557 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.7 161.83 21.81 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.774 -1.103 . . . . 74.230000000000004 110.772 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.61 -14.5 40.24 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.699 2.266 . . . . 62.43 113.303 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.59 -28.07 23.51 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.347 0.404 . . . . 74.510000000000005 110.846 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -99.89 -19.7 16.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.641 -0.708 . . . . 73.030000000000001 111.543 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.48 -62.93 1.45 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.794 0.664 . . . . 54.109999999999999 112.794 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -134.5 -50.84 0.8 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 111.589 0.218 . . . . 74.540000000000006 111.589 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.82 -142.8 10.23 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.181 -0.463 . . . . 71.340000000000003 112.013 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.98 -10.81 29.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 111.59 0.218 . . . . 51.549999999999997 111.59 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.53 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.231 -0.44 . . . . 63.549999999999997 110.373 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.55 -165.96 53.26 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.337 0.398 . . . . 73.040000000000006 113.255 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.48 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -97.5 125.72 44.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.853 -0.425 . . . . 71.030000000000001 109.853 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.16 123.95 10.45 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.29 1.993 . . . . 52.530000000000001 113.617 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.76 -45.42 1.31 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.601 -0.727 . . . . 63.229999999999997 113.466 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -99.75 -52.25 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.625 0.212 . . . . 73.329999999999998 111.516 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.48 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.1 mm -109.98 98.69 35.62 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 123.22 0.325 . . . . 74.319999999999993 111.037 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.42 165.78 31.39 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.469 2.113 . . . . 65.319999999999993 112.711 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.65 141.96 28.44 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.483 2.122 . . . . 73.209999999999994 113.17 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 56.8 46.44 19.89 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.639 0.775 . . . . 70.340000000000003 111.628 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.88 134.06 51.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.64 -0.709 . . . . 71.420000000000002 111.836 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -84.31 140.8 31.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.702 -1.135 . . . . 74.25 110.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.464 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -118.62 154.22 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.66 -0.7 . . . . 71.519999999999996 111.042 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.6 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.901 -0.591 . . . . 72.319999999999993 109.652 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.0 m-85 -133.14 132.36 41.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.135 -0.484 . . . . 71.299999999999997 110.77 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 t70 -115.98 104.19 11.35 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.075 -0.512 . . . . 62.020000000000003 110.161 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.806 HG22 HD11 ' A' ' 74' ' ' LEU . 28.2 m -105.9 153.63 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.034 -0.53 . . . . 60.420000000000002 111.143 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.15 126.1 34.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.486 -0.779 . . . . 72.230000000000004 110.397 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.643 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -73.15 101.84 3.43 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.718 -0.674 . . . . 64.0 110.465 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.8 mt -89.53 -58.33 2.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.35 -0.386 . . . . 73.510000000000005 111.567 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 122.73 0.412 . . . . 74.319999999999993 110.986 179.891 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.7 mt -118.51 143.18 46.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.345 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.465 0.301 0 O-C-N 123.421 0.45 . . . . 65.530000000000001 110.822 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 CA-C-O 119.374 -0.681 . . . . 43.119999999999997 112.661 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 135.49 18.32 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.051 2.501 . . . . 72.120000000000005 112.799 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.8 t 61.74 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.947 0.899 . . . . 74.209999999999994 111.966 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 64.9 mtt -132.1 144.2 50.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.791 -0.641 . . . . 73.209999999999994 110.905 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -121.04 27.96 6.25 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.627 0.579 . . . . 60.009999999999998 112.98 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.6 p -138.21 119.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.697 0.284 . . . . 71.540000000000006 110.553 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -118.64 119.82 35.61 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.81 -0.632 . . . . 73.140000000000001 110.599 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 16.6 t -108.03 126.66 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.006 -0.543 . . . . 62.43 110.076 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -115.6 123.65 48.96 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.649 -0.705 . . . . 74.439999999999998 110.227 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -78.0 125.85 29.96 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.166 -0.47 . . . . 74.150000000000006 110.947 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.26 -40.69 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.047 -0.979 . . . . 72.430000000000007 110.253 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -130.56 118.98 18.14 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.568 0.543 . . . . 74.319999999999993 110.35 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 129.6 16.1 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.571 2.181 . . . . 61.420000000000002 113.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.47 -120.92 4.33 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.658 -0.701 . . . . 44.329999999999998 112.099 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.84 -46.19 12.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.639 0.219 . . . . 61.450000000000003 110.947 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.24 -1.35 88.66 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.07 -0.514 . . . . 63.509999999999998 113.695 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -136.58 1.06 2.55 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.409 0.283 . . . . 75.239999999999995 111.721 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.99 92.25 3.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.06 0.457 . . . . 71.400000000000006 110.345 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -103.34 149.57 37.12 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.601 -0.727 . . . . 72.109999999999999 111.013 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.49 124.08 11.98 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.502 2.135 . . . . 64.230000000000004 112.74 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 115.391 -0.822 . . . . 72.299999999999997 111.45 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -77.26 125.79 29.89 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.645 -0.707 . . . . 75.420000000000002 111.16 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.81 -26.75 9.19 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.609 -0.723 . . . . 64.120000000000005 112.956 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 17' ' ' MLY . 0.0 OUTLIER -99.48 160.12 14.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.46 0.304 . . . . 72.140000000000001 110.715 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.62 145.23 28.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.14 -0.482 . . . . 73.129999999999995 111.366 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.9 t -119.87 116.94 26.85 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.615 -0.72 . . . . 70.120000000000005 110.597 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -91.7 110.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.398 -0.819 . . . . 63.039999999999999 109.588 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 103' ' ' LEU . 28.4 m -147.39 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.064 -0.516 . . . . 42.420000000000002 111.487 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 11.9 m-70 -102.37 125.34 49.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.365 -0.834 . . . . 75.310000000000002 109.031 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.3 p90 -116.23 167.04 11.36 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.944 0.72 . . . . 74.340000000000003 112.944 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.7 m -148.79 112.46 5.07 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 114.81 -1.086 . . . . 54.439999999999998 109.464 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -96.67 119.79 6.45 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 116.025 -0.534 . . . . 74.5 112.757 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.0 mtm -129.59 131.49 46.53 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.912 0.485 . . . . 72.230000000000004 111.129 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.23 170.41 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 42.340000000000003 111.963 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.32 -25.95 50.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.008 0.523 . . . . 72.0 112.076 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.35 -17.39 28.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.777 -0.647 . . . . 53.299999999999997 111.726 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.14 13.77 22.31 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 120.852 -0.689 . . . . 51.420000000000002 113.362 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.411 0 N-CA-C 109.745 -0.465 . . . . 63.25 109.745 179.569 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.449 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 112.92 0.711 . . . . 75.25 112.92 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.1 p90 -133.34 -14.38 2.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.186 -1.37 . . . . 74.109999999999999 111.345 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -161.55 111.63 1.63 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.047 0.451 . . . . 71.540000000000006 111.987 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 4.0 p -116.98 119.26 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.377 -0.829 . . . . 72.049999999999997 111.176 178.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.535 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 19.2 t -78.8 -35.37 44.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.154 -0.475 . . . . 71.120000000000005 112.185 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -23.13 44.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.082 0.771 . . . . 54.32 113.082 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.805 0.336 . . . . 64.340000000000003 111.124 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -92.7 -0.15 57.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.417 -0.81 . . . . 71.299999999999997 109.622 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 63.7 36.43 10.72 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.294 1.038 . . . . 72.439999999999998 111.696 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 112.156 0.428 . . . . 74.109999999999999 112.156 -179.51 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 157.97 47.36 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.924 2.416 . . . . 72.540000000000006 112.688 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -100.64 118.03 35.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.943 -0.571 . . . . 73.329999999999998 112.06 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.494 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.156 -0.929 . . . . 74.450000000000003 110.078 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.493 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 37.7 p90 -148.64 161.93 40.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.334 0.396 . . . . 73.329999999999998 111.406 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' HE2' ' A' ' 52' ' ' MLY . 29.6 ttm -106.77 130.64 54.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.136 -0.484 . . . . 71.140000000000001 110.159 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -76.38 141.46 41.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.936 -0.575 . . . . 74.219999999999999 111.926 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.66 -9.43 55.76 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.492 -0.776 . . . . 71.310000000000002 113.536 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MLY . . . . . 0.485 ' HE2' ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.388 0.275 . . . . 72.219999999999999 110.662 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 69.01 28.29 5.15 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.034 0.934 . . . . 64.219999999999999 112.296 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.4 -22.7 57.25 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.588 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.81 -175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.108 -0.951 . . . . 74.450000000000003 110.38 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -80.42 158.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.915 0.339 . . . . 53.420000000000002 111.915 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -59.24 -43.91 92.37 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.006 -0.543 . . . . 73.409999999999997 111.819 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.69 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.62 -20.75 61.98 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.547 0.53 . . . . 75.120000000000005 113.442 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.15 -43.77 14.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 122.287 0.235 . . . . 64.239999999999995 111.306 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.1 mt-10 -66.35 -37.37 85.17 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.345 0.403 . . . . 71.319999999999993 111.632 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.43 -25.99 28.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.976 -0.556 . . . . 73.219999999999999 111.743 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.7 -46.45 4.86 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.459 0.475 . . . . 71.540000000000006 113.94 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.3 p -63.59 -24.74 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.791 0.436 . . . . 73.299999999999997 111.769 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 -8.09 56.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.437 -0.801 . . . . 33.409999999999997 111.625 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.45 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.09 -10.83 37.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.799 -0.637 . . . . 54.100000000000001 111.306 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.453 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.85 156.24 18.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.315 -0.402 . . . . 71.25 111.034 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 24.0 p -110.88 166.87 10.68 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.801 -0.636 . . . . 51.25 110.556 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 103' ' ' LEU . 52.9 t -56.08 123.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.901 0.48 . . . . 53.100000000000001 111.323 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.12 4.98 70.98 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.47 -0.787 . . . . 71.340000000000003 113.232 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -96.37 141.57 29.53 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.909 0.385 . . . . 75.439999999999998 111.249 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.4 108.85 15.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.08 -0.964 . . . . 73.140000000000001 109.385 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.09 156.91 44.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.012 -0.54 . . . . 61.039999999999999 111.842 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.289 0 CA-C-N 116.026 -0.534 . . . . 72.400000000000006 110.286 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.801 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -109.89 127.06 54.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.109 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.3 m -94.62 113.82 25.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.391 -0.822 . . . . 53.119999999999997 109.598 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.9 mm -106.4 143.36 17.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.856 -0.611 . . . . 75.109999999999999 110.398 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.06 162.13 20.68 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 114.893 -1.049 . . . . 74.230000000000004 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 -17.03 48.62 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.725 2.283 . . . . 62.43 113.254 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -25.7 25.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.27 -0.423 . . . . 74.510000000000005 111.3 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.89 -18.76 15.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.076 -0.511 . . . . 73.030000000000001 111.391 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.67 -62.0 1.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.626 0.602 . . . . 54.109999999999999 112.626 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -134.94 -51.99 0.78 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.622 0.23 . . . . 74.540000000000006 111.622 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.51 -140.34 7.89 Favored Glycine 0 C--N 1.336 0.559 0 O-C-N 123.478 0.486 . . . . 71.340000000000003 112.089 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.55 -11.06 25.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.58 0.215 . . . . 51.549999999999997 111.58 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -100.06 -60.36 1.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.353 0.408 . . . . 63.549999999999997 110.511 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.75 54.2 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.322 0.389 . . . . 73.040000000000006 113.166 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.457 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -98.42 124.39 46.91 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.902 -0.407 . . . . 71.030000000000001 109.902 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.57 123.85 10.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.235 1.957 . . . . 52.530000000000001 113.627 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.81 -47.95 1.0 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.579 -0.737 . . . . 63.229999999999997 113.408 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.42 -51.98 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.584 0.192 . . . . 73.329999999999998 111.507 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.5 mm -109.71 97.87 30.43 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 123.209 0.318 . . . . 74.319999999999993 111.056 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.59 165.6 32.01 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.413 2.075 . . . . 65.319999999999993 112.765 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 143.09 29.42 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.553 2.168 . . . . 73.209999999999994 113.183 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.63 43.76 25.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.614 0.765 . . . . 70.340000000000003 111.716 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.81 133.01 53.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.695 -0.684 . . . . 71.420000000000002 111.716 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 m -82.91 139.09 33.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.755 -1.111 . . . . 74.25 110.929 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.511 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mt -117.73 152.14 35.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.592 -0.731 . . . . 71.519999999999996 110.938 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.95 130.98 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.835 -0.62 . . . . 72.319999999999993 109.599 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.583 ' O ' HD12 ' A' ' 74' ' ' LEU . 89.2 m-85 -131.63 133.74 45.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.482 . . . . 71.299999999999997 110.75 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.4 t70 -116.15 104.04 11.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.954 -0.566 . . . . 62.020000000000003 110.117 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.801 HG22 HD11 ' A' ' 74' ' ' LEU . 26.4 m -105.96 153.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.964 -0.562 . . . . 60.420000000000002 110.952 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.33 125.74 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 72.230000000000004 110.321 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.02 101.96 3.38 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.808 -0.633 . . . . 64.0 110.408 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.67 -58.53 2.49 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.098 -0.501 . . . . 73.510000000000005 111.419 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 122.803 0.441 . . . . 74.319999999999993 110.703 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -124.4 144.56 49.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.158 -0.474 . . . . 64.409999999999997 110.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.465 0.302 0 O-C-N 123.571 0.544 . . . . 65.530000000000001 110.765 179.936 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-O 119.275 -0.736 . . . . 43.119999999999997 112.527 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.64 157.64 40.02 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 123.063 2.508 . . . . 72.120000000000005 112.795 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.7 m -121.64 -42.69 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.928 -0.578 . . . . 74.209999999999994 111.299 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.2 mtt -116.34 141.36 48.26 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.357 0.41 . . . . 73.209999999999994 110.872 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -107.31 36.21 4.53 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.885 -0.598 . . . . 60.009999999999998 112.807 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 75' ' ' THR . 13.1 p -136.22 120.64 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.711 0.291 . . . . 71.540000000000006 110.584 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -119.21 120.05 35.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.783 -0.644 . . . . 73.140000000000001 110.665 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 16.6 t -108.54 126.71 65.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.036 -0.529 . . . . 62.43 110.077 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.08 123.73 48.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.635 -0.711 . . . . 74.439999999999998 110.159 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.1 m -77.93 126.03 30.23 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 110.967 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.57 -40.61 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.103 -0.953 . . . . 72.430000000000007 110.296 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 t -130.77 118.92 17.92 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 116.014 -0.539 . . . . 74.319999999999993 110.4 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.37 129.77 16.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.592 2.194 . . . . 61.420000000000002 113.404 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.51 -121.07 4.36 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.688 -0.687 . . . . 44.329999999999998 112.118 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -83.77 -46.09 12.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.633 0.216 . . . . 61.450000000000003 110.963 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.31 -1.59 88.48 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.028 -0.533 . . . . 63.509999999999998 113.689 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -136.03 0.51 2.63 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.281 . . . . 75.239999999999995 111.76 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.44 92.36 3.73 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.075 0.464 . . . . 71.400000000000006 110.301 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -103.19 149.62 37.1 Favored Pre-proline 0 C--O 1.235 0.302 0 CA-C-N 115.591 -0.731 . . . . 72.109999999999999 110.961 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -65.92 122.51 10.11 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.47 2.114 . . . . 64.230000000000004 112.698 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 115.433 -0.803 . . . . 72.299999999999997 111.554 -179.228 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 51.7 ttt180 -77.49 123.83 27.09 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.593 -0.73 . . . . 75.420000000000002 111.183 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.21 -28.66 7.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.732 -0.667 . . . . 64.120000000000005 113.282 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.4 160.29 14.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.626 0.213 . . . . 72.140000000000001 111.017 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -81.75 145.28 30.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.087 -0.506 . . . . 73.129999999999995 111.525 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 38.6 t -120.0 117.07 27.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.565 -0.743 . . . . 70.120000000000005 110.599 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.7 111.05 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.405 -0.816 . . . . 63.039999999999999 109.685 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 103' ' ' LEU . 26.7 m -147.5 151.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.073 -0.512 . . . . 42.420000000000002 111.482 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.496 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -101.69 125.38 48.34 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.308 -0.86 . . . . 75.310000000000002 108.98 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.9 p90 -115.85 166.87 11.48 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.877 0.695 . . . . 74.340000000000003 112.877 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.5 m -148.84 113.27 5.29 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.85 -1.068 . . . . 54.439999999999998 109.482 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -97.59 119.79 6.53 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.109 -0.567 . . . . 74.5 112.957 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.8 mtm -128.35 131.4 48.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.977 0.511 . . . . 72.230000000000004 111.018 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.724 HD12 ' HG3' ' A' ' 34' ' ' MLY . 12.0 mt -58.5 171.4 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.726 -0.67 . . . . 42.340000000000003 112.166 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -57.53 -25.05 59.31 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 123.067 0.547 . . . . 72.0 111.769 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -88.29 -17.8 29.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.751 -0.659 . . . . 53.299999999999997 111.275 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.06 25.39 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.616 -0.802 . . . . 51.420000000000002 113.694 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MLY . . . . . 0.724 ' HG3' HD12 ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.777 -0.823 . . . . 63.25 108.777 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MLY . . . . . 0.462 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 113.487 0.921 . . . . 75.25 113.487 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 34.9 p90 -132.53 -15.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.02 -1.446 . . . . 74.109999999999999 111.18 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.451 ' OD2' ' HD1' ' A' ' 36' ' ' PHE . 3.0 m-20 -160.98 113.42 1.92 Allowed 'General case' 0 C--N 1.357 0.913 0 CA-C-O 120.984 0.421 . . . . 71.540000000000006 111.859 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 5.2 p -118.12 119.29 34.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.41 -0.814 . . . . 72.049999999999997 111.164 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.542 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 20.1 t -78.87 -36.87 41.57 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.055 -0.521 . . . . 71.120000000000005 112.252 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -23.13 48.92 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.176 0.806 . . . . 54.32 113.176 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -23.72 67.45 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.795 0.331 . . . . 64.340000000000003 111.206 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -94.12 2.2 56.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.466 -0.788 . . . . 71.299999999999997 109.758 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 63.75 33.35 12.96 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.297 1.039 . . . . 72.439999999999998 111.839 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.404 0 N-CA-C 112.979 0.733 . . . . 74.109999999999999 112.979 -179.126 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 157.82 41.05 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 123.08 2.52 . . . . 72.540000000000006 112.647 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.46 117.83 35.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.885 -0.598 . . . . 73.329999999999998 112.087 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MLY . . . . . 0.497 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.314 0 CA-C-N 115.052 -0.976 . . . . 74.450000000000003 109.884 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 40.3 p90 -149.19 160.11 43.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.299 0.375 . . . . 73.329999999999998 111.499 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 mtm -104.28 132.18 50.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.103 -0.499 . . . . 71.140000000000001 110.637 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.46 139.81 39.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.916 -0.583 . . . . 74.219999999999999 111.632 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.07 -10.44 53.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.468 -0.787 . . . . 71.310000000000002 113.383 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 C-N-CA 122.537 0.335 . . . . 72.219999999999999 110.682 179.195 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 69.79 26.79 4.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.09 0.956 . . . . 64.219999999999999 112.263 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -21.7 59.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.089 -0.505 . . . . 75.25 110.779 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.67 -175.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.22 -0.9 . . . . 74.450000000000003 110.525 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.6 pt -81.48 158.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 111.883 0.327 . . . . 53.420000000000002 111.883 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -59.33 -44.09 92.64 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.986 -0.552 . . . . 73.409999999999997 111.891 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.681 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.6 -20.61 61.77 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 116.085 -0.507 . . . . 75.120000000000005 113.486 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -84.16 -43.77 14.64 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 122.242 0.217 . . . . 64.239999999999995 111.261 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.09 -37.52 85.97 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.359 0.412 . . . . 71.319999999999993 111.572 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.38 -25.94 28.74 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.924 -0.58 . . . . 73.219999999999999 111.794 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.92 -46.28 4.85 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.461 0.476 . . . . 71.540000000000006 113.89 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.2 p -63.85 -24.8 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.824 0.45 . . . . 73.299999999999997 111.686 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.94 -8.07 56.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.419 -0.809 . . . . 33.409999999999997 111.601 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.46 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.18 -10.3 39.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.83 -0.623 . . . . 54.100000000000001 111.211 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.79 156.58 18.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.351 -0.386 . . . . 71.25 111.118 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.408 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 21.2 p -111.38 166.7 10.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.812 -0.631 . . . . 51.25 110.538 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.9 t -55.85 123.12 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.898 0.479 . . . . 53.100000000000001 111.348 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.72 4.42 69.95 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.498 -0.774 . . . . 71.340000000000003 113.207 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.77 142.1 28.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.861 0.362 . . . . 75.439999999999998 111.347 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.01 108.84 14.79 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.135 -0.939 . . . . 73.140000000000001 109.35 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.447 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.94 156.81 44.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.049 -0.523 . . . . 61.039999999999999 111.894 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-N 116.06 -0.518 . . . . 72.400000000000006 110.384 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.31 127.45 55.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.284 -0.416 . . . . 74.519999999999996 111.144 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.2 m -94.9 114.09 25.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.455 -0.793 . . . . 53.119999999999997 109.593 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.681 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.6 mm -106.71 142.16 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.897 -0.592 . . . . 75.109999999999999 110.528 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.33 162.2 20.47 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 114.904 -1.044 . . . . 74.230000000000004 110.776 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 -17.26 50.66 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.702 2.268 . . . . 62.43 113.243 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 -25.74 26.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 111.327 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.99 -18.98 15.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.085 -0.507 . . . . 73.030000000000001 111.462 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.52 -62.8 1.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.73 0.641 . . . . 54.109999999999999 112.73 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -133.4 -52.08 0.88 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.611 0.226 . . . . 74.540000000000006 111.611 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.42 -139.77 7.52 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.496 0.497 . . . . 71.340000000000003 112.049 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 -10.51 25.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 111.568 0.21 . . . . 51.549999999999997 111.568 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.61 -60.37 1.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.28 -0.418 . . . . 63.549999999999997 110.515 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.81 53.62 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.295 0.372 . . . . 73.040000000000006 113.207 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.444 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.52 123.74 53.27 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.933 -0.395 . . . . 71.030000000000001 109.933 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.07 124.72 11.66 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.212 1.941 . . . . 52.530000000000001 113.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.76 -47.47 1.04 Allowed Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.605 -0.725 . . . . 63.229999999999997 113.348 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -101.01 -50.84 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 111.67 0.248 . . . . 73.329999999999998 111.67 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 17.7 mm -111.46 98.68 41.35 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 123.177 0.298 . . . . 74.319999999999993 111.244 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.12 165.71 31.8 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.493 2.129 . . . . 65.319999999999993 112.733 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.34 143.44 28.02 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.552 2.168 . . . . 73.209999999999994 113.22 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.76 43.2 25.57 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.609 0.764 . . . . 70.340000000000003 111.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.05 133.58 53.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.707 -0.679 . . . . 71.420000000000002 111.747 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 m -83.46 139.98 32.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.76 -1.109 . . . . 74.25 110.89 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mt -119.3 151.79 37.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.568 -0.742 . . . . 71.519999999999996 110.897 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.75 131.46 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.889 -0.596 . . . . 72.319999999999993 109.453 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.8 m-85 -131.92 133.55 44.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.165 -0.47 . . . . 71.299999999999997 110.886 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD1' ' HG2' ' A' ' 73' ' ' MLY . 8.3 t70 -115.95 102.86 10.04 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.906 -0.588 . . . . 62.020000000000003 110.0 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.814 HG22 HD11 ' A' ' 74' ' ' LEU . 26.1 m -104.81 153.34 6.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 116.012 -0.54 . . . . 60.420000000000002 111.084 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.37 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.508 -0.769 . . . . 72.230000000000004 110.356 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.97 102.35 3.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.61 . . . . 64.0 110.455 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.41 -58.76 2.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.137 -0.483 . . . . 73.510000000000005 111.306 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 122.824 0.45 . . . . 74.319999999999993 110.709 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.7 mt -126.17 144.76 50.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.132 -0.486 . . . . 64.409999999999997 110.686 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.465 0.281 0 CA-C-N 116.056 -0.52 . . . . 65.530000000000001 110.772 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 CA-C-O 119.235 -0.758 . . . . 43.119999999999997 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.77 -36.09 2.29 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.056 2.504 . . . . 72.120000000000005 113.044 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.6 t 62.87 126.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.935 0.894 . . . . 74.209999999999994 111.897 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.6 mtt 63.13 125.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.922 0.889 . . . . 73.209999999999994 111.981 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -104.9 27.23 19.68 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.84 -0.618 . . . . 60.009999999999998 113.165 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.1 p -135.82 113.93 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.816 0.341 . . . . 71.540000000000006 110.5 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.96 117.44 32.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.764 -0.653 . . . . 73.140000000000001 110.904 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.4 p -107.9 132.55 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.912 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.22 123.88 45.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 74.439999999999998 110.261 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -77.81 125.92 30.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.122 -0.49 . . . . 74.150000000000006 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.22 -38.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.092 -0.958 . . . . 72.430000000000007 110.421 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -133.01 118.83 15.44 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.0 -0.545 . . . . 74.319999999999993 110.555 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.87 130.03 16.23 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.584 2.189 . . . . 61.420000000000002 113.185 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.28 -121.93 4.48 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.832 -0.622 . . . . 44.329999999999998 112.259 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.1 -46.69 12.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.66 0.23 . . . . 61.450000000000003 110.999 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.83 -2.59 87.77 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.552 0.533 . . . . 63.509999999999998 113.827 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -134.59 -0.71 2.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.487 0.315 . . . . 75.239999999999995 111.754 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 m -119.9 93.41 4.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.033 0.444 . . . . 71.400000000000006 110.526 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -103.81 149.22 36.92 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 72.109999999999999 110.856 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.11 128.16 17.14 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.582 2.188 . . . . 64.230000000000004 113.05 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 115.374 -0.83 . . . . 72.299999999999997 111.215 -179.684 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 47.8 ttt180 -77.37 124.27 27.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.714 -0.675 . . . . 75.420000000000002 111.163 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.76 -28.81 6.88 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.712 -0.676 . . . . 64.120000000000005 113.197 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.441 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -96.67 160.15 14.54 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.43 0.292 . . . . 72.140000000000001 110.998 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.78 145.39 28.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.093 -0.503 . . . . 73.129999999999995 111.327 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 34.8 t -120.52 117.15 26.89 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.625 -0.716 . . . . 70.120000000000005 110.807 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.6 110.67 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.513 -0.767 . . . . 63.039999999999999 109.329 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 103' ' ' LEU . 28.3 m -146.91 153.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.104 -0.498 . . . . 42.420000000000002 111.475 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.4 m-70 -103.12 125.28 49.76 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.454 -0.793 . . . . 75.310000000000002 109.314 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.4 p90 -116.23 168.14 10.39 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.403 0.519 . . . . 74.340000000000003 112.403 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.2 m -148.85 105.89 3.6 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.135 -0.939 . . . . 54.439999999999998 109.484 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.51 117.95 5.21 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.105 -0.569 . . . . 74.5 112.754 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.8 mtm -133.04 135.13 45.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.019 0.528 . . . . 72.230000000000004 110.946 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.53 172.01 0.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.438 -0.801 . . . . 42.340000000000003 112.27 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.92 -27.15 50.86 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.157 0.583 . . . . 72.0 111.951 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.95 -17.43 29.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.701 -0.681 . . . . 53.299999999999997 111.634 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.41 13.7 21.99 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.736 -0.745 . . . . 51.420000000000002 113.316 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.466 0 N-CA-C 110.13 -0.322 . . . . 63.25 110.13 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.288 0 N-CA-C 112.956 0.725 . . . . 75.25 112.956 -179.569 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.9 p90 -134.81 -14.1 2.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.5 -1.227 . . . . 74.109999999999999 111.173 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.58 110.5 0.04 OUTLIER 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.13 0.49 . . . . 71.540000000000006 112.134 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -123.13 138.15 54.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.304 -0.862 . . . . 72.049999999999997 110.127 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 64.9 p -78.74 -35.74 44.28 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.792 -0.64 . . . . 71.120000000000005 112.587 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -72.37 -23.18 61.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.757 0.651 . . . . 54.32 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -28.27 69.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.871 0.367 . . . . 64.340000000000003 110.979 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -96.37 0.82 51.16 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.356 -0.838 . . . . 71.299999999999997 109.953 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.08 37.99 8.74 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.269 1.027 . . . . 72.439999999999998 111.559 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 111.717 -179.768 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -73.35 158.02 48.89 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.896 2.397 . . . . 72.540000000000006 113.02 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -102.45 118.83 37.72 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.781 -0.645 . . . . 73.329999999999998 112.097 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.504 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 115.175 -0.92 . . . . 74.450000000000003 110.034 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 40.7 p90 -149.23 161.77 41.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.314 0.384 . . . . 73.329999999999998 111.452 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.491 ' SD ' HH12 ' A' ' 52' ' ' MLY . 6.5 mtt -106.15 132.83 51.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 71.140000000000001 110.567 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.61 139.78 39.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.975 -0.557 . . . . 74.219999999999999 111.625 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.82 -10.88 50.04 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.39 -0.823 . . . . 71.310000000000002 113.373 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . 0.491 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 122.502 0.321 . . . . 72.219999999999999 110.721 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 70.05 27.27 4.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.08 0.952 . . . . 64.219999999999999 112.084 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -76.63 -13.48 60.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.043 -0.526 . . . . 75.25 110.854 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.26 -178.2 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.292 -0.867 . . . . 74.450000000000003 110.426 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -78.75 158.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 111.973 0.36 . . . . 53.420000000000002 111.973 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -59.35 -43.67 92.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.934 -0.576 . . . . 73.409999999999997 111.864 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.619 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.93 -20.21 62.04 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.062 -0.517 . . . . 75.120000000000005 113.302 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -84.17 -44.19 14.22 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 122.292 0.237 . . . . 64.239999999999995 111.072 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.72 -37.35 84.51 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.352 0.408 . . . . 71.319999999999993 111.704 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.49 -25.38 28.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.015 -0.539 . . . . 73.219999999999999 111.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.7 -46.24 4.63 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.4 0.438 . . . . 71.540000000000006 113.839 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.47 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.2 p -63.78 -25.81 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.728 0.411 . . . . 73.299999999999997 111.669 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.13 53.4 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.391 -0.822 . . . . 33.409999999999997 111.737 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -94.17 -4.94 48.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.812 -0.631 . . . . 54.100000000000001 111.324 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.512 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.13 158.22 19.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.447 -0.342 . . . . 71.25 110.645 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.653 ' C ' HD13 ' A' ' 103' ' ' LEU . 8.8 p -116.53 150.84 37.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.086 -0.506 . . . . 51.25 110.788 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.723 ' HA ' HD22 ' A' ' 103' ' ' LEU . 53.2 t -40.08 119.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.584 0.754 . . . . 53.100000000000001 112.302 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 3.57 61.64 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.301 -0.863 . . . . 71.340000000000003 113.124 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -95.8 145.3 25.45 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.902 0.382 . . . . 75.439999999999998 111.366 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.86 108.5 12.53 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.039 -0.982 . . . . 73.140000000000001 109.342 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.85 157.02 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.939 -0.573 . . . . 61.039999999999999 111.878 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-N 116.078 -0.51 . . . . 72.400000000000006 110.382 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.838 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.85 128.93 53.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.118 -0.492 . . . . 74.519999999999996 110.833 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.7 m -96.33 113.72 25.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.672 -0.694 . . . . 53.119999999999997 109.466 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.619 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.2 mm -105.27 141.46 20.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.859 -0.609 . . . . 75.109999999999999 110.356 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.34 162.17 20.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 114.941 -1.027 . . . . 74.230000000000004 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.48 -14.47 39.49 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.58 2.187 . . . . 62.43 113.201 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.83 -29.49 22.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 110.777 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -98.72 -18.52 17.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.755 -0.657 . . . . 73.030000000000001 111.569 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.5 -63.47 1.33 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.778 0.659 . . . . 54.109999999999999 112.778 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -134.21 -51.21 0.82 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.608 0.225 . . . . 74.540000000000006 111.608 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.22 -143.29 10.69 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 71.340000000000003 111.948 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.6 -9.75 34.12 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 111.617 0.229 . . . . 51.549999999999997 111.617 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 m -100.44 -60.35 1.54 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.194 -0.457 . . . . 63.549999999999997 110.469 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.88 -166.93 53.05 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.315 0.384 . . . . 73.040000000000006 113.171 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.453 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.97 124.82 46.3 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 109.87 -0.419 . . . . 71.030000000000001 109.87 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.03 123.56 10.13 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.22 1.947 . . . . 52.530000000000001 113.624 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.19 -46.48 1.16 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.579 -0.737 . . . . 63.229999999999997 113.38 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mt -100.6 -51.88 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 111.563 0.209 . . . . 73.329999999999998 111.563 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.453 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.2 mm -109.92 98.62 35.04 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 123.212 0.32 . . . . 74.319999999999993 110.982 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.61 165.56 32.13 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.432 2.088 . . . . 65.319999999999993 112.755 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.84 142.57 28.55 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.507 2.138 . . . . 73.209999999999994 113.119 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 56.82 45.11 22.19 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.636 0.774 . . . . 70.340000000000003 111.689 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.43 133.01 52.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.678 -0.692 . . . . 71.420000000000002 111.824 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -83.22 140.64 32.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.714 -1.13 . . . . 74.25 110.791 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mt -118.18 155.71 30.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.686 -0.688 . . . . 71.519999999999996 111.072 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.48 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.83 -0.623 . . . . 72.319999999999993 109.699 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.3 m-85 -130.86 134.09 46.49 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.032 -0.531 . . . . 71.299999999999997 110.611 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.8 t70 -116.44 104.88 11.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.148 -0.478 . . . . 62.020000000000003 110.255 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.838 HG22 HD11 ' A' ' 74' ' ' LEU . 25.7 m -105.98 153.55 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.063 -0.517 . . . . 60.420000000000002 111.125 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.64 124.06 29.11 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.472 -0.786 . . . . 72.230000000000004 110.173 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.752 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -73.54 103.73 4.26 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.14 0.495 . . . . 64.0 110.89 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.75 -57.37 2.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.352 -0.84 . . . . 73.510000000000005 111.344 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 C-N-CA 122.834 0.454 . . . . 74.319999999999993 110.742 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.441 HD22 HE22 ' A' ' 20' ' ' GLN . 13.2 mt -123.28 145.91 48.3 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.099 -0.5 . . . . 64.409999999999997 110.735 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 116.114 -0.493 . . . . 65.530000000000001 110.807 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 CA-C-O 119.322 -0.71 . . . . 43.119999999999997 112.656 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.86 -38.39 1.7 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.035 2.49 . . . . 72.120000000000005 113.003 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.3 t -131.43 -47.84 0.98 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.38 0.425 . . . . 74.209999999999994 110.957 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 25.1 mmt -135.95 -45.81 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.345 0.403 . . . . 73.209999999999994 111.047 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 119.23 -42.71 1.72 Allowed Glycine 0 C--N 1.34 0.783 0 O-C-N 123.446 0.467 . . . . 60.009999999999998 112.388 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.1 p -128.04 119.64 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 120.7 0.286 . . . . 71.540000000000006 110.702 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.51 117.62 29.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.767 -0.652 . . . . 73.140000000000001 110.839 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.5 p -108.55 134.09 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.917 -0.583 . . . . 62.43 110.909 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.43 124.1 43.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.487 -0.778 . . . . 74.439999999999998 110.227 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -77.65 126.56 31.07 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.881 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -109.98 -38.47 3.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.074 -0.966 . . . . 72.430000000000007 110.412 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -133.09 118.64 15.27 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.004 -0.544 . . . . 74.319999999999993 110.574 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.96 129.73 15.7 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.567 2.178 . . . . 61.420000000000002 113.152 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.98 -121.68 4.37 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.82 -0.627 . . . . 44.329999999999998 112.233 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.56 -46.34 13.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.605 0.203 . . . . 61.450000000000003 111.0 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.51 -1.69 88.61 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.568 0.542 . . . . 63.509999999999998 113.808 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -135.27 -0.91 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.494 0.318 . . . . 75.239999999999995 111.734 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -120.14 93.14 3.96 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 71.400000000000006 110.451 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.24 149.14 36.65 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.604 -0.725 . . . . 72.109999999999999 110.948 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.63 130.36 20.62 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.57 2.18 . . . . 64.230000000000004 113.189 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 115.422 -0.808 . . . . 72.299999999999997 111.059 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 56.6 ttt180 -77.39 122.12 24.72 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.667 -0.697 . . . . 75.420000000000002 111.194 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.14 -27.65 6.94 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 115.831 -0.622 . . . . 64.120000000000005 113.466 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.446 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -96.99 160.33 14.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.373 0.269 . . . . 72.140000000000001 111.086 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -84.58 145.31 28.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 111.094 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 60.2 m -124.24 119.75 30.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.669 -0.696 . . . . 70.120000000000005 110.9 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.61 111.3 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.276 -0.875 . . . . 63.039999999999999 109.563 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 103' ' ' LEU . 30.1 m -146.14 152.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.967 -0.56 . . . . 42.420000000000002 111.602 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.2 m-70 -103.73 125.48 50.22 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.367 -0.833 . . . . 75.310000000000002 109.229 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.625 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.1 p90 -116.9 167.42 11.14 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.531 0.567 . . . . 74.340000000000003 112.531 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -147.83 110.78 4.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.217 -0.901 . . . . 54.439999999999998 109.595 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.6 119.55 6.0 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.081 -0.509 . . . . 74.5 112.619 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 mtm -135.15 132.93 38.61 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.976 0.51 . . . . 72.230000000000004 110.87 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.16 172.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.527 -0.761 . . . . 42.340000000000003 112.461 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -55.73 -27.49 50.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.142 0.577 . . . . 72.0 111.981 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.37 -17.48 30.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.628 -0.714 . . . . 53.299999999999997 111.556 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.67 13.89 22.89 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 120.73 -0.748 . . . . 51.420000000000002 113.313 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.397 0 N-CA-C 110.224 -0.288 . . . . 63.25 110.224 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 N-CA-C 112.862 0.69 . . . . 75.25 112.862 -179.686 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.8 p90 -133.62 -15.19 2.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.612 -1.176 . . . . 74.109999999999999 111.316 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.54 111.47 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.081 0.467 . . . . 71.540000000000006 111.884 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -122.19 143.66 49.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.315 -0.857 . . . . 72.049999999999997 110.174 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.584 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 8.1 t -78.28 -37.24 45.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.120000000000005 112.574 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -22.78 61.91 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.477 0.547 . . . . 54.32 112.477 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -29.65 68.74 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.87 0.367 . . . . 64.340000000000003 111.178 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' O ' ' HD3' ' A' ' 44' ' ' MLY . 55.6 mtm180 -94.04 0.7 56.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.349 -0.841 . . . . 71.299999999999997 110.219 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.89 37.46 9.55 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.193 0.997 . . . . 72.439999999999998 111.676 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . 0.48 ' HD3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-N 116.046 -0.525 . . . . 74.109999999999999 111.486 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.99 157.92 53.59 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.811 2.341 . . . . 72.540000000000006 113.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CD1' ' HE1' ' A' ' 26' ' ' TYR . 19.9 t80 -104.0 118.12 35.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.685 -0.689 . . . . 73.329999999999998 111.933 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.432 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.376 0 CA-C-N 115.286 -0.87 . . . . 74.450000000000003 110.293 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' THR . 42.4 p90 -149.09 161.85 41.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.382 0.426 . . . . 73.329999999999998 111.332 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.434 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 7.0 mtt -106.8 134.85 49.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.126 -0.488 . . . . 71.140000000000001 110.661 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm? -79.56 140.72 37.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.849 -0.614 . . . . 74.219999999999999 111.57 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.54 -11.03 47.64 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.509 -0.769 . . . . 71.310000000000002 113.457 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 122.505 0.322 . . . . 72.219999999999999 110.698 179.359 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 69.21 29.62 4.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.077 0.951 . . . . 64.219999999999999 112.197 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 45.2 mt-10 -78.93 -11.54 60.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.89 -0.596 . . . . 75.25 110.889 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -131.24 -178.26 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.429 -0.805 . . . . 74.450000000000003 110.721 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 HD12 HG21 ' A' ' 76' ' ' ILE . 7.0 pt -76.91 160.25 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.045 0.387 . . . . 53.420000000000002 112.045 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -62.05 -43.17 99.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.004 -0.544 . . . . 73.409999999999997 111.842 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.82 -20.88 62.57 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 123.504 0.502 . . . . 75.120000000000005 113.25 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.403 ' CD1' HD11 ' A' ' 56' ' ' ILE . 8.1 m0 -84.2 -44.76 13.62 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 122.311 0.244 . . . . 64.239999999999995 111.18 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.5 mt-10 -65.66 -37.03 85.39 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.249 0.343 . . . . 71.319999999999993 111.605 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.47 -26.95 27.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.75 -0.659 . . . . 73.219999999999999 111.812 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.73 -46.15 4.95 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 123.507 0.504 . . . . 71.540000000000006 113.955 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.1 p -63.54 -26.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.745 0.418 . . . . 73.299999999999997 111.712 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.36 49.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.481 -0.781 . . . . 33.409999999999997 111.725 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -94.73 -2.99 50.05 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.686 -0.688 . . . . 54.100000000000001 111.25 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.519 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.78 158.29 20.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.402 -0.363 . . . . 71.25 110.785 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.658 ' C ' HD13 ' A' ' 103' ' ' LEU . 7.6 p -116.42 150.84 37.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.084 -0.507 . . . . 51.25 110.665 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.725 ' HA ' HD22 ' A' ' 103' ' ' LEU . 53.9 t -40.07 119.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.649 0.78 . . . . 53.100000000000001 112.214 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.44 4.21 60.96 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.329 -0.851 . . . . 71.340000000000003 113.133 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -96.18 145.77 25.24 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.983 0.421 . . . . 75.439999999999998 111.381 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.25 109.04 12.89 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.069 -0.969 . . . . 73.140000000000001 109.407 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.76 157.26 44.31 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.029 -0.532 . . . . 61.039999999999999 111.895 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.308 0 CA-C-N 116.127 -0.488 . . . . 72.400000000000006 110.495 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.841 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.08 134.37 47.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.076 -0.511 . . . . 74.519999999999996 110.824 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.8 m -100.41 112.95 25.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.614 -0.721 . . . . 53.119999999999997 109.371 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.555 HG21 HD12 ' A' ' 56' ' ' ILE . 7.2 mm -104.37 131.52 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.885 -0.598 . . . . 75.109999999999999 110.247 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.09 162.48 23.69 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.333 -0.849 . . . . 74.230000000000004 110.707 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -63.21 -14.4 41.63 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.343 2.029 . . . . 62.43 113.015 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.22 -28.25 21.27 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.684 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 -18.85 18.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.727 -0.67 . . . . 73.030000000000001 111.441 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.97 -64.51 1.14 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.779 0.659 . . . . 54.109999999999999 112.779 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -132.61 -53.46 0.94 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.645 0.239 . . . . 74.540000000000006 111.645 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.5 -141.33 8.5 Favored Glycine 0 C--N 1.338 0.658 0 O-C-N 123.515 0.509 . . . . 71.340000000000003 111.9 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.64 -10.56 29.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 111.586 0.217 . . . . 51.549999999999997 111.586 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.1 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.287 -0.415 . . . . 63.549999999999997 110.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.04 -168.54 53.58 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.376 0.422 . . . . 73.040000000000006 113.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -96.81 124.78 48.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.892 -0.41 . . . . 71.030000000000001 109.892 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.96 125.34 11.93 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.189 1.926 . . . . 52.530000000000001 113.601 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.52 -43.43 1.67 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.585 -0.734 . . . . 63.229999999999997 113.395 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.84 -52.12 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.651 0.225 . . . . 73.329999999999998 111.55 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 22.2 mm -111.72 99.25 44.33 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 123.186 0.304 . . . . 74.319999999999993 111.159 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.34 165.67 31.71 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.381 2.054 . . . . 65.319999999999993 112.668 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.4 143.39 27.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.543 2.162 . . . . 73.209999999999994 113.302 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 56.54 41.29 28.82 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.621 0.768 . . . . 70.340000000000003 111.845 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.2 131.04 53.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.711 -0.677 . . . . 71.420000000000002 111.763 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -81.89 140.33 34.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.731 -1.122 . . . . 74.25 110.857 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.52 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mt -117.56 155.41 29.85 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.572 -0.74 . . . . 71.519999999999996 110.979 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 129.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.822 -0.626 . . . . 72.319999999999993 109.575 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 27' ' ' THR . 88.1 m-85 -132.34 134.65 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.473 . . . . 71.299999999999997 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.0 t70 -116.46 105.54 12.61 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.076 -0.511 . . . . 62.020000000000003 110.253 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.841 HG22 HD11 ' A' ' 74' ' ' LEU . 25.8 m -105.26 153.5 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.071 -0.513 . . . . 60.420000000000002 111.031 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.24 123.62 28.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.461 -0.791 . . . . 72.230000000000004 110.063 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.729 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -73.53 102.56 3.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.122 0.487 . . . . 64.0 110.617 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.85 -56.51 3.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.448 -0.796 . . . . 73.510000000000005 111.414 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 122.843 0.457 . . . . 74.319999999999993 110.752 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.446 HD22 HE22 ' A' ' 20' ' ' GLN . 12.8 mt -122.97 146.99 47.13 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.052 -0.522 . . . . 64.409999999999997 110.737 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 N--CA 1.465 0.28 0 CA-C-N 116.137 -0.483 . . . . 65.530000000000001 110.826 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 CA-C-O 119.116 -0.825 . . . . 43.119999999999997 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.28 156.01 41.73 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.891 2.394 . . . . 72.120000000000005 112.762 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 51.8 m -127.55 146.01 50.66 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.9 -0.591 . . . . 74.209999999999994 110.931 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 21.8 mmt -100.54 149.01 24.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.918 -0.583 . . . . 73.209999999999994 111.056 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -98.2 -20.43 20.59 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.724 -0.671 . . . . 60.009999999999998 113.019 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 76' ' ' ILE . 8.5 p -118.04 119.72 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.708 0.29 . . . . 71.540000000000006 110.73 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.73 116.94 27.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.82 -0.627 . . . . 73.140000000000001 110.567 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.4 p -108.54 139.12 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.055 -0.521 . . . . 62.43 111.111 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.78 125.22 42.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.454 -0.794 . . . . 74.439999999999998 110.373 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -78.33 127.86 32.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.791 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.414 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.2 mt -110.75 -39.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.122 -0.945 . . . . 72.430000000000007 110.4 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -132.35 118.86 16.17 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.047 -0.524 . . . . 74.319999999999993 110.443 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.61 129.57 15.84 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.606 2.204 . . . . 61.420000000000002 113.307 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.16 -121.17 4.31 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.749 -0.659 . . . . 44.329999999999998 112.117 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.77 -46.26 12.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.644 0.222 . . . . 61.450000000000003 110.945 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.25 -1.86 88.42 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.077 -0.511 . . . . 63.509999999999998 113.697 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -136.35 1.5 2.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.462 0.305 . . . . 75.239999999999995 111.747 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -122.39 92.21 3.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.104 0.478 . . . . 71.400000000000006 110.213 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -103.03 149.71 37.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.511 -0.768 . . . . 72.109999999999999 110.893 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.37 126.8 16.2 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.497 2.131 . . . . 64.230000000000004 112.918 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.48 -0.782 . . . . 72.299999999999997 111.483 -179.39 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 44.2 ttt180 -77.53 120.54 22.65 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.418 -0.81 . . . . 75.420000000000002 111.372 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.98 -25.65 7.82 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.967 -0.561 . . . . 64.120000000000005 113.498 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.435 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -100.59 160.45 14.34 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.323 0.249 . . . . 72.140000000000001 110.974 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.511 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -81.92 145.09 30.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 111.131 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 32.1 m -123.86 117.83 25.73 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.574 -0.739 . . . . 70.120000000000005 110.618 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.73 111.25 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.449 -0.796 . . . . 63.039999999999999 109.805 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.5 m -145.55 151.39 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.847 -0.615 . . . . 42.420000000000002 111.398 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.5 m-70 -102.68 125.27 49.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.537 -0.756 . . . . 75.310000000000002 109.499 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.2 p90 -115.72 166.22 12.18 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.436 0.532 . . . . 74.340000000000003 112.436 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -148.15 105.97 3.7 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.119 -0.946 . . . . 54.439999999999998 109.274 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 122.84 6.78 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.137 -0.554 . . . . 74.5 113.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.4 mtm -136.86 131.38 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.19 0.596 . . . . 72.230000000000004 110.624 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.25 170.42 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.622 -0.717 . . . . 42.340000000000003 112.337 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.14 -28.08 50.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.144 0.578 . . . . 72.0 112.135 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.91 -17.28 29.9 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.713 -0.676 . . . . 53.299999999999997 111.734 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 13.48 22.88 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 120.781 -0.723 . . . . 51.420000000000002 113.012 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.419 0 N-CA-C 109.628 -0.508 . . . . 63.25 109.628 179.257 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.504 ' HD2' ' HB2' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 112.916 0.709 . . . . 75.25 112.916 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -135.91 -12.78 1.95 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.34 -1.3 . . . . 74.109999999999999 111.743 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.5 111.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.074 0.768 . . . . 71.540000000000006 113.074 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 35' ' ' MLY . 13.8 t -122.92 133.25 54.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.502 -0.772 . . . . 72.049999999999997 111.233 176.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' MLY . 52.7 p -79.63 -33.75 41.16 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.338 -0.846 . . . . 71.120000000000005 112.475 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -71.45 -39.36 71.02 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.085 0.772 . . . . 54.32 113.085 -178.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD2' HH21 ' A' ' 35' ' ' MLY . 1.1 t0 -66.73 -21.92 66.06 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.824 0.345 . . . . 64.340000000000003 110.897 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.6 -4.28 57.9 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.318 -0.855 . . . . 71.299999999999997 110.04 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 65.92 35.29 6.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.426 1.09 . . . . 72.439999999999998 112.021 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 39' ' ' SER . . . . . . . . 0 N--CA 1.472 0.651 0 CA-C-N 116.496 -0.32 . . . . 74.109999999999999 111.785 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.47 157.94 40.57 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.97 2.447 . . . . 72.540000000000006 112.847 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -102.53 117.94 35.79 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.86 -0.609 . . . . 73.329999999999998 112.06 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 115.041 -0.981 . . . . 74.450000000000003 109.929 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.9 p90 -151.97 164.18 37.7 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.242 0.339 . . . . 73.329999999999998 111.557 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.511 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.4 mpp? -107.25 135.5 48.66 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.186 -0.461 . . . . 71.140000000000001 110.603 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 60' ' ' GLU . 2.2 mm? -80.33 141.5 35.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.838 -0.619 . . . . 74.219999999999999 111.612 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.47 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 83.0 -9.42 60.38 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.519 -0.764 . . . . 71.310000000000002 113.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 110.705 179.38 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 68.43 28.38 6.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.108 0.963 . . . . 64.219999999999999 112.046 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.28 -33.44 61.23 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.948 -0.569 . . . . 75.25 110.545 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 m -104.12 -176.03 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.257 -0.883 . . . . 74.450000000000003 110.036 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -79.44 159.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 111.777 0.288 . . . . 53.420000000000002 111.777 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.23 -42.49 91.18 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.017 -0.538 . . . . 73.409999999999997 111.855 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.8 -23.14 65.12 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.858 -0.61 . . . . 75.120000000000005 113.188 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -82.45 -43.02 17.77 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 122.379 0.272 . . . . 64.239999999999995 111.231 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HA ' HD11 ' A' ' 50' ' ' LEU . 29.6 mt-10 -68.14 -37.74 81.4 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.289 0.368 . . . . 71.319999999999993 111.7 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.57 -23.34 29.71 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.513 0.508 . . . . 73.219999999999999 111.797 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.19 -46.17 4.21 Favored Glycine 0 C--N 1.343 0.961 0 O-C-N 123.512 0.507 . . . . 71.540000000000006 113.68 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.4 p -63.96 -25.3 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.633 0.373 . . . . 73.299999999999997 111.617 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 -8.47 57.05 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.338 -0.847 . . . . 33.409999999999997 111.782 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -93.1 -7.45 45.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.798 -0.637 . . . . 54.100000000000001 111.265 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -110.13 156.94 19.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.867 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.1 p -111.28 166.75 10.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.891 -0.595 . . . . 51.25 110.587 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.644 ' HA ' HD12 ' A' ' 103' ' ' LEU . 58.3 t -55.69 122.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.036 0.535 . . . . 53.100000000000001 111.205 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.17 3.09 70.22 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.493 -0.776 . . . . 71.340000000000003 113.254 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.42 142.12 27.8 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 120.932 0.396 . . . . 75.439999999999998 111.313 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -120.76 109.3 15.0 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.099 -0.955 . . . . 73.140000000000001 109.476 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.79 156.44 45.98 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.051 -0.522 . . . . 61.039999999999999 111.818 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.342 0.281 0 CA-C-N 116.128 -0.487 . . . . 72.400000000000006 110.46 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.813 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.72 124.56 50.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.11 -0.496 . . . . 74.519999999999996 110.882 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m -95.44 112.73 24.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.737 -0.665 . . . . 53.119999999999997 109.407 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.715 HD12 ' HA3' ' A' ' 58' ' ' GLY . 5.2 mm -107.46 141.48 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.284 0.564 . . . . 75.109999999999999 111.267 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.68 162.73 19.29 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 114.463 -1.244 . . . . 74.230000000000004 109.768 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.26 -17.52 57.52 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.18 1.92 . . . . 62.43 113.045 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.59 -5.79 59.27 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.29 -0.414 . . . . 74.510000000000005 111.109 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -125.01 -26.15 3.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.3 -0.863 . . . . 73.030000000000001 109.383 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.2 96.05 6.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.946 -1.024 . . . . 54.109999999999999 110.805 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 75.25 -50.7 0.65 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.914 -1.039 . . . . 74.540000000000006 112.252 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.65 -148.83 18.88 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.238 -0.506 . . . . 71.340000000000003 112.835 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.83 -8.88 56.91 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.473 0.546 . . . . 51.549999999999997 112.473 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 m -97.88 -60.19 1.61 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.52 -0.309 . . . . 63.549999999999997 110.496 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.53 -168.52 42.6 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.283 0.365 . . . . 73.040000000000006 113.292 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.551 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 4.0 t60 -94.26 129.0 38.49 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 110.155 -0.313 . . . . 71.030000000000001 110.155 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.23 123.27 9.79 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.354 2.036 . . . . 52.530000000000001 113.565 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.5 -43.19 1.72 Allowed Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.661 -0.7 . . . . 63.229999999999997 113.42 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.42 -52.08 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.599 0.199 . . . . 73.329999999999998 111.412 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 16.1 mm -110.82 99.6 42.84 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 123.245 0.34 . . . . 74.319999999999993 111.023 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.36 165.82 31.56 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.458 2.106 . . . . 65.319999999999993 112.657 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.39 142.59 30.12 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.465 2.11 . . . . 73.209999999999994 113.052 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 56.9 47.58 17.54 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.681 0.792 . . . . 70.340000000000003 111.53 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.88 136.2 52.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 111.525 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -83.49 144.61 29.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.791 -1.095 . . . . 74.25 110.88 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.23 155.08 44.02 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.691 -0.686 . . . . 71.519999999999996 111.25 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 52.8 t -121.79 133.26 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.8 -0.636 . . . . 72.319999999999993 109.44 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.564 ' O ' HD12 ' A' ' 74' ' ' LEU . 93.2 m-85 -134.75 133.28 39.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.258 -0.428 . . . . 71.299999999999997 110.856 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.2 t70 -116.46 102.56 9.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.094 -0.503 . . . . 62.020000000000003 110.177 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.813 HG22 HD11 ' A' ' 74' ' ' LEU . 25.7 m -104.51 153.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.105 -0.498 . . . . 60.420000000000002 111.118 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.17 126.43 35.6 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.453 -0.794 . . . . 72.230000000000004 110.288 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.13 102.45 3.58 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 64.0 110.324 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.03 -58.15 2.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.232 -0.44 . . . . 73.510000000000005 111.578 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 122.872 0.469 . . . . 74.319999999999993 110.811 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.435 HD22 HE22 ' A' ' 20' ' ' GLN . 11.8 mt -119.57 147.69 44.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.055 -0.52 . . . . 64.409999999999997 110.79 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.274 -0.421 . . . . 65.530000000000001 110.812 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.72 0 CA-C-O 119.279 -0.734 . . . . 43.119999999999997 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.47 153.09 39.32 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.065 2.51 . . . . 72.120000000000005 112.757 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.7 p -103.2 -43.08 5.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.893 -0.594 . . . . 74.209999999999994 111.361 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 25.6 ptt? 46.52 125.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.123 1.369 . . . . 73.209999999999994 114.041 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -95.62 40.31 2.67 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.566 -0.743 . . . . 60.009999999999998 113.084 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.2 p -139.3 114.05 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.801 0.334 . . . . 71.540000000000006 110.419 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 120.5 40.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.693 -0.685 . . . . 73.140000000000001 110.588 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 17.1 t -109.31 124.01 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.109 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -113.45 124.85 53.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.652 -0.704 . . . . 74.439999999999998 110.11 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.1 m -78.98 127.63 32.24 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.49 0.494 . . . . 74.150000000000006 110.943 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.461 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -109.09 -41.98 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.106 -0.952 . . . . 72.430000000000007 110.244 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -129.46 118.78 19.14 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.927 -0.579 . . . . 74.319999999999993 110.4 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.21 129.07 15.51 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.584 2.189 . . . . 61.420000000000002 113.412 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.78 -120.9 4.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.731 -0.668 . . . . 44.329999999999998 112.119 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.65 -45.78 13.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.636 0.218 . . . . 61.450000000000003 110.906 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 84.95 -1.51 88.83 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.009 -0.541 . . . . 63.509999999999998 113.728 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.48 1.02 2.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.473 0.309 . . . . 75.239999999999995 111.801 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.86 92.08 3.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.065 0.459 . . . . 71.400000000000006 110.251 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -102.82 149.41 36.77 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 115.511 -0.768 . . . . 72.109999999999999 110.93 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.32 124.41 12.48 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.433 2.089 . . . . 64.230000000000004 112.956 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 115.386 -0.825 . . . . 72.299999999999997 111.386 -179.407 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 46.0 ttt180 -77.35 126.39 30.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.636 -0.711 . . . . 75.420000000000002 111.342 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.35 -25.83 10.88 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.744 -0.662 . . . . 64.120000000000005 113.418 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.438 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -99.27 160.13 14.5 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.31 0.244 . . . . 72.140000000000001 111.017 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.79 145.24 28.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.148 -0.478 . . . . 73.129999999999995 111.154 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 35.9 m -122.89 119.26 29.97 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.652 -0.704 . . . . 70.120000000000005 110.846 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -91.6 110.9 23.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.281 -0.872 . . . . 63.039999999999999 109.655 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 103' ' ' LEU . 30.6 m -147.18 151.31 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.095 -0.502 . . . . 42.420000000000002 111.445 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -101.69 125.43 48.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.375 -0.83 . . . . 75.310000000000002 109.059 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.2 p90 -116.44 165.52 13.13 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.786 0.661 . . . . 74.340000000000003 112.786 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 3.0 m -149.0 112.1 4.91 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.997 -1.002 . . . . 54.439999999999998 109.379 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.9 121.08 6.79 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.999 -0.546 . . . . 74.5 112.8 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.1 mtm -130.65 131.05 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.891 0.477 . . . . 72.230000000000004 111.091 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.31 170.85 0.46 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.66 -0.7 . . . . 42.340000000000003 112.037 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -56.24 -26.5 51.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.047 0.539 . . . . 72.0 112.126 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.41 -17.34 28.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.748 -0.66 . . . . 53.299999999999997 111.75 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.59 13.76 21.51 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 120.838 -0.696 . . . . 51.420000000000002 113.337 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.893 -0.41 . . . . 63.25 109.893 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.465 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 112.853 0.686 . . . . 75.25 112.853 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 29.8 p90 -133.68 -9.63 2.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.338 -1.301 . . . . 74.109999999999999 111.42 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -167.18 111.54 0.72 Allowed 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.222 0.534 . . . . 71.540000000000006 111.714 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 3.0 p -116.9 118.15 31.67 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.863 -1.062 . . . . 72.049999999999997 110.729 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 19.6 t -78.65 -33.53 47.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.999 -0.546 . . . . 71.120000000000005 111.889 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -78.36 -23.22 47.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.78 0.659 . . . . 54.32 112.78 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -25.35 68.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.722 0.296 . . . . 64.340000000000003 111.33 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -91.68 1.24 57.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.505 -0.77 . . . . 71.299999999999997 109.734 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 62.7 36.41 13.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.144 0.978 . . . . 72.439999999999998 111.4 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 74.109999999999999 112.318 -179.164 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.56 158.01 48.1 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.937 2.425 . . . . 72.540000000000006 112.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CD1' ' HE2' ' A' ' 26' ' ' TYR . 20.5 t80 -100.65 118.63 37.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.842 -0.617 . . . . 73.329999999999998 112.02 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 115.224 -0.898 . . . . 74.450000000000003 110.225 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.1 p90 -149.77 164.91 34.01 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.374 0.421 . . . . 73.329999999999998 111.398 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.545 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 8.0 mtt -108.85 134.44 51.53 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.795 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.7 mm? -79.33 139.84 37.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 111.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.6 -10.52 50.47 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.508 -0.769 . . . . 71.310000000000002 113.375 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 122.497 0.319 . . . . 72.219999999999999 110.612 179.268 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 69.69 30.38 3.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.082 0.953 . . . . 64.219999999999999 112.181 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.545 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 44.3 mt-10 -79.62 -11.41 59.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.921 -0.581 . . . . 75.25 110.848 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.32 -177.25 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 115.378 -0.828 . . . . 74.450000000000003 110.565 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -79.23 159.94 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.066 0.395 . . . . 53.420000000000002 112.066 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -60.07 -44.5 94.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.911 -0.586 . . . . 73.409999999999997 111.816 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.26 -20.78 61.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.167 -0.47 . . . . 75.120000000000005 113.533 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -84.15 -43.48 14.95 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 116.624 0.212 . . . . 64.239999999999995 111.212 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.9 mt-10 -66.36 -37.42 85.26 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.381 0.426 . . . . 71.319999999999993 111.601 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.51 -25.63 28.68 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.945 -0.57 . . . . 73.219999999999999 111.714 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.62 -46.54 4.86 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.435 0.459 . . . . 71.540000000000006 113.888 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.32 -25.13 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.804 0.442 . . . . 73.299999999999997 111.749 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.98 -8.01 55.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.407 -0.815 . . . . 33.409999999999997 111.657 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.436 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.8 mt-30 -92.3 -11.16 35.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.76 -0.655 . . . . 54.100000000000001 111.24 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.436 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.87 156.37 18.76 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.359 0.412 . . . . 71.25 110.957 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.413 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.3 p -110.99 166.75 10.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.829 -0.623 . . . . 51.25 110.613 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 103' ' ' LEU . 60.7 t -55.98 123.07 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.03 0.532 . . . . 53.100000000000001 111.271 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.36 4.61 70.75 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 115.476 -0.784 . . . . 71.340000000000003 113.179 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -96.07 142.0 28.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.952 0.406 . . . . 75.439999999999998 111.312 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -119.81 108.25 14.17 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.1 -0.955 . . . . 73.140000000000001 109.389 178.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.415 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.49 155.06 48.05 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.974 -0.557 . . . . 61.039999999999999 111.882 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.048 -0.524 . . . . 72.400000000000006 110.255 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.65 125.63 54.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.245 -0.434 . . . . 74.519999999999996 111.092 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.5 m -93.91 114.12 26.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.419 -0.81 . . . . 53.119999999999997 109.527 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.693 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.0 mm -106.43 144.58 15.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.893 -0.594 . . . . 75.109999999999999 110.555 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.74 162.05 20.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.801 -1.091 . . . . 74.230000000000004 110.834 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.03 -17.29 51.0 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.787 2.324 . . . . 62.43 113.22 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.56 -25.7 26.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 111.313 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.09 -18.57 15.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.074 -0.512 . . . . 73.030000000000001 111.477 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.73 -62.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.673 0.619 . . . . 54.109999999999999 112.673 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -134.55 -51.98 0.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.549 0.203 . . . . 74.540000000000006 111.549 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.52 -140.18 7.79 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.475 0.484 . . . . 71.340000000000003 112.057 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.61 -10.91 26.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.602 0.223 . . . . 51.549999999999997 111.602 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.21 -60.37 1.54 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 63.549999999999997 110.533 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.17 -167.49 54.18 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.345 0.403 . . . . 73.040000000000006 113.143 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -97.23 124.15 50.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.942 -0.392 . . . . 71.030000000000001 109.942 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.5 124.07 10.82 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.213 1.942 . . . . 52.530000000000001 113.586 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.18 -47.98 0.99 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.564 -0.743 . . . . 63.229999999999997 113.404 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.03 -51.5 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 111.556 0.206 . . . . 73.329999999999998 111.556 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.7 mm -110.15 98.07 33.42 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 123.178 0.299 . . . . 74.319999999999993 111.084 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.77 165.76 31.56 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.449 2.099 . . . . 65.319999999999993 112.706 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.05 143.37 28.81 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.54 2.16 . . . . 73.209999999999994 113.164 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 56.71 42.89 26.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.634 0.774 . . . . 70.340000000000003 111.778 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.44 132.9 54.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.726 -0.67 . . . . 71.420000000000002 111.73 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -82.25 140.86 33.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.72 -1.127 . . . . 74.25 110.857 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.513 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.7 mt -119.28 153.99 34.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.66 -0.7 . . . . 71.519999999999996 111.029 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.57 131.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.791 -0.641 . . . . 72.319999999999993 109.58 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.583 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.5 m-85 -132.42 132.88 43.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.104 -0.498 . . . . 71.299999999999997 110.64 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 4.9 t70 -116.5 103.31 10.3 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.057 -0.519 . . . . 62.020000000000003 110.103 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.814 HG22 HD11 ' A' ' 74' ' ' LEU . 23.9 m -105.47 153.71 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 60.420000000000002 111.163 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.53 125.88 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.538 -0.755 . . . . 72.230000000000004 110.444 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.15 101.67 3.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.769 -0.65 . . . . 64.0 110.273 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.7 -58.67 2.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.279 -0.419 . . . . 73.510000000000005 111.361 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.926 0.49 . . . . 74.319999999999993 110.736 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.438 HD22 HE22 ' A' ' 20' ' ' GLN . 12.7 mt -120.89 149.17 43.02 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.178 -0.464 . . . . 64.409999999999997 110.814 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.027 -0.533 . . . . 65.530000000000001 110.836 179.819 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 CA-C-O 119.23 -0.761 . . . . 43.119999999999997 112.54 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.86 158.62 38.77 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.05 2.5 . . . . 72.120000000000005 112.771 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.4 t -98.08 -43.49 7.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.883 -0.599 . . . . 74.209999999999994 111.106 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 18.5 mmt -108.87 149.22 29.44 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.401 0.438 . . . . 73.209999999999994 111.074 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.69 10.81 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.625 -0.716 . . . . 60.009999999999998 112.792 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.4 p -123.23 124.9 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.66 0.267 . . . . 71.540000000000006 110.774 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.29 141.78 47.88 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.78 -0.645 . . . . 73.140000000000001 110.245 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.88 123.66 61.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.519 -0.764 . . . . 62.43 110.29 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -117.61 120.38 37.87 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.716 -0.674 . . . . 74.439999999999998 110.228 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 m -77.37 124.5 27.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.118 -0.492 . . . . 74.150000000000006 111.023 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mt -107.25 -40.29 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 114.954 -1.021 . . . . 72.430000000000007 110.24 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -131.06 118.94 17.63 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.902 -0.59 . . . . 74.319999999999993 110.436 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.64 130.33 16.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.555 2.17 . . . . 61.420000000000002 113.213 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.67 -122.16 4.6 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.724 -0.671 . . . . 44.329999999999998 112.15 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.67 -45.95 13.85 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.584 0.192 . . . . 61.450000000000003 110.961 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.84 -2.15 88.39 Favored Glycine 0 C--N 1.342 0.882 0 O-C-N 123.585 0.553 . . . . 63.509999999999998 113.833 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.97 -0.46 2.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.462 0.305 . . . . 75.239999999999995 111.698 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -120.23 93.21 3.98 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.013 0.435 . . . . 71.400000000000006 110.585 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -103.4 149.32 36.88 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.573 -0.739 . . . . 72.109999999999999 110.813 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.72 127.71 16.73 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.537 2.158 . . . . 64.230000000000004 113.102 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.41 0 CA-C-N 115.332 -0.849 . . . . 72.299999999999997 111.119 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -77.3 125.01 28.65 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.856 -0.611 . . . . 75.420000000000002 111.256 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.77 -26.25 8.54 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.672 -0.694 . . . . 64.120000000000005 113.152 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.45 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -98.94 160.15 14.46 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.441 0.297 . . . . 72.140000000000001 110.967 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.74 145.31 28.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 111.329 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 37.1 t -120.72 117.66 28.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.563 -0.744 . . . . 70.120000000000005 110.701 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.88 110.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.389 -0.823 . . . . 63.039999999999999 109.408 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.3 m -147.25 152.55 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.116 -0.493 . . . . 42.420000000000002 111.569 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.8 m-70 -103.05 125.4 49.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.39 -0.823 . . . . 75.310000000000002 109.062 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' HB3' HG12 ' A' ' 101' ' ' VAL . 42.2 p90 -115.89 165.94 12.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.718 0.636 . . . . 74.340000000000003 112.718 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.6 m -148.54 109.95 4.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.931 -1.031 . . . . 54.439999999999998 109.258 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -94.58 119.54 6.12 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.111 -0.566 . . . . 74.5 112.865 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.6 mtm -129.62 131.3 46.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.924 0.49 . . . . 72.230000000000004 111.12 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -57.25 171.1 0.42 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 42.340000000000003 112.083 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.58 -26.2 54.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.042 0.537 . . . . 72.0 112.06 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.43 -17.45 28.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.772 -0.649 . . . . 53.299999999999997 111.74 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 13.77 22.19 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 120.812 -0.708 . . . . 51.420000000000002 113.508 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.428 0 N-CA-C 109.699 -0.482 . . . . 63.25 109.699 179.567 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.454 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 112.916 0.71 . . . . 75.25 112.916 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.7 p90 -133.79 -9.79 2.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.34 -1.3 . . . . 74.109999999999999 111.435 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -166.81 111.62 0.76 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.307 0.575 . . . . 71.540000000000006 111.703 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 3.3 p -117.01 119.28 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.855 -1.066 . . . . 72.049999999999997 110.954 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.535 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.4 p -78.48 -35.43 46.57 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.009 -0.541 . . . . 71.120000000000005 112.177 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -76.9 -23.22 52.55 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.807 0.669 . . . . 54.32 112.807 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -25.16 68.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.749 0.309 . . . . 64.340000000000003 111.307 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 44' ' ' MLY . 88.5 mtt180 -92.44 0.5 57.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.471 -0.786 . . . . 71.299999999999997 109.653 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 m120 63.24 36.7 11.7 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.217 1.007 . . . . 72.439999999999998 111.416 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . 0.546 ' HD3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.67 0 CA-C-N 116.06 -0.518 . . . . 74.109999999999999 112.353 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.16 158.14 45.6 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.978 2.452 . . . . 72.540000000000006 112.794 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -100.08 118.82 37.26 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.877 -0.601 . . . . 73.329999999999998 112.029 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.556 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 115.248 -0.887 . . . . 74.450000000000003 110.215 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' THR . 40.9 p90 -149.62 163.44 37.89 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.388 0.43 . . . . 73.329999999999998 111.441 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.534 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 8.1 mtt -107.42 134.13 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.239 -0.437 . . . . 71.140000000000001 110.804 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.7 mm? -79.11 139.84 37.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 74.219999999999999 111.572 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.46 -9.87 52.88 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.544 -0.753 . . . . 71.310000000000002 113.36 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . 0.48 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.519 0 C-N-CA 122.48 0.312 . . . . 72.219999999999999 110.623 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 69.45 29.39 4.41 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.08 0.952 . . . . 64.219999999999999 112.189 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 45.6 mt-10 -78.78 -11.17 59.98 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.902 -0.59 . . . . 75.25 110.865 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.74 -177.16 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.304 -0.862 . . . . 74.450000000000003 110.571 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -79.13 158.73 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.997 0.369 . . . . 53.420000000000002 111.997 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -59.47 -44.25 93.05 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.935 -0.575 . . . . 73.409999999999997 111.852 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.692 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.51 -20.61 61.54 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 116.072 -0.513 . . . . 75.120000000000005 113.495 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.1 -43.68 14.81 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 116.698 0.249 . . . . 64.239999999999995 111.135 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.6 mt-10 -66.42 -37.18 84.62 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.309 0.381 . . . . 71.319999999999993 111.536 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -84.39 -27.0 27.93 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.935 -0.575 . . . . 73.219999999999999 111.697 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.36 -46.73 5.16 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.462 0.476 . . . . 71.540000000000006 113.981 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.39 -25.33 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.822 0.449 . . . . 73.299999999999997 111.821 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.96 -7.54 54.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.498 -0.773 . . . . 33.409999999999997 111.697 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -92.99 -6.59 48.03 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.852 -0.613 . . . . 54.100000000000001 111.351 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.517 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.23 157.81 19.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.43 -0.35 . . . . 71.25 110.879 -179.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.659 ' C ' HD13 ' A' ' 103' ' ' LEU . 7.9 p -116.48 150.56 37.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.995 -0.548 . . . . 51.25 110.665 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.731 ' HA ' HD22 ' A' ' 103' ' ' LEU . 58.9 t -40.06 119.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.634 0.774 . . . . 53.100000000000001 112.295 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.56 4.36 62.26 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.312 -0.858 . . . . 71.340000000000003 113.138 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -96.5 145.75 25.41 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.925 0.393 . . . . 75.439999999999998 111.38 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.09 106.66 10.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.063 -0.971 . . . . 73.140000000000001 109.393 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -129.91 154.48 47.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.88 -0.6 . . . . 61.039999999999999 111.669 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.421 ' HG2' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 72.400000000000006 110.227 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.801 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.63 125.93 52.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.036 0.446 . . . . 74.519999999999996 111.334 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 77.6 m -93.03 112.45 24.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.033 -0.985 . . . . 53.119999999999997 109.46 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.692 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.1 mm -105.68 142.1 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 75.109999999999999 110.379 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.03 162.02 21.16 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 114.867 -1.061 . . . . 74.230000000000004 110.94 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.38 -17.33 52.67 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.691 2.26 . . . . 62.43 113.174 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.66 -25.71 26.41 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.452 0.47 . . . . 74.510000000000005 111.346 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -101.47 -19.7 15.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.066 -0.515 . . . . 73.030000000000001 111.416 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.75 -61.6 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.674 0.62 . . . . 54.109999999999999 112.674 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.1 -52.09 0.78 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.582 0.216 . . . . 74.540000000000006 111.582 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.53 -140.54 8.02 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 123.557 0.536 . . . . 71.340000000000003 112.018 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.4 -10.95 26.45 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.56 0.207 . . . . 51.549999999999997 111.56 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.07 -60.32 1.55 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.316 -0.402 . . . . 63.549999999999997 110.52 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.6 -166.25 54.17 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 123.333 0.395 . . . . 73.040000000000006 113.15 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.462 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.93 124.6 47.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.943 -0.391 . . . . 71.030000000000001 109.943 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.59 123.9 10.61 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.224 1.949 . . . . 52.530000000000001 113.665 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.61 -0.723 . . . . 63.229999999999997 113.376 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.44 -51.88 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.573 0.187 . . . . 73.329999999999998 111.488 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.6 mm -109.86 97.95 31.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.198 0.312 . . . . 74.319999999999993 111.076 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.76 165.76 31.55 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.438 2.092 . . . . 65.319999999999993 112.672 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.91 143.11 28.97 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.514 2.143 . . . . 73.209999999999994 113.209 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.66 43.11 25.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.603 0.761 . . . . 70.340000000000003 111.799 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.4 132.64 54.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.714 -0.676 . . . . 71.420000000000002 111.698 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -82.38 140.04 33.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.727 -1.124 . . . . 74.25 110.9 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mt -118.23 152.69 35.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.637 -0.71 . . . . 71.519999999999996 110.961 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.79 130.76 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.832 -0.622 . . . . 72.319999999999993 109.514 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.57 ' O ' HD12 ' A' ' 74' ' ' LEU . 87.3 m-85 -131.57 133.48 45.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.264 -0.425 . . . . 71.299999999999997 111.042 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.6 t70 -116.4 105.63 12.73 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.949 -0.569 . . . . 62.020000000000003 110.097 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.801 HG22 HD11 ' A' ' 74' ' ' LEU . 25.3 m -108.53 153.96 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.048 -0.523 . . . . 60.420000000000002 111.119 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.57 123.83 28.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.559 -0.746 . . . . 72.230000000000004 110.268 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.745 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -73.66 103.05 4.11 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.167 0.508 . . . . 64.0 110.713 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.78 -57.93 2.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.403 -0.817 . . . . 73.510000000000005 111.353 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 122.82 0.448 . . . . 74.319999999999993 110.781 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD22 HE22 ' A' ' 20' ' ' GLN . 13.9 mt -124.22 147.54 47.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.762 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.98 -0.555 . . . . 65.530000000000001 110.833 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 CA-C-O 119.177 -0.791 . . . . 43.119999999999997 112.499 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.87 144.06 27.07 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.032 2.488 . . . . 72.120000000000005 112.771 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.8 m 63.69 137.48 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.037 0.935 . . . . 74.209999999999994 112.277 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -97.9 144.17 27.74 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.772 -0.649 . . . . 73.209999999999994 110.869 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -112.32 40.49 2.52 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.603 0.564 . . . . 60.009999999999998 112.996 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 75' ' ' THR . 9.5 p -138.28 112.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.86 0.362 . . . . 71.540000000000006 110.526 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.92 118.07 33.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.589 -0.732 . . . . 73.140000000000001 110.813 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.5 p -109.49 132.0 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.928 -0.578 . . . . 62.43 110.992 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -119.55 124.52 46.59 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.488 -0.778 . . . . 74.439999999999998 110.167 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -78.55 127.25 31.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.113 -0.494 . . . . 74.150000000000006 110.894 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.2 mt -109.31 -41.14 4.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.123 -0.944 . . . . 72.430000000000007 110.306 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -130.67 118.9 18.01 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.92 -0.582 . . . . 74.319999999999993 110.481 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.56 129.19 15.35 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.544 2.162 . . . . 61.420000000000002 113.251 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.03 -121.16 4.08 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 115.747 -0.66 . . . . 44.329999999999998 112.189 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.18 -46.19 12.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.613 0.206 . . . . 61.450000000000003 110.941 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.96 -1.69 87.82 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.552 0.532 . . . . 63.509999999999998 113.757 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -136.62 1.2 2.55 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.399 0.28 . . . . 75.239999999999995 111.745 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -122.23 92.65 3.77 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.064 0.459 . . . . 71.400000000000006 110.247 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -103.6 149.98 37.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 72.109999999999999 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.87 126.85 17.38 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.469 2.113 . . . . 64.230000000000004 112.578 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 115.426 -0.806 . . . . 72.299999999999997 111.459 -179.083 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 62.3 ttt180 -77.46 125.07 28.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.594 -0.73 . . . . 75.420000000000002 111.088 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.54 -29.22 7.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.782 -0.645 . . . . 64.120000000000005 113.249 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 160.27 14.42 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.415 0.286 . . . . 72.140000000000001 110.989 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.19 145.28 30.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.033 -0.53 . . . . 73.129999999999995 111.499 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.2 t -119.78 116.53 26.1 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.576 -0.738 . . . . 70.120000000000005 110.514 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.81 110.71 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.436 -0.802 . . . . 63.039999999999999 109.682 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 103' ' ' LEU . 28.6 m -147.69 152.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.029 -0.532 . . . . 42.420000000000002 111.502 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.0 m-70 -102.45 125.4 49.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.387 -0.824 . . . . 75.310000000000002 109.196 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.633 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.6 p90 -114.79 166.88 11.29 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.904 0.705 . . . . 74.340000000000003 112.904 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.8 m -149.19 110.72 4.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.856 -1.065 . . . . 54.439999999999998 109.272 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.02 118.99 6.0 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.096 -0.573 . . . . 74.5 112.962 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 mtm -128.48 131.93 48.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.913 0.485 . . . . 72.230000000000004 111.114 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.5 170.96 0.66 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.745 -0.661 . . . . 42.340000000000003 111.953 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.4 -26.16 52.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.053 0.541 . . . . 72.0 112.013 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.05 -17.34 29.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.734 -0.666 . . . . 53.299999999999997 111.686 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.6 13.8 21.36 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 120.84 -0.695 . . . . 51.420000000000002 113.375 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.878 -0.416 . . . . 63.25 109.878 179.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.459 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 112.89 0.7 . . . . 75.25 112.89 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.6 p90 -134.55 -8.6 2.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.245 -1.343 . . . . 74.109999999999999 111.229 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -165.46 111.55 0.92 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.341 0.591 . . . . 71.540000000000006 111.505 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 4.8 p -118.18 118.33 31.56 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.812 -1.086 . . . . 72.049999999999997 111.033 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.526 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 p -78.72 -36.31 43.57 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.996 -0.547 . . . . 71.120000000000005 112.252 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -23.24 52.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.914 0.709 . . . . 54.32 112.914 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -24.15 67.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.778 0.323 . . . . 64.340000000000003 111.172 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -93.76 -0.19 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.432 -0.804 . . . . 71.299999999999997 109.687 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.83 36.02 10.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.241 1.017 . . . . 72.439999999999998 111.679 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 CA-C-N 116.239 -0.437 . . . . 74.109999999999999 112.161 -179.419 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.79 158.02 47.17 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.015 2.476 . . . . 72.540000000000006 112.69 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -100.85 118.55 37.14 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.611 0.569 . . . . 73.329999999999998 112.084 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 115.132 -0.94 . . . . 74.450000000000003 109.887 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 40.4 p90 -148.79 159.49 44.1 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.323 0.39 . . . . 73.329999999999998 111.48 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' HH12 ' A' ' 52' ' ' MLY . 6.4 mtt -104.3 132.3 50.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.734 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.38 139.94 39.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 74.219999999999999 111.654 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.434 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.24 -10.84 52.65 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.536 -0.757 . . . . 71.310000000000002 113.308 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . 0.445 HH12 ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 122.577 0.351 . . . . 72.219999999999999 110.718 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 69.86 27.55 4.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.114 0.966 . . . . 64.219999999999999 112.147 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' OE1' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -76.93 -13.25 60.0 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.93 -0.577 . . . . 75.25 110.932 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.29 -179.36 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.316 -0.856 . . . . 74.450000000000003 110.519 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 76' ' ' ILE . 7.2 pt -76.92 158.6 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.036 0.384 . . . . 53.420000000000002 112.036 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.32 -42.72 96.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.964 -0.562 . . . . 73.409999999999997 111.843 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.29 -20.42 63.09 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 113.183 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -84.25 -45.0 13.33 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.336 0.254 . . . . 64.239999999999995 111.189 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.39 -37.51 87.2 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.291 0.37 . . . . 71.319999999999993 111.682 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.55 -26.14 28.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.935 -0.575 . . . . 73.219999999999999 111.792 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.41 -45.85 4.84 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.421 0.45 . . . . 71.540000000000006 113.958 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.1 p -63.75 -25.77 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.665 0.386 . . . . 73.299999999999997 111.757 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.62 -5.34 44.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.367 -0.833 . . . . 33.409999999999997 111.707 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -95.34 -11.14 28.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.637 -0.711 . . . . 54.100000000000001 111.215 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -105.74 156.6 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.268 0.355 . . . . 71.25 110.772 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.419 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 23.4 p -111.18 166.58 10.96 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.934 -0.575 . . . . 51.25 110.612 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.635 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.6 t -55.84 123.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 122.964 0.506 . . . . 53.100000000000001 111.23 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.38 2.76 70.14 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.565 -0.743 . . . . 71.340000000000003 113.179 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -94.04 142.67 27.12 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 120.953 0.406 . . . . 75.439999999999998 111.382 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -121.34 109.22 14.64 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.055 -0.975 . . . . 73.140000000000001 109.347 178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.08 156.43 46.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.141 -0.481 . . . . 61.039999999999999 111.944 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.324 0 CA-C-N 116.063 -0.517 . . . . 72.400000000000006 110.263 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.919 HD11 HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -105.1 134.29 48.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.037 -0.529 . . . . 74.519999999999996 110.699 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.1 m -99.74 114.07 26.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.649 -0.705 . . . . 53.119999999999997 109.557 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG21 HD12 ' A' ' 56' ' ' ILE . 7.4 mm -106.18 134.24 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 110.136 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.63 162.12 22.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.402 -0.817 . . . . 74.230000000000004 110.755 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.17 -17.07 50.28 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.508 2.138 . . . . 62.43 113.111 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.93 -25.26 24.46 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.44 0.463 . . . . 74.510000000000005 111.24 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -101.41 -18.38 16.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 73.030000000000001 111.415 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.12 -62.34 1.54 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.649 0.611 . . . . 54.109999999999999 112.649 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -133.85 -54.0 0.87 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.63 0.233 . . . . 74.540000000000006 111.63 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.45 -139.84 7.29 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.536 0.522 . . . . 71.340000000000003 112.019 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.47 -10.78 26.69 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 111.59 0.218 . . . . 51.549999999999997 111.59 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.63 -60.33 1.54 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.314 -0.403 . . . . 63.549999999999997 110.534 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.52 -166.99 54.53 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 123.318 0.386 . . . . 73.040000000000006 113.155 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.446 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.58 124.08 49.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.942 -0.392 . . . . 71.030000000000001 109.942 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.5 124.0 10.75 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.208 1.939 . . . . 52.530000000000001 113.625 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.18 -48.17 0.97 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.553 -0.749 . . . . 63.229999999999997 113.372 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.97 -51.49 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.57 0.211 . . . . 73.329999999999998 111.57 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.9 mm -110.06 97.71 31.23 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 123.159 0.287 . . . . 74.319999999999993 111.111 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.37 165.61 31.9 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.391 2.061 . . . . 65.319999999999993 112.744 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.05 143.74 29.24 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.651 2.234 . . . . 73.209999999999994 113.249 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 56.54 41.3 28.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.652 0.781 . . . . 70.340000000000003 111.8 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.23 54.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.713 -0.676 . . . . 71.420000000000002 111.731 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -82.82 138.72 33.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.747 -1.115 . . . . 74.25 110.926 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.532 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 mt -116.67 155.07 29.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.526 -0.761 . . . . 71.519999999999996 110.901 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.48 129.59 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.824 -0.625 . . . . 72.319999999999993 109.481 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' O ' HD12 ' A' ' 74' ' ' LEU . 85.3 m-85 -130.94 133.26 45.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.072 -0.513 . . . . 71.299999999999997 110.741 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -116.6 102.63 9.63 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.586 0.554 . . . . 62.020000000000003 110.359 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.919 HG22 HD11 ' A' ' 74' ' ' LEU . 24.0 m -103.56 153.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.08 -0.509 . . . . 60.420000000000002 110.943 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.29 125.97 39.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 72.230000000000004 110.201 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.93 101.92 3.32 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.86 -0.609 . . . . 64.0 110.455 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.28 -58.38 2.52 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.146 -0.479 . . . . 73.510000000000005 111.394 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 122.821 0.448 . . . . 74.319999999999993 110.774 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.9 mt -122.77 146.31 47.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.087 -0.506 . . . . 64.409999999999997 110.799 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.003 -0.544 . . . . 65.530000000000001 110.809 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 CA-C-O 119.019 -0.878 . . . . 43.119999999999997 112.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.16 139.72 24.2 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.887 2.391 . . . . 72.120000000000005 112.784 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.1 t 61.91 118.37 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.96 0.904 . . . . 74.209999999999994 111.929 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.61 150.74 51.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.747 -0.66 . . . . 73.209999999999994 110.857 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -96.4 28.9 11.3 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 115.938 -0.573 . . . . 60.009999999999998 112.996 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG23 HD13 ' A' ' 76' ' ' ILE . 12.0 p -140.75 121.84 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.443 0.297 . . . . 71.540000000000006 110.433 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.78 120.29 36.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.851 -0.613 . . . . 73.140000000000001 110.76 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -106.36 122.76 60.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.98 -0.554 . . . . 62.43 109.912 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 73' ' ' MLY . 8.2 pt-20 -113.19 121.24 43.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.452 -0.795 . . . . 74.439999999999998 111.249 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -76.79 130.7 38.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.012 -0.54 . . . . 74.150000000000006 111.257 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.52 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.0 mt -113.91 -41.23 3.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.095 -0.957 . . . . 72.430000000000007 110.12 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 t -129.72 118.16 18.68 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 110.433 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.72 127.58 13.24 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.59 2.193 . . . . 61.420000000000002 113.448 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.71 -121.64 4.31 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.772 -0.649 . . . . 44.329999999999998 111.856 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.49 -45.61 19.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.558 0.179 . . . . 61.450000000000003 110.79 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 81.99 -1.68 86.0 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.067 -0.515 . . . . 63.509999999999998 113.663 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -138.23 4.17 2.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.614 0.366 . . . . 75.239999999999995 111.66 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.7 m -128.33 92.95 3.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.648 -0.501 . . . . 71.400000000000006 109.648 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.59 151.82 38.2 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.678 -0.692 . . . . 72.109999999999999 109.815 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.4 132.21 39.86 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.291 1.994 . . . . 64.230000000000004 111.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.51 0 O-C-N 123.452 0.47 . . . . 72.299999999999997 112.26 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -77.9 133.9 38.01 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.221 -0.9 . . . . 75.420000000000002 111.256 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.2 -21.3 46.31 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.183 -0.532 . . . . 64.120000000000005 113.222 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -100.84 159.26 15.34 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.632 0.254 . . . . 72.140000000000001 110.796 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.645 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -78.26 134.93 37.48 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.917 -0.583 . . . . 73.129999999999995 111.201 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 50' ' ' LEU . 66.0 m -111.04 109.81 20.07 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.955 -0.566 . . . . 70.120000000000005 110.263 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.73 109.38 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.447 -0.797 . . . . 63.039999999999999 109.812 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG12 ' HA ' ' A' ' 103' ' ' LEU . 29.8 m -146.0 150.06 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.862 -0.608 . . . . 42.420000000000002 111.299 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 10.5 m-70 -101.09 125.34 47.7 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.416 -0.811 . . . . 75.310000000000002 109.058 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.6 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.4 p90 -116.3 166.33 12.17 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.86 0.689 . . . . 74.340000000000003 112.86 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.6 m -148.94 111.47 4.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.871 -1.059 . . . . 54.439999999999998 109.394 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -96.25 120.1 6.5 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.029 -0.532 . . . . 74.5 112.844 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.0 mtm -129.09 132.1 47.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.967 0.507 . . . . 72.230000000000004 111.015 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.5 170.77 0.5 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.776 -0.647 . . . . 42.340000000000003 112.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.62 -26.63 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.122 0.569 . . . . 72.0 112.159 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.41 -17.23 29.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.766 -0.652 . . . . 53.299999999999997 111.687 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.8 13.79 21.02 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 120.82 -0.705 . . . . 51.420000000000002 113.226 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.912 -0.403 . . . . 63.25 109.912 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.473 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.433 0 N-CA-C 112.824 0.676 . . . . 75.25 112.824 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.8 p90 -133.26 -14.54 2.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 74.109999999999999 111.288 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -161.68 111.51 1.59 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-O 121.018 0.437 . . . . 71.540000000000006 111.862 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 3.2 p -117.01 119.91 36.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.403 -0.817 . . . . 72.049999999999997 110.968 177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.6 p -78.49 -37.02 44.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.209 -0.451 . . . . 71.120000000000005 112.092 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.32 -24.32 57.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 54.32 112.98 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -25.48 68.35 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.733 0.302 . . . . 64.340000000000003 111.319 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -93.54 3.53 55.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.503 -0.771 . . . . 71.299999999999997 109.705 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 62.61 34.05 15.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.219 1.008 . . . . 72.439999999999998 111.713 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.416 0 N-CA-C 113.179 0.807 . . . . 74.109999999999999 113.179 -178.847 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.18 157.93 37.7 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.215 2.61 . . . . 72.540000000000006 112.652 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -99.01 118.26 35.38 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.961 -0.563 . . . . 73.329999999999998 112.013 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.31 0 CA-C-N 115.091 -0.959 . . . . 74.450000000000003 110.086 178.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.7 p90 -152.15 162.38 41.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.302 0.376 . . . . 73.329999999999998 111.537 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.645 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -105.09 132.96 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.396 -0.365 . . . . 71.140000000000001 110.929 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD11 ' HA ' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -77.8 143.49 37.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.73 -0.668 . . . . 74.219999999999999 111.658 179.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.49 -6.46 60.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.547 -0.751 . . . . 71.310000000000002 113.438 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.6 0.36 . . . . 72.219999999999999 110.695 179.437 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 69.51 28.71 4.56 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.163 0.985 . . . . 64.219999999999999 112.125 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.46 -33.63 60.86 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.942 -0.572 . . . . 75.25 110.563 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 m -102.16 -174.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.161 -0.927 . . . . 74.450000000000003 110.042 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 pt -80.6 157.89 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.761 0.282 . . . . 53.420000000000002 111.761 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -58.75 -44.02 90.44 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.035 -0.53 . . . . 73.409999999999997 111.839 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.664 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.45 -20.21 60.94 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.128 -0.487 . . . . 75.120000000000005 113.307 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -84.24 -44.69 13.64 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 122.319 0.248 . . . . 64.239999999999995 111.325 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 50' ' ' LEU . 30.3 mt-10 -66.07 -38.19 87.68 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.252 0.345 . . . . 71.319999999999993 111.596 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.43 -24.87 29.37 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.219999999999999 111.722 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.34 -46.22 4.74 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.45 0.468 . . . . 71.540000000000006 113.793 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.37 -25.56 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.772 0.429 . . . . 73.299999999999997 111.691 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.41 -9.54 58.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.284 -0.871 . . . . 33.409999999999997 111.723 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.51 -11.08 41.26 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.783 -0.644 . . . . 54.100000000000001 111.174 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -106.66 156.4 18.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.11 -0.495 . . . . 71.25 110.437 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 18.5 p -107.69 165.01 11.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.086 -0.506 . . . . 51.25 110.604 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HA ' HD12 ' A' ' 103' ' ' LEU . 72.2 t -57.78 122.06 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.988 0.515 . . . . 53.100000000000001 110.857 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 92.02 5.86 65.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.301 -0.863 . . . . 71.340000000000003 112.98 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -97.69 145.44 26.32 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.336 . . . . 75.439999999999998 111.387 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -120.55 110.62 16.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.441 -0.8 . . . . 73.140000000000001 109.362 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -134.06 152.7 51.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 61.039999999999999 112.031 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 C--N 1.344 0.354 0 CA-C-N 116.108 -0.496 . . . . 72.400000000000006 110.586 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.824 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.6 129.59 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.859 -0.609 . . . . 74.519999999999996 111.228 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.1 m -95.71 113.77 25.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.353 -0.84 . . . . 53.119999999999997 109.467 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.664 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.7 mm -106.45 142.36 19.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.967 -0.56 . . . . 75.109999999999999 110.56 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.31 162.49 19.7 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 114.877 -1.056 . . . . 74.230000000000004 110.683 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 -14.42 41.79 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.501 2.134 . . . . 62.43 113.234 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.57 -28.63 24.74 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.378 0.424 . . . . 74.510000000000005 110.793 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.9 -19.75 16.48 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.738 -0.665 . . . . 73.030000000000001 111.562 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.14 -62.44 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.763 0.653 . . . . 54.109999999999999 112.763 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.81 -52.71 0.8 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.547 0.203 . . . . 74.540000000000006 111.547 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.08 -140.27 7.76 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 116.139 -0.482 . . . . 71.340000000000003 112.007 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.89 -10.81 25.7 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 111.549 0.203 . . . . 51.549999999999997 111.549 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.03 -60.23 1.57 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.222 -0.444 . . . . 63.549999999999997 110.432 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 -168.53 53.98 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.357 0.411 . . . . 73.040000000000006 113.231 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.45 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.62 124.31 51.06 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.868 -0.419 . . . . 71.030000000000001 109.868 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.58 124.67 11.39 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.234 1.956 . . . . 52.530000000000001 113.637 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.43 -45.51 1.29 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.581 -0.736 . . . . 63.229999999999997 113.432 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.46 -51.57 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.632 0.216 . . . . 73.329999999999998 111.581 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.8 mm -111.03 98.94 41.05 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 123.202 0.314 . . . . 74.319999999999993 111.141 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.55 165.66 31.79 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.463 2.109 . . . . 65.319999999999993 112.683 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.32 143.91 28.64 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.522 2.148 . . . . 73.209999999999994 113.225 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.3 41.9 28.53 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.649 0.78 . . . . 70.340000000000003 111.799 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.91 131.81 53.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 71.420000000000002 111.807 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -81.01 141.9 33.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.732 -1.122 . . . . 74.25 110.856 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.508 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.8 mt -120.59 152.18 38.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.743 -0.662 . . . . 71.519999999999996 111.085 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -119.14 132.12 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 72.319999999999993 109.41 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.561 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.9 m-85 -133.16 132.93 42.18 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.381 0.426 . . . . 71.299999999999997 111.057 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 6.5 t70 -115.95 103.13 10.3 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.955 -0.566 . . . . 62.020000000000003 110.038 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 74' ' ' LEU . 24.0 m -106.17 153.37 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.919 -0.582 . . . . 60.420000000000002 111.127 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.68 125.65 36.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.536 -0.756 . . . . 72.230000000000004 110.184 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.98 101.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.621 -0.718 . . . . 64.0 110.523 -179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.68 -58.1 2.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.524 -0.307 . . . . 73.510000000000005 111.649 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 122.702 0.401 . . . . 74.319999999999993 111.285 -179.812 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.33 151.21 25.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.161 -0.472 . . . . 64.409999999999997 110.343 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 65.530000000000001 110.79 179.705 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.731 0 CA-C-O 119.222 -0.765 . . . . 43.119999999999997 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.81 150.64 35.05 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.028 2.485 . . . . 72.120000000000005 112.737 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.8 m -128.17 144.39 51.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.936 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.7 mtt -101.27 144.43 30.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.87 -0.605 . . . . 73.209999999999994 110.825 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -107.01 35.43 5.04 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.952 -0.567 . . . . 60.009999999999998 112.966 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.4 p -137.36 118.81 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.707 0.289 . . . . 71.540000000000006 110.539 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.65 119.26 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.777 -0.647 . . . . 73.140000000000001 110.655 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 19.0 t -107.74 124.74 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.946 -0.57 . . . . 62.43 109.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.34 122.79 47.76 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.697 -0.683 . . . . 74.439999999999998 110.251 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -76.96 126.35 30.83 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.115 -0.493 . . . . 74.150000000000006 111.007 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.403 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.6 mt -109.71 -39.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.011 -0.995 . . . . 72.430000000000007 110.271 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -131.25 118.62 17.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 74.319999999999993 110.384 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.29 130.52 17.6 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.543 2.162 . . . . 61.420000000000002 113.231 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.67 -121.59 4.49 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.79 -0.641 . . . . 44.329999999999998 112.386 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.4 -45.93 14.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.552 0.176 . . . . 61.450000000000003 110.696 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.4 -1.18 88.54 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.026 -0.534 . . . . 63.509999999999998 114.033 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -137.33 -1.03 2.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.369 0.267 . . . . 75.239999999999995 111.694 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -118.82 93.42 4.09 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 71.400000000000006 110.533 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.2 149.01 36.52 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.57 -0.741 . . . . 72.109999999999999 110.817 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.91 129.1 18.93 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.55 2.167 . . . . 64.230000000000004 113.201 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 CA-C-N 115.358 -0.837 . . . . 72.299999999999997 111.125 -179.738 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.35 124.64 28.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 75.420000000000002 111.36 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.88 -25.15 9.08 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.685 -0.688 . . . . 64.120000000000005 113.295 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.438 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -100.12 160.18 14.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.322 0.249 . . . . 72.140000000000001 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -84.94 145.34 27.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 111.007 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 59.7 m -124.32 120.64 32.76 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.758 -0.655 . . . . 70.120000000000005 111.01 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 t -90.27 111.32 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.263 -0.881 . . . . 63.039999999999999 109.633 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 103' ' ' LEU . 29.5 m -146.03 151.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.063 -0.517 . . . . 42.420000000000002 111.481 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.0 m-70 -103.03 125.33 49.73 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.596 -0.729 . . . . 75.310000000000002 109.394 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.8 p90 -116.09 167.61 10.83 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.365 0.505 . . . . 74.340000000000003 112.365 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.74 105.56 3.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.093 -0.958 . . . . 54.439999999999998 109.417 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.78 118.27 5.32 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 121.017 -0.611 . . . . 74.5 112.806 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 mtm -133.16 134.78 44.6 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.067 0.547 . . . . 72.230000000000004 110.901 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.19 172.12 0.33 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.439 -0.8 . . . . 42.340000000000003 112.359 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.88 -27.3 51.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.099 0.56 . . . . 72.0 111.993 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.79 -17.4 29.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.639 -0.71 . . . . 53.299999999999997 111.695 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.99 13.77 22.6 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 120.738 -0.744 . . . . 51.420000000000002 113.314 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 N-CA-C 110.065 -0.346 . . . . 63.25 110.065 179.639 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.314 0 N-CA-C 113.017 0.747 . . . . 75.25 113.017 -179.52 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 22.3 p90 -134.09 -14.31 2.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.546 -1.207 . . . . 74.109999999999999 111.231 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.98 110.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.104 0.478 . . . . 71.540000000000006 112.141 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 31.4 t -123.18 138.6 54.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.302 -0.863 . . . . 72.049999999999997 110.039 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.488 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 65.1 p -78.75 -33.14 46.79 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.696 0.628 . . . . 71.120000000000005 112.696 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -74.42 -23.13 58.9 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.636 0.606 . . . . 54.32 112.636 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' HA ' HH21 ' A' ' 40' ' ' ARG . 0.5 OUTLIER -62.96 -29.18 70.61 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.857 0.36 . . . . 64.340000000000003 110.91 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -95.7 -0.21 51.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.274 -0.876 . . . . 71.299999999999997 110.023 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 64.45 37.44 8.19 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.227 1.011 . . . . 72.439999999999998 111.771 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.573 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.765 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.92 158.1 50.39 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.893 2.395 . . . . 72.540000000000006 112.919 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.05 118.39 36.69 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.74 -0.664 . . . . 73.329999999999998 112.039 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.502 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 115.237 -0.892 . . . . 74.450000000000003 110.208 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' THR . 42.3 p90 -150.44 163.44 38.39 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.371 0.42 . . . . 73.329999999999998 111.382 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.418 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 7.5 mtt -106.96 133.98 50.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.767 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -78.83 139.88 38.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.98 -0.554 . . . . 74.219999999999999 111.497 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.92 -10.0 54.31 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.512 -0.767 . . . . 71.310000000000002 113.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 122.562 0.345 . . . . 72.219999999999999 110.696 179.228 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 69.82 27.51 4.54 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.13 0.972 . . . . 64.219999999999999 112.142 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 46.4 mt-10 -77.32 -12.76 59.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.0 -0.545 . . . . 75.25 110.863 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.33 -177.68 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.322 -0.854 . . . . 74.450000000000003 110.49 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.09 158.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 111.993 0.368 . . . . 53.420000000000002 111.993 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -59.55 -44.32 93.29 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.968 -0.56 . . . . 73.409999999999997 111.834 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.688 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.64 -20.28 61.45 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 123.533 0.521 . . . . 75.120000000000005 113.421 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -84.12 -43.9 14.57 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 122.307 0.243 . . . . 64.239999999999995 111.156 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.7 mt-10 -66.29 -37.76 86.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.329 0.393 . . . . 71.319999999999993 111.673 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.43 -25.04 29.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.987 -0.551 . . . . 73.219999999999999 111.857 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -88.35 -45.88 4.85 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.46 0.475 . . . . 71.540000000000006 113.839 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.76 -25.16 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.786 0.434 . . . . 73.299999999999997 111.646 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.97 -8.07 56.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.395 -0.82 . . . . 33.409999999999997 111.742 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.51 -4.43 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.819 -0.628 . . . . 54.100000000000001 111.201 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.536 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.42 158.37 19.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.332 -0.395 . . . . 71.25 110.874 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.652 ' C ' HD13 ' A' ' 103' ' ' LEU . 10.3 p -117.14 150.52 38.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.021 -0.536 . . . . 51.25 110.655 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.737 ' HA ' HD22 ' A' ' 103' ' ' LEU . 54.4 t -40.24 117.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 53.100000000000001 112.356 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.24 59.2 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.187 -0.915 . . . . 71.340000000000003 113.08 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -96.73 144.84 26.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.369 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -122.69 109.26 14.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.09 -0.959 . . . . 73.140000000000001 109.247 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.06 157.58 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.907 -0.588 . . . . 61.039999999999999 111.918 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.295 0 CA-C-N 115.947 -0.569 . . . . 72.400000000000006 110.283 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.795 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.16 125.25 52.83 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 111.235 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.9 m -93.56 113.82 26.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.389 -0.823 . . . . 53.119999999999997 109.531 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.5 mm -105.82 143.1 17.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.852 -0.613 . . . . 75.109999999999999 110.577 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.66 161.79 21.74 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.877 -1.056 . . . . 74.230000000000004 110.916 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.14 -17.25 51.2 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.768 2.312 . . . . 62.43 113.192 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.99 -25.65 25.89 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.435 0.46 . . . . 74.510000000000005 111.341 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.73 -18.76 15.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.066 -0.516 . . . . 73.030000000000001 111.405 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.66 -63.07 1.4 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.722 0.638 . . . . 54.109999999999999 112.722 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.46 -50.99 0.86 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.593 0.22 . . . . 74.540000000000006 111.593 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.08 -141.48 8.99 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.533 0.52 . . . . 71.340000000000003 112.03 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.79 -11.16 27.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.607 0.225 . . . . 51.549999999999997 111.607 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -99.51 -60.33 1.55 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.267 -0.424 . . . . 63.549999999999997 110.49 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 -168.04 53.38 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.342 0.401 . . . . 73.040000000000006 113.21 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.451 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.93 124.67 49.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.932 -0.395 . . . . 71.030000000000001 109.932 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.86 124.16 10.77 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.195 1.93 . . . . 52.530000000000001 113.629 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.2 -46.3 1.19 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.604 -0.725 . . . . 63.229999999999997 113.394 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.7 -51.84 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 111.619 0.229 . . . . 73.329999999999998 111.619 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.9 mm -110.09 98.56 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.184 0.302 . . . . 74.319999999999993 111.045 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.71 165.65 31.87 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.404 2.07 . . . . 65.319999999999993 112.713 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.93 142.9 28.65 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.551 2.167 . . . . 73.209999999999994 113.188 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 56.67 44.34 23.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.598 0.759 . . . . 70.340000000000003 111.688 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.64 133.5 53.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.713 -0.676 . . . . 71.420000000000002 111.78 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.35 140.84 32.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.693 -1.14 . . . . 74.25 110.737 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.463 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.8 mt -118.74 155.01 31.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.743 -0.662 . . . . 71.519999999999996 111.164 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -121.24 129.95 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.865 -0.607 . . . . 72.319999999999993 109.712 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.2 m-85 -132.27 133.27 43.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.075 -0.511 . . . . 71.299999999999997 110.614 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.7 t70 -116.43 104.2 11.21 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.554 0.534 . . . . 62.020000000000003 110.159 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.795 HG22 HD11 ' A' ' 74' ' ' LEU . 24.9 m -106.0 153.46 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.078 -0.51 . . . . 60.420000000000002 111.179 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.86 124.84 30.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.488 -0.778 . . . . 72.230000000000004 110.239 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.761 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -74.38 104.15 5.02 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.133 0.492 . . . . 64.0 110.721 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.37 -57.74 2.73 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.429 -0.805 . . . . 73.510000000000005 111.372 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 122.887 0.475 . . . . 74.319999999999993 110.748 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.438 HD22 HE22 ' A' ' 20' ' ' GLN . 13.3 mt -125.4 147.07 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.099 -0.5 . . . . 64.409999999999997 110.66 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.059 -0.519 . . . . 65.530000000000001 110.766 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 CA-C-O 119.044 -0.864 . . . . 43.119999999999997 112.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.12 -35.55 2.99 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.851 2.367 . . . . 72.120000000000005 113.108 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.4 m -107.51 -42.74 4.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.373 0.421 . . . . 74.209999999999994 111.325 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 84.4 mmm -100.83 133.73 44.87 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.405 0.44 . . . . 73.209999999999994 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -117.73 15.07 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 115.862 -0.608 . . . . 60.009999999999998 113.165 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.597 HG23 HD13 ' A' ' 76' ' ' ILE . 11.2 p -123.03 126.36 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 122.331 0.252 . . . . 71.540000000000006 110.621 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.77 141.47 48.37 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.839 -0.619 . . . . 73.140000000000001 110.447 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.88 124.07 62.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.443 -0.799 . . . . 62.43 110.107 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.08 120.54 38.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.718 -0.674 . . . . 74.439999999999998 110.317 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -77.35 124.55 28.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.112 -0.494 . . . . 74.150000000000006 110.853 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -107.32 -40.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.986 -1.006 . . . . 72.430000000000007 110.307 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -131.43 119.13 17.31 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.031 -0.531 . . . . 74.319999999999993 110.391 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.45 129.82 16.39 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.551 2.167 . . . . 61.420000000000002 113.378 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.53 -121.36 4.42 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.742 -0.663 . . . . 44.329999999999998 112.121 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -83.82 -46.37 12.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.647 0.223 . . . . 61.450000000000003 110.954 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.49 -0.96 88.49 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.051 -0.522 . . . . 63.509999999999998 113.662 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -136.82 0.91 2.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.795 0.295 . . . . 75.239999999999995 111.795 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.74 92.8 3.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.026 0.441 . . . . 71.400000000000006 110.327 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.52 149.39 37.0 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.57 -0.741 . . . . 72.109999999999999 110.949 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.21 125.75 14.57 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.533 2.155 . . . . 64.230000000000004 112.939 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.435 -0.802 . . . . 72.299999999999997 111.558 -179.325 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' NE ' ' HA3' ' A' ' 51' ' ' GLY . 41.7 ttt180 -77.43 124.25 27.63 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.525 -0.761 . . . . 75.420000000000002 111.468 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -24.3 11.81 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.889 -0.596 . . . . 64.120000000000005 113.51 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.437 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -100.7 160.17 14.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.573 0.225 . . . . 72.140000000000001 110.976 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.664 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -80.51 145.14 32.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.046 -0.525 . . . . 73.129999999999995 111.315 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 53.6 m -123.08 116.3 23.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.581 -0.736 . . . . 70.120000000000005 110.485 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.1 110.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.554 -0.748 . . . . 63.039999999999999 109.762 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.2 m -147.12 149.97 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.013 -0.54 . . . . 42.420000000000002 111.38 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.8 m-70 -101.13 125.33 47.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.411 -0.813 . . . . 75.310000000000002 109.059 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.617 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.8 p90 -116.38 166.55 11.94 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 74.340000000000003 112.783 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.3 m -148.81 111.64 4.83 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.966 -1.015 . . . . 54.439999999999998 109.405 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.8 119.83 6.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.938 -0.574 . . . . 74.5 112.706 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.1 mtm -129.79 131.5 46.22 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.875 0.47 . . . . 72.230000000000004 111.115 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.8 mt -57.04 170.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.651 -0.704 . . . . 42.340000000000003 112.027 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.15 -25.9 48.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.058 0.543 . . . . 72.0 112.052 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.44 -17.39 28.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.762 -0.654 . . . . 53.299999999999997 111.639 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.87 13.77 22.83 Favored Glycine 0 C--N 1.346 1.125 0 C-N-CA 120.86 -0.686 . . . . 51.420000000000002 113.324 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.767 -0.457 . . . . 63.25 109.767 179.547 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.446 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 112.942 0.719 . . . . 75.25 112.942 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.6 p90 -133.47 -15.16 2.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.176 -1.375 . . . . 74.109999999999999 111.301 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 36' ' ' PHE . 2.9 m-20 -160.89 111.47 1.76 Allowed 'General case' 0 C--N 1.357 0.921 0 CA-C-O 121.014 0.435 . . . . 71.540000000000006 112.052 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 2.9 p -116.95 119.88 36.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.404 -0.816 . . . . 72.049999999999997 110.917 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 53.9 p -78.35 -35.5 47.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.178 -0.464 . . . . 71.120000000000005 112.179 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH21 HH22 ' A' ' 35' ' ' MLY . 18.1 ptt180 -76.6 -23.25 53.45 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.797 0.665 . . . . 54.32 112.797 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -24.76 67.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.8 0.333 . . . . 64.340000000000003 111.392 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' O ' ' HE2' ' A' ' 44' ' ' MLY . 63.3 mtm180 -92.87 1.43 57.3 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.437 -0.802 . . . . 71.299999999999997 109.704 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 63.16 35.55 12.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.212 1.005 . . . . 72.439999999999998 111.529 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . 0.526 ' HE2' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 112.478 0.548 . . . . 74.109999999999999 112.478 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.96 158.1 46.44 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 123.023 2.482 . . . . 72.540000000000006 112.768 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -98.74 118.27 35.1 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.973 -0.558 . . . . 73.329999999999998 112.029 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.577 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 115.241 -0.89 . . . . 74.450000000000003 110.163 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.5 p90 -151.21 164.11 37.33 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.289 0.368 . . . . 73.329999999999998 111.671 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.8 OUTLIER -107.51 135.82 48.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.338 -0.392 . . . . 71.140000000000001 110.528 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -79.45 140.77 37.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.813 -0.63 . . . . 74.219999999999999 111.59 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' HA3' ' NE ' ' A' ' 18' ' ' ARG . . . 81.49 -7.61 60.96 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.551 -0.749 . . . . 71.310000000000002 113.294 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 122.597 0.359 . . . . 72.219999999999999 110.661 179.387 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 70.1 26.83 4.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.146 0.978 . . . . 64.219999999999999 112.202 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.02 -15.29 60.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.981 -0.554 . . . . 75.25 110.744 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.92 -177.69 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.244 -0.889 . . . . 74.450000000000003 110.431 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.77 159.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.04 0.385 . . . . 53.420000000000002 112.04 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -59.69 -44.21 93.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.975 -0.557 . . . . 73.409999999999997 111.774 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.69 -20.44 61.76 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 123.505 0.503 . . . . 75.120000000000005 113.462 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -84.1 -43.44 15.05 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 116.688 0.244 . . . . 64.239999999999995 111.065 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.6 mt-10 -66.52 -36.86 83.75 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.368 0.417 . . . . 71.319999999999993 111.514 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.49 -26.8 27.89 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.894 -0.594 . . . . 73.219999999999999 111.651 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -86.96 -46.93 4.93 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.438 0.461 . . . . 71.540000000000006 114.01 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.01 -25.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.826 0.45 . . . . 73.299999999999997 111.788 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.43 56.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.423 -0.808 . . . . 33.409999999999997 111.66 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 55.3 mt-30 -91.97 -9.15 44.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.817 -0.629 . . . . 54.100000000000001 111.256 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -109.27 156.29 20.12 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 71.25 111.008 -179.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 21.8 p -111.27 167.09 10.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 51.25 110.509 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.0 t -56.14 123.08 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.965 0.506 . . . . 53.100000000000001 111.229 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.99 4.24 69.34 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.445 -0.798 . . . . 71.340000000000003 113.177 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -95.68 142.58 27.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.894 0.378 . . . . 75.439999999999998 111.376 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -120.54 107.34 12.74 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.066 -0.97 . . . . 73.140000000000001 109.383 178.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.07 154.4 47.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 61.039999999999999 111.633 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.435 ' HG2' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-N 116.034 -0.53 . . . . 72.400000000000006 110.201 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.798 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.03 126.55 54.92 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.046 0.451 . . . . 74.519999999999996 111.364 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 76.7 m -93.58 112.35 24.22 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.041 -0.981 . . . . 53.119999999999997 109.496 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.693 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.7 mm -105.63 141.21 21.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.02 -0.536 . . . . 75.109999999999999 110.477 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 162.07 21.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 114.837 -1.074 . . . . 74.230000000000004 110.91 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.47 -17.34 53.15 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.655 2.236 . . . . 62.43 113.221 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.41 -25.77 26.8 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.457 0.473 . . . . 74.510000000000005 111.368 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.7 -19.98 15.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.082 -0.508 . . . . 73.030000000000001 111.392 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.14 -61.79 1.76 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.651 0.611 . . . . 54.109999999999999 112.651 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.59 -52.51 0.81 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.558 0.207 . . . . 74.540000000000006 111.558 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.91 -140.56 7.98 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 116.109 -0.496 . . . . 71.340000000000003 112.051 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.92 26.62 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.609 0.225 . . . . 51.549999999999997 111.609 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.1 -60.33 1.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.254 -0.43 . . . . 63.549999999999997 110.441 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.05 -168.55 54.21 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.367 0.417 . . . . 73.040000000000006 113.16 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.449 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.95 123.8 52.16 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.949 -0.389 . . . . 71.030000000000001 109.949 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.22 124.73 11.61 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.216 1.944 . . . . 52.530000000000001 113.633 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.48 -47.47 1.04 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.545 -0.752 . . . . 63.229999999999997 113.332 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.87 -51.68 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 111.62 0.23 . . . . 73.329999999999998 111.62 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.2 mm -110.13 98.17 33.75 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 123.207 0.317 . . . . 74.319999999999993 111.136 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.73 165.62 31.98 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.39 2.06 . . . . 65.319999999999993 112.684 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.12 143.8 29.1 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.552 2.168 . . . . 73.209999999999994 113.227 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 56.64 41.79 27.92 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.641 0.776 . . . . 70.340000000000003 111.77 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.33 132.19 54.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.749 -0.66 . . . . 71.420000000000002 111.751 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 m -82.6 139.27 33.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.787 -1.097 . . . . 74.25 110.901 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mt -117.96 151.45 37.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.589 -0.732 . . . . 71.519999999999996 110.939 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 37.4 t -119.14 129.61 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.88 -0.6 . . . . 72.319999999999993 109.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.0 m-85 -130.42 134.04 46.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.256 -0.429 . . . . 71.299999999999997 111.093 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.7 t70 -116.48 105.26 12.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.914 -0.585 . . . . 62.020000000000003 110.092 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.798 HG22 HD11 ' A' ' 74' ' ' LEU . 27.6 m -107.59 153.94 8.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.02 -0.536 . . . . 60.420000000000002 111.014 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.11 125.33 32.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.495 -0.775 . . . . 72.230000000000004 110.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.11 100.49 3.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.784 -0.644 . . . . 64.0 110.125 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -88.6 -58.33 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.407 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 122.747 0.419 . . . . 74.319999999999993 110.781 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 HE22 ' A' ' 20' ' ' GLN . 13.0 mt -125.45 145.55 50.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 64.409999999999997 110.72 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.004 -0.544 . . . . 65.530000000000001 110.865 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 CA-C-O 119.03 -0.872 . . . . 43.119999999999997 112.635 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.15 142.62 27.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.774 2.316 . . . . 72.120000000000005 112.796 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.4 m -127.82 146.59 50.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.897 -0.592 . . . . 74.209999999999994 110.957 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.5 mtt -118.76 -41.87 2.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.595 . . . . 73.209999999999994 111.219 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.8 1.68 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.489 0.493 . . . . 60.009999999999998 112.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.5 p -120.38 121.22 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.735 0.303 . . . . 71.540000000000006 110.633 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.3 119.23 32.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.806 -0.634 . . . . 73.140000000000001 110.844 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 13.9 p -110.65 135.69 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.977 -0.556 . . . . 62.43 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.25 125.64 45.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.474 -0.785 . . . . 74.439999999999998 110.279 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.27 128.68 34.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.15 -0.477 . . . . 74.150000000000006 110.912 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -111.46 -39.55 3.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.116 -0.947 . . . . 72.430000000000007 110.365 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -132.25 118.79 16.26 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.011 -0.54 . . . . 74.319999999999993 110.475 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.58 130.48 17.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.63 2.22 . . . . 61.420000000000002 113.29 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.64 -121.37 4.44 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.745 -0.661 . . . . 44.329999999999998 112.168 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.21 -46.42 11.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.682 0.241 . . . . 61.450000000000003 111.034 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 86.16 -1.01 87.66 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.548 0.53 . . . . 63.509999999999998 113.708 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -136.57 0.39 2.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.476 0.31 . . . . 75.239999999999995 111.819 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.52 92.91 3.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.022 0.439 . . . . 71.400000000000006 110.35 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -103.8 149.62 37.33 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.524 -0.762 . . . . 72.109999999999999 111.039 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.82 122.49 9.86 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.466 2.111 . . . . 64.230000000000004 112.707 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 115.419 -0.81 . . . . 72.299999999999997 111.649 -179.298 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 46.3 ttt180 -77.42 126.63 31.22 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.612 -0.722 . . . . 75.420000000000002 111.134 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.41 -27.98 8.99 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.767 -0.651 . . . . 64.120000000000005 113.162 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.443 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -98.26 160.18 14.46 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.337 0.255 . . . . 72.140000000000001 110.896 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.47 145.28 29.03 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.086 -0.506 . . . . 73.129999999999995 111.379 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 36.9 t -120.4 116.95 26.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.633 -0.712 . . . . 70.120000000000005 110.629 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.78 110.7 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.526 -0.761 . . . . 63.039999999999999 109.529 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 103' ' ' LEU . 26.4 m -146.95 153.17 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.988 -0.551 . . . . 42.420000000000002 111.525 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.7 m-70 -103.36 125.33 49.92 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.485 -0.78 . . . . 75.310000000000002 109.412 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.607 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.8 p90 -115.15 167.46 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.534 0.568 . . . . 74.340000000000003 112.534 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.2 m -147.96 107.01 3.85 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.044 -0.98 . . . . 54.439999999999998 109.38 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.22 119.93 5.82 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.02 -0.536 . . . . 74.5 112.692 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.4 mtm -135.48 131.82 36.59 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.978 0.511 . . . . 72.230000000000004 110.915 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.6 mt -55.52 171.83 0.18 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.495 -0.775 . . . . 42.340000000000003 112.512 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.6 -27.81 51.57 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.188 0.595 . . . . 72.0 111.996 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.5 -17.38 30.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.672 -0.695 . . . . 53.299999999999997 111.657 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.59 13.9 23.01 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.849 -0.691 . . . . 51.420000000000002 113.228 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.441 0 N-CA-C 110.097 -0.334 . . . . 63.25 110.097 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.284 0 N-CA-C 112.937 0.718 . . . . 75.25 112.937 -179.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 25.2 p90 -132.81 -15.25 2.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.552 -1.204 . . . . 74.109999999999999 111.401 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.0 111.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.096 0.474 . . . . 71.540000000000006 112.223 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 28.4 t -122.29 142.66 50.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.274 -0.875 . . . . 72.049999999999997 110.093 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.5 p -78.65 -38.19 40.12 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.788 -0.642 . . . . 71.120000000000005 112.55 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.425 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -70.03 -22.93 63.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.529 0.566 . . . . 54.32 112.529 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -29.23 70.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.899 0.381 . . . . 64.340000000000003 110.834 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -96.9 -0.32 47.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.243 -0.889 . . . . 71.299999999999997 110.079 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t30 64.47 37.63 8.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.277 1.031 . . . . 72.439999999999998 111.717 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 111.588 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.46 157.93 55.24 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.859 2.372 . . . . 72.540000000000006 112.935 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.18 118.16 36.16 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.83 -0.623 . . . . 73.329999999999998 112.081 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.482 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 115.126 -0.943 . . . . 74.450000000000003 109.788 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 39.9 p90 -149.37 163.25 38.26 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.308 0.38 . . . . 73.329999999999998 111.451 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.2 mtt -107.0 133.74 51.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.052 -0.522 . . . . 71.140000000000001 110.779 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.97 141.16 36.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.836 -0.62 . . . . 74.219999999999999 111.588 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.15 -11.0 51.47 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.541 -0.754 . . . . 71.310000000000002 113.478 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.741 0.305 . . . . 72.219999999999999 110.63 179.312 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 68.34 30.4 5.5 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.08 0.952 . . . . 64.219999999999999 112.186 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.959 -0.564 . . . . 75.25 110.544 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -103.8 -173.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.23 -0.896 . . . . 74.450000000000003 110.194 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 76' ' ' ILE . 7.4 pt -81.62 158.28 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 111.695 0.257 . . . . 53.420000000000002 111.695 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -59.63 -43.42 93.85 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.054 -0.521 . . . . 73.409999999999997 111.974 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.62 -19.82 63.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 123.515 0.509 . . . . 75.120000000000005 113.227 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -84.14 -44.6 13.84 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 122.294 0.237 . . . . 64.239999999999995 111.083 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.82 -37.44 86.25 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.19 0.306 . . . . 71.319999999999993 111.477 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.49 -25.8 28.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.852 -0.613 . . . . 73.219999999999999 111.736 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.62 -46.8 4.48 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.503 0.502 . . . . 71.540000000000006 113.867 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -63.79 -26.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.754 0.422 . . . . 73.299999999999997 111.705 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -7.15 52.76 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.308 -0.86 . . . . 33.409999999999997 111.732 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -93.96 -8.56 39.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.748 -0.66 . . . . 54.100000000000001 111.32 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.445 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.35 156.58 19.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.38 . . . . 71.25 110.85 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.412 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.7 p -111.14 166.83 10.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.863 -0.608 . . . . 51.25 110.612 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' HD12 ' A' ' 103' ' ' LEU . 55.1 t -55.74 122.78 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.0 0.52 . . . . 53.100000000000001 111.215 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.55 3.63 68.79 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.487 -0.779 . . . . 71.340000000000003 113.257 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.76 142.95 26.86 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 120.928 0.394 . . . . 75.439999999999998 111.361 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.69 109.38 14.66 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.065 -0.971 . . . . 73.140000000000001 109.5 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.84 154.69 50.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.053 -0.522 . . . . 61.039999999999999 111.826 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.242 0 CA-C-N 116.028 -0.533 . . . . 72.400000000000006 110.463 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.866 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.26 135.77 48.2 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.167 -0.469 . . . . 74.519999999999996 110.782 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.4 m -101.46 111.56 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.655 -0.702 . . . . 53.119999999999997 109.324 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.619 HG21 HD12 ' A' ' 56' ' ' ILE . 7.9 mm -102.94 130.7 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.873 -0.603 . . . . 75.109999999999999 110.262 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.32 161.44 27.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.304 -0.862 . . . . 74.230000000000004 110.869 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.41 -17.49 53.74 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.507 2.138 . . . . 62.43 113.007 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.61 -25.16 23.71 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.432 0.458 . . . . 74.510000000000005 111.228 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -99.72 -19.45 16.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.042 -0.526 . . . . 73.030000000000001 111.301 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.85 -63.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.793 0.664 . . . . 54.109999999999999 112.793 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' A' ' 91' ' ' ILE . 77.2 m-85 -132.17 -53.66 0.97 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.534 0.198 . . . . 74.540000000000006 111.534 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.35 -139.83 7.43 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.522 0.513 . . . . 71.340000000000003 111.997 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.7 -10.57 26.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.608 0.225 . . . . 51.549999999999997 111.608 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 m -100.13 -60.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.253 -0.43 . . . . 63.549999999999997 110.431 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.7 -170.22 52.91 Favored Glycine 0 C--N 1.346 1.087 0 O-C-N 123.369 0.418 . . . . 73.040000000000006 113.204 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.427 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -95.9 124.02 53.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.928 -0.397 . . . . 71.030000000000001 109.928 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.72 125.53 12.27 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.25 1.967 . . . . 52.530000000000001 113.674 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.27 -43.34 1.69 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.617 -0.72 . . . . 63.229999999999997 113.413 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.26 -51.89 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.653 0.227 . . . . 73.329999999999998 111.569 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 22.8 mm -111.66 99.32 44.36 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 123.255 0.347 . . . . 74.319999999999993 111.177 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.63 165.65 31.87 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.379 2.053 . . . . 65.319999999999993 112.663 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.44 143.72 28.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.611 2.207 . . . . 73.209999999999994 113.264 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 56.48 41.21 29.06 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.62 0.768 . . . . 70.340000000000003 111.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.81 131.68 54.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.74 -0.664 . . . . 71.420000000000002 111.652 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.96 138.71 33.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.787 -1.097 . . . . 74.25 110.897 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 3.5 mt -115.12 156.46 25.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.543 -0.753 . . . . 71.519999999999996 110.908 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.94 119.84 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 109.721 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.9 m-85 -122.17 135.28 54.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.142 -0.481 . . . . 71.299999999999997 111.009 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.544 ' OD1' HH23 ' A' ' 73' ' ' MLY . 9.3 t70 -116.6 103.92 10.87 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.595 0.559 . . . . 62.020000000000003 110.212 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.866 HG22 HD11 ' A' ' 74' ' ' LEU . 26.6 m -104.72 153.17 6.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.187 -0.461 . . . . 60.420000000000002 111.065 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.13 125.75 35.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.472 -0.786 . . . . 72.230000000000004 110.209 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.658 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -72.95 101.93 3.33 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.867 -0.606 . . . . 64.0 110.455 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.39 -58.24 2.56 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.049 -0.523 . . . . 73.510000000000005 111.471 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 122.843 0.457 . . . . 74.319999999999993 110.775 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.443 HD22 HE22 ' A' ' 20' ' ' GLN . 12.1 mt -124.11 144.44 49.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.06 -0.518 . . . . 64.409999999999997 110.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.465 0.317 0 O-C-N 123.499 0.499 . . . . 65.530000000000001 110.796 179.877 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 CA-C-O 119.042 -0.866 . . . . 43.119999999999997 112.657 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.25 -35.89 2.71 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.849 2.366 . . . . 72.120000000000005 113.098 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.7 p -103.72 138.07 40.87 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.415 0.447 . . . . 74.209999999999994 110.964 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.6 mtt -125.86 146.44 49.81 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.645 0.59 . . . . 73.209999999999994 111.086 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -114.04 -14.08 9.53 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.68 -0.691 . . . . 60.009999999999998 113.0 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 75' ' ' THR . 14.8 p -120.0 122.8 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 122.352 0.261 . . . . 71.540000000000006 110.799 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.36 118.97 29.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.84 -0.618 . . . . 73.140000000000001 110.491 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.7 t -107.11 132.41 54.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.092 -0.504 . . . . 62.43 110.254 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -120.47 123.65 43.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.571 -0.74 . . . . 74.439999999999998 110.138 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -78.35 126.37 30.68 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 110.945 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.64 -41.24 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.063 -0.971 . . . . 72.430000000000007 110.282 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t -130.2 119.08 18.53 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.979 -0.555 . . . . 74.319999999999993 110.405 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.2 130.43 17.57 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.6 2.2 . . . . 61.420000000000002 113.451 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -121.09 4.5 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.674 -0.694 . . . . 44.329999999999998 112.137 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.48 -46.24 12.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.67 0.235 . . . . 61.450000000000003 111.01 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.51 -1.41 88.34 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.091 -0.504 . . . . 63.509999999999998 113.75 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -135.98 0.56 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.428 0.291 . . . . 75.239999999999995 111.713 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.93 92.28 3.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.038 0.447 . . . . 71.400000000000006 110.189 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -102.61 149.73 37.01 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 115.611 -0.722 . . . . 72.109999999999999 111.032 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.52 128.67 19.63 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.505 2.137 . . . . 64.230000000000004 112.696 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.331 0 CA-C-N 115.472 -0.786 . . . . 72.299999999999997 111.343 -179.046 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HE ' ' CA ' ' A' ' 51' ' ' GLY . 65.7 ttt180 -77.42 121.81 24.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.62 -0.718 . . . . 75.420000000000002 110.998 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.2 -28.96 6.37 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.998 -0.546 . . . . 64.120000000000005 113.322 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.45 160.56 14.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.403 0.281 . . . . 72.140000000000001 110.949 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.01 145.2 30.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.217 -0.447 . . . . 73.129999999999995 111.14 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 61.7 m -125.23 120.79 32.26 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.741 -0.663 . . . . 70.120000000000005 110.996 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.74 111.71 24.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.19 -0.914 . . . . 63.039999999999999 109.743 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 103' ' ' LEU . 25.6 m -147.51 152.79 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.898 -0.592 . . . . 42.420000000000002 111.403 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 7.4 m-70 -103.48 125.19 49.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.488 -0.778 . . . . 75.310000000000002 109.311 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.1 p90 -115.95 167.66 10.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.493 0.553 . . . . 74.340000000000003 112.493 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.99 105.53 3.54 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.063 -0.971 . . . . 54.439999999999998 109.374 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.49 118.05 5.23 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.072 -0.585 . . . . 74.5 112.811 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.9 mtm -133.08 134.93 44.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.088 0.555 . . . . 72.230000000000004 110.92 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.18 172.03 0.33 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.435 -0.802 . . . . 42.340000000000003 112.318 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -55.97 -27.21 51.64 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.116 0.566 . . . . 72.0 111.947 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.79 -17.44 29.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.665 -0.698 . . . . 53.299999999999997 111.669 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.04 13.74 22.56 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.716 -0.755 . . . . 51.420000000000002 113.307 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.447 0 N-CA-C 110.067 -0.346 . . . . 63.25 110.067 179.601 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.31 0 N-CA-C 113.055 0.761 . . . . 75.25 113.055 -179.513 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 22.1 p90 -134.69 -14.27 2.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.538 -1.21 . . . . 74.109999999999999 111.135 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.7 110.5 0.04 OUTLIER 'General case' 0 C--N 1.359 1.019 0 CA-C-O 121.088 0.47 . . . . 71.540000000000006 112.186 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -122.98 138.77 54.59 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.371 -0.832 . . . . 72.049999999999997 110.121 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 63.6 p -78.69 -36.56 43.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.879 -0.601 . . . . 71.120000000000005 112.557 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -22.97 62.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.68 0.622 . . . . 54.32 112.68 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -28.89 69.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.822 0.344 . . . . 64.340000000000003 110.904 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -95.5 -0.36 52.28 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.32 -0.854 . . . . 71.299999999999997 110.055 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 64.49 37.43 8.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.233 1.013 . . . . 72.439999999999998 111.822 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.585 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.33 157.92 55.68 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.839 2.359 . . . . 72.540000000000006 112.811 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -102.48 117.25 34.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 112.108 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.436 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 C--O 1.235 0.313 0 CA-C-N 115.147 -0.933 . . . . 74.450000000000003 109.858 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 21' ' ' THR . 31.3 p90 -147.18 165.58 29.58 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.347 0.405 . . . . 73.329999999999998 111.334 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 ttm -110.37 124.39 51.62 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.319 -0.623 . . . . 71.140000000000001 109.319 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -80.17 138.49 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.73 -0.668 . . . . 74.219999999999999 112.06 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.556 ' CA ' ' HE ' ' A' ' 18' ' ' ARG . . . 88.62 -5.57 84.52 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.13 -0.941 . . . . 71.310000000000002 112.899 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 122.443 0.297 . . . . 72.219999999999999 110.723 179.427 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 70.17 30.95 3.33 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.174 0.99 . . . . 64.219999999999999 112.159 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.03 -32.37 44.96 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.966 -0.561 . . . . 75.25 110.751 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 m -108.49 -175.87 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.254 -0.885 . . . . 74.450000000000003 110.37 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 pt -82.32 159.66 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.138 0.421 . . . . 53.420000000000002 112.138 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -59.17 -43.96 92.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.905 -0.589 . . . . 73.409999999999997 111.755 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.672 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -64.06 -18.36 62.35 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 123.532 0.52 . . . . 75.120000000000005 113.444 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.408 ' O ' HG12 ' A' ' 63' ' ' VAL . 3.4 m0 -84.21 -46.05 12.27 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 122.504 0.322 . . . . 64.239999999999995 111.328 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.32 -36.07 80.73 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.422 0.451 . . . . 71.319999999999993 111.448 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.68 -23.94 29.2 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 111.597 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.05 -44.6 5.33 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.387 0.429 . . . . 71.540000000000006 113.623 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 59' ' ' TRP . 5.0 p -65.55 -22.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.816 0.447 . . . . 73.299999999999997 111.616 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.92 -9.35 58.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.581 -0.736 . . . . 33.409999999999997 111.522 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -91.16 -11.92 36.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.64 -0.709 . . . . 54.100000000000001 111.336 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -108.42 156.64 19.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.365 -0.379 . . . . 71.25 111.02 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.416 ' C ' ' HG ' ' A' ' 103' ' ' LEU . 21.6 p -111.66 167.36 10.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.783 -0.644 . . . . 51.25 110.579 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.632 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.8 t -56.26 123.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.937 0.495 . . . . 53.100000000000001 111.238 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.4 4.2 71.15 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.501 -0.772 . . . . 71.340000000000003 113.15 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' A' ' 66' ' ' MET . 8.9 tt0 -96.12 141.74 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.899 0.38 . . . . 75.439999999999998 111.335 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.18 108.85 15.17 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.167 -0.924 . . . . 73.140000000000001 109.297 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.22 156.59 45.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.992 -0.549 . . . . 61.039999999999999 111.864 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.292 0 CA-C-N 116.04 -0.527 . . . . 72.400000000000006 110.214 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.8 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -109.95 124.99 52.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.297 -0.41 . . . . 74.519999999999996 111.169 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m -93.55 112.78 24.75 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.283 -0.872 . . . . 53.119999999999997 109.464 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.672 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.8 mm -104.25 141.33 20.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 115.803 -0.635 . . . . 75.109999999999999 110.415 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.32 161.32 23.42 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.874 -1.057 . . . . 74.230000000000004 110.817 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.09 -16.97 49.32 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.78 2.32 . . . . 62.43 113.278 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.38 -25.49 25.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.392 0.433 . . . . 74.510000000000005 111.338 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -101.67 -19.28 15.48 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.013 -0.54 . . . . 73.030000000000001 111.369 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.19 -63.2 1.39 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.728 0.64 . . . . 54.109999999999999 112.728 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -133.68 -51.02 0.85 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.615 0.228 . . . . 74.540000000000006 111.615 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.15 -141.92 9.38 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.556 0.535 . . . . 71.340000000000003 112.029 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.42 -11.22 28.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 111.585 0.217 . . . . 51.549999999999997 111.585 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.54 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 63.549999999999997 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.16 -166.78 53.46 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.341 0.401 . . . . 73.040000000000006 113.223 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.465 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -97.93 124.92 46.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.885 -0.413 . . . . 71.030000000000001 109.885 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.96 123.74 10.33 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.223 1.949 . . . . 52.530000000000001 113.588 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.57 -46.08 1.22 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.618 -0.719 . . . . 63.229999999999997 113.394 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.77 -51.79 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.596 0.198 . . . . 73.329999999999998 111.527 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.4 mm -110.14 98.52 35.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 123.2 0.312 . . . . 74.319999999999993 111.013 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.69 165.71 31.7 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.427 2.085 . . . . 65.319999999999993 112.71 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.96 142.43 27.99 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.604 2.203 . . . . 73.209999999999994 113.197 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 56.84 44.44 23.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.599 0.76 . . . . 70.340000000000003 111.701 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.83 133.25 53.18 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.724 -0.671 . . . . 71.420000000000002 111.8 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -83.56 140.37 32.3 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.791 -1.095 . . . . 74.25 110.781 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.6 mt -117.26 155.7 29.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.651 -0.704 . . . . 71.519999999999996 111.064 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.93 127.97 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.828 -0.623 . . . . 72.319999999999993 109.772 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' O ' HD12 ' A' ' 74' ' ' LEU . 89.0 m-85 -130.13 132.64 46.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.126 -0.488 . . . . 71.299999999999997 110.565 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 t70 -115.37 104.3 11.65 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.13 -0.486 . . . . 62.020000000000003 110.142 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.8 HG22 HD11 ' A' ' 74' ' ' LEU . 26.2 m -106.78 153.13 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.08 -0.509 . . . . 60.420000000000002 111.126 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.94 125.98 36.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.507 -0.77 . . . . 72.230000000000004 110.24 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.06 101.96 3.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.708 -0.678 . . . . 64.0 110.485 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.91 -58.05 2.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.331 -0.395 . . . . 73.510000000000005 111.37 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 122.788 0.435 . . . . 74.319999999999993 110.862 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.32 147.61 49.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.07 -0.514 . . . . 64.409999999999997 110.622 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.465 0.287 0 CA-C-N 116.271 -0.422 . . . . 65.530000000000001 110.745 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 CA-C-O 119.059 -0.856 . . . . 43.119999999999997 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.51 135.91 18.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.881 2.387 . . . . 72.120000000000005 112.777 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.9 m -128.69 146.86 50.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.889 -0.596 . . . . 74.209999999999994 110.922 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.9 mmt 71.09 -49.08 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.43 1.092 . . . . 73.209999999999994 112.533 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 131.4 -22.33 4.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.465 -0.398 . . . . 60.009999999999998 112.986 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 75' ' ' THR . 11.9 p -116.38 122.91 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.409 0.284 . . . . 71.540000000000006 110.449 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.9 119.63 32.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.896 -0.593 . . . . 73.140000000000001 111.054 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.8 p -108.67 138.92 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.951 -0.568 . . . . 62.43 111.027 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -125.08 123.93 40.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.524 -0.762 . . . . 74.439999999999998 110.27 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.15 126.18 30.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.255 -0.429 . . . . 74.150000000000006 110.928 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -109.05 -39.83 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.087 -0.96 . . . . 72.430000000000007 110.337 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -132.13 119.16 16.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 123.54 0.525 . . . . 74.319999999999993 110.467 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 130.33 17.01 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.619 2.213 . . . . 61.420000000000002 113.32 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.66 -121.45 4.46 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.746 -0.661 . . . . 44.329999999999998 112.18 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.09 -46.47 11.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.652 0.226 . . . . 61.450000000000003 111.015 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 86.13 -1.32 87.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 116.005 -0.543 . . . . 63.509999999999998 113.646 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -136.5 0.73 2.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.872 0.323 . . . . 75.239999999999995 111.872 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.91 92.79 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.056 0.455 . . . . 71.400000000000006 110.352 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.8 149.96 37.69 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.52 -0.764 . . . . 72.109999999999999 110.929 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -64.95 128.66 21.26 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.468 2.112 . . . . 64.230000000000004 112.639 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.409 0 CA-C-N 115.423 -0.808 . . . . 72.299999999999997 111.524 -178.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 64.7 ttt180 -77.36 125.87 30.02 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.583 -0.735 . . . . 75.420000000000002 111.191 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.81 -26.31 10.84 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 116.006 -0.543 . . . . 64.120000000000005 113.231 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 160.26 14.5 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.364 0.266 . . . . 72.140000000000001 110.891 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.535 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -81.91 145.15 30.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.023 -0.535 . . . . 73.129999999999995 111.523 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.5 t -120.1 115.66 24.12 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.48 -0.782 . . . . 70.120000000000005 110.343 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -89.65 110.49 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.612 -0.722 . . . . 63.039999999999999 109.745 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 103' ' ' LEU . 29.8 m -147.44 151.75 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.035 -0.529 . . . . 42.420000000000002 111.464 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -102.28 125.41 48.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.386 -0.825 . . . . 75.310000000000002 109.031 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.616 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.3 p90 -116.15 167.79 10.68 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.877 0.695 . . . . 74.340000000000003 112.877 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.3 m -148.91 112.14 4.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.015 . . . . 54.439999999999998 109.535 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.27 119.18 6.09 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.042 -0.526 . . . . 74.5 112.698 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.8 mtm -130.06 131.3 45.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.876 0.47 . . . . 72.230000000000004 111.126 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.04 170.12 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.67 -0.696 . . . . 42.340000000000003 112.069 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -56.19 -25.24 46.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.108 0.563 . . . . 72.0 112.147 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.12 -17.36 27.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.83 -0.623 . . . . 53.299999999999997 111.351 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.34 13.79 21.9 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.765 -0.731 . . . . 51.420000000000002 113.377 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.851 -0.425 . . . . 63.25 109.851 179.63 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.435 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 112.916 0.71 . . . . 75.25 112.916 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 27.3 p90 -133.62 -14.54 2.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.266 -1.334 . . . . 74.109999999999999 111.275 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -161.62 111.54 1.6 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.069 0.461 . . . . 71.540000000000006 111.99 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.435 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 2.5 p -116.55 120.54 39.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.36 -0.836 . . . . 72.049999999999997 110.865 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.558 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 55.7 p -78.36 -35.5 47.31 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.231 -0.441 . . . . 71.120000000000005 112.159 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -76.73 -23.31 53.04 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.853 0.686 . . . . 54.32 112.853 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -25.37 68.19 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.752 0.311 . . . . 64.340000000000003 111.32 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -92.05 1.07 57.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.417 -0.81 . . . . 71.299999999999997 109.747 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 63.0 36.43 12.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.195 0.998 . . . . 72.439999999999998 111.441 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 112.393 0.516 . . . . 74.109999999999999 112.393 -179.287 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.92 158.07 46.61 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.901 2.401 . . . . 72.540000000000006 112.748 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -99.41 118.3 35.72 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.049 -0.523 . . . . 73.329999999999998 112.046 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.477 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.223 -0.898 . . . . 74.450000000000003 110.004 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 21' ' ' THR . 38.6 p90 -150.43 160.76 43.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.245 0.341 . . . . 73.329999999999998 111.621 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.535 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.3 mpp? -104.69 134.59 47.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.321 -0.399 . . . . 71.140000000000001 110.589 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.9 mm? -78.57 140.34 38.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.811 -0.632 . . . . 74.219999999999999 111.739 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 81.84 -8.14 60.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 115.437 -0.801 . . . . 71.310000000000002 113.354 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 122.562 0.345 . . . . 72.219999999999999 110.722 179.32 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 69.61 27.84 4.68 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.098 0.959 . . . . 64.219999999999999 112.203 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.75 -13.26 60.04 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.005 -0.543 . . . . 75.25 110.764 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.53 -178.56 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.157 -0.928 . . . . 74.450000000000003 110.544 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.495 HD12 HG21 ' A' ' 76' ' ' ILE . 7.2 pt -77.56 158.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.999 0.37 . . . . 53.420000000000002 111.999 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -59.81 -42.88 94.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.862 -0.608 . . . . 73.409999999999997 111.893 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.34 -20.59 63.38 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.031 -0.531 . . . . 75.120000000000005 113.253 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -84.12 -44.41 14.05 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 116.699 0.25 . . . . 64.239999999999995 111.052 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.9 mt-10 -65.89 -36.96 84.85 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.212 0.32 . . . . 71.319999999999993 111.53 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -84.57 -26.75 27.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.894 -0.594 . . . . 73.219999999999999 111.784 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.53 -46.35 4.95 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 123.435 0.459 . . . . 71.540000000000006 113.974 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.452 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.1 p -63.51 -25.95 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.754 0.422 . . . . 73.299999999999997 111.697 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.53 -7.25 53.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.42 -0.809 . . . . 33.409999999999997 111.618 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -93.77 -9.89 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.78 -0.645 . . . . 54.100000000000001 111.316 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.451 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.55 156.26 19.2 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.35 -0.386 . . . . 71.25 110.785 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.412 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.8 p -110.76 167.09 10.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.851 -0.613 . . . . 51.25 110.63 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' HA ' HD12 ' A' ' 103' ' ' LEU . 54.0 t -56.21 123.23 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.92 0.488 . . . . 53.100000000000001 111.165 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.28 3.34 69.7 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.421 -0.809 . . . . 71.340000000000003 113.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.87 142.07 27.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 75.439999999999998 111.353 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -120.75 108.73 14.33 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.401 178.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.38 157.08 44.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.02 -0.536 . . . . 61.039999999999999 111.848 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--N 1.343 0.299 0 CA-C-N 116.083 -0.508 . . . . 72.400000000000006 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.821 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.02 134.57 47.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 74.519999999999996 110.828 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.2 m -100.48 113.14 25.68 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 53.119999999999997 109.402 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.539 HD12 ' HA3' ' A' ' 58' ' ' GLY . 8.5 mm -105.16 134.83 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.255 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.92 161.64 23.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.175 -0.92 . . . . 74.230000000000004 110.712 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.94 -16.99 48.6 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.634 2.223 . . . . 62.43 113.237 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.76 -25.32 24.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.152 -0.476 . . . . 74.510000000000005 111.284 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -101.37 -19.18 15.71 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.0 -0.545 . . . . 73.030000000000001 111.362 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.78 -63.24 1.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.724 0.639 . . . . 54.109999999999999 112.724 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -133.51 -52.43 0.88 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.634 0.235 . . . . 74.540000000000006 111.634 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.79 -140.32 7.84 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.458 0.474 . . . . 71.340000000000003 112.053 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 -10.87 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 111.629 0.233 . . . . 51.549999999999997 111.629 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.29 -60.36 1.54 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.26 -0.427 . . . . 63.549999999999997 110.507 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.04 -166.93 54.41 Favored Glycine 0 C--N 1.346 1.108 0 O-C-N 123.331 0.394 . . . . 73.040000000000006 113.232 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.452 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.63 124.11 49.59 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.909 -0.404 . . . . 71.030000000000001 109.909 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.56 123.66 10.38 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.242 1.961 . . . . 52.530000000000001 113.589 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.66 -48.45 0.94 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.573 -0.739 . . . . 63.229999999999997 113.361 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.96 -51.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 111.594 0.22 . . . . 73.329999999999998 111.594 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 20.0 mm -109.55 97.54 27.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 123.273 0.358 . . . . 74.319999999999993 111.079 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.49 165.56 32.09 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.381 2.054 . . . . 65.319999999999993 112.747 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.06 143.55 29.01 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.558 2.172 . . . . 73.209999999999994 113.256 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.67 41.85 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.641 0.776 . . . . 70.340000000000003 111.793 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.94 132.32 54.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.683 -0.69 . . . . 71.420000000000002 111.697 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -83.27 136.85 34.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.719 -1.128 . . . . 74.25 110.991 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -115.18 153.32 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.518 -0.764 . . . . 71.519999999999996 110.875 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.88 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 72.319999999999993 109.559 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.3 m-85 -130.15 135.13 47.85 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.128 -0.487 . . . . 71.299999999999997 110.775 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.3 t70 -116.33 104.82 11.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.973 -0.558 . . . . 62.020000000000003 110.186 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.821 HG22 HD11 ' A' ' 74' ' ' LEU . 26.7 m -105.9 153.0 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 115.979 -0.555 . . . . 60.420000000000002 110.972 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.8 125.37 35.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.752 . . . . 72.230000000000004 110.182 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.643 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -72.98 100.94 3.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.77 -0.65 . . . . 64.0 110.388 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.3 -57.91 2.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.049 -0.523 . . . . 73.510000000000005 111.391 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 122.827 0.451 . . . . 74.319999999999993 110.774 -179.897 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -123.78 145.42 49.05 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.077 -0.511 . . . . 64.409999999999997 110.734 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.465 0.305 0 O-C-N 123.523 0.514 . . . . 65.530000000000001 110.821 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 118.993 -0.893 . . . . 43.119999999999997 112.687 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.38 157.63 41.1 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.824 2.349 . . . . 72.120000000000005 112.794 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.3 m -127.36 -40.9 1.77 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.842 -0.617 . . . . 74.209999999999994 111.258 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 72.4 mtm -97.36 -40.87 8.51 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.388 0.43 . . . . 73.209999999999994 111.29 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 123.98 -42.06 1.64 Allowed Glycine 0 C--N 1.339 0.713 0 O-C-N 123.508 0.505 . . . . 60.009999999999998 112.484 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.2 p -121.71 118.81 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.741 0.305 . . . . 71.540000000000006 110.736 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.23 118.34 30.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.714 -0.675 . . . . 73.140000000000001 110.751 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.5 p -108.76 138.13 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.887 -0.597 . . . . 62.43 111.039 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.41 124.31 42.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.452 -0.795 . . . . 74.439999999999998 110.181 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 m -78.01 127.05 31.73 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.447 0.467 . . . . 74.150000000000006 110.973 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mt -110.17 -39.58 3.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.132 -0.94 . . . . 72.430000000000007 110.323 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -132.42 119.24 16.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.526 . . . . 74.319999999999993 110.473 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.52 131.0 18.03 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.644 2.229 . . . . 61.420000000000002 113.336 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.34 -121.4 4.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.727 -0.67 . . . . 44.329999999999998 112.236 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -84.21 -46.58 11.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.688 0.244 . . . . 61.450000000000003 111.045 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 86.59 -1.32 87.16 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.111 -0.495 . . . . 63.509999999999998 113.679 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -136.43 0.92 2.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.405 0.282 . . . . 75.239999999999995 111.76 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -122.35 92.88 3.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.101 0.477 . . . . 71.400000000000006 110.291 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -103.39 149.77 37.33 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 115.552 -0.749 . . . . 72.109999999999999 111.12 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.97 125.01 12.5 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.465 2.11 . . . . 64.230000000000004 112.74 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.397 0 CA-C-N 115.441 -0.8 . . . . 72.299999999999997 111.35 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.36 128.75 34.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 75.420000000000002 111.112 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.74 10.93 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.847 -0.615 . . . . 64.120000000000005 113.066 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.438 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -99.56 160.43 14.3 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.54 0.336 . . . . 72.140000000000001 110.843 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.32 144.91 30.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.331 -0.395 . . . . 73.129999999999995 111.336 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 38.8 t -122.61 117.89 26.9 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.606 -0.724 . . . . 70.120000000000005 110.714 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.75 110.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.497 -0.774 . . . . 63.039999999999999 109.613 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 103' ' ' LEU . 24.7 m -147.85 153.33 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.019 -0.537 . . . . 42.420000000000002 111.457 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.2 m-70 -103.66 125.31 50.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.45 -0.795 . . . . 75.310000000000002 109.355 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.9 p90 -116.5 165.95 12.65 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 74.340000000000003 112.361 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.5 m -148.05 108.45 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.189 -0.914 . . . . 54.439999999999998 109.402 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -89.17 119.96 5.6 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.032 -0.531 . . . . 74.5 112.954 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 mtm -133.59 129.98 37.74 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.032 0.533 . . . . 72.230000000000004 111.0 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -54.79 170.53 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.622 -0.717 . . . . 42.340000000000003 112.457 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.5 -27.32 47.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.214 0.606 . . . . 72.0 112.184 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -88.98 -17.17 30.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.831 -0.622 . . . . 53.299999999999997 111.279 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.5 13.78 21.61 Favored Glycine 0 C--N 1.346 1.102 0 C-N-CA 120.823 -0.703 . . . . 51.420000000000002 113.004 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.722 -0.473 . . . . 63.25 109.722 179.488 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.552 ' HG3' ' O ' ' A' ' 28' ' ' GLY . . . . . . . . 0 CA--C 1.508 -0.653 0 CA-C-N 115.973 -0.558 . . . . 75.25 112.252 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.4 p90 -131.99 -11.52 3.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.586 -1.188 . . . . 74.109999999999999 111.945 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.84 115.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 112.708 0.633 . . . . 71.540000000000006 112.708 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.8 t -122.82 147.02 47.02 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.395 -0.82 . . . . 72.049999999999997 110.681 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.546 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 53.4 p -78.59 -30.56 46.76 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.574 -0.739 . . . . 71.120000000000005 112.115 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -75.17 -24.81 57.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.839 0.681 . . . . 54.32 112.839 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CG ' HH21 ' A' ' 35' ' ' MLY . 3.1 t70 -60.86 -29.63 69.64 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.746 0.308 . . . . 64.340000000000003 111.061 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -92.54 1.33 57.32 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.455 -0.793 . . . . 71.299999999999997 109.999 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 61.79 40.13 13.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.127 0.971 . . . . 72.439999999999998 111.498 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 111.887 -179.297 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -71.49 157.88 55.26 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.741 2.294 . . . . 72.540000000000006 112.801 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -101.96 117.46 34.88 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.895 -0.593 . . . . 73.329999999999998 112.123 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.472 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 115.134 -0.939 . . . . 74.450000000000003 109.833 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' THR . 29.3 p90 -148.12 165.22 31.52 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.405 0.441 . . . . 73.329999999999998 111.401 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mtt -109.46 126.94 54.02 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.03 -0.532 . . . . 71.140000000000001 109.75 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -82.6 138.05 34.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.688 -0.687 . . . . 74.219999999999999 112.11 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.46 -6.28 82.33 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.067 -0.969 . . . . 71.310000000000002 112.872 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 122.49 0.316 . . . . 72.219999999999999 110.673 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 69.16 31.61 3.96 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.186 0.994 . . . . 64.219999999999999 112.071 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -79.55 -32.03 42.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.872 -0.604 . . . . 75.25 110.84 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.46 -174.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.447 -0.797 . . . . 74.450000000000003 110.246 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.694 HD12 HG21 ' A' ' 76' ' ' ILE . 9.5 pt -81.98 157.95 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 111.903 0.334 . . . . 53.420000000000002 111.903 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -59.68 -43.83 93.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.001 -0.545 . . . . 73.409999999999997 112.166 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.45 -18.27 63.12 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.452 0.47 . . . . 75.120000000000005 113.326 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.415 ' CD1' HD11 ' A' ' 56' ' ' ILE . 5.2 m0 -84.26 -46.81 11.44 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 122.438 0.295 . . . . 64.239999999999995 111.372 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.31 -36.35 83.79 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.265 0.353 . . . . 71.319999999999993 111.369 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.46 -24.21 29.59 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 73.219999999999999 111.69 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.05 -45.18 4.87 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.436 0.46 . . . . 71.540000000000006 113.639 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.33 -24.21 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.796 0.438 . . . . 73.299999999999997 111.489 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.14 -7.17 54.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.445 -0.798 . . . . 33.409999999999997 111.53 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -94.3 -11.46 30.06 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.672 -0.695 . . . . 54.100000000000001 111.306 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.444 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.61 156.4 18.63 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.305 0.378 . . . . 71.25 110.794 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.412 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 24.5 p -110.91 167.33 10.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.941 -0.572 . . . . 51.25 110.639 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.633 ' HA ' HD12 ' A' ' 103' ' ' LEU . 55.4 t -56.21 123.36 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.928 0.491 . . . . 53.100000000000001 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.08 3.49 69.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.504 -0.771 . . . . 71.340000000000003 113.179 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.89 142.68 27.19 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 120.97 0.414 . . . . 75.439999999999998 111.352 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.04 109.2 14.77 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.097 -0.956 . . . . 73.140000000000001 109.413 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -132.33 156.34 46.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.034 -0.53 . . . . 61.039999999999999 111.917 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.549 HH23 ' OD2' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-N 116.111 -0.495 . . . . 72.400000000000006 110.455 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.827 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.26 135.29 46.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.912 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.0 m -100.77 111.46 23.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.705 -0.68 . . . . 53.119999999999997 109.344 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.694 HG21 HD12 ' A' ' 56' ' ' ILE . 7.6 mm -103.01 130.99 52.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 110.19 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.49 161.48 27.66 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.294 -0.866 . . . . 74.230000000000004 111.027 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.37 -17.11 51.41 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.626 2.217 . . . . 62.43 113.223 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.43 -27.13 21.74 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.511 0.507 . . . . 74.510000000000005 111.221 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.38 -18.96 18.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 73.030000000000001 111.362 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' HB2' HG22 ' A' ' 76' ' ' ILE . . . -85.87 -60.13 2.1 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.597 0.592 . . . . 54.109999999999999 112.597 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 91' ' ' ILE . 89.7 m-85 -129.59 -49.97 1.16 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 111.704 0.261 . . . . 74.540000000000006 111.704 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 128.97 55.71 0.11 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.216 -0.516 . . . . 71.340000000000003 113.572 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 64.38 -12.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.939 1.089 . . . . 51.549999999999997 113.939 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 m -98.26 -60.22 1.6 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.257 -0.275 . . . . 63.549999999999997 110.257 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.22 -174.76 29.84 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.36 0.412 . . . . 73.040000000000006 113.66 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.563 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 5.1 t60 -93.92 128.55 40.97 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.915 -0.402 . . . . 71.030000000000001 109.915 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.04 122.96 10.09 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.271 1.981 . . . . 52.530000000000001 113.586 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.14 -46.69 1.13 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.573 -0.74 . . . . 63.229999999999997 113.293 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.57 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.511 0.189 . . . . 73.329999999999998 111.511 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.563 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 30.2 mm -109.85 98.72 35.27 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 123.249 0.343 . . . . 74.319999999999993 110.9 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.71 165.59 32.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.439 2.093 . . . . 65.319999999999993 112.629 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.5 146.89 31.45 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.466 2.11 . . . . 73.209999999999994 113.298 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 55.67 37.71 29.22 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.659 0.784 . . . . 70.340000000000003 111.993 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.37 128.97 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.734 -0.666 . . . . 71.420000000000002 111.73 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 m -83.41 135.44 34.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.828 -1.078 . . . . 74.25 110.688 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 3.1 mt -111.72 158.11 19.71 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.606 -0.725 . . . . 71.519999999999996 111.164 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.13 114.6 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.982 -0.554 . . . . 72.319999999999993 109.842 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 74' ' ' LEU . 86.8 m-85 -116.79 136.16 53.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.131 -0.486 . . . . 71.299999999999997 111.043 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.549 ' OD2' HH23 ' A' ' 73' ' ' MLY . 10.0 t70 -116.58 104.69 11.65 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.909 -0.587 . . . . 62.020000000000003 110.197 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.827 HG22 HD11 ' A' ' 74' ' ' LEU . 25.0 m -105.57 152.71 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.076 -0.511 . . . . 60.420000000000002 110.967 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.3 125.46 36.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.543 -0.753 . . . . 72.230000000000004 110.085 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.98 101.22 3.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.724 -0.671 . . . . 64.0 110.548 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.87 -57.69 2.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 111.399 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 122.843 0.457 . . . . 74.319999999999993 110.843 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.438 HD22 HE22 ' A' ' 20' ' ' GLN . 11.6 mt -124.65 145.6 49.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.02 -0.536 . . . . 64.409999999999997 110.664 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.281 -0.418 . . . . 65.530000000000001 110.757 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.715 0 CA-C-O 119.253 -0.748 . . . . 43.119999999999997 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.54 -34.68 3.22 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.059 2.506 . . . . 72.120000000000005 113.124 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.8 m 63.25 128.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.01 0.924 . . . . 74.209999999999994 112.148 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -97.84 -41.0 8.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.78 -0.646 . . . . 73.209999999999994 111.374 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 126.11 -39.58 1.99 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 123.449 0.468 . . . . 60.009999999999998 112.597 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG23 HD13 ' A' ' 76' ' ' ILE . 15.0 p -119.83 123.19 70.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.694 0.283 . . . . 71.540000000000006 110.701 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.72 120.22 32.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.839 -0.619 . . . . 73.140000000000001 110.485 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 11.6 t -107.89 128.83 62.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.119 -0.491 . . . . 62.43 110.232 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.41 123.87 47.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.596 -0.729 . . . . 74.439999999999998 110.007 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.4 m -78.81 128.61 33.59 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.482 0.489 . . . . 74.150000000000006 110.959 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.483 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -110.35 -41.73 4.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.175 -0.92 . . . . 72.430000000000007 110.259 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -129.67 118.84 18.95 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.938 -0.574 . . . . 74.319999999999993 110.399 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.33 129.36 15.83 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.568 2.179 . . . . 61.420000000000002 113.375 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.67 -120.96 4.17 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.661 -0.7 . . . . 44.329999999999998 112.157 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.74 -46.19 12.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.634 0.217 . . . . 61.450000000000003 111.003 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.4 -1.23 88.52 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.04 -0.527 . . . . 63.509999999999998 113.72 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -136.85 1.4 2.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.501 0.32 . . . . 75.239999999999995 111.76 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -122.21 92.73 3.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.048 0.451 . . . . 71.400000000000006 110.202 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -103.12 149.57 37.03 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.57 -0.741 . . . . 72.109999999999999 110.956 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.5 124.66 12.73 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.55 2.167 . . . . 64.230000000000004 112.962 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 CA-C-N 115.498 -0.774 . . . . 72.299999999999997 111.464 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.41 123.19 26.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.6 -0.727 . . . . 75.420000000000002 111.565 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.19 -23.5 10.55 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.881 -0.6 . . . . 64.120000000000005 113.668 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.555 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -102.44 160.27 14.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.796 0.298 . . . . 72.140000000000001 110.985 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.662 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -79.37 143.5 35.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.133 -0.485 . . . . 73.129999999999995 111.276 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 57.3 m -122.36 116.22 23.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.662 -0.699 . . . . 70.120000000000005 110.44 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 t -90.4 110.78 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.492 -0.776 . . . . 63.039999999999999 109.863 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.2 m -146.94 151.73 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.915 -0.584 . . . . 42.420000000000002 111.327 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 8.7 m-70 -102.51 125.28 49.18 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.502 -0.772 . . . . 75.310000000000002 109.162 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.0 p90 -115.89 167.68 10.74 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.651 0.611 . . . . 74.340000000000003 112.651 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.8 m -148.92 108.54 4.0 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.042 -0.981 . . . . 54.439999999999998 109.58 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 115.76 5.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 121.163 -0.541 . . . . 74.5 112.555 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.3 mtm -130.44 136.48 49.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.039 0.535 . . . . 72.230000000000004 110.702 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.49 172.29 0.51 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.616 -0.72 . . . . 42.340000000000003 112.205 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -56.07 -26.29 48.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.157 0.583 . . . . 72.0 112.008 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.93 -17.39 28.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.671 -0.695 . . . . 53.299999999999997 111.307 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.55 13.79 21.5 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.715 -0.755 . . . . 51.420000000000002 113.385 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.43 0 N-CA-C 110.191 -0.3 . . . . 63.25 110.191 179.712 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.418 ' HE3' ' CG2' ' A' ' 27' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 112.876 0.695 . . . . 75.25 112.876 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 24.4 p90 -134.63 -12.35 2.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.512 -1.222 . . . . 74.109999999999999 110.98 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 179.18 110.96 0.03 OUTLIER 'General case' 0 C--N 1.36 1.049 0 CA-C-O 121.054 0.454 . . . . 71.540000000000006 112.089 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 t -122.26 137.39 54.86 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.339 -0.846 . . . . 72.049999999999997 110.131 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.59 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.2 t -78.52 -34.07 47.54 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.627 -0.715 . . . . 71.120000000000005 112.288 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -75.27 -23.17 57.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.422 0.527 . . . . 54.32 112.422 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -24.29 67.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.8 0.333 . . . . 64.340000000000003 111.051 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -96.13 -0.42 50.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.37 -0.832 . . . . 71.299999999999997 109.754 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 64.04 36.34 9.93 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.188 0.995 . . . . 72.439999999999998 111.525 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.115 -0.493 . . . . 74.109999999999999 111.873 -179.365 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -72.69 158.06 51.17 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.961 2.441 . . . . 72.540000000000006 113.056 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.01 118.85 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.848 -0.615 . . . . 73.329999999999998 112.068 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.548 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-N 115.297 -0.865 . . . . 74.450000000000003 110.286 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.3 p90 -151.05 164.36 36.62 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.295 0.372 . . . . 73.329999999999998 111.546 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.662 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -107.57 134.79 50.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.302 -0.408 . . . . 71.140000000000001 110.525 178.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -78.88 141.71 37.43 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.817 -0.629 . . . . 74.219999999999999 111.569 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.84 62.04 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.605 -0.725 . . . . 71.310000000000002 113.277 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 122.63 0.372 . . . . 72.219999999999999 110.707 179.362 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 70.02 27.5 4.34 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.147 0.979 . . . . 64.219999999999999 112.2 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.25 -19.9 57.9 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.016 -0.538 . . . . 75.25 110.715 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.86 -178.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.217 -0.901 . . . . 74.450000000000003 110.443 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -77.82 160.39 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 53.420000000000002 112.101 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -60.59 -44.43 96.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.024 -0.535 . . . . 73.409999999999997 111.811 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.7 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.8 -20.05 61.54 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 116.099 -0.5 . . . . 75.120000000000005 113.418 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -84.1 -43.67 14.81 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.677 0.239 . . . . 64.239999999999995 111.07 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' HD11 ' A' ' 50' ' ' LEU . 30.8 mt-10 -66.83 -37.72 85.04 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.367 0.417 . . . . 71.319999999999993 111.594 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.45 -25.25 29.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.961 -0.563 . . . . 73.219999999999999 111.74 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.08 -46.35 4.78 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.445 0.465 . . . . 71.540000000000006 113.89 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.55 -25.41 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.827 0.451 . . . . 73.299999999999997 111.714 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.67 -8.72 57.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.342 -0.845 . . . . 33.409999999999997 111.728 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -91.69 -8.86 45.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.877 -0.601 . . . . 54.100000000000001 111.202 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.437 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.01 156.49 19.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.265 -0.425 . . . . 71.25 110.969 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.404 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.3 p -111.47 166.79 10.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.823 -0.626 . . . . 51.25 110.565 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.65 ' HA ' HD12 ' A' ' 103' ' ' LEU . 54.7 t -55.92 123.21 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.93 0.492 . . . . 53.100000000000001 111.279 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 3.73 70.2 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.475 -0.784 . . . . 71.340000000000003 113.122 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -95.51 141.38 29.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.96 0.41 . . . . 75.439999999999998 111.306 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.483 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -119.69 109.2 15.36 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.113 -0.949 . . . . 73.140000000000001 109.339 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.96 155.43 47.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.909 -0.587 . . . . 61.039999999999999 111.833 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-N 116.105 -0.498 . . . . 72.400000000000006 110.085 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.813 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.32 124.86 53.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.297 -0.41 . . . . 74.519999999999996 111.161 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.8 m -93.08 112.8 24.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.322 -0.853 . . . . 53.119999999999997 109.364 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.7 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.8 mm -104.4 142.1 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.758 -0.656 . . . . 75.109999999999999 110.463 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.93 161.57 22.54 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 114.807 -1.088 . . . . 74.230000000000004 110.784 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.91 -17.19 49.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.806 2.338 . . . . 62.43 113.274 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.21 -25.29 25.7 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.465 0.478 . . . . 74.510000000000005 111.287 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -101.38 -19.52 15.56 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.037 -0.529 . . . . 73.030000000000001 111.456 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.25 1.37 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.785 0.661 . . . . 54.109999999999999 112.785 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -133.31 -51.16 0.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.637 0.236 . . . . 74.540000000000006 111.637 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.29 -141.44 8.92 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.489 0.493 . . . . 71.340000000000003 112.056 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.76 -11.31 27.18 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.569 0.211 . . . . 51.549999999999997 111.569 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.51 -60.39 1.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.303 -0.408 . . . . 63.549999999999997 110.46 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.84 53.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.368 0.418 . . . . 73.040000000000006 113.126 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.457 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.29 124.48 48.98 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.86 -0.422 . . . . 71.030000000000001 109.86 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.72 124.03 10.7 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.211 1.941 . . . . 52.530000000000001 113.653 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.99 -46.88 1.11 Allowed Glycine 0 C--N 1.337 0.605 0 CA-C-N 115.615 -0.721 . . . . 63.229999999999997 113.373 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.9 -51.67 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 111.602 0.223 . . . . 73.329999999999998 111.602 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.4 mm -109.95 98.36 33.89 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 123.176 0.298 . . . . 74.319999999999993 111.09 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.69 165.71 31.7 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.454 2.103 . . . . 65.319999999999993 112.676 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.03 143.09 28.54 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.544 2.163 . . . . 73.209999999999994 113.192 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 56.66 43.24 25.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.628 0.771 . . . . 70.340000000000003 111.795 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.82 132.84 53.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.731 -0.668 . . . . 71.420000000000002 111.773 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -82.55 141.22 32.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.784 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -119.01 154.46 33.04 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.693 -0.685 . . . . 71.519999999999996 111.068 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 128.01 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.835 -0.62 . . . . 72.319999999999993 109.838 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 74' ' ' LEU . 89.8 m-85 -130.19 132.95 46.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.063 -0.517 . . . . 71.299999999999997 110.617 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 5.6 t70 -116.22 104.95 12.03 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.091 -0.504 . . . . 62.020000000000003 110.243 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.813 HG22 HD11 ' A' ' 74' ' ' LEU . 24.8 m -107.03 153.2 8.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.008 -0.542 . . . . 60.420000000000002 111.09 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.89 125.96 34.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.497 -0.774 . . . . 72.230000000000004 110.482 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.17 101.54 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.771 -0.649 . . . . 64.0 110.219 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -89.84 -58.53 2.48 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.222 -0.445 . . . . 73.510000000000005 111.391 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 122.839 0.456 . . . . 74.319999999999993 110.765 -179.896 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.555 HD22 HE22 ' A' ' 20' ' ' GLN . 9.7 mt -124.36 146.14 49.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.15 -0.477 . . . . 64.409999999999997 110.671 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 45.4 mt-10 . . . . . 0 N--CA 1.464 0.264 0 O-C-N 123.503 0.502 . . . . 65.530000000000001 110.818 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 CA-C-O 119.236 -0.758 . . . . 43.119999999999997 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.95 136.23 18.3 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 123.037 2.491 . . . . 72.120000000000005 112.814 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 45.8 p -128.09 -43.05 1.51 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.904 -0.589 . . . . 74.209999999999994 111.327 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 5.6 tpt -129.0 -43.25 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.425 0.453 . . . . 73.209999999999994 110.98 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 123.85 -46.84 1.06 Allowed Glycine 0 C--N 1.339 0.749 0 O-C-N 123.486 0.491 . . . . 60.009999999999998 112.455 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 75' ' ' THR . 14.4 p -122.75 122.56 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.638 0.256 . . . . 71.540000000000006 110.615 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.69 119.52 32.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 73.140000000000001 110.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 12.6 t -107.73 129.27 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.083 -0.508 . . . . 62.43 110.113 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.46 123.4 45.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.617 -0.72 . . . . 74.439999999999998 110.163 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -78.19 125.45 29.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.221 -0.445 . . . . 74.150000000000006 111.001 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -107.69 -41.35 5.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 110.272 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -129.98 119.19 18.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 110.382 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.29 130.43 17.46 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.623 2.215 . . . . 61.420000000000002 113.416 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.03 -121.11 4.47 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.712 -0.676 . . . . 44.329999999999998 112.096 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -83.96 -46.14 12.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.648 0.224 . . . . 61.450000000000003 110.939 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.66 -1.44 88.17 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.542 0.526 . . . . 63.509999999999998 113.757 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -136.33 0.6 2.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.427 0.291 . . . . 75.239999999999995 111.781 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 92.46 3.74 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.032 0.444 . . . . 71.400000000000006 110.333 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -103.49 149.56 37.16 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.544 -0.753 . . . . 72.109999999999999 110.958 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.88 123.06 10.79 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.51 2.14 . . . . 64.230000000000004 112.714 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 115.384 -0.825 . . . . 72.299999999999997 111.44 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -77.3 127.85 33.31 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.725 -0.67 . . . . 75.420000000000002 111.317 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.04 -26.34 11.56 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.716 -0.675 . . . . 64.120000000000005 113.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.428 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -99.77 160.23 14.46 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.443 0.297 . . . . 72.140000000000001 110.866 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.29 145.19 29.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 111.308 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.3 t -120.08 116.93 26.68 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.563 -0.744 . . . . 70.120000000000005 110.544 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -90.91 110.79 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.415 -0.812 . . . . 63.039999999999999 109.584 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 103' ' ' LEU . 25.1 m -147.89 152.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.052 -0.522 . . . . 42.420000000000002 111.521 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.1 m-70 -102.62 125.27 49.3 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.401 -0.818 . . . . 75.310000000000002 109.066 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.602 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.5 p90 -115.33 166.3 12.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.802 0.667 . . . . 74.340000000000003 112.802 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.8 m -149.15 110.56 4.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.884 -1.053 . . . . 54.439999999999998 109.237 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -95.43 117.26 5.59 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.157 -0.544 . . . . 74.5 112.994 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.0 mtm -126.38 129.97 49.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.918 0.487 . . . . 72.230000000000004 111.15 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.96 171.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.709 -0.678 . . . . 42.340000000000003 112.181 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -57.09 -26.27 60.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.085 0.554 . . . . 72.0 111.94 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.25 -17.95 28.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.812 -0.631 . . . . 53.299999999999997 111.716 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.03 14.1 23.56 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 120.75 -0.738 . . . . 51.420000000000002 113.367 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.379 0 N-CA-C 108.635 -0.876 . . . . 63.25 108.635 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.434 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 113.372 0.879 . . . . 75.25 113.372 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 34.5 p90 -134.12 -10.28 2.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.127 -1.397 . . . . 74.109999999999999 111.339 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -163.44 111.57 1.22 Allowed 'General case' 0 C--N 1.355 0.827 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 111.698 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.434 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 5.4 p -119.18 117.7 29.35 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.838 -1.074 . . . . 72.049999999999997 111.115 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 65.0 p -78.79 -36.49 42.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.929 -0.578 . . . . 71.120000000000005 112.25 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -23.1 53.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.979 0.733 . . . . 54.32 112.979 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -24.0 67.63 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.842 0.353 . . . . 64.340000000000003 111.233 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -93.7 -0.25 56.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.394 -0.821 . . . . 71.299999999999997 109.68 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 63.51 36.25 11.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.29 1.036 . . . . 72.439999999999998 111.568 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 112.147 -179.402 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.68 158.07 51.2 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.937 2.424 . . . . 72.540000000000006 112.756 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.405 ' CD1' ' HE2' ' A' ' 26' ' ' TYR . 18.6 t80 -101.16 118.45 37.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 112.046 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 115.172 -0.922 . . . . 74.450000000000003 110.061 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.2 p90 -149.09 161.63 41.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.308 0.38 . . . . 73.329999999999998 111.383 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.43 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 7.2 mtt -105.78 132.26 52.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.69 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.7 mm? -77.45 139.51 39.67 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.946 -0.57 . . . . 74.219999999999999 111.657 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.73 53.99 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.524 -0.762 . . . . 71.310000000000002 113.249 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 122.516 0.327 . . . . 72.219999999999999 110.693 179.186 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 70.0 27.06 4.47 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.121 0.968 . . . . 64.219999999999999 112.152 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 49' ' ' MET . 46.3 mt-10 -76.31 -14.37 60.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.974 -0.557 . . . . 75.25 110.867 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.9 m -127.25 -177.63 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.342 -0.845 . . . . 74.450000000000003 110.537 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.89 159.76 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.086 0.402 . . . . 53.420000000000002 112.086 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -60.17 -44.18 95.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.999 -0.546 . . . . 73.409999999999997 111.784 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.44 -20.78 61.57 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.081 -0.509 . . . . 75.120000000000005 113.467 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -84.15 -43.7 14.73 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.636 0.218 . . . . 64.239999999999995 111.208 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.9 mt-10 -66.3 -37.9 86.5 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.364 0.415 . . . . 71.319999999999993 111.536 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.44 -25.63 28.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.872 -0.604 . . . . 73.219999999999999 111.759 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.68 -46.37 4.89 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.399 0.437 . . . . 71.540000000000006 113.894 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.3 p -63.67 -25.02 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.766 0.426 . . . . 73.299999999999997 111.776 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 -8.43 56.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.362 -0.836 . . . . 33.409999999999997 111.678 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -91.9 -11.38 36.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.857 -0.611 . . . . 54.100000000000001 111.274 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.436 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.69 156.07 19.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.349 -0.387 . . . . 71.25 110.991 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.6 p -110.96 166.92 10.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.818 -0.628 . . . . 51.25 110.588 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.654 ' HA ' HD12 ' A' ' 103' ' ' LEU . 54.2 t -56.13 123.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 122.942 0.497 . . . . 53.100000000000001 111.274 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.78 4.58 69.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.448 -0.796 . . . . 71.340000000000003 113.148 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.16 141.71 29.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.971 0.415 . . . . 75.439999999999998 111.298 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.54 108.47 14.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.093 -0.958 . . . . 73.140000000000001 109.305 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.67 156.42 44.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.975 -0.557 . . . . 61.039999999999999 111.825 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.291 0 CA-C-N 116.078 -0.51 . . . . 72.400000000000006 110.312 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.82 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.27 124.76 52.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 111.117 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.8 m -93.4 113.33 25.47 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.412 -0.813 . . . . 53.119999999999997 109.567 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.715 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.2 mm -105.52 142.63 18.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.892 -0.594 . . . . 75.109999999999999 110.509 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.56 162.14 20.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.829 -1.078 . . . . 74.230000000000004 110.708 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.33 -17.21 45.72 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.767 2.311 . . . . 62.43 113.242 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 111.235 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -101.89 -19.14 15.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.993 -0.549 . . . . 73.030000000000001 111.364 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.78 -62.7 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.677 0.621 . . . . 54.109999999999999 112.677 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -133.52 -53.85 0.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.598 0.221 . . . . 74.540000000000006 111.598 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.59 -137.71 6.02 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 123.497 0.498 . . . . 71.340000000000003 111.991 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.56 -9.14 25.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.558 0.21 . . . . 51.549999999999997 111.564 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 m -102.63 -60.38 1.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.303 -0.408 . . . . 63.549999999999997 110.577 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.41 -169.34 54.16 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.395 0.435 . . . . 73.040000000000006 113.156 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.65 123.34 54.41 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.901 -0.407 . . . . 71.030000000000001 109.901 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.76 125.21 12.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.166 1.911 . . . . 52.530000000000001 113.638 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.23 -47.95 1.0 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.566 -0.743 . . . . 63.229999999999997 113.292 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.31 -51.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 111.576 0.213 . . . . 73.329999999999998 111.576 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.434 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.2 mm -111.63 98.48 41.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.187 0.305 . . . . 74.319999999999993 111.213 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.09 165.75 31.68 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 122.448 2.099 . . . . 65.319999999999993 112.709 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.23 143.9 28.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.571 2.181 . . . . 73.209999999999994 113.164 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 56.88 41.66 27.59 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.569 0.748 . . . . 70.340000000000003 111.818 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.59 132.46 54.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 111.776 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -82.45 139.87 33.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.69 -1.141 . . . . 74.25 110.904 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.534 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.4 mt -118.86 152.2 36.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.617 -0.719 . . . . 71.519999999999996 110.9 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.2 132.03 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.82 -0.627 . . . . 72.319999999999993 109.503 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.5 m-85 -132.87 132.94 42.65 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 71.299999999999997 110.787 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 73' ' ' MLY . 8.5 t70 -116.28 103.39 10.45 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.943 -0.571 . . . . 62.020000000000003 109.899 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.82 HG22 HD11 ' A' ' 74' ' ' LEU . 24.7 m -105.97 153.66 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.991 -0.549 . . . . 60.420000000000002 111.17 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.2 125.82 35.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.466 -0.788 . . . . 72.230000000000004 110.38 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.654 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -73.11 102.11 3.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.803 -0.635 . . . . 64.0 110.385 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.2 -58.84 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.139 -0.482 . . . . 73.510000000000005 111.334 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 122.74 0.416 . . . . 74.319999999999993 110.767 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD22 HE22 ' A' ' 20' ' ' GLN . 11.9 mt -126.84 144.46 50.96 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.045 -0.525 . . . . 64.409999999999997 110.679 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.464 0.268 0 O-C-N 123.534 0.521 . . . . 65.530000000000001 110.802 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 CA-C-O 119.185 -0.786 . . . . 43.119999999999997 112.47 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.86 134.69 16.7 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 123.069 2.513 . . . . 72.120000000000005 112.741 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.9 m -129.79 -42.26 1.28 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.881 -0.599 . . . . 74.209999999999994 111.267 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 21.5 mmt -117.83 154.22 32.17 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.398 0.436 . . . . 73.209999999999994 111.05 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -90.79 -26.07 23.35 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.844 -0.616 . . . . 60.009999999999998 113.002 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.2 p -131.27 118.8 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.72 0.295 . . . . 71.540000000000006 110.471 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.73 121.18 40.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.816 -0.629 . . . . 73.140000000000001 110.656 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 15.7 t -109.72 125.5 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.022 -0.536 . . . . 62.43 110.179 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.21 125.14 53.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.578 -0.737 . . . . 74.439999999999998 110.066 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -79.33 127.68 32.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.946 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.467 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.4 mt -108.93 -42.14 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.166 -0.924 . . . . 72.430000000000007 110.294 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -129.3 118.89 19.33 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.919 -0.582 . . . . 74.319999999999993 110.38 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.2 129.45 16.11 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.637 2.225 . . . . 61.420000000000002 113.406 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.98 -120.9 4.22 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.702 -0.681 . . . . 44.329999999999998 112.141 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.86 -46.22 12.39 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.678 0.239 . . . . 61.450000000000003 110.91 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.64 -1.43 88.2 Favored Glycine 0 C--N 1.342 0.87 0 O-C-N 123.561 0.538 . . . . 63.509999999999998 113.699 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -136.64 1.02 2.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.482 0.313 . . . . 75.239999999999995 111.799 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.99 92.45 3.73 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.055 0.455 . . . . 71.400000000000006 110.27 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -103.51 149.39 36.99 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.558 -0.746 . . . . 72.109999999999999 110.938 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.39 123.49 11.22 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.474 2.116 . . . . 64.230000000000004 112.851 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.39 -0.823 . . . . 72.299999999999997 111.467 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -77.31 124.86 28.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.502 -0.772 . . . . 75.420000000000002 111.328 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.6 -26.86 9.22 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.756 -0.657 . . . . 64.120000000000005 113.158 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.433 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -98.9 160.16 14.45 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.425 0.29 . . . . 72.140000000000001 110.904 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.541 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -83.58 145.09 29.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 111.318 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 37.6 t -120.65 116.19 24.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.437 -0.802 . . . . 70.120000000000005 110.39 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.64 110.42 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.577 -0.738 . . . . 63.039999999999999 109.557 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 103' ' ' LEU . 31.1 m -146.86 152.06 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.086 -0.506 . . . . 42.420000000000002 111.585 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 11.3 m-70 -102.51 125.34 49.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.27 -0.877 . . . . 75.310000000000002 109.004 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' VAL . 42.8 p90 -115.65 166.1 12.3 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.814 0.672 . . . . 74.340000000000003 112.814 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 3.2 m -148.83 112.18 4.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.838 -1.074 . . . . 54.439999999999998 109.328 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -96.23 120.18 6.53 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.131 -0.557 . . . . 74.5 112.813 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 mtm -129.8 131.3 46.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.963 0.505 . . . . 72.230000000000004 111.123 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.62 170.9 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.696 -0.684 . . . . 42.340000000000003 112.002 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.51 -26.12 53.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.082 0.553 . . . . 72.0 112.049 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.38 -17.4 28.89 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.762 -0.654 . . . . 53.299999999999997 111.76 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.52 13.79 21.56 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 120.828 -0.701 . . . . 51.420000000000002 113.394 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.411 0 N-CA-C 109.775 -0.454 . . . . 63.25 109.775 179.575 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.452 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 75.25 112.938 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 26.8 p90 -134.09 -9.36 2.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.369 -1.287 . . . . 74.109999999999999 111.393 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -166.55 111.59 0.79 Allowed 'General case' 0 C--N 1.355 0.846 0 CA-C-O 121.203 0.525 . . . . 71.540000000000006 111.621 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 4.2 p -116.94 118.22 31.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.893 -1.048 . . . . 72.049999999999997 111.012 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.527 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 21.1 t -78.82 -34.68 45.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.953 -0.567 . . . . 71.120000000000005 112.06 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.45 -23.25 46.63 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.973 0.731 . . . . 54.32 112.973 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.89 -24.91 67.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.771 0.319 . . . . 64.340000000000003 111.236 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -92.86 0.07 57.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.395 -0.82 . . . . 71.299999999999997 109.7 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 m120 63.29 36.11 11.98 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 72.439999999999998 111.568 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.237 0.458 . . . . 74.109999999999999 112.237 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.85 158.01 43.02 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.956 2.437 . . . . 72.540000000000006 112.708 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -100.07 118.53 36.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.974 -0.557 . . . . 73.329999999999998 112.074 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.506 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 115.225 -0.898 . . . . 74.450000000000003 110.029 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' THR . 37.3 p90 -151.58 161.82 42.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.358 0.411 . . . . 73.329999999999998 111.571 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.541 ' SD ' HG23 ' A' ' 21' ' ' THR . 3.7 mpp? -105.67 135.18 47.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.415 -0.357 . . . . 71.140000000000001 110.48 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -78.31 140.18 38.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.838 -0.619 . . . . 74.219999999999999 111.648 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -8.57 61.95 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.442 -0.799 . . . . 71.310000000000002 113.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.849 0.357 . . . . 72.219999999999999 110.733 179.276 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 70.04 27.4 4.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 64.219999999999999 112.145 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.18 -14.58 60.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.021 -0.536 . . . . 75.25 110.82 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -126.72 -178.34 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.246 -0.888 . . . . 74.450000000000003 110.453 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.15 158.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.06 0.392 . . . . 53.420000000000002 112.06 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -59.37 -44.05 92.78 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.987 -0.551 . . . . 73.409999999999997 111.775 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.687 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.67 -20.58 61.88 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 113.461 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.13 -43.55 14.9 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 116.684 0.242 . . . . 64.239999999999995 111.107 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.7 mt-10 -66.16 -37.6 86.06 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.344 0.403 . . . . 71.319999999999993 111.566 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.51 -25.57 28.72 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.966 -0.561 . . . . 73.219999999999999 111.734 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.57 -46.34 4.94 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.477 0.486 . . . . 71.540000000000006 113.903 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.6 -25.09 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 122.768 0.427 . . . . 73.299999999999997 111.738 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 -8.64 57.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.355 -0.839 . . . . 33.409999999999997 111.651 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.75 -11.39 36.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.713 -0.676 . . . . 54.100000000000001 111.255 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.44 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.19 155.97 19.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.283 -0.417 . . . . 71.25 110.949 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 23.2 p -110.88 167.02 10.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.807 -0.633 . . . . 51.25 110.598 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.652 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.1 t -56.18 123.2 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.927 0.491 . . . . 53.100000000000001 111.231 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.55 4.68 70.12 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.421 -0.809 . . . . 71.340000000000003 113.137 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.2 142.01 28.88 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 120.943 0.401 . . . . 75.439999999999998 111.305 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -119.84 107.95 13.78 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.039 -0.982 . . . . 73.140000000000001 109.36 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.45 154.34 48.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.968 -0.56 . . . . 61.039999999999999 111.837 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.309 0 CA-C-N 116.04 -0.527 . . . . 72.400000000000006 110.248 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.824 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.31 126.05 54.49 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.444 0.465 . . . . 74.519999999999996 111.079 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.6 m -93.68 113.63 25.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.439 -0.801 . . . . 53.119999999999997 109.585 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.687 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.0 mm -106.16 143.47 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.874 -0.603 . . . . 75.109999999999999 110.433 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.17 161.88 21.46 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 114.871 -1.059 . . . . 74.230000000000004 110.814 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.94 -17.19 49.78 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.789 2.326 . . . . 62.43 113.243 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.94 -25.56 26.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.394 0.433 . . . . 74.510000000000005 111.288 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -101.86 -18.97 15.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.047 -0.524 . . . . 73.030000000000001 111.469 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 -61.82 1.7 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.696 0.628 . . . . 54.109999999999999 112.696 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -134.96 -52.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.586 0.217 . . . . 74.540000000000006 111.586 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 151.1 -140.34 7.81 Favored Glycine 0 C--N 1.337 0.617 0 O-C-N 123.516 0.51 . . . . 71.340000000000003 112.037 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.37 -11.13 26.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.603 0.223 . . . . 51.549999999999997 111.603 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 m -100.12 -60.43 1.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.236 -0.438 . . . . 63.549999999999997 110.516 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.14 -166.36 54.58 Favored Glycine 0 C--N 1.345 1.069 0 O-C-N 123.343 0.402 . . . . 73.040000000000006 113.16 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.7 t60 -97.82 124.43 48.04 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.918 -0.401 . . . . 71.030000000000001 109.918 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.52 124.17 10.91 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.278 1.986 . . . . 52.530000000000001 113.614 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.52 -47.92 1.0 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.575 -0.738 . . . . 63.229999999999997 113.364 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.65 -51.77 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.574 0.212 . . . . 73.329999999999998 111.574 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.1 mm -109.88 97.96 31.64 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 123.248 0.342 . . . . 74.319999999999993 111.055 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.65 165.67 31.81 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.451 2.101 . . . . 65.319999999999993 112.733 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.97 143.2 28.86 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.52 2.147 . . . . 73.209999999999994 113.259 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.8 42.56 26.46 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.613 0.765 . . . . 70.340000000000003 111.821 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.07 132.43 54.1 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.692 -0.686 . . . . 71.420000000000002 111.722 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -81.83 140.77 33.97 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.741 -1.118 . . . . 74.25 110.847 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.5 mt -119.09 153.77 34.26 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.657 -0.701 . . . . 71.519999999999996 111.076 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.89 130.35 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.842 -0.617 . . . . 72.319999999999993 109.595 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' O ' HD12 ' A' ' 74' ' ' LEU . 90.2 m-85 -131.33 133.41 45.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 110.557 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -116.47 102.51 9.56 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 123.542 0.526 . . . . 62.020000000000003 110.119 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 74' ' ' LEU . 26.4 m -104.34 153.75 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.884 -0.598 . . . . 60.420000000000002 111.101 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.16 125.44 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 72.230000000000004 110.413 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.15 101.93 3.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.855 -0.611 . . . . 64.0 110.203 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.88 -58.97 2.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 111.376 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 122.769 0.428 . . . . 74.319999999999993 110.792 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD22 HE22 ' A' ' 20' ' ' GLN . 13.2 mt -125.48 146.64 49.55 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.128 -0.487 . . . . 64.409999999999997 110.707 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.025 -0.534 . . . . 65.530000000000001 110.759 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 CA-C-O 119.186 -0.785 . . . . 43.119999999999997 112.453 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.85 151.37 35.73 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.041 2.494 . . . . 72.120000000000005 112.739 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.7 t -99.87 -43.33 6.45 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 115.882 -0.599 . . . . 74.209999999999994 111.038 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.4 mtt -100.4 144.45 29.38 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.452 0.47 . . . . 73.209999999999994 110.826 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -118.09 27.76 7.25 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.943 -0.571 . . . . 60.009999999999998 113.136 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.5 p -131.3 113.88 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.827 0.346 . . . . 71.540000000000006 110.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.19 116.97 29.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.638 -0.71 . . . . 73.140000000000001 110.701 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 13.8 p -107.22 134.77 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.984 -0.553 . . . . 62.43 110.936 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.45 124.44 44.47 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.462 -0.79 . . . . 74.439999999999998 110.266 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -78.12 126.28 30.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.463 0.477 . . . . 74.150000000000006 110.815 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.3 mt -109.29 -39.18 3.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.132 -0.94 . . . . 72.430000000000007 110.404 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -132.73 119.0 15.82 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 74.319999999999993 110.49 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 129.84 16.23 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.573 2.182 . . . . 61.420000000000002 113.327 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.25 -121.25 4.34 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.776 -0.647 . . . . 44.329999999999998 112.221 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.19 -46.29 12.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.702 0.251 . . . . 61.450000000000003 110.977 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.77 -1.5 88.04 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.545 0.528 . . . . 63.509999999999998 113.695 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -136.61 1.08 2.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.745 0.276 . . . . 75.239999999999995 111.745 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.9 92.54 3.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.034 0.445 . . . . 71.400000000000006 110.353 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -103.53 149.71 37.33 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.564 -0.744 . . . . 72.109999999999999 110.986 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.73 123.29 10.85 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.488 2.125 . . . . 64.230000000000004 112.677 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.461 0 CA-C-N 115.435 -0.802 . . . . 72.299999999999997 111.573 -179.344 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 44.9 ttt180 -77.42 122.92 25.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.555 -0.748 . . . . 75.420000000000002 111.162 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.58 -29.21 6.75 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.814 -0.63 . . . . 64.120000000000005 113.225 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.435 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -97.29 160.31 14.41 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.45 0.3 . . . . 72.140000000000001 110.985 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -82.61 145.3 29.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.095 -0.502 . . . . 73.129999999999995 111.42 -179.518 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 35.2 t -120.81 117.19 26.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.625 -0.716 . . . . 70.120000000000005 110.693 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.62 110.75 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.562 -0.745 . . . . 63.039999999999999 109.472 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 103' ' ' LEU . 24.7 m -146.89 152.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.949 -0.569 . . . . 42.420000000000002 111.456 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.6 m-70 -103.12 125.17 49.71 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.532 -0.758 . . . . 75.310000000000002 109.437 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.619 ' HB3' HG12 ' A' ' 101' ' ' VAL . 39.5 p90 -115.45 166.82 11.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.284 0.476 . . . . 74.340000000000003 112.284 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.508 HG21 HH21 ' A' ' 40' ' ' ARG . 0.8 OUTLIER -147.72 106.12 3.78 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.173 -0.921 . . . . 54.439999999999998 109.454 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.73 116.46 4.88 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.05 -0.523 . . . . 74.5 112.707 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.7 mtm -131.89 134.41 45.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.043 0.537 . . . . 72.230000000000004 110.833 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mt -56.38 172.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 42.340000000000003 112.462 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.89 -27.02 50.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.125 0.57 . . . . 72.0 111.893 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.36 -17.47 30.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.685 -0.688 . . . . 53.299999999999997 111.487 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.11 13.84 22.19 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.726 -0.75 . . . . 51.420000000000002 113.373 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.447 0 CA-C-O 120.696 0.284 . . . . 63.25 110.405 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 N-CA-C 112.934 0.716 . . . . 75.25 112.934 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 21.2 p90 -131.59 -16.05 3.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.619 -1.173 . . . . 74.109999999999999 111.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.8 110.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.025 0.441 . . . . 71.540000000000006 111.977 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.566 ' HB3' ' OD1' ' A' ' 41' ' ' ASP . 43.5 t -123.24 143.38 50.08 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.42 -0.809 . . . . 72.049999999999997 109.901 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 64.3 p -78.82 -24.63 44.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.815 0.672 . . . . 71.120000000000005 112.815 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.508 HH21 HG21 ' A' ' 27' ' ' THR . 6.0 ptt180 -82.93 -26.26 31.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.363 0.505 . . . . 54.32 112.363 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 38' ' ' SER . 14.8 p30 -70.04 -18.09 63.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.102 0.477 . . . . 64.340000000000003 110.709 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.442 ' HG2' ' OD2' ' A' ' 41' ' ' ASP . 19.8 mmt180 -97.23 -6.48 34.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.863 -1.062 . . . . 71.299999999999997 109.532 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 66.73 40.9 3.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.488 1.115 . . . . 72.439999999999998 111.81 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 116.309 -0.405 . . . . 74.109999999999999 111.836 -179.754 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.36 157.87 55.68 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.693 2.262 . . . . 72.540000000000006 112.807 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -103.29 118.2 36.24 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.86 -0.609 . . . . 73.329999999999998 112.115 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.466 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 115.097 -0.956 . . . . 74.450000000000003 109.788 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 39.6 p90 -149.6 162.7 39.67 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.284 0.365 . . . . 73.329999999999998 111.422 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 mtt -106.65 133.27 51.59 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.118 -0.492 . . . . 71.140000000000001 110.795 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.38 141.31 37.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.925 -0.58 . . . . 74.219999999999999 111.649 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.447 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.31 -11.72 48.81 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.52 -0.764 . . . . 71.310000000000002 113.481 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.775 0.321 . . . . 72.219999999999999 110.609 179.309 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 68.18 30.11 5.87 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.11 0.964 . . . . 64.219999999999999 112.102 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.02 -31.15 56.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.918 -0.583 . . . . 75.25 110.62 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -106.2 -174.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.325 -0.852 . . . . 74.450000000000003 110.247 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -81.51 158.47 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 111.774 0.287 . . . . 53.420000000000002 111.774 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -59.46 -43.82 93.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.058 -0.519 . . . . 73.409999999999997 111.913 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.654 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.62 -20.48 61.65 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 123.54 0.525 . . . . 75.120000000000005 113.321 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -84.21 -44.29 14.08 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 122.255 0.222 . . . . 64.239999999999995 111.147 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.58 -36.64 83.13 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.256 0.348 . . . . 71.319999999999993 111.571 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.53 -26.29 28.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.934 -0.575 . . . . 73.219999999999999 111.855 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.31 -46.52 4.66 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.454 0.472 . . . . 71.540000000000006 113.872 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 1.9 p -63.66 -25.66 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.754 0.421 . . . . 73.299999999999997 111.734 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.74 -7.18 53.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.395 -0.82 . . . . 33.409999999999997 111.669 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -93.86 -8.77 39.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.792 -0.64 . . . . 54.100000000000001 111.297 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.445 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.16 156.49 19.26 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.374 -0.376 . . . . 71.25 110.873 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.5 p -110.99 166.52 10.98 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.946 -0.57 . . . . 51.25 110.626 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.645 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.6 t -55.63 122.64 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.042 0.537 . . . . 53.100000000000001 111.216 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 91.71 2.78 69.33 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.47 -0.786 . . . . 71.340000000000003 113.236 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -94.16 142.12 27.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.947 0.403 . . . . 75.439999999999998 111.315 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.401 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -120.94 109.11 14.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.094 -0.957 . . . . 73.140000000000001 109.416 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.86 156.76 45.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.013 -0.539 . . . . 61.039999999999999 111.882 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.303 0 CA-C-N 116.063 -0.517 . . . . 72.400000000000006 110.426 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.98 127.7 53.33 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 74.519999999999996 110.858 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m -95.32 112.64 24.32 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.675 -0.693 . . . . 53.119999999999997 109.393 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD12 ' HA3' ' A' ' 58' ' ' GLY . 11.5 mm -104.46 140.83 21.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.903 -0.59 . . . . 75.109999999999999 110.519 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.16 162.09 21.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.84 -1.073 . . . . 74.230000000000004 110.671 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.77 -14.43 40.45 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.577 2.185 . . . . 62.43 113.231 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -28.96 22.9 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.4 . . . . 74.510000000000005 110.797 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -98.99 -19.37 17.32 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.753 -0.658 . . . . 73.030000000000001 111.594 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.78 -63.17 1.4 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.848 0.684 . . . . 54.109999999999999 112.848 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -134.43 -50.85 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.691 0.256 . . . . 74.540000000000006 111.691 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.88 -143.66 11.21 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 123.494 0.496 . . . . 71.340000000000003 111.957 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.43 -10.03 33.73 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 111.612 0.227 . . . . 51.549999999999997 111.612 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.02 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.201 -0.454 . . . . 63.549999999999997 110.388 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.27 -167.24 53.31 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.326 0.391 . . . . 73.040000000000006 113.187 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.452 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -97.6 124.49 48.29 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 109.876 -0.416 . . . . 71.030000000000001 109.876 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.8 123.64 10.29 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.195 1.93 . . . . 52.530000000000001 113.628 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.94 -46.86 1.11 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.601 -0.727 . . . . 63.229999999999997 113.436 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.4 -51.74 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 111.577 0.214 . . . . 73.329999999999998 111.577 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 19.2 mm -109.88 98.38 33.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 123.224 0.327 . . . . 74.319999999999993 111.068 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.3 165.66 31.75 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.439 2.093 . . . . 65.319999999999993 112.76 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.92 143.14 28.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.521 2.148 . . . . 73.209999999999994 113.157 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.57 43.87 24.95 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.644 0.778 . . . . 70.340000000000003 111.738 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.09 132.69 53.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.663 -0.699 . . . . 71.420000000000002 111.795 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 m -83.29 140.3 32.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.771 -1.104 . . . . 74.25 110.839 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.2 mt -117.94 154.31 32.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.635 -0.712 . . . . 71.519999999999996 111.026 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.3 t -121.68 127.84 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.829 -0.623 . . . . 72.319999999999993 109.684 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' O ' HD12 ' A' ' 74' ' ' LEU . 91.0 m-85 -129.94 132.87 46.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.06 -0.518 . . . . 71.299999999999997 110.709 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.9 t70 -115.02 103.71 11.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.067 -0.515 . . . . 62.020000000000003 110.273 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.814 HG22 HD11 ' A' ' 74' ' ' LEU . 25.7 m -104.64 152.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 60.420000000000002 111.02 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.83 125.99 35.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 72.230000000000004 110.384 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.65 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -73.03 101.98 3.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.825 -0.625 . . . . 64.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.35 -58.1 2.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.046 -0.524 . . . . 73.510000000000005 111.469 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 122.819 0.448 . . . . 74.319999999999993 110.728 -179.842 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.435 HD22 HE22 ' A' ' 20' ' ' GLN . 12.5 mt -122.21 145.83 47.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.098 -0.501 . . . . 64.409999999999997 110.792 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.466 0.327 0 O-C-N 123.506 0.504 . . . . 65.530000000000001 110.825 179.878 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 119.012 -0.882 . . . . 43.119999999999997 112.66 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.18 141.99 26.78 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.869 2.38 . . . . 72.120000000000005 112.725 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.7 m -108.53 -39.9 5.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.867 -0.606 . . . . 74.209999999999994 111.346 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -96.85 151.22 19.88 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.407 0.442 . . . . 73.209999999999994 111.115 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -94.64 -15.86 44.78 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.809 -0.632 . . . . 60.009999999999998 113.334 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 76' ' ' ILE . 13.5 p -117.65 123.38 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.381 0.272 . . . . 71.540000000000006 110.593 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.78 121.11 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.902 -0.59 . . . . 73.140000000000001 110.611 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 14.0 t -108.9 130.14 62.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.101 -0.5 . . . . 62.43 110.079 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -119.23 123.48 44.4 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.617 -0.72 . . . . 74.439999999999998 110.161 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -77.93 126.29 30.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.245 -0.434 . . . . 74.150000000000006 110.934 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.405 HD12 ' HD3' ' A' ' 71' ' ' ARG . 2.7 mt -108.64 -41.1 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 110.229 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -130.17 118.86 18.48 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.948 -0.569 . . . . 74.319999999999993 110.341 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 129.17 15.52 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.602 2.201 . . . . 61.420000000000002 113.433 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.79 -120.89 4.18 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.744 -0.662 . . . . 44.329999999999998 112.033 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.69 -45.89 12.91 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.676 0.238 . . . . 61.450000000000003 110.865 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 84.94 -1.4 88.89 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.028 -0.533 . . . . 63.509999999999998 113.705 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -136.71 1.06 2.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.493 0.317 . . . . 75.239999999999995 111.853 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -121.96 92.84 3.82 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.097 0.475 . . . . 71.400000000000006 110.281 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -103.13 149.69 37.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.521 -0.763 . . . . 72.109999999999999 110.898 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.1 126.44 15.8 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.517 2.145 . . . . 64.230000000000004 112.95 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 115.433 -0.803 . . . . 72.299999999999997 111.551 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 41.9 ttt180 -77.54 121.14 23.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.376 -0.829 . . . . 75.420000000000002 111.428 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.46 -24.2 9.27 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.014 -0.539 . . . . 64.120000000000005 113.48 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.422 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -101.2 160.33 14.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.356 0.262 . . . . 72.140000000000001 110.977 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.63 HG23 ' SD ' ' A' ' 49' ' ' MET . 0.3 OUTLIER -80.43 145.1 32.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 111.219 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.9 m -124.19 116.59 22.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.645 -0.707 . . . . 70.120000000000005 110.475 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -89.97 111.08 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.497 -0.774 . . . . 63.039999999999999 109.76 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' ' 103' ' ' LEU . 30.9 m -145.81 151.42 14.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.898 -0.592 . . . . 42.420000000000002 111.36 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.4 m-70 -102.68 125.32 49.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.653 -0.703 . . . . 75.310000000000002 109.389 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 101' ' ' VAL . 40.3 p90 -115.71 166.35 12.03 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.51 0.559 . . . . 74.340000000000003 112.51 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 1.3 m -148.22 107.06 3.82 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.091 -0.958 . . . . 54.439999999999998 109.375 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.12 119.43 5.79 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 116.038 -0.528 . . . . 74.5 112.739 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.5 mtm -134.38 132.21 39.17 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.989 0.516 . . . . 72.230000000000004 110.827 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mt -54.74 171.41 0.13 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.594 -0.73 . . . . 42.340000000000003 112.464 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -55.27 -27.65 48.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.18 0.592 . . . . 72.0 112.114 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.32 -17.26 29.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.663 -0.698 . . . . 53.299999999999997 111.709 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.65 13.76 21.38 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 120.828 -0.701 . . . . 51.420000000000002 113.167 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.457 0 N-CA-C 110.219 -0.289 . . . . 63.25 110.219 179.721 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.912 0.708 . . . . 75.25 112.912 -179.738 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 26.6 p90 -133.13 -15.24 2.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.532 -1.213 . . . . 74.109999999999999 111.364 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.16 111.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.121 0.486 . . . . 71.540000000000006 112.184 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' HG3' ' A' ' 40' ' ' ARG . 29.3 t -122.58 142.6 50.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.275 -0.875 . . . . 72.049999999999997 109.971 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.519 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 54.6 p -78.55 -36.68 44.29 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.593 0.59 . . . . 71.120000000000005 112.593 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.17 -23.08 61.98 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.543 0.571 . . . . 54.32 112.543 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -30.47 71.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.882 0.372 . . . . 64.340000000000003 110.817 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 44' ' ' MLY . 49.0 mtm180 -95.43 -1.84 50.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.262 -0.881 . . . . 71.299999999999997 110.183 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 66.18 37.62 4.98 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.297 1.039 . . . . 72.439999999999998 111.897 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . 0.444 ' HD3' ' O ' ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 111.52 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.78 157.97 51.05 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.974 2.45 . . . . 72.540000000000006 112.847 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -102.22 118.26 36.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.883 -0.598 . . . . 73.329999999999998 112.13 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 115.139 -0.937 . . . . 74.450000000000003 110.092 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 21' ' ' THR . 39.0 p90 -151.97 165.17 35.45 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.349 0.405 . . . . 73.329999999999998 111.627 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.63 ' SD ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -107.81 135.95 48.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.182 -0.463 . . . . 71.140000000000001 110.61 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.9 mm? -80.62 140.93 35.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.882 -0.599 . . . . 74.219999999999999 111.506 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.474 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 83.32 -9.42 61.32 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.562 -0.745 . . . . 71.310000000000002 113.295 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.72 179.408 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 68.55 28.25 5.93 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.076 0.95 . . . . 64.219999999999999 112.102 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -75.25 -33.32 61.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.006 -0.543 . . . . 75.25 110.543 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 m -103.4 -174.63 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 115.21 -0.905 . . . . 74.450000000000003 110.11 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 pt -81.1 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 111.706 0.262 . . . . 53.420000000000002 111.706 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.85 -43.79 90.87 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 73.409999999999997 111.852 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.689 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -63.09 -20.26 62.45 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.53 0.519 . . . . 75.120000000000005 113.406 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -84.11 -43.76 14.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 116.65 0.225 . . . . 64.239999999999995 111.1 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.3 mt-10 -66.27 -37.47 85.54 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.304 0.378 . . . . 71.319999999999993 111.6 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.5 -25.44 28.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.872 -0.604 . . . . 73.219999999999999 111.765 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.17 -46.39 4.74 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.413 0.446 . . . . 71.540000000000006 113.871 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.33 -25.44 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.829 0.452 . . . . 73.299999999999997 111.728 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.74 -8.97 58.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.33 -0.85 . . . . 33.409999999999997 111.699 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -91.61 -7.8 49.08 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.811 -0.631 . . . . 54.100000000000001 111.189 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -110.0 156.6 20.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.321 -0.4 . . . . 71.25 111.066 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 22.1 p -111.06 167.19 10.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.816 -0.629 . . . . 51.25 110.529 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.641 ' HA ' HD12 ' A' ' 103' ' ' LEU . 66.8 t -56.05 123.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.035 0.534 . . . . 53.100000000000001 111.261 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.05 4.32 72.02 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.532 -0.758 . . . . 71.340000000000003 113.244 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -95.54 141.42 29.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.909 0.385 . . . . 75.439999999999998 111.296 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HD3' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -119.48 109.07 15.31 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.138 -0.937 . . . . 73.140000000000001 109.399 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.58 156.97 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.959 -0.564 . . . . 61.039999999999999 111.883 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.467 ' HG2' ' OD2' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--O 1.235 0.325 0 CA-C-N 116.026 -0.534 . . . . 72.400000000000006 110.317 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.806 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.91 124.82 52.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.272 -0.422 . . . . 74.519999999999996 111.231 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m -93.6 112.84 24.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.325 -0.852 . . . . 53.119999999999997 109.417 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.689 HD12 ' HA3' ' A' ' 58' ' ' GLY . 12.7 mm -104.29 142.18 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.864 -0.607 . . . . 75.109999999999999 110.557 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.7 161.83 21.81 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.774 -1.103 . . . . 74.230000000000004 110.772 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.61 -14.5 40.24 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.699 2.266 . . . . 62.43 113.303 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.59 -28.07 23.51 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.347 0.404 . . . . 74.510000000000005 110.846 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -99.89 -19.7 16.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.641 -0.708 . . . . 73.030000000000001 111.543 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.48 -62.93 1.45 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.794 0.664 . . . . 54.109999999999999 112.794 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -134.5 -50.84 0.8 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 111.589 0.218 . . . . 74.540000000000006 111.589 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.82 -142.8 10.23 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.181 -0.463 . . . . 71.340000000000003 112.013 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.98 -10.81 29.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 111.59 0.218 . . . . 51.549999999999997 111.59 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -99.53 -60.38 1.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.231 -0.44 . . . . 63.549999999999997 110.373 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.55 -165.96 53.26 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.337 0.398 . . . . 73.040000000000006 113.255 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.48 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -97.5 125.72 44.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.853 -0.425 . . . . 71.030000000000001 109.853 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.16 123.95 10.45 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.29 1.993 . . . . 52.530000000000001 113.617 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.76 -45.42 1.31 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.601 -0.727 . . . . 63.229999999999997 113.466 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -99.75 -52.25 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.625 0.212 . . . . 73.329999999999998 111.516 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.48 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.1 mm -109.98 98.69 35.62 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 123.22 0.325 . . . . 74.319999999999993 111.037 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.42 165.78 31.39 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.469 2.113 . . . . 65.319999999999993 112.711 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.65 141.96 28.44 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.483 2.122 . . . . 73.209999999999994 113.17 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 56.8 46.44 19.89 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.639 0.775 . . . . 70.340000000000003 111.628 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.88 134.06 51.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.64 -0.709 . . . . 71.420000000000002 111.836 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -84.31 140.8 31.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.702 -1.135 . . . . 74.25 110.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.464 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.5 mt -118.62 154.22 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.66 -0.7 . . . . 71.519999999999996 111.042 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.6 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.901 -0.591 . . . . 72.319999999999993 109.652 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.0 m-85 -133.14 132.36 41.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.135 -0.484 . . . . 71.299999999999997 110.77 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 t70 -115.98 104.19 11.35 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.075 -0.512 . . . . 62.020000000000003 110.161 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.806 HG22 HD11 ' A' ' 74' ' ' LEU . 28.2 m -105.9 153.63 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.034 -0.53 . . . . 60.420000000000002 111.143 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.15 126.1 34.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.486 -0.779 . . . . 72.230000000000004 110.397 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.643 ' HA ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -73.15 101.84 3.43 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.718 -0.674 . . . . 64.0 110.465 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.8 mt -89.53 -58.33 2.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.35 -0.386 . . . . 73.510000000000005 111.567 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 122.73 0.412 . . . . 74.319999999999993 110.986 179.891 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 HE22 ' A' ' 20' ' ' GLN . 12.7 mt -118.51 143.18 46.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.345 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.465 0.301 0 O-C-N 123.421 0.45 . . . . 65.530000000000001 110.822 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 CA-C-O 119.374 -0.681 . . . . 43.119999999999997 112.661 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 135.49 18.32 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.051 2.501 . . . . 72.120000000000005 112.799 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.8 t 61.74 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.947 0.899 . . . . 74.209999999999994 111.966 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 64.9 mtt -132.1 144.2 50.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.791 -0.641 . . . . 73.209999999999994 110.905 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -121.04 27.96 6.25 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.627 0.579 . . . . 60.009999999999998 112.98 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 75' ' ' THR . 12.6 p -138.21 119.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.697 0.284 . . . . 71.540000000000006 110.553 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.64 119.82 35.61 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.81 -0.632 . . . . 73.140000000000001 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 16.6 t -108.03 126.66 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.006 -0.543 . . . . 62.43 110.076 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -115.6 123.65 48.96 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.649 -0.705 . . . . 74.439999999999998 110.227 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 m -78.0 125.85 29.96 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.166 -0.47 . . . . 74.150000000000006 110.947 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.26 -40.69 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.047 -0.979 . . . . 72.430000000000007 110.253 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t -130.56 118.98 18.14 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.568 0.543 . . . . 74.319999999999993 110.35 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 129.6 16.1 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.571 2.181 . . . . 61.420000000000002 113.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.47 -120.92 4.33 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.658 -0.701 . . . . 44.329999999999998 112.099 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.84 -46.19 12.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.639 0.219 . . . . 61.450000000000003 110.947 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.24 -1.35 88.66 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.07 -0.514 . . . . 63.509999999999998 113.695 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -136.58 1.06 2.55 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.409 0.283 . . . . 75.239999999999995 111.721 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.99 92.25 3.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.06 0.457 . . . . 71.400000000000006 110.345 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -103.34 149.57 37.12 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.601 -0.727 . . . . 72.109999999999999 111.013 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.49 124.08 11.98 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.502 2.135 . . . . 64.230000000000004 112.74 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 115.391 -0.822 . . . . 72.299999999999997 111.45 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -77.26 125.79 29.89 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.645 -0.707 . . . . 75.420000000000002 111.16 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.81 -26.75 9.19 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.609 -0.723 . . . . 64.120000000000005 112.956 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.432 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -99.48 160.12 14.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.46 0.304 . . . . 72.140000000000001 110.715 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -83.62 145.23 28.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.14 -0.482 . . . . 73.129999999999995 111.366 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 39.9 t -119.87 116.94 26.85 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.615 -0.72 . . . . 70.120000000000005 110.597 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -91.7 110.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.398 -0.819 . . . . 63.039999999999999 109.588 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 103' ' ' LEU . 28.4 m -147.39 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.064 -0.516 . . . . 42.420000000000002 111.487 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 11.9 m-70 -102.37 125.34 49.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.365 -0.834 . . . . 75.310000000000002 109.031 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.3 p90 -116.23 167.04 11.36 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.944 0.72 . . . . 74.340000000000003 112.944 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.7 m -148.79 112.46 5.07 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 114.81 -1.086 . . . . 54.439999999999998 109.464 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -96.67 119.79 6.45 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 116.025 -0.534 . . . . 74.5 112.757 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.0 mtm -129.59 131.49 46.53 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.912 0.485 . . . . 72.230000000000004 111.129 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.23 170.41 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 42.340000000000003 111.963 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.32 -25.95 50.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.008 0.523 . . . . 72.0 112.076 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.35 -17.39 28.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.777 -0.647 . . . . 53.299999999999997 111.726 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.14 13.77 22.31 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 120.852 -0.689 . . . . 51.420000000000002 113.362 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.411 0 N-CA-C 109.745 -0.465 . . . . 63.25 109.745 179.569 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.449 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 112.92 0.711 . . . . 75.25 112.92 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 28.1 p90 -133.34 -14.38 2.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.186 -1.37 . . . . 74.109999999999999 111.345 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -161.55 111.63 1.63 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.047 0.451 . . . . 71.540000000000006 111.987 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 4.0 p -116.98 119.26 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.377 -0.829 . . . . 72.049999999999997 111.176 178.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.535 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 19.2 t -78.8 -35.37 44.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.154 -0.475 . . . . 71.120000000000005 112.185 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -23.13 44.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.082 0.771 . . . . 54.32 113.082 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.805 0.336 . . . . 64.340000000000003 111.124 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -92.7 -0.15 57.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.417 -0.81 . . . . 71.299999999999997 109.622 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 63.7 36.43 10.72 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.294 1.038 . . . . 72.439999999999998 111.696 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 112.156 0.428 . . . . 74.109999999999999 112.156 -179.51 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 157.97 47.36 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.924 2.416 . . . . 72.540000000000006 112.688 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -100.64 118.03 35.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.943 -0.571 . . . . 73.329999999999998 112.06 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.494 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.156 -0.929 . . . . 74.450000000000003 110.078 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.493 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 37.7 p90 -148.64 161.93 40.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.334 0.396 . . . . 73.329999999999998 111.406 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' HE2' ' A' ' 52' ' ' MLY . 29.6 ttm -106.77 130.64 54.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.136 -0.484 . . . . 71.140000000000001 110.159 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 60' ' ' GLU . 1.8 mm? -76.38 141.46 41.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.936 -0.575 . . . . 74.219999999999999 111.926 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.66 -9.43 55.76 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.492 -0.776 . . . . 71.310000000000002 113.536 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . 0.485 ' HE2' ' SD ' ' A' ' 49' ' ' MET . . . . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.388 0.275 . . . . 72.219999999999999 110.662 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 69.01 28.29 5.15 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.034 0.934 . . . . 64.219999999999999 112.296 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.4 -22.7 57.25 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.588 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.81 -175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.108 -0.951 . . . . 74.450000000000003 110.38 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 pt -80.42 158.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.915 0.339 . . . . 53.420000000000002 111.915 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -59.24 -43.91 92.37 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.006 -0.543 . . . . 73.409999999999997 111.819 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.69 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.62 -20.75 61.98 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.547 0.53 . . . . 75.120000000000005 113.442 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -84.15 -43.77 14.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 122.287 0.235 . . . . 64.239999999999995 111.306 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HA ' HD11 ' A' ' 50' ' ' LEU . 31.1 mt-10 -66.35 -37.37 85.17 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.345 0.403 . . . . 71.319999999999993 111.632 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -84.43 -25.99 28.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.976 -0.556 . . . . 73.219999999999999 111.743 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.7 -46.45 4.86 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.459 0.475 . . . . 71.540000000000006 113.94 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.3 p -63.59 -24.74 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.791 0.436 . . . . 73.299999999999997 111.769 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 -8.09 56.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.437 -0.801 . . . . 33.409999999999997 111.625 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.45 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.09 -10.83 37.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.799 -0.637 . . . . 54.100000000000001 111.306 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.453 ' CE ' HG23 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -106.85 156.24 18.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.315 -0.402 . . . . 71.25 111.034 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 24.0 p -110.88 166.87 10.68 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.801 -0.636 . . . . 51.25 110.556 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 103' ' ' LEU . 52.9 t -56.08 123.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.901 0.48 . . . . 53.100000000000001 111.323 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.12 4.98 70.98 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.47 -0.787 . . . . 71.340000000000003 113.232 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -96.37 141.57 29.53 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.909 0.385 . . . . 75.439999999999998 111.249 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.4 108.85 15.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.08 -0.964 . . . . 73.140000000000001 109.385 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -131.09 156.91 44.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.012 -0.54 . . . . 61.039999999999999 111.842 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.234 0.289 0 CA-C-N 116.026 -0.534 . . . . 72.400000000000006 110.286 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.801 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -109.89 127.06 54.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.109 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.3 m -94.62 113.82 25.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.391 -0.822 . . . . 53.119999999999997 109.598 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.9 mm -106.4 143.36 17.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.856 -0.611 . . . . 75.109999999999999 110.398 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.06 162.13 20.68 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 114.893 -1.049 . . . . 74.230000000000004 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 -17.03 48.62 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.725 2.283 . . . . 62.43 113.254 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -25.7 25.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.27 -0.423 . . . . 74.510000000000005 111.3 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.89 -18.76 15.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.076 -0.511 . . . . 73.030000000000001 111.391 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.67 -62.0 1.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.626 0.602 . . . . 54.109999999999999 112.626 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -134.94 -51.99 0.78 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.622 0.23 . . . . 74.540000000000006 111.622 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.51 -140.34 7.89 Favored Glycine 0 C--N 1.336 0.559 0 O-C-N 123.478 0.486 . . . . 71.340000000000003 112.089 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.55 -11.06 25.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.58 0.215 . . . . 51.549999999999997 111.58 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.2 m -100.06 -60.36 1.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.353 0.408 . . . . 63.549999999999997 110.511 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.75 54.2 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.322 0.389 . . . . 73.040000000000006 113.166 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.457 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.8 t60 -98.42 124.39 46.91 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.902 -0.407 . . . . 71.030000000000001 109.902 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.57 123.85 10.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.235 1.957 . . . . 52.530000000000001 113.627 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.81 -47.95 1.0 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.579 -0.737 . . . . 63.229999999999997 113.408 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.42 -51.98 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.584 0.192 . . . . 73.329999999999998 111.507 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 18.5 mm -109.71 97.87 30.43 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 123.209 0.318 . . . . 74.319999999999993 111.056 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.59 165.6 32.01 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.413 2.075 . . . . 65.319999999999993 112.765 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 143.09 29.42 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.553 2.168 . . . . 73.209999999999994 113.183 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 56.63 43.76 25.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.614 0.765 . . . . 70.340000000000003 111.716 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.81 133.01 53.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.695 -0.684 . . . . 71.420000000000002 111.716 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 m -82.91 139.09 33.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.755 -1.111 . . . . 74.25 110.929 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.511 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mt -117.73 152.14 35.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.592 -0.731 . . . . 71.519999999999996 110.938 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.95 130.98 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.835 -0.62 . . . . 72.319999999999993 109.599 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.583 ' O ' HD12 ' A' ' 74' ' ' LEU . 89.2 m-85 -131.63 133.74 45.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.482 . . . . 71.299999999999997 110.75 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 8.4 t70 -116.15 104.04 11.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.954 -0.566 . . . . 62.020000000000003 110.117 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.801 HG22 HD11 ' A' ' 74' ' ' LEU . 26.4 m -105.96 153.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.964 -0.562 . . . . 60.420000000000002 110.952 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.33 125.74 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 72.230000000000004 110.321 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -73.02 101.96 3.38 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.808 -0.633 . . . . 64.0 110.408 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mt -89.67 -58.53 2.49 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.098 -0.501 . . . . 73.510000000000005 111.419 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 122.803 0.441 . . . . 74.319999999999993 110.703 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.432 HD22 HE22 ' A' ' 20' ' ' GLN . 12.4 mt -124.4 144.56 49.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.158 -0.474 . . . . 64.409999999999997 110.778 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.465 0.302 0 O-C-N 123.571 0.544 . . . . 65.530000000000001 110.765 179.936 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-O 119.275 -0.736 . . . . 43.119999999999997 112.527 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.64 157.64 40.02 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 123.063 2.508 . . . . 72.120000000000005 112.795 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.7 m -121.64 -42.69 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.928 -0.578 . . . . 74.209999999999994 111.299 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.2 mtt -116.34 141.36 48.26 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.357 0.41 . . . . 73.209999999999994 110.872 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -107.31 36.21 4.53 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.885 -0.598 . . . . 60.009999999999998 112.807 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 75' ' ' THR . 13.1 p -136.22 120.64 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.711 0.291 . . . . 71.540000000000006 110.584 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.21 120.05 35.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.783 -0.644 . . . . 73.140000000000001 110.665 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' MLY . 16.6 t -108.54 126.71 65.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.036 -0.529 . . . . 62.43 110.077 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.08 123.73 48.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.635 -0.711 . . . . 74.439999999999998 110.159 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.1 m -77.93 126.03 30.23 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 110.967 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -108.57 -40.61 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.103 -0.953 . . . . 72.430000000000007 110.296 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 t -130.77 118.92 17.92 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 116.014 -0.539 . . . . 74.319999999999993 110.4 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.37 129.77 16.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.592 2.194 . . . . 61.420000000000002 113.404 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.51 -121.07 4.36 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.688 -0.687 . . . . 44.329999999999998 112.118 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -83.77 -46.09 12.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.633 0.216 . . . . 61.450000000000003 110.963 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' H ' ' CB ' ' A' ' 67' ' ' SER . . . 85.31 -1.59 88.48 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.028 -0.533 . . . . 63.509999999999998 113.689 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -136.03 0.51 2.63 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.281 . . . . 75.239999999999995 111.76 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -121.44 92.36 3.73 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.075 0.464 . . . . 71.400000000000006 110.301 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -103.19 149.62 37.1 Favored Pre-proline 0 C--O 1.235 0.302 0 CA-C-N 115.591 -0.731 . . . . 72.109999999999999 110.961 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -65.92 122.51 10.11 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.47 2.114 . . . . 64.230000000000004 112.698 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 115.433 -0.803 . . . . 72.299999999999997 111.554 -179.228 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HE ' ' HA3' ' A' ' 51' ' ' GLY . 51.7 ttt180 -77.49 123.83 27.09 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.593 -0.73 . . . . 75.420000000000002 111.183 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.21 -28.66 7.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.732 -0.667 . . . . 64.120000000000005 113.282 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.493 HE22 HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -99.4 160.29 14.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.626 0.213 . . . . 72.140000000000001 111.017 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -81.75 145.28 30.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.087 -0.506 . . . . 73.129999999999995 111.525 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' MLY . 38.6 t -120.0 117.07 27.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.565 -0.743 . . . . 70.120000000000005 110.599 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.7 111.05 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.405 -0.816 . . . . 63.039999999999999 109.685 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 103' ' ' LEU . 26.7 m -147.5 151.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.073 -0.512 . . . . 42.420000000000002 111.482 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.496 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 12.9 m-70 -101.69 125.38 48.34 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.308 -0.86 . . . . 75.310000000000002 108.98 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' HB3' HG12 ' A' ' 101' ' ' VAL . 41.9 p90 -115.85 166.87 11.48 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.877 0.695 . . . . 74.340000000000003 112.877 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 2.5 m -148.84 113.27 5.29 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.85 -1.068 . . . . 54.439999999999998 109.482 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 35' ' ' MLY . . . -97.59 119.79 6.53 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.109 -0.567 . . . . 74.5 112.957 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.8 mtm -128.35 131.4 48.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.977 0.511 . . . . 72.230000000000004 111.018 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.724 HD12 ' HG3' ' A' ' 34' ' ' MLY . 12.0 mt -58.5 171.4 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.726 -0.67 . . . . 42.340000000000003 112.166 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -57.53 -25.05 59.31 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 123.067 0.547 . . . . 72.0 111.769 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -88.29 -17.8 29.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.751 -0.659 . . . . 53.299999999999997 111.275 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.06 25.39 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.616 -0.802 . . . . 51.420000000000002 113.694 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MLY . . . . . 0.724 ' HG3' HD12 ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.777 -0.823 . . . . 63.25 108.777 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MLY . . . . . 0.462 ' HD2' ' HB3' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 113.487 0.921 . . . . 75.25 113.487 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' A' ' 97' ' ' LEU . 34.9 p90 -132.53 -15.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.02 -1.446 . . . . 74.109999999999999 111.18 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.451 ' OD2' ' HD1' ' A' ' 36' ' ' PHE . 3.0 m-20 -160.98 113.42 1.92 Allowed 'General case' 0 C--N 1.357 0.913 0 CA-C-O 120.984 0.421 . . . . 71.540000000000006 111.859 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 35' ' ' MLY . 5.2 p -118.12 119.29 34.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.41 -0.814 . . . . 72.049999999999997 111.164 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.542 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 20.1 t -78.87 -36.87 41.57 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.055 -0.521 . . . . 71.120000000000005 112.252 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -23.13 48.92 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.176 0.806 . . . . 54.32 113.176 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -23.72 67.45 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.795 0.331 . . . . 64.340000000000003 111.206 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -94.12 2.2 56.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.466 -0.788 . . . . 71.299999999999997 109.758 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.3 m120 63.75 33.35 12.96 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.297 1.039 . . . . 72.439999999999998 111.839 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.404 0 N-CA-C 112.979 0.733 . . . . 74.109999999999999 112.979 -179.126 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 157.82 41.05 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 123.08 2.52 . . . . 72.540000000000006 112.647 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.46 117.83 35.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.885 -0.598 . . . . 73.329999999999998 112.087 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MLY . . . . . 0.497 ' HA ' ' O ' ' A' ' 22' ' ' CYS . . . . . . . . 0 N--CA 1.465 0.314 0 CA-C-N 115.052 -0.976 . . . . 74.450000000000003 109.884 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' HZ ' HG11 ' A' ' 63' ' ' VAL . 40.3 p90 -149.19 160.11 43.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.299 0.375 . . . . 73.329999999999998 111.499 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 mtm -104.28 132.18 50.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.103 -0.499 . . . . 71.140000000000001 110.637 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.46 139.81 39.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.916 -0.583 . . . . 74.219999999999999 111.632 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' HA3' ' HE ' ' A' ' 18' ' ' ARG . . . 82.07 -10.44 53.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.468 -0.787 . . . . 71.310000000000002 113.383 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 C-N-CA 122.537 0.335 . . . . 72.219999999999999 110.682 179.195 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 69.79 26.79 4.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.09 0.956 . . . . 64.219999999999999 112.263 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -21.7 59.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.089 -0.505 . . . . 75.25 110.779 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.67 -175.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.22 -0.9 . . . . 74.450000000000003 110.525 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.6 pt -81.48 158.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 111.883 0.327 . . . . 53.420000000000002 111.883 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -59.33 -44.09 92.64 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.986 -0.552 . . . . 73.409999999999997 111.891 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.681 ' HA3' HD12 ' A' ' 76' ' ' ILE . . . -62.6 -20.61 61.77 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 116.085 -0.507 . . . . 75.120000000000005 113.486 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -84.16 -43.77 14.64 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 122.242 0.217 . . . . 64.239999999999995 111.261 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.09 -37.52 85.97 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.359 0.412 . . . . 71.319999999999993 111.572 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.38 -25.94 28.74 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.924 -0.58 . . . . 73.219999999999999 111.794 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' ' NE2' ' A' ' 65' ' ' GLN . . . -87.92 -46.28 4.85 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.461 0.476 . . . . 71.540000000000006 113.89 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG11 ' HZ ' ' A' ' 48' ' ' PHE . 2.2 p -63.85 -24.8 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.824 0.45 . . . . 73.299999999999997 111.686 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.94 -8.07 56.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.419 -0.809 . . . . 33.409999999999997 111.601 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.46 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 54.2 mt-30 -92.18 -10.3 39.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.83 -0.623 . . . . 54.100000000000001 111.211 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.79 156.58 18.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.351 -0.386 . . . . 71.25 111.118 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.408 ' CB ' ' H ' ' A' ' 12' ' ' GLY . 21.2 p -111.38 166.7 10.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.812 -0.631 . . . . 51.25 110.538 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 103' ' ' LEU . 53.9 t -55.85 123.12 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.898 0.479 . . . . 53.100000000000001 111.348 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 103' ' ' LEU . . . 90.72 4.42 69.95 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.498 -0.774 . . . . 71.340000000000003 113.207 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -95.77 142.1 28.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.861 0.362 . . . . 75.439999999999998 111.347 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.01 108.84 14.79 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.135 -0.939 . . . . 73.140000000000001 109.35 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.447 ' HB3' ' SD ' ' A' ' 66' ' ' MET . . . -130.94 156.81 44.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.049 -0.523 . . . . 61.039999999999999 111.894 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 4' ' ' VAL . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-N 116.06 -0.518 . . . . 72.400000000000006 110.384 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD11 HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.31 127.45 55.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.284 -0.416 . . . . 74.519999999999996 111.144 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.2 m -94.9 114.09 25.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.455 -0.793 . . . . 53.119999999999997 109.593 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.681 HD12 ' HA3' ' A' ' 58' ' ' GLY . 10.6 mm -106.71 142.16 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.897 -0.592 . . . . 75.109999999999999 110.528 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.33 162.2 20.47 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 114.904 -1.044 . . . . 74.230000000000004 110.776 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 -17.26 50.66 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.702 2.268 . . . . 62.43 113.243 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 -25.74 26.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 111.327 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.99 -18.98 15.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.085 -0.507 . . . . 73.030000000000001 111.462 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.52 -62.8 1.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.73 0.641 . . . . 54.109999999999999 112.73 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -133.4 -52.08 0.88 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.611 0.226 . . . . 74.540000000000006 111.611 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 150.42 -139.77 7.52 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.496 0.497 . . . . 71.340000000000003 112.049 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 -10.51 25.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 111.568 0.21 . . . . 51.549999999999997 111.568 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 m -100.61 -60.37 1.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.28 -0.418 . . . . 63.549999999999997 110.515 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.81 53.62 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.295 0.372 . . . . 73.040000000000006 113.207 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.444 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 3.6 t60 -96.52 123.74 53.27 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.933 -0.395 . . . . 71.030000000000001 109.933 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.07 124.72 11.66 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.212 1.941 . . . . 52.530000000000001 113.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.76 -47.47 1.04 Allowed Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.605 -0.725 . . . . 63.229999999999997 113.348 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -101.01 -50.84 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 111.67 0.248 . . . . 73.329999999999998 111.67 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 17.7 mm -111.46 98.68 41.35 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 123.177 0.298 . . . . 74.319999999999993 111.244 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.12 165.71 31.8 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.493 2.129 . . . . 65.319999999999993 112.733 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.34 143.44 28.02 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.552 2.168 . . . . 73.209999999999994 113.22 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.76 43.2 25.57 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.609 0.764 . . . . 70.340000000000003 111.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.05 133.58 53.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.707 -0.679 . . . . 71.420000000000002 111.747 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 m -83.46 139.98 32.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.76 -1.109 . . . . 74.25 110.89 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mt -119.3 151.79 37.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.568 -0.742 . . . . 71.519999999999996 110.897 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.75 131.46 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.889 -0.596 . . . . 72.319999999999993 109.453 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' O ' HD12 ' A' ' 74' ' ' LEU . 88.8 m-85 -131.92 133.55 44.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.165 -0.47 . . . . 71.299999999999997 110.886 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD1' ' HG2' ' A' ' 73' ' ' MLY . 8.3 t70 -115.95 102.86 10.04 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.906 -0.588 . . . . 62.020000000000003 110.0 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.814 HG22 HD11 ' A' ' 74' ' ' LEU . 26.1 m -104.81 153.34 6.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 116.012 -0.54 . . . . 60.420000000000002 111.084 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.37 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.508 -0.769 . . . . 72.230000000000004 110.356 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -72.97 102.35 3.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.61 . . . . 64.0 110.455 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.41 -58.76 2.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.137 -0.483 . . . . 73.510000000000005 111.306 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 122.824 0.45 . . . . 74.319999999999993 110.709 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.493 HD22 HE22 ' A' ' 20' ' ' GLN . 10.7 mt -126.17 144.76 50.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.132 -0.486 . . . . 64.409999999999997 110.686 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.465 0.281 0 CA-C-N 116.056 -0.52 . . . . 65.530000000000001 110.772 -179.984 . . . . . . . . 0 0 . 1 stop_ save_